dataset_id	Total_reads	Mapped	MND	MEND	seq_length	disease	age_at_dx	pedaya	gender	race	ethnicity	cohort_code	cohort_name	doi_link	source_repository	repository_cohort_accession	repository_dataset_accession	genes_expressed_above_0	genes_expressed_above_1	genes_expressed_above_2	genes_expressed_above_3	genes_expressed_above_4	genes_expressed_above_5
TARGET-10-DCC001-03A-01R	108969629	95350003	82680982	39305215.8	75	acute lymphoblastic leukemia	NA	NA	NA	NA	NA	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-DCC001-03A-01R	29025	17140	14533	13092	12084	11302
TARGET-10-DCC002-09A-01R	35070742	27893862	23895040	15181142.375	100	acute lymphoblastic leukemia	NA	NA	NA	NA	NA	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-DCC002-09A-01R	25512	16774	14553	13268	12330	11627
TARGET-10-PAKHZT-03A-01R	55632774	47621057	40017860	18450874.13	50	acute lymphoblastic leukemia	13.91	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PAKHZT-03A-01R	24598	15147	12826	11537	10579	9863
TARGET-10-PAKKCA-03A-01R	69083700	65377325	61626778.5	21430926.045	75	acute lymphoblastic leukemia	11.64	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PAKKCA-03A-01R	27217	17893	15447	13948	12846	11952
TARGET-10-PAKKXB-03A-01R	90877937	76138103	66741172.5	23623496.26	75	acute lymphoblastic leukemia	14.54	Yes, age < 30 years	female	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PAKKXB-03A-01R	25650	15161	12839	11436	10382	9513
TARGET-10-PAKSWW-04A-01R	226488834	206841836	23295541.5	16024637.01	75	acute lymphoblastic leukemia	15.1	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PAKSWW-04A-01R	24027	11772	9380	8052	7058	6360
TARGET-10-PAKTAL-03A-01R	50648562	44553750	38495865	17194928.38	50	acute lymphoblastic leukemia	12.24	Yes, age < 30 years	female	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PAKTAL-03A-01R	24744	14531	12229	10839	9844	9099
TARGET-10-PAKVKK-03A-01R	51874221	47029254	39341837	22800636.92	50	acute lymphoblastic leukemia	14.37	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PAKVKK-03A-01R	24772	14070	11981	10649	9756	9033
TARGET-10-PAKYEP-03A-01R	84653984	64927638	60058417	21996974.73	75	acute lymphoblastic leukemia	2.7	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PAKYEP-03A-01R	28611	18230	15605	14032	12890	11999
TARGET-10-PALETF-03A-01R	76682586	67103377	61511807.5	18430483.65	75	acute lymphoblastic leukemia	7.63	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PALETF-03A-01R	24323	16665	14402	13079	12087	11314
TARGET-10-PALIBN-09A-01R	53006499	47818381	41660540	12212169.8	75	acute lymphoblastic leukemia	14.3	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PALIBN-09A-01R	26480	18612	15944	14318	13108	12162
TARGET-10-PALJDL-09A-01R	53143252	48938785	43416902	14472768.75	75	acute lymphoblastic leukemia	3.2	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PALJDL-09A-01R	24567	15800	13328	11820	10744	9847
TARGET-10-PAMDRM-09A-01R	68544138	61642645	53550279.5	17615748.45	75	acute lymphoblastic leukemia	7.87	Yes, age < 30 years	male	Asian	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PAMDRM-09A-01R	24790	15286	12916	11545	10465	9644
TARGET-10-PANATY-09B-01R	110342643	106127878	92309731	25410388.32	75	acute lymphoblastic leukemia	4.22	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PANATY-09B-01R	29551	17972	15110	13458	12173	11221
TARGET-10-PANDBX-09B-01R	106443448	99667866	91350979	25876915.665	75	acute lymphoblastic leukemia	3.83	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PANDBX-09B-01R	28747	17747	15220	13662	12568	11698
TARGET-10-PANEHF-09A-01R	79838052	77284231	64553346	38829631.26	101	acute lymphoblastic leukemia	15.65	Yes, age < 30 years	male	Asian	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PANEHF-09A-01R	26282	14677	12608	11340	10527	9863
TARGET-10-PANKAK-04A-02R	264511128	246442466	72722979.5	42562987.28	75	acute lymphoblastic leukemia	6.41	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PANKAK-04A-02R	30778	14928	12612	11205	10279	9621
TARGET-10-PANLGK-03B-01R	92149230	87014219	79054145	23018761.08	75	acute lymphoblastic leukemia	1	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PANLGK-03B-01R	30577	19337	16239	14481	13162	12112
TARGET-10-PANNGL-09A-01R	46009620	44676643	37654694	24643441.55	101	acute lymphoblastic leukemia	12.85	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PANNGL-09A-01R	25852	14481	12331	11089	10180	9468
TARGET-10-PANSBK-03B-01R	111433671	104396579	94385225.5	30164629.26	75	acute lymphoblastic leukemia	5.16	Yes, age < 30 years	female	NA	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PANSBK-03B-01R	28615	16843	14301	12765	11655	10800
TARGET-10-PANSFD-09A-01R	42694010	41568684	35737753.5	23499808.05	101	acute lymphoblastic leukemia	5.44	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PANSFD-09A-01R	26088	15722	13542	12313	11348	10605
TARGET-10-PANTTZ-09B-01R	98935010	94937592	84477422.5	23501052.105	75	acute lymphoblastic leukemia	2.6	Yes, age < 30 years	female	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PANTTZ-09B-01R	28712	17764	15130	13545	12399	11458
TARGET-10-PANUUF-09A-02R	225054674	204450454	61718775	30675055.05	75	acute lymphoblastic leukemia	11.03	Yes, age < 30 years	female	Black/African American	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PANUUF-09A-02R	37700	14342	11571	10065	9059	8304
TARGET-10-PANWEZ-09B-01R	114603832	107535305	99793319	28369802.54	75	acute lymphoblastic leukemia	14.34	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PANWEZ-09B-01R	30816	18046	15170	13395	12142	11186
TARGET-10-PANXDB-03A-01R	191496452	171359806	69259089	19462254.91	75	acute lymphoblastic leukemia	7.98	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PANXDB-03A-01R	40017	20604	15205	12819	11353	10279
TARGET-10-PAPAXK-09B-01R	119369383	113218252	101146197.5	36376406.7	75	acute lymphoblastic leukemia	9.56	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PAPAXK-09B-01R	30875	18536	15785	14197	13016	12105
TARGET-10-PAPCUR-09A-01R	210825420	194045490	15568400.5	13235774.98	75	acute lymphoblastic leukemia	3.01	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PAPCUR-09A-01R	23041	12107	10026	8675	7595	6725
TARGET-10-PAPEWB-09A-01R	185734114	174465488	51846912.5	36092951.28	75	acute lymphoblastic leukemia	7.13	Yes, age < 30 years	female	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PAPEWB-09A-01R	26279	13942	11879	10675	9851	9126
TARGET-10-PAPHPX-03B-01R	108322757	102967826	93811762.5	28335272.55	75	acute lymphoblastic leukemia	5.17	Yes, age < 30 years	female	White	NA	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PAPHPX-03B-01R	30098	18540	15700	14015	12788	11855
TARGET-10-PAPHYN-09B-01R	108967982	104669719	95478264	25646646.51	75	acute lymphoblastic leukemia	5.69	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PAPHYN-09B-01R	30869	19643	16728	14893	13544	12508
TARGET-10-PAPIYG-03B-01R	108707374	102224671	92689178	29851981.06	75	acute lymphoblastic leukemia	4.49	Yes, age < 30 years	female	NA	NA	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PAPIYG-03B-01R	29357	17494	14931	13401	12320	11442
TARGET-10-PAPJXI-04A-01R	233687146	219137298	81989935.5	47421282.48	75	acute lymphoblastic leukemia	8.9	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PAPJXI-04A-01R	29215	16593	14045	12731	11801	11111
TARGET-10-PAPKNJ-09B-01R	131815740	124556483	113053799	32757552.75	75	acute lymphoblastic leukemia	4.32	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PAPKNJ-09B-01R	29665	18664	16169	14668	13569	12669
TARGET-10-PAPRMM-09B-01R	121139635	113539771	102796738	29213760.86	75	acute lymphoblastic leukemia	3.76	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PAPRMM-09B-01R	30221	18761	15926	14316	13104	12142
TARGET-10-PAPTAT-09B-01R	101968856	98114486	88893123	30955724.38	75	acute lymphoblastic leukemia	2.54	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PAPTAT-09B-01R	29300	17893	15243	13760	12607	11717
TARGET-10-PARAPE-09B-01R	105236198	100991733	90951730.5	25133000.9	75	acute lymphoblastic leukemia	3.22	Yes, age < 30 years	female	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARAPE-09B-01R	29112	17028	14312	12753	11594	10620
TARGET-10-PARAYM-09A-01R	52808127	50929127	46112110.5	14362022.22	101	acute lymphoblastic leukemia	15.25	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARAYM-09A-01R	29864	14717	11910	10263	8960	8002
TARGET-10-PARBGL-09B-01R	109239933	105262477	97064010.5	30050928.645	75	acute lymphoblastic leukemia	3.25	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARBGL-09B-01R	31223	20066	17042	15244	13985	12944
TARGET-10-PARCVM-03A-01R	54680537	51218360	45229391	16503307.2	101	acute lymphoblastic leukemia	3.99	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARCVM-03A-01R	28361	13980	11484	9974	8885	7995
TARGET-10-PARDWN-09B-01R	102857801	99232561	89539473.5	28075982.04	75	acute lymphoblastic leukemia	1.97	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARDWN-09B-01R	29139	17601	14863	13306	12070	11151
TARGET-10-PAREGZ-09A-01R	59764604	55216972	42418915.5	21565958.6	101	acute lymphoblastic leukemia	8.56	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PAREGZ-09A-01R	27245	11273	8779	7105	5969	5088
TARGET-10-PARFDL-09A-01R	51983451	48078334	41326170	13979235.6	101	acute lymphoblastic leukemia	20.51	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARFDL-09A-01R	27187	12848	10193	8591	7415	6493
TARGET-10-PARFIH-09A-01R	54002975	51108510	42270317.5	22287945.12	101	acute lymphoblastic leukemia	5.27	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARFIH-09A-01R	27696	13099	10883	9593	8638	7811
TARGET-10-PARFPJ-09A-01R	57735432	53122988	45439396	13967690.555	101	acute lymphoblastic leukemia	3.69	Yes, age < 30 years	male	NA	NA	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARFPJ-09A-01R	28882	12634	9688	8006	6811	5908
TARGET-10-PARFWD-03B-01R	117269681	110217562	85223157	21512742.71	75	acute lymphoblastic leukemia	1.25	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARFWD-03B-01R	29411	17262	14534	12860	11587	10632
TARGET-10-PARFXJ-09A-01R	51794566	50107442	44427911	13443203.3	101	acute lymphoblastic leukemia	11.62	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARFXJ-09A-01R	28568	12144	9109	7362	6090	5159
TARGET-10-PARGFL-09A-01R	48694788	45137770	25927332	16350157.6	101	acute lymphoblastic leukemia	4.1	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARGFL-09A-01R	24903	9369	6992	5598	4628	3887
TARGET-10-PARHBI-09A-01R	56969612	54154221	47138336.5	15080429.455	101	acute lymphoblastic leukemia	7.89	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARHBI-09A-01R	26886	11857	9075	7450	6309	5363
TARGET-10-PARHBT-09A-01R	52497713	46770603	32361673	10562096.545	101	acute lymphoblastic leukemia	17.01	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARHBT-09A-01R	28008	9561	6834	5376	4478	3789
TARGET-10-PARHES-09A-01R	48509836	45018434	34052197.5	10237111.86	101	acute lymphoblastic leukemia	4.65	Yes, age < 30 years	male	Black/African American	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARHES-09A-01R	30264	10737	7421	5660	4554	3783
TARGET-10-PARIYD-09A-01R	54272808	50927793	39364890	17107437.705	101	acute lymphoblastic leukemia	8.97	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARIYD-09A-01R	27671	11571	8863	7194	6040	5187
TARGET-10-PARIZN-09A-01R	54129721	51082696	43784206	15814692.9	101	acute lymphoblastic leukemia	10.2	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARIZN-09A-01R	27504	11580	8923	7229	6102	5218
TARGET-10-PARJAY-09A-01R	54727449	51446003	42746517.5	15444512.1	101	acute lymphoblastic leukemia	15.47	Yes, age < 30 years	female	NA	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARJAY-09A-01R	29668	12193	9151	7437	6312	5419
TARGET-10-PARJLA-09B-01R	96743546	93444004	85713273.5	26996618.925	75	acute lymphoblastic leukemia	9.91	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARJLA-09B-01R	28533	17474	14899	13378	12252	11355
TARGET-10-PARJNX-09A-01R	55653508	52864361	46414889.5	15806197.68	101	acute lymphoblastic leukemia	3.1	Yes, age < 30 years	female	Black/African American	NA	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARJNX-09A-01R	28388	12317	9463	7800	6720	5894
TARGET-10-PARJPL-09A-01R	53507299	50360662	30097418	21119147.79	101	acute lymphoblastic leukemia	3.76	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARJPL-09A-01R	24495	9296	7048	5570	4618	3832
TARGET-10-PARJXW-09A-01R	48375222	45610969	33796518.5	16273959.31	101	acute lymphoblastic leukemia	14.82	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARJXW-09A-01R	28454	12003	9442	7725	6427	5467
TARGET-10-PARKLK-09A-01R	48536305	45930132	32721848	18046140.84	101	acute lymphoblastic leukemia	1.81	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARKLK-09A-01R	26941	10525	8410	6972	5949	5101
TARGET-10-PARLJA-09A-01R	48820024	46133739	38567041.5	14806723.52	101	acute lymphoblastic leukemia	8.63	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARLJA-09A-01R	28917	12203	9440	7718	6468	5485
TARGET-10-PARLST-09A-01R	53683145	50557809	43345578.5	13158109.055	101	acute lymphoblastic leukemia	9.44	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARLST-09A-01R	28818	12802	9549	7782	6516	5578
TARGET-10-PARMFF-09A-01R	58541063	55154651	44099717.5	17523009.75	101	acute lymphoblastic leukemia	8.32	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARMFF-09A-01R	29680	12533	9598	7864	6631	5708
TARGET-10-PARMIH-09A-01R	47650458	45583502	42356364.5	9144941.34	101	acute lymphoblastic leukemia	12.42	Yes, age < 30 years	male	NA	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARMIH-09A-01R	27690	14759	11630	9794	8411	7379
TARGET-10-PARMKK-09A-01R	42932507	40189938	24522281	14870575.77	101	acute lymphoblastic leukemia	3.35	Yes, age < 30 years	male	Black/African American	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARMKK-09A-01R	24900	8870	6407	4983	4124	3487
TARGET-10-PARMKM-03A-01R	38662006	36535088	19546875.5	11145960.44	101	acute lymphoblastic leukemia	1.59	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARMKM-03A-01R	24784	9460	6944	5370	4260	3527
TARGET-10-PARMMV-09A-01R	51965889	47421117	39364174.5	16982899.56	101	acute lymphoblastic leukemia	6.36	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARMMV-09A-01R	26792	10954	8315	6774	5675	4861
TARGET-10-PARMRF-09A-01R	48781694	44292663	14491557.5	7093502.31	101	acute lymphoblastic leukemia	5.98	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARMRF-09A-01R	24871	8454	5677	4292	3442	2856
TARGET-10-PARMUC-03A-01R	54113951	50530193	46660122.5	13196330.5	101	acute lymphoblastic leukemia	2.65	Yes, age < 30 years	male	NA	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARMUC-03A-01R	27741	17355	14485	12822	11614	10767
TARGET-10-PARMWH-09A-01R	61231780	58166206	36007399	25544806.17	101	acute lymphoblastic leukemia	20.57	Yes, age < 30 years	female	NA	NA	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARMWH-09A-01R	26142	10222	7969	6462	5316	4509
TARGET-10-PARNBN-09A-01R	57396468	51890526	32318992.5	15212393.265	101	acute lymphoblastic leukemia	10.06	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARNBN-09A-01R	28784	9808	7106	5714	4712	4021
TARGET-10-PARNEH-09A-01R	54147368	51641379	42773716	14389889.85	101	acute lymphoblastic leukemia	4.01	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARNEH-09A-01R	28451	11236	8091	6259	5047	4212
TARGET-10-PARNJB-09A-01R	45209564	43833753	27797610	17435280.375	101	acute lymphoblastic leukemia	22.54	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARNJB-09A-01R	25565	9060	6550	5074	4014	3303
TARGET-10-PARNMV-09A-01R	54045574	51081573	39141678.5	17849370.225	101	acute lymphoblastic leukemia	9.53	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARNMV-09A-01R	28453	11741	9205	7549	6284	5305
TARGET-10-PARNSP-09A-01R	52135203	49568018	37697688	24473095.785	101	acute lymphoblastic leukemia	6.04	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARNSP-09A-01R	25924	11281	9349	8053	7038	6219
TARGET-10-PARNXJ-09A-01R	52840217	49044566	38188432	18703719.46	101	acute lymphoblastic leukemia	4.82	Yes, age < 30 years	male	NA	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARNXJ-09A-01R	28534	13027	10641	9151	8030	7090
TARGET-10-PARPET-09A-01R	55389188	50931261	39623099	19369790.225	101	acute lymphoblastic leukemia	4.96	Yes, age < 30 years	female	Black/African American	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARPET-09A-01R	27128	12164	9865	8466	7374	6468
TARGET-10-PARPHB-09A-01R	49003619	46726497	31799957.5	16593091.4	101	acute lymphoblastic leukemia	1.1	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARPHB-09A-01R	27039	10195	7627	6053	4973	4207
TARGET-10-PARPUL-09A-01R	47643763	45573533	34834977.5	17798401.32	101	acute lymphoblastic leukemia	2.25	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARPUL-09A-01R	28505	12501	10072	8496	7346	6389
TARGET-10-PARPYJ-09A-01R	48788989	45700380	33014885	18654334.66	101	acute lymphoblastic leukemia	7.44	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARPYJ-09A-01R	27364	10935	8489	6870	5623	4693
TARGET-10-PARRKK-09A-01R	47646529	45819879	32332733.5	10919939.4	101	acute lymphoblastic leukemia	8.88	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARRKK-09A-01R	27826	11705	8766	7055	5855	4947
TARGET-10-PARSET-09A-01R	58603474	56641851	37828456	24615844.8	101	acute lymphoblastic leukemia	10.91	Yes, age < 30 years	male	Black/African American	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARSET-09A-01R	25499	9989	7834	6337	5294	4480
TARGET-10-PARSJG-09A-01R	50692138	45056384	39839770.5	12853860.565	101	acute lymphoblastic leukemia	11.97	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARSJG-09A-01R	29865	14320	11129	9228	7866	6837
TARGET-10-PARSLL-09B-01R	100850447	96726306	87992394.5	25808116.125	75	acute lymphoblastic leukemia	4.52	Yes, age < 30 years	female	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARSLL-09B-01R	31118	19851	16803	15024	13725	12764
TARGET-10-PARSNX-09A-01R	60693658	58578892	35788145	22498872.66	101	acute lymphoblastic leukemia	13.46	Yes, age < 30 years	male	Black/African American	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARSNX-09A-01R	27449	9525	6903	5160	4064	3303
TARGET-10-PARTBP-09A-01R	53418477	50749637	44103983	15786195.3	101	acute lymphoblastic leukemia	5.63	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARTBP-09A-01R	27249	12343	9623	7938	6745	5841
TARGET-10-PARTLY-09A-01R	52787649	49056858	42554451	17633976.36	101	acute lymphoblastic leukemia	12.3	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARTLY-09A-01R	30224	14116	11343	9764	8643	7737
TARGET-10-PARTPW-09A-01R	59143200	57055006	37111829	19984799.52	101	acute lymphoblastic leukemia	15.01	Yes, age < 30 years	male	Asian	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARTPW-09A-01R	26182	9397	6918	5355	4338	3601
TARGET-10-PARUAT-09B-01R	103835038	99785023	90039689	23234671.37	75	acute lymphoblastic leukemia	2.5	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARUAT-09B-01R	29993	19141	16305	14593	13256	12238
TARGET-10-PARUEU-09A-01R	49954825	46577932	38096121	17988655.69	101	acute lymphoblastic leukemia	5.57	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARUEU-09A-01R	28149	13362	11003	9505	8358	7444
TARGET-10-PARUFL-09B-01R	99098884	93423040	84187025	22358294.33	75	acute lymphoblastic leukemia	4.59	Yes, age < 30 years	female	NA	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARUFL-09B-01R	30399	19921	17013	15198	13911	12888
TARGET-10-PARUKW-09A-01R	54230485	50155713	35735669.5	14630821.04	101	acute lymphoblastic leukemia	9.79	Yes, age < 30 years	female	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARUKW-09A-01R	26118	10319	7655	6172	5154	4411
TARGET-10-PARUNW-09B-01R	111944710	106679750	98230218.5	22352125.825	75	acute lymphoblastic leukemia	1.38	Yes, age < 30 years	female	Asian	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARUNW-09B-01R	28995	18781	16177	14537	13330	12368
TARGET-10-PARUYU-03B-01R	114577639	110185919	99845536	29248057.32	75	acute lymphoblastic leukemia	11.02	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARUYU-03B-01R	29329	18226	15659	14194	13058	12144
TARGET-10-PARVEI-09A-01R	54849754	51100772	39234850	14172319.35	101	acute lymphoblastic leukemia	3.43	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARVEI-09A-01R	29377	11472	8649	7019	5860	4970
TARGET-10-PARVHY-09A-01R	53571001	50896200	43573017.5	18848767.96	101	acute lymphoblastic leukemia	15.66	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARVHY-09A-01R	28765	12486	10019	8462	7282	6317
TARGET-10-PARVMR-09A-01R	51865546	48638058	42079107	15690357.35	101	acute lymphoblastic leukemia	4.96	Yes, age < 30 years	male	NA	NA	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARVMR-09A-01R	28050	14218	11411	9797	8561	7593
TARGET-10-PARWDM-09B-01R	54255045	51450046	44372558	14403848.55	101	acute lymphoblastic leukemia	15.92	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARWDM-09B-01R	28501	13994	11099	9366	8142	7152
TARGET-10-PARWID-09A-01R	54056400	49623920	44645842	13155374.86	101	acute lymphoblastic leukemia	19.31	Yes, age < 30 years	male	Black/African American	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARWID-09A-01R	26777	12940	10253	8646	7409	6490
TARGET-10-PARWLP-09A-01R	54876682	51374145	44998619	13861599.98	101	acute lymphoblastic leukemia	7.9	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARWLP-09A-01R	29242	13257	10071	8330	7151	6226
TARGET-10-PARWMF-09A-01R	53086650	50449445	41713356.5	12383684.95	101	acute lymphoblastic leukemia	11.7	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARWMF-09A-01R	28713	12545	9299	7417	6102	5093
TARGET-10-PARWNW-09A-01R	54766680	51669518	44078924	14154946.26	101	acute lymphoblastic leukemia	11.95	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARWNW-09A-01R	28371	11984	9128	7488	6359	5553
TARGET-10-PARWRJ-09B-01R	102067143	97505912	88167999.5	24725437.11	75	acute lymphoblastic leukemia	1.05	Yes, age < 30 years	female	NA	NA	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARWRJ-09B-01R	29420	17801	14981	13303	12052	11066
TARGET-10-PARWXF-03B-01R	105996038	102192130	91252933.5	30725084.25	75	acute lymphoblastic leukemia	13.57	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARWXF-03B-01R	30416	16833	13770	11966	10736	9813
TARGET-10-PARXCD-09B-01R	102862560	98238879	89791638	22292462.975	75	acute lymphoblastic leukemia	14.37	Yes, age < 30 years	female	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARXCD-09B-01R	29082	17926	14991	13180	11902	10979
TARGET-10-PARXHT-03A-01R	55351047	51854805	42057938	13447626.465	101	acute lymphoblastic leukemia	13.98	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARXHT-03A-01R	28245	11750	8878	7259	6247	5427
TARGET-10-PARXLS-09A-01R	56080590	51617294	45523659.5	16930138.92	101	acute lymphoblastic leukemia	4.38	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARXLS-09A-01R	26489	12064	9496	7926	6877	5993
TARGET-10-PARXMV-03A-01R	53715551	50540200	40074899.5	19111285.5	101	acute lymphoblastic leukemia	12.38	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARXMV-03A-01R	25859	11044	8741	7247	6119	5234
TARGET-10-PARXVS-09A-01R	38551686	35834199	30321858.5	13677558.84	101	acute lymphoblastic leukemia	11.75	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARXVS-09A-01R	27382	13100	10636	9032	7888	6994
TARGET-10-PARYAJ-09B-01R	109475166	102781365	93331214	25059210.84	75	acute lymphoblastic leukemia	1.16	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARYAJ-09B-01R	29766	18924	16230	14685	13580	12710
TARGET-10-PARYGI-03A-01R	53915039	50141546	44104715.5	15649297.65	101	acute lymphoblastic leukemia	5.08	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARYGI-03A-01R	27313	13551	11035	9347	8158	7253
TARGET-10-PARZYX-09B-01R	98536992	94694280	87330619	22461714.54	75	acute lymphoblastic leukemia	11.4	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PARZYX-09B-01R	28161	17836	15347	13779	12670	11745
TARGET-10-PASDYM-09B-01R	106215268	101613066	82777800	25168654.16	75	acute lymphoblastic leukemia	19.74	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASDYM-09B-01R	29580	16599	13726	11953	10786	9881
TARGET-10-PASEVJ-09B-01R	268371194	239791950	61463262.5	39166939.77	75	acute lymphoblastic leukemia	11.19	Yes, age < 30 years	female	NA	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASEVJ-09B-01R	26786	13289	11279	10037	9040	8226
TARGET-10-PASFHR-09A-01R	42604653	39911137	33374867.5	16305403.06	101	acute lymphoblastic leukemia	14.57	Yes, age < 30 years	male	White	NA	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASFHR-09A-01R	28003	12493	10149	8604	7468	6612
TARGET-10-PASFKA-09A-01R	56460383	53459216	45108414	14970134.27	101	acute lymphoblastic leukemia	12.77	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASFKA-09A-01R	28432	12232	9213	7422	6233	5351
TARGET-10-PASFLK-09A-01R	45748723	43102068	34661468.5	16302935.22	101	acute lymphoblastic leukemia	12.02	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASFLK-09A-01R	25259	11925	9470	8005	6927	6073
TARGET-10-PASGFH-09A-01R	56454255	52076869	37253031.5	13463232.75	101	acute lymphoblastic leukemia	17.76	Yes, age < 30 years	male	Black/African American	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASGFH-09A-01R	29963	9812	6947	5414	4438	3691
TARGET-10-PASHDV-09A-01R	55280652	51837204	40100699	16145136.48	101	acute lymphoblastic leukemia	11.66	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASHDV-09A-01R	28408	12087	9440	7801	6550	5645
TARGET-10-PASHNK-09A-01R	56659262	52185071	37746753.5	18045654.275	101	acute lymphoblastic leukemia	6.61	Yes, age < 30 years	male	White	NA	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASHNK-09A-01R	28201	10899	8268	6620	5409	4524
TARGET-10-PASHUP-09A-01R	54223694	50360807	34568944	20687456.1	101	acute lymphoblastic leukemia	9.68	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASHUP-09A-01R	27496	10520	8212	6671	5501	4664
TARGET-10-PASHXL-09A-01R	54679956	51089466	35202719	23842595	101	acute lymphoblastic leukemia	13.53	Yes, age < 30 years	female	Black/African American	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASHXL-09A-01R	27005	11357	9312	7967	6882	6050
TARGET-10-PASIGB-03B-01R	128651440	121641653	108918612.5	30718530.075	75	acute lymphoblastic leukemia	2.62	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASIGB-03B-01R	31390	20132	17222	15530	14304	13235
TARGET-10-PASIIY-09A-01R	57342390	54750931	40592533	19195931.43	101	acute lymphoblastic leukemia	5.94	Yes, age < 30 years	male	White	NA	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASIIY-09A-01R	28166	12548	10094	8499	7223	6251
TARGET-10-PASILP-09B-01R	105038711	101009272	91594708	24775937.2	75	acute lymphoblastic leukemia	9.93	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASILP-09B-01R	31572	20056	17074	15179	13767	12583
TARGET-10-PASILW-09A-01R	56731896	54206268	29869222.5	19441950.48	101	acute lymphoblastic leukemia	12.42	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASILW-09A-01R	26494	10819	8651	7160	5982	5122
TARGET-10-PASINX-09A-01R	53512286	50398833	44030360.5	13452092.29	101	acute lymphoblastic leukemia	11.36	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASINX-09A-01R	29978	13897	10777	8843	7515	6394
TARGET-10-PASIZE-09B-01R	107810331	103637172	88465149.5	24968385.75	75	acute lymphoblastic leukemia	1.56	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASIZE-09B-01R	30226	18852	15944	14277	13042	12060
TARGET-10-PASJJR-09A-01R	51186481	47297203	30874700	15329891.1	101	acute lymphoblastic leukemia	14.28	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASJJR-09A-01R	26979	10930	8359	6793	5684	4824
TARGET-10-PASJLN-09A-01R	59663880	56057375	35206217.5	16141608.51	101	acute lymphoblastic leukemia	10.93	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASJLN-09A-01R	27231	11075	8481	6809	5569	4629
TARGET-10-PASJMK-09A-01R	57413198	54129616	9125016.5	6074011.38	101	acute lymphoblastic leukemia	6.3	Yes, age < 30 years	female	NA	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASJMK-09A-01R	20719	5816	3903	3015	2459	2100
TARGET-10-PASJYI-09A-01R	58367599	55139328	45529453.5	16169602.95	101	acute lymphoblastic leukemia	14.31	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASJYI-09A-01R	31064	12205	9211	7368	6082	5142
TARGET-10-PASKAD-09A-01R	53502077	50189094	39928720.5	17111532.795	101	acute lymphoblastic leukemia	10.43	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASKAD-09A-01R	29916	13777	11118	9486	8297	7308
TARGET-10-PASKCL-09B-01R	53202231	50451759	42326333.5	14255043.075	101	acute lymphoblastic leukemia	12.68	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASKCL-09B-01R	27493	12297	9535	7843	6665	5786
TARGET-10-PASKGG-09A-01R	53870784	49800968	31734877	11257615.35	101	acute lymphoblastic leukemia	15.56	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASKGG-09A-01R	28724	10731	7685	6099	4993	4238
TARGET-10-PASKIC-09A-01R	58389509	54077349	32531696.5	17986266.06	101	acute lymphoblastic leukemia	11.2	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASKIC-09A-01R	27684	9279	6716	5315	4375	3698
TARGET-10-PASKRN-03A-01R	54703555	50560682	44961195	16661972.7	101	acute lymphoblastic leukemia	5.19	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASKRN-03A-01R	29328	15746	12892	11270	10089	9132
TARGET-10-PASKSY-09A-01R	59177539	56135107	34407637	15080339.01	101	acute lymphoblastic leukemia	9.72	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASKSY-09A-01R	29742	8775	5989	4376	3349	2657
TARGET-10-PASKTG-09A-01R	53458520	48069924	25408822.5	10078507.12	101	acute lymphoblastic leukemia	5.83	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASKTG-09A-01R	26598	6099	3601	2483	1821	1483
TARGET-10-PASKXN-09A-01R	61810009	59141654	34505197	12592584.19	101	acute lymphoblastic leukemia	9.42	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASKXN-09A-01R	27987	10258	7652	6268	5331	4669
TARGET-10-PASLAB-09A-01R	55614345	52333098	35118461.5	13375808.22	101	acute lymphoblastic leukemia	4.81	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASLAB-09A-01R	29671	8796	5979	4394	3458	2818
TARGET-10-PASLBB-09A-01R	50272390	47176481	38258198.5	12547192.84	101	acute lymphoblastic leukemia	7.87	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASLBB-09A-01R	28252	13797	10756	8962	7625	6523
TARGET-10-PASLCJ-03B-01R	107075619	102451945	81946147.5	26012189.94	75	acute lymphoblastic leukemia	1.05	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASLCJ-03B-01R	30041	18746	15934	14154	12946	11978
TARGET-10-PASLMB-03B-01R	116284304	110716454	96175035.5	24324763.05	75	acute lymphoblastic leukemia	5.63	Yes, age < 30 years	male	Black/African American	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASLMB-03B-01R	29519	19151	16495	14779	13533	12527
TARGET-10-PASMGZ-09B-01R	119990865	115202203	103443045.5	31111550.865	75	acute lymphoblastic leukemia	4.51	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASMGZ-09B-01R	30098	18735	15985	14382	13209	12273
TARGET-10-PASMHF-09A-01R	52112486	48036120	34425305.5	15936948.53	101	acute lymphoblastic leukemia	12.07	Yes, age < 30 years	female	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASMHF-09A-01R	27435	9788	7030	5373	4188	3383
TARGET-10-PASMIC-09A-01R	54849286	51302233	43736389.5	16279146	101	acute lymphoblastic leukemia	13.46	Yes, age < 30 years	female	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASMIC-09A-01R	28558	12634	9758	8058	6811	5859
TARGET-10-PASMNV-09A-01R	57001587	52209325	34790222	21348039.645	101	acute lymphoblastic leukemia	12.76	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASMNV-09A-01R	27546	10918	8837	7395	6317	5447
TARGET-10-PASNEH-09A-01R	58125374	55405346	44955035	23797682.475	101	acute lymphoblastic leukemia	5.93	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASNEH-09A-01R	29380	13999	11624	10157	9098	8275
TARGET-10-PASNJI-09B-01R	119487332	113101356	101736816.5	29903969.58	75	acute lymphoblastic leukemia	3.75	Yes, age < 30 years	male	NA	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASNJI-09B-01R	29710	17837	15251	13681	12462	11608
TARGET-10-PASNTZ-09A-01R	58510120	54916346	42140304	21532548.5	101	acute lymphoblastic leukemia	7.19	Yes, age < 30 years	male	NA	NA	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASNTZ-09A-01R	26913	12495	10300	8972	7942	7124
TARGET-10-PASPBU-09A-01R	54186182	50502746	33531041	16858691.325	101	acute lymphoblastic leukemia	15.53	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASPBU-09A-01R	27571	10594	7983	6411	5311	4442
TARGET-10-PASPDS-09A-01R	56148042	51702205	42503337	15652234.35	101	acute lymphoblastic leukemia	10.92	Yes, age < 30 years	male	NA	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASPDS-09A-01R	30160	13021	10180	8375	7052	6008
TARGET-10-PASPPN-09A-01R	53772951	50739555	41711948.5	16798985.85	101	acute lymphoblastic leukemia	12.57	Yes, age < 30 years	male	NA	NA	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASPPN-09A-01R	28429	11588	8897	7064	5698	4679
TARGET-10-PASRCV-09A-01R	54539310	50929004	41774398	18828746.625	101	acute lymphoblastic leukemia	3.4	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASRCV-09A-01R	30004	13988	11428	9972	8846	7903
TARGET-10-PASREU-09B-01R	97441592	92970081	78633361	22756468.93	75	acute lymphoblastic leukemia	1.87	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASREU-09B-01R	29688	16683	13808	12071	10856	9924
TARGET-10-PASRMM-09A-01R	53918608	51207029	44997186.5	15113798.245	101	acute lymphoblastic leukemia	4.37	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASRMM-09A-01R	27230	12581	9973	8304	7135	6155
TARGET-10-PASRSV-03B-01R	97869099	94241617	82998776	25227905.865	75	acute lymphoblastic leukemia	5.13	Yes, age < 30 years	male	Black/African American	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASRSV-03B-01R	29699	18483	15583	13870	12615	11653
TARGET-10-PASRWZ-03B-01R	112224810	107243838	95250525	25690567.07	75	acute lymphoblastic leukemia	5	Yes, age < 30 years	female	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASRWZ-03B-01R	30076	18367	15426	13659	12413	11438
TARGET-10-PASRYW-03B-01R	105792786	101565115	87249832.5	25807323.3	75	acute lymphoblastic leukemia	15.56	Yes, age < 30 years	male	NA	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASRYW-03B-01R	29946	17509	14713	13017	11791	10830
TARGET-10-PASSEF-09A-01R	54807776	50873430	41009650.5	19547663.69	101	acute lymphoblastic leukemia	4.94	Yes, age < 30 years	female	NA	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASSEF-09A-01R	27848	13052	10738	9241	8189	7366
TARGET-10-PASSHC-09A-01R	55176107	51015616	38288167.5	19704474.75	101	acute lymphoblastic leukemia	15.25	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASSHC-09A-01R	28131	12082	9711	8218	7149	6329
TARGET-10-PASSPP-09A-01R	53910523	50758625	39897216.5	20709280.15	101	acute lymphoblastic leukemia	9.97	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASSPP-09A-01R	29315	13910	11471	9974	8868	8000
TARGET-10-PASSRP-09A-01R	51663865	49488789	36391973	17737867.65	101	acute lymphoblastic leukemia	4.5	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASSRP-09A-01R	29083	10774	8199	6746	5670	4843
TARGET-10-PASSSR-09A-01R	52866853	50323476	39936551.5	16422794.96	101	acute lymphoblastic leukemia	7.88	Yes, age < 30 years	male	Asian	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASSSR-09A-01R	27710	12335	9793	8273	7186	6329
TARGET-10-PASSZA-09A-01R	51594641	48922696	37837308	20834388.175	101	acute lymphoblastic leukemia	14.83	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASSZA-09A-01R	28061	12848	10607	9193	8164	7335
TARGET-10-PASTDU-09A-01R	54462113	51029389	44136412	12780997.905	101	acute lymphoblastic leukemia	8.86	Yes, age < 30 years	male	NA	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASTDU-09A-01R	28425	10792	7802	6125	5088	4356
TARGET-10-PASTHE-09A-01R	55814606	52099765	42974422	18890489.64	101	acute lymphoblastic leukemia	6.37	Yes, age < 30 years	female	Asian	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASTHE-09A-01R	29225	14616	11720	10013	8889	8022
TARGET-10-PASTLM-03B-01R	111318910	105899161	95439063.5	22667302.1	75	acute lymphoblastic leukemia	2.09	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASTLM-03B-01R	30665	19878	16894	15121	13798	12813
TARGET-10-PASTLP-09A-01R	54464866	50624091	43889494.5	16539342.75	101	acute lymphoblastic leukemia	9.36	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASTLP-09A-01R	29531	14497	11686	9839	8618	7697
TARGET-10-PASTPT-09A-01R	56508814	52297759	43483662.5	19087789.125	101	acute lymphoblastic leukemia	4.86	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASTPT-09A-01R	29586	14572	11622	9960	8811	7918
TARGET-10-PASTSR-09B-01R	104793462	100887661	89484840	23661614.67	75	acute lymphoblastic leukemia	10.44	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASTSR-09B-01R	28857	18457	15777	14237	13089	12193
TARGET-10-PASTXU-09A-01R	56951246	53077649	42628463.5	19046200.95	101	acute lymphoblastic leukemia	12.9	Yes, age < 30 years	female	Native Hawaiian or Other Pacific Islander	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASTXU-09A-01R	28180	11823	9294	7817	6648	5741
TARGET-10-PASTYT-09B-01R	116270025	111265424	99554118	30858328.605	75	acute lymphoblastic leukemia	3.03	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASTYT-09B-01R	29869	18143	15446	13829	12610	11697
TARGET-10-PASUGC-09A-01R	53069308	49929290	41275877.5	16983439.44	101	acute lymphoblastic leukemia	9.62	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASUGC-09A-01R	32032	11330	8449	6687	5443	4521
TARGET-10-PASUIN-09A-01R	50918143	48429434	36554991.5	18631860.6	101	acute lymphoblastic leukemia	13.7	Yes, age < 30 years	male	Native Hawaiian or Other Pacific Islander	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASUIN-09A-01R	27206	11742	9429	7877	6696	5705
TARGET-10-PASUSV-09A-01R	50276938	47803913	40940840.5	19059637.665	101	acute lymphoblastic leukemia	8.56	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASUSV-09A-01R	29812	14676	12015	10509	9435	8616
TARGET-10-PASUWG-03B-01R	113786169	108481841	99430141.5	27526239.96	75	acute lymphoblastic leukemia	6.02	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASUWG-03B-01R	30669	18828	15926	14216	12944	11946
TARGET-10-PASVIN-09A-01R	55568203	52349735	48557358.5	16797614.85	101	acute lymphoblastic leukemia	7.17	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASVIN-09A-01R	28115	17590	14843	13196	12057	11168
TARGET-10-PASVPZ-09A-01R	52738891	49791685	42117380.5	16039053.12	101	acute lymphoblastic leukemia	3.65	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASVPZ-09A-01R	28039	11383	8671	7130	6088	5274
TARGET-10-PASWFN-09A-01R	56422856	53977780	45944988	17983623.02	101	acute lymphoblastic leukemia	11.32	Yes, age < 30 years	male	Black/African American	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASWFN-09A-01R	27994	11897	9129	7548	6373	5499
TARGET-10-PASWNU-09A-01R	54226138	52574088	39589949.5	21761331.06	101	acute lymphoblastic leukemia	15.28	Yes, age < 30 years	female	White	NA	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASWNU-09A-01R	27068	10867	8653	7421	6475	5714
TARGET-10-PASWSR-09A-01R	47690208	45876487	35929450	17938636.37	101	acute lymphoblastic leukemia	3.42	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASWSR-09A-01R	27375	11493	9037	7460	6389	5503
TARGET-10-PASWXB-09A-01R	55592393	52367247	44271341.5	16102424.25	101	acute lymphoblastic leukemia	9.65	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASWXB-09A-01R	28155	11792	9040	7416	6261	5363
TARGET-10-PASWXZ-09A-01R	51988573	47445916	32158451.5	17267314.8	101	acute lymphoblastic leukemia	7.55	Yes, age < 30 years	female	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASWXZ-09A-01R	27080	10467	7936	6290	5054	4189
TARGET-10-PASWZJ-09A-01R	54427451	50534022	35197331.5	17702557.3	101	acute lymphoblastic leukemia	5.22	Yes, age < 30 years	male	Black/African American	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASWZJ-09A-01R	28161	11434	9050	7665	6702	5935
TARGET-10-PASXFY-09B-01R	95371928	91693825	81458918	25138682.13	75	acute lymphoblastic leukemia	2.6	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASXFY-09B-01R	30316	17999	14910	13151	11939	10919
TARGET-10-PASXIL-09A-01R	69132144	63936600	39685563.5	21521185.98	101	acute lymphoblastic leukemia	8.82	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASXIL-09A-01R	27133	9861	7256	5572	4520	3734
TARGET-10-PASXLT-09A-01R	53095252	49875439	37997856.5	19731861.325	101	acute lymphoblastic leukemia	4.08	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASXLT-09A-01R	28581	11333	8799	7072	5795	4822
TARGET-10-PASXLZ-09A-01R	53226154	49708898	40251340.5	15912100.6	101	acute lymphoblastic leukemia	5.23	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASXLZ-09A-01R	29102	12810	10030	8416	7172	6242
TARGET-10-PASXMF-09A-01R	57964429	55005090	44588549	16712792.55	101	acute lymphoblastic leukemia	10.44	Yes, age < 30 years	male	Native Hawaiian or Other Pacific Islander	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASXMF-09A-01R	27952	13172	10579	9006	7904	7026
TARGET-10-PASXSI-09A-01R	57011636	52661135	37344891.5	15571350.96	101	acute lymphoblastic leukemia	8.96	Yes, age < 30 years	male	NA	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASXSI-09A-01R	27909	12212	9627	8049	6750	5865
TARGET-10-PASXUC-09A-01R	53440950	50293072	40682853	17486561.84	101	acute lymphoblastic leukemia	6.82	Yes, age < 30 years	female	Asian	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASXUC-09A-01R	29361	12422	9792	8299	7229	6384
TARGET-10-PASXUU-09A-01R	52099993	48893473	42639579.5	15777822.99	101	acute lymphoblastic leukemia	7.01	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASXUU-09A-01R	28807	15274	12582	10943	9678	8751
TARGET-10-PASXZH-09B-01R	117942629	112757173	103000801	25061887.08	75	acute lymphoblastic leukemia	3.24	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASXZH-09B-01R	29922	18588	15919	14285	13058	12065
TARGET-10-PASYAJ-09A-01R	57548384	53038988	42747325	16948515.64	101	acute lymphoblastic leukemia	3.05	Yes, age < 30 years	male	Black/African American	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASYAJ-09A-01R	29761	12358	9489	7739	6394	5417
TARGET-10-PASYCN-09A-01R	86081083	83512988	59920919.5	25394500.035	101	acute lymphoblastic leukemia	10.98	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASYCN-09A-01R	29373	10925	8412	6925	5842	5031
TARGET-10-PASYHN-09A-01R	56050997	50929604	33916042	17429420.82	101	acute lymphoblastic leukemia	17.43	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASYHN-09A-01R	27768	10870	8409	6823	5715	4867
TARGET-10-PASYIS-09A-01R	57103332	52732650	36175035	15106709.58	101	acute lymphoblastic leukemia	8.04	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASYIS-09A-01R	27821	10113	7299	5565	4389	3619
TARGET-10-PASYSJ-09A-01R	57397051	52888419	33401573	22040008	101	acute lymphoblastic leukemia	14.73	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASYSJ-09A-01R	28549	11464	9198	7653	6556	5685
TARGET-10-PASYWF-03A-01R	43646714	41151982	32965300.5	15252089.625	101	acute lymphoblastic leukemia	5.54	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASYWF-03A-01R	26532	12068	9580	8024	6885	6076
TARGET-10-PASZEW-09A-01R	61310478	56507522	39685819	23512428.67	101	acute lymphoblastic leukemia	7.34	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASZEW-09A-01R	28000	12308	9995	8615	7600	6787
TARGET-10-PASZIY-09A-01R	60581447	56521610	44640528.5	21843240.19	101	acute lymphoblastic leukemia	14.33	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASZIY-09A-01R	29778	12470	10002	8534	7489	6649
TARGET-10-PASZJW-03A-01R	55380192	51785391	35021530	24481631.925	101	acute lymphoblastic leukemia	29.97	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PASZJW-03A-01R	27226	11352	9301	7905	6824	5967
TARGET-10-PATAAH-09B-01R	111947674	107043444	94198600	28459438.245	75	acute lymphoblastic leukemia	18.08	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATAAH-09B-01R	28300	16303	13884	12332	11216	10355
TARGET-10-PATALJ-09A-01R	54600199	52462999	42815436	27428392.53	101	acute lymphoblastic leukemia	12.78	Yes, age < 30 years	male	Black/African American	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATALJ-09A-01R	29209	14364	12024	10773	9844	9110
TARGET-10-PATAXS-09A-01R	54493823	51224746	23625556.5	10242301.96	101	acute lymphoblastic leukemia	1	Yes, age < 30 years	male	Asian	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATAXS-09A-01R	26785	12645	9941	8347	7086	6109
TARGET-10-PATAYT-09A-01R	53570972	50369164	37663188	14695771.225	101	acute lymphoblastic leukemia	5.91	Yes, age < 30 years	female	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATAYT-09A-01R	27825	12384	9765	8194	7041	6213
TARGET-10-PATBDJ-09A-01R	54164207	50781569	31559009	18671858.79	101	acute lymphoblastic leukemia	15.89	Yes, age < 30 years	male	Black/African American	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATBDJ-09A-01R	28559	10163	7629	6109	5016	4295
TARGET-10-PATBDK-09A-01R	53284960	50059553	31233097	21912182.76	101	acute lymphoblastic leukemia	7.94	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATBDK-09A-01R	28119	10462	8317	6834	5770	4952
TARGET-10-PATBGC-09A-01R	55152610	51990808	44039765	16142367.435	101	acute lymphoblastic leukemia	10.8	Yes, age < 30 years	female	Black/African American	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATBGC-09A-01R	27388	12061	9449	7858	6645	5748
TARGET-10-PATBNT-09A-01R	54744273	52040235	44861522	15063598.55	101	acute lymphoblastic leukemia	13.52	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATBNT-09A-01R	27896	11952	9093	7470	6368	5560
TARGET-10-PATBRV-09A-01R	54697135	51744903	34416317	23603178	101	acute lymphoblastic leukemia	8.36	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATBRV-09A-01R	26279	10943	8951	7522	6428	5579
TARGET-10-PATBTX-09A-01R	54015214	50567895	36724758	19613066.6	101	acute lymphoblastic leukemia	3.15	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATBTX-09A-01R	27689	11564	8983	7556	6452	5642
TARGET-10-PATBYK-09A-01R	54213913	51465527	45252321	16299121.05	101	acute lymphoblastic leukemia	16.43	Yes, age < 30 years	female	Black/African American	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATBYK-09A-01R	27857	12987	10341	8685	7397	6468
TARGET-10-PATCDM-09A-01R	53649109	49570957	42618305	14822196.48	101	acute lymphoblastic leukemia	3.26	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATCDM-09A-01R	32104	12565	9320	7419	6102	5210
TARGET-10-PATCDZ-09A-01R	49900863	46598990	33355349	18779650.55	101	acute lymphoblastic leukemia	13.24	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATCDZ-09A-01R	27117	11592	9430	8003	6887	6001
TARGET-10-PATCJJ-09B-01R	110705774	106529288	90042853.5	29697388.4	75	acute lymphoblastic leukemia	10.34	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATCJJ-09B-01R	30616	17852	14996	13315	12108	11120
TARGET-10-PATCKV-09A-01R	38362823	36014479	27532947.5	13647020.725	101	acute lymphoblastic leukemia	14.42	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATCKV-09A-01R	26527	11461	9079	7458	6304	5433
TARGET-10-PATCNI-09A-01R	48550049	46576933	34394707.5	20308768.62	101	acute lymphoblastic leukemia	4.61	Yes, age < 30 years	female	Black/African American	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATCNI-09A-01R	29040	11880	9591	8029	6868	5938
TARGET-10-PATCUK-09A-01R	54272593	51564649	38972485	18785987.06	101	acute lymphoblastic leukemia	12.04	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATCUK-09A-01R	28124	11160	8621	6940	5723	4746
TARGET-10-PATCZN-09A-01R	52805070	49766979	37825385	15616062	101	acute lymphoblastic leukemia	4.94	Yes, age < 30 years	female	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATCZN-09A-01R	28056	10320	7427	5668	4454	3639
TARGET-10-PATDBU-09A-01R	63253992	59940779	46183981.5	19034934.6	101	acute lymphoblastic leukemia	9.72	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATDBU-09A-01R	27357	10325	7664	5988	4835	4042
TARGET-10-PATDDZ-09A-01R	47282865	44433344	30234695	17481862.9	101	acute lymphoblastic leukemia	12.59	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATDDZ-09A-01R	26745	10294	7867	6306	5212	4433
TARGET-10-PATDFE-09A-01R	35131221	31905112	18434793.5	9551578.68	101	acute lymphoblastic leukemia	5.02	Yes, age < 30 years	female	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATDFE-09A-01R	27132	10791	8183	6586	5468	4621
TARGET-10-PATDGZ-09A-01R	54864847	50870002	33764181.5	18320617.98	101	acute lymphoblastic leukemia	2.57	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATDGZ-09A-01R	26546	10256	7819	6274	5172	4323
TARGET-10-PATDKT-09A-01R	49443641	47007169	39374874.5	13968299.25	101	acute lymphoblastic leukemia	22.37	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATDKT-09A-01R	28573	12366	9426	7599	6291	5338
TARGET-10-PATDLG-09A-01R	52400082	49993427	41185863.5	15824488.36	101	acute lymphoblastic leukemia	11.79	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATDLG-09A-01R	26418	11593	8937	7310	6088	5180
TARGET-10-PATDMN-09A-01R	49420262	46279143	31767420.5	15012188.38	101	acute lymphoblastic leukemia	6.92	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATDMN-09A-01R	27152	9907	6924	5100	3972	3107
TARGET-10-PATDRC-03A-01R	55294264	51943340	37718993.5	16442173.935	101	acute lymphoblastic leukemia	6.74	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATDRC-03A-01R	29765	9528	6678	5100	4087	3371
TARGET-10-PATEAK-09A-01R	52763571	50930960	33459420.5	19334600.17	101	acute lymphoblastic leukemia	17.94	Yes, age < 30 years	male	Asian	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATEAK-09A-01R	27049	11015	8631	7152	5984	5121
TARGET-10-PATEFF-09A-01R	47392763	44900149	29852619	15775359.18	101	acute lymphoblastic leukemia	6.48	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATEFF-09A-01R	26831	10365	7844	6261	5139	4363
TARGET-10-PATEHZ-03A-01R	50662404	47956053	32629916.5	16560397.425	101	acute lymphoblastic leukemia	8.76	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATEHZ-03A-01R	26430	8274	5740	4486	3656	3049
TARGET-10-PATEIT-09A-01R	50811280	48602912	29878700.5	18969383.2	101	acute lymphoblastic leukemia	9.54	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATEIT-09A-01R	27127	9931	7480	5985	4936	4166
TARGET-10-PATELK-03B-01R	101105423	97064868	88198950.5	22268489.55	75	acute lymphoblastic leukemia	2.33	Yes, age < 30 years	female	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATELK-03B-01R	29292	18836	16062	14319	13013	12007
TARGET-10-PATEMI-09A-01R	49387366	47343871	27801597.5	18761448	101	acute lymphoblastic leukemia	17.77	Yes, age < 30 years	female	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATEMI-09A-01R	27380	10141	7618	6019	4915	4091
TARGET-10-PATENL-09A-01R	37944699	35343495	25025833	14628394.51	101	acute lymphoblastic leukemia	3.68	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATENL-09A-01R	26912	10528	8026	6426	5232	4378
TARGET-10-PATEVE-09B-01R	110464817	104859157	86982596.5	21240473.825	75	acute lymphoblastic leukemia	7.55	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATEVE-09B-01R	34669	20875	17103	14867	13274	12001
TARGET-10-PATEVL-09A-01R	45610839	42763668	34578662.5	15802384.76	101	acute lymphoblastic leukemia	3.36	Yes, age < 30 years	male	Black/African American	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATEVL-09A-01R	28935	12773	10095	8474	7231	6264
TARGET-10-PATEYS-09A-01R	42856958	40727121	28636994	17066651.39	101	acute lymphoblastic leukemia	5.23	Yes, age < 30 years	male	Black/African American	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATEYS-09A-01R	27608	10861	8557	7028	5886	5088
TARGET-10-PATFJD-09A-01R	50186531	47488286	39249657.5	12196964.4	101	acute lymphoblastic leukemia	2.52	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATFJD-09A-01R	28999	13019	9892	8028	6698	5854
TARGET-10-PATFJP-09A-01R	43041355	41213427	33731261	14951531.16	101	acute lymphoblastic leukemia	8.9	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATFJP-09A-01R	28178	12408	9893	8218	7024	6122
TARGET-10-PATFRM-09A-01R	38996231	37186488	22068714	14523956.055	101	acute lymphoblastic leukemia	18.33	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATFRM-09A-01R	28775	11967	9774	8190	7036	6033
TARGET-10-PATFVG-09A-01R	51289482	48992173	44137732	13226957.3	101	acute lymphoblastic leukemia	5.83	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATFVG-09A-01R	28337	14065	11091	9277	7938	6865
TARGET-10-PATFWF-09A-01R	55715068	52618374	33278186	17091644.22	101	acute lymphoblastic leukemia	17.42	Yes, age < 30 years	male	NA	NA	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATFWF-09A-01R	25774	8999	6303	4749	3682	2937
TARGET-10-PATFYZ-09A-01R	45765080	44170517	28541112.5	14342693.45	101	acute lymphoblastic leukemia	15.4	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATFYZ-09A-01R	26991	9542	6800	4993	3882	3072
TARGET-10-PATGBY-09A-01R	56510672	53905603	36126676	21895306.67	101	acute lymphoblastic leukemia	21.12	Yes, age < 30 years	male	White	NA	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATGBY-09A-01R	27055	10945	8783	7293	6125	5196
TARGET-10-PATGKE-09A-01R	53051326	50327006	37569649.5	19453231.14	101	acute lymphoblastic leukemia	11.5	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATGKE-09A-01R	28728	12365	9913	8333	7173	6229
TARGET-10-PATGLV-09A-01R	50394304	47082492	39459975.5	13663840.95	101	acute lymphoblastic leukemia	6.18	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATGLV-09A-01R	28868	12705	9666	7826	6502	5447
TARGET-10-PATGMP-09A-01R	51757534	49266477	42923267	14861169.45	101	acute lymphoblastic leukemia	10.74	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATGMP-09A-01R	28950	13749	10807	8976	7700	6638
TARGET-10-PATGVX-09A-01R	54830593	52036862	42440776	13455821.47	101	acute lymphoblastic leukemia	7.3	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATGVX-09A-01R	28309	12164	9096	7379	6195	5378
TARGET-10-PATGWP-09A-01R	53176482	50804243	35132223	18576233.76	101	acute lymphoblastic leukemia	14.21	Yes, age < 30 years	male	Black/African American	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATGWP-09A-01R	26133	10296	7927	6406	5334	4479
TARGET-10-PATGXS-09A-01R	50602926	48012155	38816187	12971698.65	101	acute lymphoblastic leukemia	13.89	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATGXS-09A-01R	27840	10953	8064	6247	5050	4153
TARGET-10-PATGYH-09A-01R	53774961	50782267	32103476	16853253.875	101	acute lymphoblastic leukemia	16.31	Yes, age < 30 years	male	Black/African American	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATGYH-09A-01R	29856	9083	6084	4357	3320	2610
TARGET-10-PATGZA-09A-01R	53387375	50857661	44639685	18795153.08	101	acute lymphoblastic leukemia	14.38	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATGZA-09A-01R	28397	13739	11212	9700	8574	7665
TARGET-10-PATHBG-09A-01R	50541801	48194492	42868302.5	14157363.15	101	acute lymphoblastic leukemia	2.96	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATHBG-09A-01R	28670	14030	11239	9450	8145	7165
TARGET-10-PATHFE-09A-01R	55531253	52658804	33823685.5	19931587.07	101	acute lymphoblastic leukemia	11.17	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATHFE-09A-01R	26330	10727	8544	7002	5905	5031
TARGET-10-PATHGY-09A-01R	44659142	41932233	25661467.5	17525504.88	101	acute lymphoblastic leukemia	3.61	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATHGY-09A-01R	25591	10331	8071	6591	5514	4698
TARGET-10-PATHJF-09A-01R	53400022	51150735	46213172	13617162.42	101	acute lymphoblastic leukemia	10.25	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATHJF-09A-01R	27783	13270	10417	8742	7549	6717
TARGET-10-PATHRF-09A-01R	52872412	50147571	40085055	15236131.61	101	acute lymphoblastic leukemia	5.17	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATHRF-09A-01R	28356	10621	7773	6004	4843	4000
TARGET-10-PATHWV-09A-01R	47580080	45307387	31061744	21145986.8	101	acute lymphoblastic leukemia	8.56	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATHWV-09A-01R	25839	11111	8908	7352	6239	5392
TARGET-10-PATIBE-09A-01R	53219357	50302829	39437133.5	16710098.24	101	acute lymphoblastic leukemia	11.24	Yes, age < 30 years	female	Black/African American	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATIBE-09A-01R	29201	10685	7955	6119	4869	3991
TARGET-10-PATIKN-03A-01R	47951636	45089299	33255248	16147757.32	101	acute lymphoblastic leukemia	1.91	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATIKN-03A-01R	26417	9664	7163	5718	4724	4002
TARGET-10-PATITB-09A-01R	51787806	48578220	28694609.5	12969240.51	101	acute lymphoblastic leukemia	15.1	Yes, age < 30 years	male	Black/African American	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATITB-09A-01R	27571	8670	5617	4016	3064	2456
TARGET-10-PATITY-09A-01R	46431609	44478821	27953459	17890124	101	acute lymphoblastic leukemia	8.56	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATITY-09A-01R	25646	10279	7927	6441	5418	4622
TARGET-10-PATJBC-09A-01R	49555984	48256608	30078725	15765204.84	101	acute lymphoblastic leukemia	5.33	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATJBC-09A-01R	26676	8916	6215	4721	3756	3088
TARGET-10-PATJLT-09A-01R	57385479	54877821	47609535.5	17902672.625	101	acute lymphoblastic leukemia	12.09	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATJLT-09A-01R	29983	13638	10833	9137	7955	6921
TARGET-10-PATJZK-09A-01R	59616391	56284387	38853246.5	21805762.49	101	acute lymphoblastic leukemia	18.74	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATJZK-09A-01R	27869	10423	7866	6232	5126	4302
TARGET-10-PATKGP-09A-01R	49645433	46402642	35342369	16014010.83	101	acute lymphoblastic leukemia	10.57	Yes, age < 30 years	female	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATKGP-09A-01R	27697	10804	8236	6614	5440	4588
TARGET-10-PATKVD-09A-01R	48557011	46738178	29448496.5	18020685.72	101	acute lymphoblastic leukemia	2.48	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATKVD-09A-01R	25479	9081	6618	5157	4161	3435
TARGET-10-PATKWU-09A-01R	46054149	43772072	31155944.5	16830444.52	101	acute lymphoblastic leukemia	13.23	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATKWU-09A-01R	25864	11096	8855	7398	6308	5553
TARGET-10-PATKYI-09A-01R	55715043	52872320	47145067.5	15294334.965	101	acute lymphoblastic leukemia	20.85	Yes, age < 30 years	male	Black/African American	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATKYI-09A-01R	30757	14217	11015	9220	7970	7081
TARGET-10-PATLGU-09A-01R	53440921	49614698	42125230	13505304.54	101	acute lymphoblastic leukemia	7.06	Yes, age < 30 years	male	Asian	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATLGU-09A-01R	26859	11279	8455	6754	5584	4737
TARGET-10-PATLHH-09A-01R	47506019	44380969	27926537	19435517.59	101	acute lymphoblastic leukemia	7.75	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATLHH-09A-01R	26758	10628	8454	6937	5794	4942
TARGET-10-PATLHS-09A-01R	44284754	41309573	31212438	14220323.6	101	acute lymphoblastic leukemia	10.96	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATLHS-09A-01R	27299	11504	8982	7288	6095	5179
TARGET-10-PATLMA-03A-01R	56076734	52375239	42910762.5	20798293.32	101	acute lymphoblastic leukemia	8.53	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATLMA-03A-01R	27115	13055	10587	9125	8067	7224
TARGET-10-PATLNS-09A-01R	50898530	48195649	30887141	18768727.485	101	acute lymphoblastic leukemia	2.25	Yes, age < 30 years	female	Black/African American	NA	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATLNS-09A-01R	28087	9286	6901	5398	4297	3472
TARGET-10-PATLNZ-09A-01R	55435469	52492887	44652493.5	15181033.5	101	acute lymphoblastic leukemia	9.86	Yes, age < 30 years	male	White	NA	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATLNZ-09A-01R	28855	12867	9801	8087	6925	6019
TARGET-10-PATLPN-03A-01R	54175186	49418893	34485484	16182965.29	101	acute lymphoblastic leukemia	2.59	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATLPN-03A-01R	28721	11547	8883	7151	5899	4871
TARGET-10-PATLRZ-09A-01R	54655443	49745832	32528785	20101806.855	101	acute lymphoblastic leukemia	13.98	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATLRZ-09A-01R	27178	11207	8956	7383	6248	5392
TARGET-10-PATMAF-09A-01R	59556771	55765965	35143092.5	21350356.4	101	acute lymphoblastic leukemia	16.46	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATMAF-09A-01R	26714	9235	6881	5416	4377	3664
TARGET-10-PATMRE-09A-01R	51270843	48946143	40771422	14808240.9	101	acute lymphoblastic leukemia	6.77	Yes, age < 30 years	male	Black/African American	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATMRE-09A-01R	27282	11841	9126	7483	6307	5480
TARGET-10-PATMTV-09A-01R	46049457	42717560	26136573	18222606.495	101	acute lymphoblastic leukemia	11.07	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATMTV-09A-01R	26382	10367	8000	6456	5397	4581
TARGET-10-PATMVH-09A-01R	50727714	47327858	29911207.5	19827055.6	101	acute lymphoblastic leukemia	18.41	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATMVH-09A-01R	27552	10086	7635	6054	4976	4161
TARGET-10-PATMXN-09A-01R	56312992	53421981	50898419.5	14802155.08	101	acute lymphoblastic leukemia	14.92	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATMXN-09A-01R	30085	19909	16878	15030	13733	12643
TARGET-10-PATMYZ-09A-01R	54859116	51983029	45195835	12486165.12	101	acute lymphoblastic leukemia	12.1	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATMYZ-09A-01R	27103	11722	8784	7110	5971	5148
TARGET-10-PATNAM-09A-01R	59527091	56187952	28380295	15825528.66	101	acute lymphoblastic leukemia	2.23	Yes, age < 30 years	female	NA	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATNAM-09A-01R	25853	7051	4441	3185	2475	2019
TARGET-10-PATNIA-09A-01R	54884394	52007993	26802079	19980647.61	101	acute lymphoblastic leukemia	6.57	Yes, age < 30 years	female	Asian	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATNIA-09A-01R	24770	8057	5635	4318	3406	2790
TARGET-10-PATPDA-09A-01R	54233890	51308055	31219431	16944311.805	101	acute lymphoblastic leukemia	2.05	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATPDA-09A-01R	26536	8509	6103	4729	3790	3155
TARGET-10-PATPGE-09A-01R	51369076	48733437	42166284.5	15785435.25	101	acute lymphoblastic leukemia	19.72	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATPGE-09A-01R	28377	12091	9370	7757	6621	5759
TARGET-10-PATPWF-03A-01R	54847136	52837602	26962154.5	15854812.75	101	acute lymphoblastic leukemia	1.81	Yes, age < 30 years	male	NA	NA	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATPWF-03A-01R	24791	8398	5862	4438	3539	2916
TARGET-10-PATRAB-09A-01R	51610377	48385859	29077922.5	17700204.71	101	acute lymphoblastic leukemia	4.67	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATRAB-09A-01R	25446	9689	7316	5813	4775	4056
TARGET-10-PATRGV-09A-01R	52021237	49061125	32149049	16258514.4	101	acute lymphoblastic leukemia	1.58	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATRGV-09A-01R	27477	9181	6633	5171	4188	3508
TARGET-10-PATRHL-09A-01R	51143075	47038357	30948439	16002110.46	101	acute lymphoblastic leukemia	6.29	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATRHL-09A-01R	27439	10755	8188	6591	5427	4604
TARGET-10-PATRNA-09A-01R	45670417	42200162	26829841	14042201.04	101	acute lymphoblastic leukemia	2.2	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATRNA-09A-01R	26451	9197	6604	5079	4040	3326
TARGET-10-PATRUN-09A-01R	47249971	44871532	34534713.5	17847438.95	101	acute lymphoblastic leukemia	4.83	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATRUN-09A-01R	27153	11427	9095	7744	6738	5950
TARGET-10-PATRXL-09A-01R	55165201	52685931	27056722	15445033.33	101	acute lymphoblastic leukemia	4.84	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATRXL-09A-01R	25111	7518	4990	3537	2688	2147
TARGET-10-PATSDS-03A-01R	55774902	53021570	35169604.5	18843655.74	101	acute lymphoblastic leukemia	14.86	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATSDS-03A-01R	29786	10298	7868	6405	5386	4607
TARGET-10-PATSIL-09A-01R	57028612	55214627	35100647.5	22547965.95	101	acute lymphoblastic leukemia	15.61	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATSIL-09A-01R	26385	9507	7355	6037	5020	4316
TARGET-10-PATSIY-09A-01R	54347486	51170195	44396142.5	14167815.935	101	acute lymphoblastic leukemia	9.32	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATSIY-09A-01R	30104	13356	10224	8370	7040	6070
TARGET-10-PATSLH-09A-01R	58285580	56126988	35130061	18383999.76	101	acute lymphoblastic leukemia	2.26	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATSLH-09A-01R	26604	8454	6018	4666	3739	3144
TARGET-10-PATTHR-09A-01R	56115309	51868787	35161340.5	16593799.76	101	acute lymphoblastic leukemia	16.2	Yes, age < 30 years	male	Asian	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATTHR-09A-01R	28863	10525	7659	5949	4771	3985
TARGET-10-PATVDA-03A-01R	53219382	50255875	42183538.5	17399814.96	101	acute lymphoblastic leukemia	2.14	Yes, age < 30 years	female	Asian	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATVDA-03A-01R	28746	15640	12830	11148	10014	9145
TARGET-10-PATWHB-09A-01R	50139437	47494993	33868915.5	10222194.255	101	acute lymphoblastic leukemia	10.69	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATWHB-09A-01R	28201	8587	5172	3507	2591	1988
TARGET-10-PATWIJ-09A-01R	48845784	46142414	32968330	16000172.2	101	acute lymphoblastic leukemia	14.2	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATWIJ-09A-01R	27263	10484	8011	6330	5106	4187
TARGET-10-PATWJU-09A-01R	40782842	39219357	25204111.5	12986666.28	101	acute lymphoblastic leukemia	5.82	Yes, age < 30 years	male	White	NA	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATWJU-09A-01R	25757	8702	5983	4446	3514	2880
TARGET-10-PATWNL-09A-01R	54254432	52468552	26076221.5	13934561.24	101	acute lymphoblastic leukemia	1.73	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATWNL-09A-01R	26080	7098	4452	3182	2438	1978
TARGET-10-PATWXC-09A-01R	54913079	51449954	28146772	14598206.28	101	acute lymphoblastic leukemia	15.03	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATWXC-09A-01R	25240	7234	4663	3344	2590	2114
TARGET-10-PATWYL-09A-01R	52695001	50170141	44858869	16688730.425	101	acute lymphoblastic leukemia	15.29	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATWYL-09A-01R	29585	15641	12707	11024	9850	8879
TARGET-10-PATWYZ-09A-01R	58685389	56762085	28630167.5	17152514.41	101	acute lymphoblastic leukemia	3.79	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATWYZ-09A-01R	24841	7855	5309	3920	3069	2471
TARGET-10-PATXAL-09A-01R	70588911	64908678	45753210	18614234.76	101	acute lymphoblastic leukemia	15.4	Yes, age < 30 years	male	Black/African American	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATXAL-09A-01R	29374	11002	8023	6264	4969	4098
TARGET-10-PATXKW-03A-01R	53586968	50237442	37497506.5	19693185.12	101	acute lymphoblastic leukemia	18.18	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATXKW-03A-01R	29453	11336	8921	7334	6144	5200
TARGET-10-PATXNK-09A-01R	56644630	54646413	37691446	19069133.75	101	acute lymphoblastic leukemia	9.39	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATXNK-09A-01R	27039	10563	8087	6454	5273	4464
TARGET-10-PATXNR-09A-01R	53725928	50267058	33105613	20782590.795	101	acute lymphoblastic leukemia	17.13	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATXNR-09A-01R	27018	10867	8754	7358	6246	5387
TARGET-10-PATXSK-09A-01R	50497008	47133487	27667199	15931325.72	101	acute lymphoblastic leukemia	6.24	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATXSK-09A-01R	26126	9629	7072	5385	4287	3527
TARGET-10-PATYCH-09A-01R	66748302	63117509	43622567	23477564.675	101	acute lymphoblastic leukemia	3.92	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATYCH-09A-01R	28680	13705	11271	9853	8783	7908
TARGET-10-PATYJK-09A-01R	55780373	52306402	46617620.5	16115921.55	101	acute lymphoblastic leukemia	12.19	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATYJK-09A-01R	29751	14239	11341	9643	8370	7379
TARGET-10-PATYMP-09A-01R	72443076	68159483	37595991.5	20117937.42	101	acute lymphoblastic leukemia	18.46	Yes, age < 30 years	male	NA	NA	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATYMP-09A-01R	27836	9008	6341	4772	3744	3069
TARGET-10-PATYWV-09A-01R	45905108	42983607	28755781.5	15078259.56	101	acute lymphoblastic leukemia	7.66	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATYWV-09A-01R	27318	10483	8083	6515	5403	4545
TARGET-10-PATZFF-09A-01R	46896941	44291140	30200389	15884365.14	101	acute lymphoblastic leukemia	10.69	Yes, age < 30 years	female	White	NA	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATZFF-09A-01R	26317	10175	7834	6355	5340	4536
TARGET-10-PATZSL-09A-01R	43645259	41561510	28160757.5	14976632.58	101	acute lymphoblastic leukemia	10.03	Yes, age < 30 years	female	Asian	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATZSL-09A-01R	27204	9764	7297	5694	4638	3767
TARGET-10-PATZVD-09A-01R	72689879	68462978	56349682	16903862.42	101	acute lymphoblastic leukemia	4.16	Yes, age < 30 years	male	NA	NA	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATZVD-09A-01R	28936	12118	9107	7320	6120	5199
TARGET-10-PATZWA-03A-01R	56399570	53085910	39211778	21878296.605	101	acute lymphoblastic leukemia	10.09	Yes, age < 30 years	female	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATZWA-03A-01R	28377	11432	9193	7673	6414	5457
TARGET-10-PATZYC-09A-01R	51443465	48053186	30116213.5	15960740.88	101	acute lymphoblastic leukemia	3.7	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATZYC-09A-01R	26108	9155	6567	5002	4057	3351
TARGET-10-PATZYR-03A-01R	56585361	53634122	38291657.5	24302838.24	101	acute lymphoblastic leukemia	8.91	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PATZYR-03A-01R	26805	11251	9212	7846	6787	5927
TARGET-10-PAUACG-09A-01R	70344943	66230180	56481133.5	18074989.66	101	acute lymphoblastic leukemia	4.95	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PAUACG-09A-01R	30030	15387	12369	10578	9268	8218
TARGET-10-PAUAFN-09A-01R	43918293	42307694	31507135	14770638.7	101	acute lymphoblastic leukemia	3.93	Yes, age < 30 years	male	NA	NA	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PAUAFN-09A-01R	26576	11417	8932	7289	6127	5222
TARGET-10-PAUAJA-09A-01R	69281044	65099367	53910009	18114808.05	101	acute lymphoblastic leukemia	11.89	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PAUAJA-09A-01R	29079	13041	10181	8344	7038	6017
TARGET-10-PAUAYB-09A-01R	57751546	55835058	31596965.5	22267819.27	101	acute lymphoblastic leukemia	18.29	Yes, age < 30 years	male	Asian	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PAUAYB-09A-01R	25028	9497	7061	5488	4362	3540
TARGET-10-PAUAZV-09A-01R	48824521	47207841	32244085	19313343.97	101	acute lymphoblastic leukemia	8.32	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PAUAZV-09A-01R	27297	10852	8489	6946	5754	4836
TARGET-10-PAUBCB-09A-01R	75142731	70384221	38137456	19497671.875	101	acute lymphoblastic leukemia	15.39	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PAUBCB-09A-01R	25823	7369	4996	3719	2960	2442
TARGET-10-PAUBCT-09A-01R	78483166	74435440	54193238.5	19903072.5	101	acute lymphoblastic leukemia	13.02	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PAUBCT-09A-01R	30920	14397	11499	9815	8548	7528
TARGET-10-PAUBLL-09A-01R	67700449	64030541	53326767	13529622.33	101	acute lymphoblastic leukemia	7.16	Yes, age < 30 years	female	Black/African American	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PAUBLL-09A-01R	30051	13775	10322	8236	6769	5650
TARGET-10-PAUBPY-09A-01R	52702172	49204505	31242477.5	16176676.74	101	acute lymphoblastic leukemia	11.55	Yes, age < 30 years	male	NA	Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PAUBPY-09A-01R	25807	9905	7366	5764	4752	3988
TARGET-10-PAUBRD-09A-01R	68991802	64327423	39068785	22300540.43	101	acute lymphoblastic leukemia	4.8	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PAUBRD-09A-01R	27716	9074	6497	4991	3997	3356
TARGET-10-PAUBTC-09A-01R	50113266	47601121	32624427.5	14822920.365	101	acute lymphoblastic leukemia	1.83	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PAUBTC-09A-01R	27175	10946	8444	6764	5567	4663
TARGET-10-PAUBXP-09A-01R	50996555	47704449	31522520.5	20221538.625	101	acute lymphoblastic leukemia	8.31	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PAUBXP-09A-01R	27407	11062	8896	7356	6221	5316
TARGET-10-PAUCDC-09A-01R	41718682	39515108	29601046.5	15725806.32	101	acute lymphoblastic leukemia	16.84	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PAUCDC-09A-01R	27794	11198	8893	7378	6207	5276
TARGET-10-PAUCDY-09A-01R	75650187	70824030	60102966	17998591.52	101	acute lymphoblastic leukemia	9.94	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_1	TARGET-10	NA	dbGaP	phs000218	TARGET-10-PAUCDY-09A-01R	29514	14048	11136	9346	8073	7094
TARGET-20-PABGKN-09A-01R	134967526	130592008	84157259	60581378.6	75	acute myeloid leukemia	18.18	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PABGKN-09A-01R	26809	13092	10971	9766	8867	8151
TARGET-20-PABHET-03A-02R	148373892	143062475	31435119.5	23920431.56	75	acute myeloid leukemia	14.7	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PABHET-03A-02R	24833	12750	10734	9546	8697	8035
TARGET-20-PABHET-09A-01R	23776511	22985780	18484583	14061083.96	51	acute myeloid leukemia	14.7	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PABHET-09A-01R	22470	13716	11738	10750	9958	9334
TARGET-20-PABHKY-03A-01R	38598094	37362941	31185906	22963709.245	51	acute myeloid leukemia	12.86	Yes, age < 30 years	female	Black/African American	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PABHKY-03A-01R	24967	14797	12807	11643	10844	10181
TARGET-20-PABHKY-03A-02R	161230126	154921130	102568388	65212385.475	75	acute myeloid leukemia	12.86	Yes, age < 30 years	female	Black/African American	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PABHKY-03A-02R	29749	16008	13534	12175	11186	10471
TARGET-20-PACDZR-09A-02R	106540696	102414945	76234714	52174616.7	75	acute myeloid leukemia	4.55	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PACDZR-09A-02R	26306	13239	11257	10166	9293	8623
TARGET-20-PADDXZ-03A-02R	176665229	170182034	70264765.5	51167422.32	75	acute myeloid leukemia	13.31	Yes, age < 30 years	male	Black/African American	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PADDXZ-03A-02R	25301	12052	10022	8815	7977	7349
TARGET-20-PADZKD-09A-02R	175754045	169435028	98461025	69969947.86	75	acute myeloid leukemia	13.38	Yes, age < 30 years	female	Black/African American	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PADZKD-09A-02R	27025	13375	11244	10014	9084	8398
TARGET-20-PAEAFC-09A-01R	17147095	16434257	12514456	9668956	51	acute myeloid leukemia	13.98	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PAEAFC-09A-01R	21423	13373	11641	10627	9805	9151
TARGET-20-PAEAFC-09A-03R	173785688	165448650	108978008	82811486.76	75	acute myeloid leukemia	13.98	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PAEAFC-09A-03R	28838	13342	11540	10463	9604	8901
TARGET-20-PAECBZ-09A-03R	134536200	129796809	83246021	70620549.87	75	acute myeloid leukemia	3.82	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PAECBZ-09A-03R	26916	12507	10687	9493	8627	7955
TARGET-20-PAECCE-04A-01R	259377108	224026722	65017637.5	52545588.48	75	acute myeloid leukemia	2.46	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PAECCE-04A-01R	27835	14311	12372	11261	10432	9768
TARGET-20-PAEENN-09A-01R	186469359	178336534	129284196	82122949.325	75	acute myeloid leukemia	3.92	Yes, age < 30 years	female	Black/African American	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PAEENN-09A-01R	30007	14501	12060	10618	9633	8866
TARGET-20-PAEEYP-09A-02R	152641246	147280217	67536996	58972512.445	75	acute myeloid leukemia	1.55	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PAEEYP-09A-02R	25223	11640	9686	8557	7753	7099
TARGET-20-PAEFHC-09A-01R	23989408	22927135	16883571	14131992.57	51	acute myeloid leukemia	7	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PAEFHC-09A-01R	21259	12527	10740	9745	8973	8347
TARGET-20-PAEFHC-09A-02R	168959425	160847824	100480497.5	76228637.05	75	acute myeloid leukemia	7	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PAEFHC-09A-02R	28144	12892	10770	9600	8742	8041
TARGET-20-PAEGRE-03A-02R	155031159	147427385	96491802	72537363.81	75	acute myeloid leukemia	15.07	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PAEGRE-03A-02R	26718	12486	10462	9262	8402	7710
TARGET-20-PAEGRI-03A-01R	159807119	153867193	94691029.5	80943299.19	75	acute myeloid leukemia	16.48	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PAEGRI-03A-01R	26706	12487	10735	9727	8923	8286
TARGET-20-PAEJBT-09A-02R	189536597	180514659	119079600	79659741.84	75	acute myeloid leukemia	10.06	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PAEJBT-09A-02R	28817	13647	11463	10202	9265	8553
TARGET-20-PAERAH-09A-01R	25639186	24660374	18615011	14468601.99	51	acute myeloid leukemia	17.43	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PAERAH-09A-01R	22083	12851	11200	10194	9397	8761
TARGET-20-PAERAH-09A-03R	155975026	147997254	68917382	51737831.865	75	acute myeloid leukemia	17.43	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PAERAH-09A-03R	27490	12764	10941	9822	8976	8285
TARGET-20-PAESVN-09A-02R	140613208	134880828	89044973.5	48406712.13	75	acute myeloid leukemia	10.65	Yes, age < 30 years	female	NA	Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PAESVN-09A-02R	29431	14924	12518	11087	10074	9247
TARGET-20-PAKHBF-09A-01R	159911254	153442686	110588192.5	66110222.29	75	acute myeloid leukemia	2.23	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PAKHBF-09A-01R	29585	14730	12434	11108	10256	9517
TARGET-20-PAKKBK-09A-02R	149502294	143572212	64391719	52188576.8	75	acute myeloid leukemia	1.93	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PAKKBK-09A-02R	25497	12728	10879	9703	8816	8067
TARGET-20-PAKRUP-09A-02R	80129891	77678397	58125085.5	45434484.765	75	acute myeloid leukemia	8.2	Yes, age < 30 years	male	Black/African American	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PAKRUP-09A-02R	26122	13043	11219	10125	9245	8560
TARGET-20-PAKVYM-09A-01R	26520275	25480054	20299948	13671438.75	51	acute myeloid leukemia	15.87	Yes, age < 30 years	male	Black/African American	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PAKVYM-09A-01R	22065	13480	11490	10358	9526	8860
TARGET-20-PAKVYM-09A-02R	158718054	152169335	88424912.5	61867160.01	75	acute myeloid leukemia	15.87	Yes, age < 30 years	male	Black/African American	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PAKVYM-09A-02R	26613	13051	10964	9756	8858	8149
TARGET-20-PALBYP-09A-02R	162515124	156092608	100677476.5	48731620.7	75	acute myeloid leukemia	5.87	Yes, age < 30 years	female	Asian	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PALBYP-09A-02R	30455	15421	12714	11147	10084	9186
TARGET-20-PALFVW-09A-01R	138190747	132393851	80978459.5	48822132.125	75	acute myeloid leukemia	11.45	Yes, age < 30 years	female	Black/African American	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PALFVW-09A-01R	28968	15265	12838	11518	10515	9706
TARGET-20-PALHVV-09A-01R	21093993	20045210	15879660	10984909.55	51	acute myeloid leukemia	13.24	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PALHVV-09A-01R	22409	13402	11296	10044	9113	8429
TARGET-20-PALHVV-09A-02R	123479053	119020516	57688144	36044961.025	75	acute myeloid leukemia	13.24	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PALHVV-09A-02R	27261	13481	11059	9595	8629	7824
TARGET-20-PALNAT-09A-01R	19462724	18602567	8646762	5370291.62	51	acute myeloid leukemia	0.83	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PALNAT-09A-01R	22728	9965	7592	6186	5219	4511
TARGET-20-PALVKV-09A-01R	27479559	26300493	19489835	15111099.6	50	acute myeloid leukemia	13.42	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PALVKV-09A-01R	21141	12417	10714	9678	8879	8217
TARGET-20-PALVKV-09A-02R	157616709	152397459	58715157	46207940.54	75	acute myeloid leukemia	13.42	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PALVKV-09A-02R	24383	11093	9044	7865	6969	6321
TARGET-20-PAMVVP-09A-03R	171118474	163633675	96644663	54029118.885	75	acute myeloid leukemia	9.18	Yes, age < 30 years	male	White	NA	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PAMVVP-09A-03R	28800	13837	11445	9936	8864	8012
TARGET-20-PAMYJX-09A-04R	456285836	365616934	16016827	10292007.17	75	acute myeloid leukemia	12.61	Yes, age < 30 years	female	NA	NA	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PAMYJX-09A-04R	22494	10339	7913	6499	5526	4785
TARGET-20-PAMYWW-09A-01R	28095595	27368193	3511131	2773060.45	51	acute myeloid leukemia	20.8	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PAMYWW-09A-01R	16943	2111	978	660	520	447
TARGET-20-PANBWF-09A-01R	20490946	19590893	12887489	9897885.36	51	acute myeloid leukemia	17.03	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PANBWF-09A-01R	22069	12797	11009	9873	8976	8257
TARGET-20-PANBWF-09A-03R	168679777	160745289	64722384	53486086	75	acute myeloid leukemia	17.03	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PANBWF-09A-03R	26286	11756	9769	8519	7539	6786
TARGET-20-PANBYS-09A-03R	178072660	173139916	111190250.5	72595951.26	75	acute myeloid leukemia	12.21	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PANBYS-09A-03R	27027	13349	11132	9893	9030	8328
TARGET-20-PANJGR-09A-01R	21327111	20387927	16305817	11764405.84	51	acute myeloid leukemia	12.11	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PANJGR-09A-01R	21665	13175	11112	9913	9081	8382
TARGET-20-PANJGR-09A-03R	259704362	230805868	19687565.5	15631537.41	75	acute myeloid leukemia	12.11	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PANJGR-09A-03R	21764	10341	8307	7065	6224	5596
TARGET-20-PANJTK-09A-01R	23990525	23169425	17908995	13187017.36	51	acute myeloid leukemia	14.81	Yes, age < 30 years	male	NA	Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PANJTK-09A-01R	23230	13839	11808	10686	9879	9170
TARGET-20-PANJVI-03A-02R	145219637	139781375	105279649	65520352.8	75	acute myeloid leukemia	6.23	Yes, age < 30 years	male	Black/African American	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PANJVI-03A-02R	30754	15857	13230	11818	10859	10114
TARGET-20-PANKFG-09A-02R	251175732	226264274	70974139	57165251.22	75	acute myeloid leukemia	1.12	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PANKFG-09A-02R	27286	12902	11059	9910	9100	8409
TARGET-20-PANLRE-09A-01R	24289824	23565870	15338969	11852134.36	51	acute myeloid leukemia	9.36	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PANLRE-09A-01R	21875	12285	10400	9171	8280	7532
TARGET-20-PANLRE-09A-05R	158661097	152625741	37734422.5	27426793.485	75	acute myeloid leukemia	9.36	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PANLRE-09A-05R	25546	13183	10955	9728	8760	7994
TARGET-20-PANLXK-09A-03R	140816742	135341473	83181888.5	62446303.62	75	acute myeloid leukemia	2.7	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PANLXK-09A-03R	27131	13106	11148	9897	8916	8181
TARGET-20-PANNJI-09A-03R	250106942	217395060	17311075.5	14327733.6	75	acute myeloid leukemia	14.17	Yes, age < 30 years	male	Black/African American	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PANNJI-09A-03R	22467	11264	9221	7914	6987	6286
TARGET-20-PANRIK-09A-01R	24552363	23871801	16844088	13132841.56	51	acute myeloid leukemia	15.47	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PANRIK-09A-01R	21423	12064	10245	9134	8343	7699
TARGET-20-PANVBP-09A-02R	146590210	141265423	15256974	11876252.7	75	acute myeloid leukemia	15.74	Yes, age < 30 years	female	NA	Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PANVBP-09A-02R	20991	10795	8605	7300	6371	5681
TARGET-20-PANVGP-09A-01R	32348576	31367404	22542586	16850047.77	51	acute myeloid leukemia	13.55	Yes, age < 30 years	male	NA	NA	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PANVGP-09A-01R	22892	12558	10580	9461	8571	7885
TARGET-20-PANYGP-09A-01R	204275756	187095162	20499725	17759861.2	75	acute myeloid leukemia	5.64	Yes, age < 30 years	male	NA	Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PANYGP-09A-01R	21264	10718	8766	7543	6646	5965
TARGET-20-PANZWB-09A-02R	168759996	145108266	11200061	9236627.19	75	acute myeloid leukemia	13.5	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PANZWB-09A-02R	20203	11029	8978	7690	6822	6091
TARGET-20-PAPAEG-09A-01R	28194373	27185411	13921706	10525797.71	51	acute myeloid leukemia	8.07	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PAPAEG-09A-01R	22585	11478	9432	8052	7038	6183
TARGET-20-PAPAEG-09A-02R	166071747	157469162	55279243	38628977.295	75	acute myeloid leukemia	8.07	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PAPAEG-09A-02R	27349	12574	10377	9046	8031	7207
TARGET-20-PAPUNR-09A-02R	145266490	140048716	55348607	36826670.75	75	acute myeloid leukemia	13.27	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PAPUNR-09A-02R	27544	13335	11013	9634	8589	7813
TARGET-20-PAPVGE-09A-03R	167406679	161727052	80650806	57358740.28	75	acute myeloid leukemia	13.16	Yes, age < 30 years	male	Black/African American	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PAPVGE-09A-03R	28930	13303	11136	9800	8838	8040
TARGET-20-PAPWZR-09A-01R	142252877	138228969	74430178	40464917.565	75	acute myeloid leukemia	13.51	Yes, age < 30 years	female	White	Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PAPWZR-09A-01R	27970	14642	12188	10769	9763	8959
TARGET-20-PAPXUF-09A-01R	211713283	202762221	108396203.5	87129935.415	75	acute myeloid leukemia	17.62	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PAPXUF-09A-01R	27928	13187	11412	10295	9474	8830
TARGET-20-PAPZIZ-09A-03R	165012429	157347079	45528849	39120472.15	75	acute myeloid leukemia	15.36	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PAPZIZ-09A-03R	23594	9858	7809	6538	5674	5097
TARGET-20-PAPZLT-09A-02R	159314931	152136215	67447489.5	58389678.36	75	acute myeloid leukemia	3.72	Yes, age < 30 years	male	Other	Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PAPZLT-09A-02R	25108	11600	9534	8264	7379	6715
TARGET-20-PARAHF-09A-01R	13731868	13266883	3984511	3030895.575	50	acute myeloid leukemia	14.98	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PARAHF-09A-01R	16793	6879	4465	3241	2474	2000
TARGET-20-PARBFZ-03A-02R	102879114	97632860	12981130	9661796.235	75	acute myeloid leukemia	14.51	Yes, age < 30 years	female	NA	Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PARBFZ-03A-02R	21521	12758	10616	9294	8376	7635
TARGET-20-PARBTV-09A-01R	21270076	20497821	15849146	12433631.89	51	acute myeloid leukemia	17.17	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PARBTV-09A-01R	22680	13678	11658	10467	9530	8851
TARGET-20-PARBTV-09A-02R	149285265	144685790	47849389.5	36028314.99	75	acute myeloid leukemia	17.17	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PARBTV-09A-02R	26116	13333	11240	9942	8955	8193
TARGET-20-PARBVE-09A-02R	147750374	141847624	77942329.5	55571913.79	75	acute myeloid leukemia	12.77	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PARBVE-09A-02R	27648	13598	11374	10036	9072	8325
TARGET-20-PARBXE-09A-04R	260071158	230828790	81794760	61534895.52	75	acute myeloid leukemia	1.22	Yes, age < 30 years	female	NA	NA	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PARBXE-09A-04R	26525	12917	10964	9791	8919	8276
TARGET-20-PARCEV-09A-02R	166650705	161142596	75915154.5	62309730.435	75	acute myeloid leukemia	11.37	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PARCEV-09A-02R	26664	12629	10829	9664	8746	8012
TARGET-20-PARCHW-09A-01R	136338710	132040667	97223529.5	54946189.365	75	acute myeloid leukemia	11.52	Yes, age < 30 years	male	Other	Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PARCHW-09A-01R	27897	14393	12159	10777	9813	9056
TARGET-20-PARDDA-09A-01R	16886482	16280759	12743690	9507871.125	51	acute myeloid leukemia	12.57	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PARDDA-09A-01R	20617	12632	10788	9716	8954	8313
TARGET-20-PARDDA-09A-02R	143347449	138261529	60062928	42678519.075	75	acute myeloid leukemia	12.57	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PARDDA-09A-02R	25417	11935	9934	8689	7758	7116
TARGET-20-PARDZW-09A-01R	142613260	136675663	67515882	47380650.83	75	acute myeloid leukemia	7.69	Yes, age < 30 years	female	Asian	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PARDZW-09A-01R	27051	12023	9764	8371	7422	6653
TARGET-20-PAREFM-09A-02R	176668442	171032128	46884868	37875824.6	75	acute myeloid leukemia	11.92	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PAREFM-09A-02R	24257	11528	9531	8298	7435	6753
TARGET-20-PARFGK-09A-01R	18871291	18187261	5925835	4559399.39	51	acute myeloid leukemia	0.93	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PARFGK-09A-01R	18588	8032	5785	4504	3669	3074
TARGET-20-PARGTL-09A-02R	149245257	143844392	54045297.5	38332149.27	75	acute myeloid leukemia	15.84	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PARGTL-09A-02R	25624	12338	10129	8975	8103	7455
TARGET-20-PARHBA-03A-02R	140410345	135752146	46022196.5	33852726.94	75	acute myeloid leukemia	18.83	Yes, age < 30 years	female	NA	NA	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PARHBA-03A-02R	25276	13126	11038	9896	8987	8257
TARGET-20-PARHJV-09A-01R	147835062	140119812	100182089.5	62246835.35	75	acute myeloid leukemia	2.57	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PARHJV-09A-01R	35092	13072	10646	9234	8295	7586
TARGET-20-PARHPP-03A-01R	15005544	14165316	12096491	7683980.4	51	acute myeloid leukemia	13.09	Yes, age < 30 years	female	Black/African American	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PARHPP-03A-01R	21532	14549	12314	11066	10157	9452
TARGET-20-PARHVI-03A-03R	187893117	179866426	92794377.5	69077848.37	75	acute myeloid leukemia	16.44	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PARHVI-03A-03R	27578	13185	11204	10029	9161	8469
TARGET-20-PARJWH-09A-01R	110561347	105891383	54382938.5	40031817.15	75	acute myeloid leukemia	0.96	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PARJWH-09A-01R	27429	12819	10519	9115	8124	7382
TARGET-20-PARKFB-09A-02R	156544432	152142522	71767965.5	52653796.95	75	acute myeloid leukemia	18.15	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PARKFB-09A-02R	28318	13704	11589	10427	9511	8802
TARGET-20-PARLMY-09A-01R	152514219	146792378	36476387	22249653.18	75	acute myeloid leukemia	7.95	Yes, age < 30 years	female	White	Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PARLMY-09A-01R	24548	12317	10067	8737	7777	7037
TARGET-20-PARLSW-09A-02R	130920013	125579167	25713079	18361072.835	75	acute myeloid leukemia	13.43	Yes, age < 30 years	female	White	Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PARLSW-09A-02R	22621	11517	9405	8151	7212	6445
TARGET-20-PARLVL-09A-01R	16610455	16086678	2154288	1782994.83	51	acute myeloid leukemia	2.64	Yes, age < 30 years	male	Black/African American	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PARLVL-09A-01R	11830	1027	558	383	318	270
TARGET-20-PARMME-09A-02R	177115238	171795391	115022531	78645849.88	75	acute myeloid leukemia	10.49	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PARMME-09A-02R	29984	13904	11726	10496	9593	8879
TARGET-20-PARMZC-09A-02R	169387387	163833016	66641726	44113535.76	75	acute myeloid leukemia	16.44	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PARMZC-09A-02R	27143	12618	10362	8969	7988	7205
TARGET-20-PARPBF-09A-02R	157433953	151709567	83626706.5	63767680.515	75	acute myeloid leukemia	17.59	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PARPBF-09A-02R	27640	13239	11300	10118	9274	8564
TARGET-20-PARPVZ-09A-02R	145781834	141771245	107364511.5	68557650.155	75	acute myeloid leukemia	11.38	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PARPVZ-09A-02R	30283	15594	13061	11759	10798	10085
TARGET-20-PARTST-09A-02R	144868534	140484525	105414612.5	64643830.7	75	acute myeloid leukemia	3.38	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PARTST-09A-02R	31236	15923	13351	11853	10860	10033
TARGET-20-PARTXH-09A-02R	125656636	121533465	89441423	56397458.35	75	acute myeloid leukemia	9.27	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PARTXH-09A-02R	29985	16016	13529	12252	11354	10573
TARGET-20-PARTXH-09A-03R	160907072	155852003	73992005.5	51667265.525	75	acute myeloid leukemia	9.27	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PARTXH-09A-03R	28362	13955	11836	10624	9751	8961
TARGET-20-PARTYK-09A-01R	18580787	17909630	8964783	6463740.92	51	acute myeloid leukemia	5.39	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PARTYK-09A-01R	21596	11652	9315	7732	6614	5712
TARGET-20-PARTYV-09A-03R	123721870	119971275	66182950.5	48827257.11	75	acute myeloid leukemia	4.48	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PARTYV-09A-03R	25678	12370	10462	9332	8516	7863
TARGET-20-PARURW-09A-02R	151708775	146837727	59052424.5	42437573.16	75	acute myeloid leukemia	10.55	Yes, age < 30 years	male	Other	Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PARURW-09A-02R	33759	13350	11121	9767	8753	7975
TARGET-20-PARVSF-09A-02R	146302795	141327495	72222134.5	46722732	75	acute myeloid leukemia	6.38	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PARVSF-09A-02R	27940	12706	10428	8997	7967	7192
TARGET-20-PARVUA-03A-02R	138058018	133663361	100358230	72146325.68	75	acute myeloid leukemia	15.84	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PARVUA-03A-02R	29706	15373	13122	11827	10976	10288
TARGET-20-PARWXU-09A-02R	140816583	134943895	64763842.5	55134636.015	75	acute myeloid leukemia	1.52	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PARWXU-09A-02R	24869	11394	9377	8211	7394	6733
TARGET-20-PARXZP-09A-01R	131422885	126320927	73025087.5	49022166.06	75	acute myeloid leukemia	18.23	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PARXZP-09A-01R	30059	12718	10376	8993	7963	7115
TARGET-20-PARYEB-09A-01R	27994927	26868514	19226260	16304827.72	51	acute myeloid leukemia	19.13	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PARYEB-09A-01R	22168	12766	11076	10101	9360	8720
TARGET-20-PASAFM-09A-01R	29343808	28306955	19888684	15883050.18	51	acute myeloid leukemia	10.05	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PASAFM-09A-01R	22645	12546	10754	9729	8901	8245
TARGET-20-PASBPW-09A-02R	154519993	148452942	47426680	32452296.2	75	acute myeloid leukemia	14.28	Yes, age < 30 years	male	Asian	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PASBPW-09A-02R	26378	13524	11319	9900	8969	8246
TARGET-20-PASBSB-03A-01R	145612349	141474318	84145829.5	74047191.295	75	acute myeloid leukemia	17.09	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PASBSB-03A-01R	25606	12263	10591	9553	8717	8067
TARGET-20-PASDGX-09A-02R	132846336	129236515	75489161	57681104.805	75	acute myeloid leukemia	16.35	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PASDGX-09A-02R	27397	12959	10884	9557	8675	7953
TARGET-20-PASECW-09A-04R	152354965	147897163	112800822.5	72752173.2	75	acute myeloid leukemia	2.28	Yes, age < 30 years	male	Black/African American	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PASECW-09A-04R	32085	15617	13196	11901	10961	10220
TARGET-20-PASEFD-09A-01R	141869319	137976825	57476976	36014332.125	75	acute myeloid leukemia	3.76	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PASEFD-09A-01R	28214	13927	11621	10236	9216	8450
TARGET-20-PASEGC-09A-01R	162811210	157451421	115611640	76620204.36	75	acute myeloid leukemia	11.81	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PASEGC-09A-01R	29890	14520	12206	11023	10101	9439
TARGET-20-PASFJB-09A-01R	21281865	20736307	8409886	6059437.02	51	acute myeloid leukemia	11.36	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PASFJB-09A-01R	20555	10388	8109	6592	5538	4696
TARGET-20-PASFNP-09A-02R	173797105	168111677	71795812.5	48810872.46	75	acute myeloid leukemia	5.3	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PASFNP-09A-02R	29386	12690	10260	8907	7958	7230
TARGET-20-PASHWN-09A-01R	162502674	157325183	108108892	67788026.575	75	acute myeloid leukemia	7.13	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PASHWN-09A-01R	30952	14628	12314	10964	9908	9113
TARGET-20-PASIEP-09A-01R	21966517	20952718	14608736	10211485.755	51	acute myeloid leukemia	16.65	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PASIEP-09A-01R	22609	13073	11165	10010	9118	8405
TARGET-20-PASILA-09A-01R	24537043	23184510	20478634	12566025.29	51	acute myeloid leukemia	14.75	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PASILA-09A-01R	23241	14747	12508	11191	10244	9556
TARGET-20-PASIZX-09A-01R	148276512	144277991	103011083	65760535.175	75	acute myeloid leukemia	6.23	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PASIZX-09A-01R	30219	14896	12441	11131	10203	9443
TARGET-20-PASJEJ-09A-02R	158363622	153448889	95455698.5	63600039.82	75	acute myeloid leukemia	17.34	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PASJEJ-09A-02R	30075	13781	11589	10300	9333	8561
TARGET-20-PASKGH-09A-01R	144832108	140232481	110418227	69321540.12	75	acute myeloid leukemia	10.38	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PASKGH-09A-01R	29500	15114	12875	11665	10774	10030
TARGET-20-PASKUA-09A-01R	29896916	28864935	23735390	18867188.445	51	acute myeloid leukemia	10.08	Yes, age < 30 years	male	Black/African American	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PASKUA-09A-01R	23375	14306	12583	11598	10889	10267
TARGET-20-PASLDL-09A-02R	195379090	189225168	81928347	58059439.9	75	acute myeloid leukemia	8.11	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PASLDL-09A-02R	29036	12841	10743	9453	8425	7607
TARGET-20-PASLTF-09A-02R	140721676	136343223	74946511	53884247.13	75	acute myeloid leukemia	16.86	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PASLTF-09A-02R	27574	12451	10357	9136	8145	7367
TARGET-20-PASLYX-09A-02R	145568212	141266055	67827331.5	57426127.79	75	acute myeloid leukemia	14.76	Yes, age < 30 years	female	White	Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PASLYX-09A-02R	26509	12644	10804	9567	8680	7954
TARGET-20-PASNIY-09A-02R	153959376	149590592	69220395.5	42149546	75	acute myeloid leukemia	2.55	Yes, age < 30 years	female	White	Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PASNIY-09A-02R	28097	14219	11758	10367	9353	8546
TARGET-20-PASPFE-09A-01R	172272601	166699538	92472242.5	69835869.225	75	acute myeloid leukemia	1.26	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PASPFE-09A-01R	28559	12998	10894	9618	8667	7933
TARGET-20-PASPSV-09A-02R	137187940	133507951	83445489.5	62861226.12	75	acute myeloid leukemia	13.02	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PASPSV-09A-02R	28192	13483	11372	10121	9247	8527
TARGET-20-PASPTW-09A-02R	163139961	158516107	98556312	64457345.4	75	acute myeloid leukemia	6.89	Yes, age < 30 years	female	Black/African American	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PASPTW-09A-02R	28078	13648	11480	10208	9265	8537
TARGET-20-PASPWZ-03A-01R	166527520	161295383	124432366.5	80687919.06	75	acute myeloid leukemia	0.03	Yes, age < 30 years	female	White	Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PASPWZ-03A-01R	30461	15432	13090	11726	10790	10018
TARGET-20-PASREH-09A-02R	160893466	156231706	108058597	78641133.63	75	acute myeloid leukemia	7.14	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PASREH-09A-02R	27855	13483	11478	10201	9290	8627
TARGET-20-PASRRB-03A-01R	167472350	161977261	54850319	44807908.8	75	acute myeloid leukemia	12.22	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PASRRB-03A-01R	24283	10396	8300	7038	6126	5459
TARGET-20-PASRTP-09A-01R	185773234	180170416	140346906.5	91222033.56	75	acute myeloid leukemia	14.75	Yes, age < 30 years	female	Other	NA	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PASRTP-09A-01R	29838	14706	12411	11162	10298	9547
TARGET-20-PASSWG-03A-01R	186340264	179591517	131996579	79855317.2	75	acute myeloid leukemia	0.31	Yes, age < 30 years	female	NA	NA	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PASSWG-03A-01R	33010	14511	12085	10660	9694	8938
TARGET-20-PASTPU-09A-01R	140856167	135721295	76074557.5	44361233.8	75	acute myeloid leukemia	16.2	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PASTPU-09A-01R	28450	12654	10369	8951	7991	7241
TARGET-20-PASUHK-09A-01R	168124242	161519394	101500792	65215158.12	75	acute myeloid leukemia	1.5	Yes, age < 30 years	female	White	Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PASUHK-09A-01R	30007	15367	13014	11679	10780	10065
TARGET-20-PASWTY-09A-01R	152338026	147571054	100440916.5	67302444.475	75	acute myeloid leukemia	13.99	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PASWTY-09A-01R	29552	14049	11667	10316	9390	8695
TARGET-20-PASXVC-09A-01R	182260694	176191161	114540023.5	80543405.01	75	acute myeloid leukemia	20.38	Yes, age < 30 years	male	Black/African American	Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PASXVC-09A-01R	30281	13846	11699	10414	9444	8638
TARGET-20-PASYDC-09A-01R	20582692	19597280	14209421	8989014.6	50	acute myeloid leukemia	10.64	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PASYDC-09A-01R	24371	13505	11289	9968	9047	8262
TARGET-20-PATAST-09A-01R	223938056	202504216	34916893	17340663.435	75	acute myeloid leukemia	16.22	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PATAST-09A-01R	28751	11743	9192	7722	6706	5951
TARGET-20-PATBFL-09A-01R	173782591	167569242	102690583.5	67504903.2	75	acute myeloid leukemia	11.09	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PATBFL-09A-01R	29455	14485	12302	11110	10196	9455
TARGET-20-PATFDF-09A-01R	135964176	132097393	98671489.5	64982948.94	75	acute myeloid leukemia	2.37	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PATFDF-09A-01R	32600	16780	14088	12628	11654	10849
TARGET-20-PATGAN-03A-01R	131126417	127886334	89881445.5	55377400.55	75	acute myeloid leukemia	0.76	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_3	TARGET-20	NA	dbGaP	phs000218	TARGET-20-PATGAN-03A-01R	30069	14854	12261	10739	9696	8848
TARGET-21-PAMXZY-09A-03R	443159392	230154854	55706253	34483299.555	75	acute myeloid leukemia	8.42	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_30	TARGET-21	NA	dbGaP	phs000218	TARGET-21-PAMXZY-09A-03R	21175	12718	10521	9220	8226	7537
TARGET-21-PAMYMA-41A-01R	475949820	300737391	79064326.5	47601577.59	75	acute myeloid leukemia	1.23	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_30	TARGET-21	NA	dbGaP	phs000218	TARGET-21-PAMYMA-41A-01R	21969	12507	10258	8951	8056	7361
TARGET-21-PANZLR-41A-02R	466002909	284754159	80178879.5	58131076.5	75	acute myeloid leukemia	13.12	Yes, age < 30 years	female	Black/African American	Not Hispanic or Latino	Cohort_30	TARGET-21	NA	dbGaP	phs000218	TARGET-21-PANZLR-41A-02R	22651	13335	11235	9982	9067	8337
TARGET-21-PARBTV-09A-03R	447151231	245362817	69893712	50486359.025	75	acute myeloid leukemia	17.17	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_30	TARGET-21	NA	dbGaP	phs000218	TARGET-21-PARBTV-09A-03R	23453	13387	11185	9857	8883	8173
TARGET-21-PARBTV-41A-02R	532566307	358127438	121937082	67661942.92	75	acute myeloid leukemia	17.17	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_30	TARGET-21	NA	dbGaP	phs000218	TARGET-21-PARBTV-41A-02R	24884	15304	12858	11409	10434	9657
TARGET-21-PARHRS-09A-02R	460113606	194882279	32533214.5	20612894.34	75	acute myeloid leukemia	9.95	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_30	TARGET-21	NA	dbGaP	phs000218	TARGET-21-PARHRS-09A-02R	21593	10887	8591	7140	6171	5441
TARGET-21-PARLSL-41A-02R	463732470	259299854	73043762	43655198.84	75	acute myeloid leukemia	12.2	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_30	TARGET-21	NA	dbGaP	phs000218	TARGET-21-PARLSL-41A-02R	22383	12977	10729	9431	8542	7785
TARGET-21-PARNAW-09A-01R	461393140	278494665	88528856.5	46365972.665	75	acute myeloid leukemia	1.18	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_30	TARGET-21	NA	dbGaP	phs000218	TARGET-21-PARNAW-09A-01R	25879	15905	13235	11657	10621	9808
TARGET-21-PARNAW-41A-01R	382865061	213152953	60356227	25384899.44	75	acute myeloid leukemia	1.18	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_30	TARGET-21	NA	dbGaP	phs000218	TARGET-21-PARNAW-41A-01R	20063	14787	12887	11549	10563	9772
TARGET-21-PARZIA-41A-02R	324498496	220012791	77219670.5	44624819.52	75	acute myeloid leukemia	16.67	Yes, age < 30 years	female	Asian	Not Hispanic or Latino	Cohort_30	TARGET-21	NA	dbGaP	phs000218	TARGET-21-PARZIA-41A-02R	23370	14341	11969	10610	9666	8899
TARGET-21-PASDKZ-03A-02R	403744984	251104626	91308066	49364040.905	75	acute myeloid leukemia	5.13	Yes, age < 30 years	female	Asian	Not Hispanic or Latino	Cohort_30	TARGET-21	NA	dbGaP	phs000218	TARGET-21-PASDKZ-03A-02R	23855	14094	11816	10507	9546	8882
TARGET-21-PASDXR-09A-02R	429636981	282223620	100652803	60122523.46	75	acute myeloid leukemia	9.42	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_30	TARGET-21	NA	dbGaP	phs000218	TARGET-21-PASDXR-09A-02R	24384	14378	12246	10945	10062	9368
TARGET-21-PASDXR-41A-03R	354769634	193899973	51170107.5	33103935.28	75	acute myeloid leukemia	9.42	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_30	TARGET-21	NA	dbGaP	phs000218	TARGET-21-PASDXR-41A-03R	20762	13586	11420	10137	9211	8423
TARGET-21-PASFHK-09A-01R	238164451	124155672	44140757	25401300.76	75	acute myeloid leukemia	5.92	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_30	TARGET-21	NA	dbGaP	phs000218	TARGET-21-PASFHK-09A-01R	22319	13238	11043	9765	8852	8144
TARGET-21-PASIGA-09A-01R	461425978	265781169	102487057	53325789.575	75	acute myeloid leukemia	0.87	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_30	TARGET-21	NA	dbGaP	phs000218	TARGET-21-PASIGA-09A-01R	21164	15407	13573	12248	11202	10413
TARGET-21-PASIGA-41A-01R	409114530	211522399	63459334	31412475.24	75	acute myeloid leukemia	0.87	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_30	TARGET-21	NA	dbGaP	phs000218	TARGET-21-PASIGA-41A-01R	22985	15462	13007	11447	10437	9653
TARGET-21-PASLZE-41A-02R	667997032	459275159	175112877	75943653.695	75	acute myeloid leukemia	10.16	Yes, age < 30 years	female	Black/African American	Not Hispanic or Latino	Cohort_30	TARGET-21	NA	dbGaP	phs000218	TARGET-21-PASLZE-41A-02R	22457	15365	13137	11611	10590	9823
TARGET-21-PASNKZ-41A-02R	360793472	210710488	79958298.5	43766707.195	75	acute myeloid leukemia	17.77	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_30	TARGET-21	NA	dbGaP	phs000218	TARGET-21-PASNKZ-41A-02R	24934	15199	12771	11378	10438	9638
TARGET-21-PASSLT-09A-01R	465622167	215742310	74518063	35917308.9	75	acute myeloid leukemia	14.8	Yes, age < 30 years	male	NA	Hispanic or Latino	Cohort_30	TARGET-21	NA	dbGaP	phs000218	TARGET-21-PASSLT-09A-01R	22601	13141	10960	9657	8770	8020
TARGET-21-PASYEJ-41A-03R	414225961	199334376	57329252	30988287.89	75	acute myeloid leukemia	2.43	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_30	TARGET-21	NA	dbGaP	phs000218	TARGET-21-PASYEJ-41A-03R	23738	14986	12617	11265	10314	9559
TARGET-21-PATISD-41A-01R	404232013	222182537	79556864.5	40879198.315	75	acute myeloid leukemia	10.68	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_30	TARGET-21	NA	dbGaP	phs000218	TARGET-21-PATISD-41A-01R	25445	13976	11465	10092	9145	8368
TARGET-21-PATKKJ-09A-01R	382297325	213947661	78552976.5	48906520.605	75	acute myeloid leukemia	23.49	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_30	TARGET-21	NA	dbGaP	phs000218	TARGET-21-PATKKJ-09A-01R	25697	14745	12480	11145	10186	9471
TARGET-21-PATKWH-41A-02R	461017023	248203297	73143124	40713178.44	75	acute myeloid leukemia	16.45	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_30	TARGET-21	NA	dbGaP	phs000218	TARGET-21-PATKWH-41A-02R	22255	14133	11735	10360	9331	8564
TARGET-30-PARRBU-01A-01R	92206286	78361407	55655294	33286296.12	75	neuroblastoma	3.96	NA	male	White	Not Hispanic or Latino	Cohort_41	TARGET-30	NA	dbGaP	phs000218	TARGET-30-PARRBU-01A-01R	31412	19047	16208	14595	13474	12617
TARGET-30-PARSHT-01A-01R	90020149	78283255	69868289	35176518.195	75	neuroblastoma	2.06	NA	male	White	Not Hispanic or Latino	Cohort_41	TARGET-30	NA	dbGaP	phs000218	TARGET-30-PARSHT-01A-01R	31956	19722	16710	15023	13847	12869
TARGET-30-PASCLP-01A-01R	78775845	62639222	50248447	27937358.36	50	neuroblastoma	1.76	NA	male	White	Not Hispanic or Latino	Cohort_41	TARGET-30	NA	dbGaP	phs000218	TARGET-30-PASCLP-01A-01R	26717	15146	12930	11685	10660	9836
TARGET-30-PASDZJ-01A-01R	76104408	57998660	41492896	21912427.42	50	neuroblastoma	2.47	NA	female	White	Hispanic or Latino	Cohort_41	TARGET-30	NA	dbGaP	phs000218	TARGET-30-PASDZJ-01A-01R	26455	13954	11414	9625	8258	7253
TARGET-30-PASFRV-01A-01R	80284763	66902795	46380899	23734890.725	50	neuroblastoma	2.89	NA	female	White	Not Hispanic or Latino	Cohort_41	TARGET-30	NA	dbGaP	phs000218	TARGET-30-PASFRV-01A-01R	29561	16812	14162	12539	11330	10256
TARGET-30-PASGPY-01A-01R	74712787	63338549	38244572	25492144.3	50	neuroblastoma	5.4	NA	female	White	Not Hispanic or Latino	Cohort_41	TARGET-30	NA	dbGaP	phs000218	TARGET-30-PASGPY-01A-01R	27406	17202	14885	13602	12617	11781
TARGET-30-PASLGS-01A-01R	117134129	107611255	77806062	31495308.675	50	neuroblastoma	3.33	NA	male	NA	Not Hispanic or Latino	Cohort_41	TARGET-30	NA	dbGaP	phs000218	TARGET-30-PASLGS-01A-01R	29665	17875	15143	13541	12380	11466
TARGET-40-0A4HLD-01A-01R	63966014	46118956	12503728.5	5476992.56	101	osteosarcoma	19.86	Yes, age < 30 years	male	NA	NA	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811185,SRR1811141	26506	18414	15449	13698	12443	11418
TARGET-40-0A4HMC-01A-01R	85254249	69997704	31986747.5	27329870.26	100	osteosarcoma	27.94	Yes, age < 30 years	male	White	NA	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811159	27897	15261	13078	11762	10777	10001
TARGET-40-0A4HX8-01A-01R	40925718	36969915	19555107.5	15687210.385	101	osteosarcoma	29.12	Yes, age < 30 years	male	White	NA	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811140	27702	17522	15154	13926	12983	12179
TARGET-40-0A4HXS-01A-01R	61259661	55644501	33153740	30672201.285	101	osteosarcoma	23.19	Yes, age < 30 years	male	White	NA	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811150	24451	14554	12812	11720	10853	10195
TARGET-40-0A4HY5-01A-01R	62629215	50296267	21662604	19292709.005	100	osteosarcoma	19.89	Yes, age < 30 years	male	NA	NA	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811158	24303	15105	13241	12123	11288	10536
TARGET-40-0A4I0Q-01A-01R	72782559	56065047	27602067.5	25561374.56	101	osteosarcoma	19.9	Yes, age < 30 years	female	NA	NA	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811149	23920	13895	12009	10850	9926	9131
TARGET-40-0A4I0S-01A-01R	119758588	107224308	59955429.5	50363572.46	100	osteosarcoma	24.95	NA	male	NA	NA	Cohort_7	TARGET-40	NA	dbGaP	phs000218	TARGET-40-0A4I0S-01A-01R	29950	15394	13370	12248	11369	10681
TARGET-40-0A4I0W-01A-01R	81263138	48479847	12746338.5	10189366.33	81	osteosarcoma	20.07	Yes, age < 30 years	male	Asian	NA	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811165,SRR11161	26692	15452	12954	11485	10363	9369
TARGET-40-0A4I3S-01A-01R	67121856	61620812	25962333	22398321.85	101	osteosarcoma	22.76	Yes, age < 30 years	male	Black/African American	NA	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811139	26048	15967	13928	12796	11882	11186
TARGET-40-0A4I42-01A-01R	30862463	21438653	11799757	10506232.44	101	osteosarcoma	17.16	Yes, age < 30 years	female	NA	NA	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811182,SRR1811179,SRR1811184,SRR1811138	22476	15036	13071	11925	10996	10321
TARGET-40-0A4I48-01A-01R	68119349	61943213	17759417	15167137.5	101	osteosarcoma	16.03	Yes, age < 30 years	female	NA	NA	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811135	26196	16199	14163	12891	12025	11304
TARGET-40-0A4I4E-01A-01R	70709724	30962635	12432556.5	10785918.1	101	osteosarcoma	16.37	Yes, age < 30 years	male	NA	NA	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811153	23109	15580	13556	12382	11436	10662
TARGET-40-0A4I4M-01A-01R	56331389	52780563	24964456.5	21739210.88	101	osteosarcoma	18.93	Yes, age < 30 years	female	Asian	NA	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811134	26847	15257	13287	12029	11113	10316
TARGET-40-0A4I4O-01A-01R	54188771	48768001	27686648	23521232.25	100	osteosarcoma	32.38	Yes, age < 30 years	male	White	NA	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811157	26302	16233	14125	12897	12043	11260
TARGET-40-0A4I5B-01A-01R	61329804	56358531	41738179	36601753.09	100	osteosarcoma	20.85	Yes, age < 30 years	male	NA	NA	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811155	28227	16080	14054	12976	12100	11417
TARGET-40-0A4I65-01A-01R	69014500	64129981	21885669.5	19795088.8	101	osteosarcoma	17.85	Yes, age < 30 years	male	NA	NA	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811136	24603	14885	13087	11952	11101	10371
TARGET-40-0A4I6O-01A-01R	112026702	53920527	12116295	11039833.44	101	osteosarcoma	18.45	Yes, age < 30 years	male	NA	NA	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811148	22070	15208	13362	12288	11429	10671
TARGET-40-0A4I8U-01A-01R	152839004	120585721	19143096	15717077.25	101	osteosarcoma	20.06	Yes, age < 30 years	male	NA	NA	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811183,SRR1811133	27132	15235	13177	11760	10681	9830
TARGET-40-0A4I9K-01A-01R	61736569	55777826	38800595.5	35781123.96	101	osteosarcoma	22.55	Yes, age < 30 years	male	NA	NA	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811154	25420	15001	13099	12043	11242	10538
TARGET-40-PAKFVX-01A-01R	90355049	73556213	42818688	38149507.125	81	osteosarcoma	14.8	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811026,SRR1811030	26562	14098	12090	10787	9816	9085
TARGET-40-PAKUZU-01A-01R	80431863	34321691	9591955.5	8352784.875	101	osteosarcoma	19.9	Yes, age < 30 years	male	Asian	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811186	21986	14489	12659	11460	10554	9739
TARGET-40-PAKXLD-01A-01R	18305182	7787096	7461525.5	6639534.72	101	osteosarcoma	14.36	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811205	21528	15601	13468	12259	11341	10537
TARGET-40-PAKZZK-01A-01R	51514190	46065871	21481803	18229879.035	81	osteosarcoma	13.32	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811095,SRR1811104	27692	15295	13231	11930	10919	10065
TARGET-40-PALECC-01A-01R	43951577	32321706	13249150.5	11803132.11	101	osteosarcoma	10.02	Yes, age < 30 years	female	NA	Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811109,SRR1811099	22997	14031	12062	10783	9768	8976
TARGET-40-PALFYN-01A-01R	76302752	59079718	9909422.5	7516748.485	81	osteosarcoma	13.25	Yes, age < 30 years	female	White	NA	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811031,SRR1811025,SRR1811046	23029	12031	9416	7686	6505	5645
TARGET-40-PALHRL-01A-01R	41208053	32391157	13840393.5	12228561.5	81	osteosarcoma	16.48	Yes, age < 30 years	male	Black/African American	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811045,SRR1811028	24569	14297	11913	10501	9484	8656
TARGET-40-PALKDP-01A-01R	97677482	80728496	57843078.5	51618643.125	81	osteosarcoma	9.28	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811024,SRR1811032	28502	15733	13770	12709	11950	11277
TARGET-40-PALKGN-01A-01R	50175293	34905863	17416029.5	15731020	81	osteosarcoma	16.95	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811027,SRR1811029	25371	14971	12759	11420	10380	9587
TARGET-40-PALWWX-01A-01R	82799354	62842958	42105060	37220841.375	81	osteosarcoma	12.22	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811201,SRR1811202	27317	15382	13476	12354	11483	10822
TARGET-40-PALZGU-01A-01R	62080263	49874249	24503554.5	21849584.1	81	osteosarcoma	15.34	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811043,SRR1811044	24757	15303	13457	12350	11500	10881
TARGET-40-PAMEKS-01A-01R	19223002	12495581	10975098.5	9896003.64	101	osteosarcoma	10.79	Yes, age < 30 years	male	Asian	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811204	20972	15263	13471	12438	11711	11127
TARGET-40-PAMHLF-01A-01R	59784620	47986018	31507484.5	27666708.685	81	osteosarcoma	8.85	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811071,SRR1811073,SRR1811080,SRR1811078	27743	16143	14133	12926	12027	11299
TARGET-40-PAMHYN-01A-01R	80559314	57042535	22482321	17483556.475	81	osteosarcoma	9.58	Yes, age < 30 years	female	Asian	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811042,SRR1811037	27114	14973	12811	11475	10507	9702
TARGET-40-PAMJXS-01A-01R	76576937	66009673	44424556.5	40459470.84	81	osteosarcoma	11.23	Yes, age < 30 years	male	Black/African American	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811036,SRR1811041	27293	15499	13603	12585	11759	11123
TARGET-40-PAMLKS-01A-01R	48406706	36356860	19997018	17281399.98	81	osteosarcoma	12.34	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811064,SRR1811081,SRR1811147	24499	12957	10791	9481	8553	7779
TARGET-40-PAMRHD-01A-01R	47226940	36177700	23908532	20049739.245	81	osteosarcoma	10.79	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811075,SRR1811068,SRR1811146	26571	15725	13686	12447	11486	10708
TARGET-40-PAMTCM-01A-01R	93530568	71753034	37413343.5	34271217.07	101	osteosarcoma	13.52	Yes, age < 30 years	female	Black/African American	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811102,SRR1811111	24401	13967	12350	11356	10535	9881
TARGET-40-PAMYYJ-01A-01R	82088520	67930933	43700948	39306656.96	81	osteosarcoma	17.73	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811040,SRR1811035	28084	15368	13337	12153	11247	10519
TARGET-40-PANGPE-01A-01R	72441954	63529288	40129951.5	36267298.04	81	osteosarcoma	13.13	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811125,SRR1811126	28291	15181	13353	12320	11444	10715
TARGET-40-PANGRW-01A-01R	97429511	74611571	23122823	20716093.6	81	osteosarcoma	16.67	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811113,SRR1811096	26952	14625	12365	10873	9700	8775
TARGET-40-PANMIG-01A-01R	88981322	75490666	32374486.5	28307783.79	81	osteosarcoma	14.67	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811097,SRR1811098,SRR1811087,SRR1811088	28022	15183	13179	11944	10989	10205
TARGET-40-PANPUM-01A-01R	81200639	68005702	46790889.5	39682536.26	81	osteosarcoma	16.42	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811034,SRR1811039	29856	16395	14311	13058	12142	11415
TARGET-40-PANSEN-01A-01R	65537688	50389303	31230201	24088569.57	81	osteosarcoma	14.33	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811038,SRR1811033	26738	16725	14438	13174	12270	11512
TARGET-40-PANVJJ-01A-01R	68601169	58468730	39176630	33482160.66	81	osteosarcoma	13.81	Yes, age < 30 years	female	White	NA	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811079,SRR1811072,SRR1811145	28866	16173	14073	12808	11888	11122
TARGET-40-PANXSC-01A-01R	64824445	48545849	31203417	24548281.46	81	osteosarcoma	15.18	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811200,SRR1811203	32090	15805	13385	12025	10940	10091
TARGET-40-PANZHX-01A-01R	65707277	59427483	30620884	28514810.61	81	osteosarcoma	14.04	Yes, age < 30 years	female	Asian	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811092,SRR1811107	25650	14423	12674	11516	10656	9899
TARGET-40-PANZZJ-01A-01R	44265476	39573423	19372674.5	17535123.06	81	osteosarcoma	18.77	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811105,SRR1811094	24525	13498	11406	10000	8874	7980
TARGET-40-PAPFLB-01A-01R	73707594	67050637	47060300.5	41359773.84	81	osteosarcoma	15.05	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811127,SRR1811124	28936	15722	13852	12786	11915	11226
TARGET-40-PAPIJR-01A-01R	47113772	39186465	20392657	17243436.21	101	osteosarcoma	12.59	Yes, age < 30 years	female	White	Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811152	24373	14978	13008	11820	10814	9991
TARGET-40-PAPKWD-01A-01R	51672535	45786971	23520405.5	20949859.315	81	osteosarcoma	9.52	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811108,SRR1811091	25660	14525	12509	11258	10361	9529
TARGET-40-PAPNVD-01A-01R	23652658	9758821	5740422	5023953.375	101	osteosarcoma	14.48	Yes, age < 30 years	female	White	Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811187	21482	16046	14060	12831	11884	11173
TARGET-40-PAPWWC-01A-01R	56223589	33056675	6505749.5	5903810.65	101	osteosarcoma	9.84	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811103,SRR1811112	19963	14448	12731	11537	10593	9795
TARGET-40-PAPXGT-01A-01R	95426594	77371238	46692295	39545087.355	81	osteosarcoma	11.42	Yes, age < 30 years	female	Black/African American	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811058,SRR1811059	29416	15264	13231	12049	11077	10291
TARGET-40-PARBGW-01A-01R	59035263	54237895	27258051.5	22932920	81	osteosarcoma	12.69	Yes, age < 30 years	female	NA	Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811106,SRR1811093	30646	13992	12021	10736	9764	8949
TARGET-40-PARDAX-01A-01R	38560403	32401322	23478654.5	20247894.975	81	osteosarcoma	10.08	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811063,SRR1811082	26541	15972	13862	12673	11805	11058
TARGET-40-PARFTG-01A-01R	43099048	36411713	21022629	19043977.4	81	osteosarcoma	13.65	Yes, age < 30 years	female	Asian	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811084,SRR1811062	24313	14371	12548	11447	10520	9739
TARGET-40-PARGTM-01A-01R	38935433	34223700	24898662	22575720.375	81	osteosarcoma	16.22	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811061,SRR1811083	26124	15293	13272	12165	11296	10593
TARGET-40-PARJXU-01A-01R	37859849	32807742	24162160.5	21331801.645	81	osteosarcoma	12.66	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811060,SRR1811086	25185	14988	13061	11920	11092	10466
TARGET-40-PARKAF-01A-01R	30804022	22315424	16801064	15410110.02	81	osteosarcoma	16.66	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811085	23463	14861	13037	11973	11110	10349
TARGET-40-PASEBY-01A-01R	50579102	45113595	28216816.5	22462371.6	81	osteosarcoma	11.63	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811052,SRR1811049	30486	15298	13248	12071	11152	10400
TARGET-40-PASEFS-01A-01R	77026502	69155354	50590567	42535259.2	81	osteosarcoma	18.14	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811054,SRR1811055	33908	17175	14868	13592	12616	11852
TARGET-40-PASFCV-01A-01R	56352307	50685232	34785618	31356605.67	81	osteosarcoma	10.54	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811048,SRR1811051	27357	15249	13399	12400	11548	10903
TARGET-40-PASKZZ-01A-01R	59905366	51342910	12501592.5	9621093.735	81	osteosarcoma	13.16	Yes, age < 30 years	female	White	Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811056,SRR1811057	25610	14146	12038	10658	9558	8626
TARGET-40-PASNZV-01A-01R	67509394	61448308	40982216.5	36737895.36	81	osteosarcoma	16.28	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811128,SRR1811123	28320	15629	13775	12693	11845	11133
TARGET-40-PASRNE-01A-01R	49877619	39329584	27208789.5	22197156	81	osteosarcoma	3.56	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811144,SRR1811070,SRR1811077	27848	16102	13906	12677	11821	11103
TARGET-40-PASSLM-01A-01R	56586953	50954086	37110939	30671614	81	osteosarcoma	9.69	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811050,SRR1811047	29710	15839	13908	12816	12013	11394
TARGET-40-PASUUH-01A-01R	33830522	27612270	17277897.5	15114913.58	101	osteosarcoma	14.08	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811100,SRR1811110	25718	14553	12272	10800	9734	8896
TARGET-40-PASYUK-01A-01R	48293656	34695973	24162161.5	20801232.46	81	osteosarcoma	16.24	Yes, age < 30 years	female	NA	Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811067,SRR1811074,SRR1811143	26625	15233	13165	11913	10922	10064
TARGET-40-PATAWV-01A-01R	37816482	33009753	25245486.5	22122954.36	81	osteosarcoma	15.52	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811089,SRR1811090	24883	15359	13491	12424	11595	10936
TARGET-40-PATEEM-01A-01R	50341855	31260696	21299304.5	18255146.4	101	osteosarcoma	16.08	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811101	26292	16395	14134	12862	11891	11043
TARGET-40-PATJVI-01A-01R	41503927	31852458	17974696.5	15006605.2	81	osteosarcoma	15.76	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811142,SRR1811076,SRR1811069	24507	15336	13414	12155	11227	10450
TARGET-40-PATKSS-01A-01R	61200715	40819074	15886010.5	13356306.62	101	osteosarcoma	13.39	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811198	24175	15486	13559	12485	11620	10931
TARGET-40-PATMIF-01A-01R	104732632	86971675	41262824.5	37282061.41	101	osteosarcoma	12	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811151	26755	14877	13063	11915	10993	10205
TARGET-40-PATMPU-01A-01R	69195109	61401643	43169416.5	37094052.06	81	osteosarcoma	13.85	Yes, age < 30 years	male	NA	NA	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811122,SRR1811129	28804	15955	13961	12788	11942	11174
TARGET-40-PATMXR-01A-01R	69887166	52591422	37609099	31705429.08	81	osteosarcoma	20.89	Yes, age < 30 years	female	NA	Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811130,SRR1811121	28448	16047	13973	12834	11924	11211
TARGET-40-PATPBS-01A-01R	97393455	79988918	56336397	50262266.67	81	osteosarcoma	15.09	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811120,SRR1811131	30794	16206	14158	12921	12033	11327
TARGET-40-PATUXZ-01A-01R	60981002	47626996	21544315.5	10908356.67	81	osteosarcoma	17.37	Yes, age < 30 years	female	NA	Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811132,SRR1811119	38533	19402	14981	13166	11960	11089
TARGET-40-PAUBIT-01A-01R	86117682	63581906	26900910	24510732.945	101	osteosarcoma	12.36	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811189,SRR1811181,SRR1811178	26459	15120	13249	12152	11327	10660
TARGET-40-PAUTWB-01A-01R	52309172	37818947	16476856.5	14326213.5	101	osteosarcoma	13.86	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811199	24476	15546	13641	12526	11634	10922
TARGET-40-PAUTYB-01A-01R	81773376	56486646	15143580.5	12652367.13	101	osteosarcoma	12.1	Yes, age < 30 years	female	White	Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811197	24360	14500	12420	11045	10066	9226
TARGET-40-PAUUML-01A-01R	39782455	25946370	17000278.5	14422756.125	101	osteosarcoma	5.96	Yes, age < 30 years	male	NA	Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811194	24542	15467	13516	12456	11700	11105
TARGET-40-PAUVUL-01A-01R	92272901	55821633	10450349	8162516.25	101	osteosarcoma	5.55	Yes, age < 30 years	female	Black/African American	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811195	24232	14164	12174	10977	10050	9278
TARGET-40-PAUXPZ-01A-01R	51260446	31559439	9923416.5	7991501.08	101	osteosarcoma	12.34	Yes, age < 30 years	female	NA	NA	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811196	23175	14180	12193	10950	9893	9086
TARGET-40-PAUYTT-01A-01R	73207237	43764304	7596855	6291846.2	101	osteosarcoma	18.35	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811192	21564	13120	11390	10280	9431	8652
TARGET-40-PAVALD-01A-01R	82842947	49509379	14345013.5	12669526.08	101	osteosarcoma	16.22	Yes, age < 30 years	male	White	Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811192	22807	14503	12904	11857	11030	10371
TARGET-40-PAVCLP-01A-01R	74670668	59289988	14809835	12984564.385	101	osteosarcoma	11.12	Yes, age < 30 years	female	Black/African American	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811193,SRR1811177,SRR1811180	23668	14922	13150	11943	11010	10278
TARGET-40-PAVDTY-01A-01R	53409866	28245569	6923318	5918445.75	101	osteosarcoma	13.41	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811190	21147	13699	11701	10452	9458	8689
TARGET-40-PAVECB-01A-01R	93199022	44549355	9237435.5	8006947.33	101	osteosarcoma	8.96	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_7	TARGET-40	NA	dbGaP	phs000218	SRR1811188	22556	15053	13139	11901	10983	10226
TARGET-50-CAAAAB-01A-01R	191872424	176699600	56947866.5	45697959.675	75	wilms tumor	4.81	NA	female	White	NA	Cohort_47	TARGET-50	NA	dbGaP	phs000218	TARGET-50-CAAAAB-01A-01R	31631	15875	13722	12562	11757	11023
TARGET-50-CAAAAP-01A-01R	219953354	184035250	72037382.5	62475657.72	75	wilms tumor	2.26	NA	male	White	Not Hispanic or Latino	Cohort_47	TARGET-50	NA	dbGaP	phs000218	TARGET-50-CAAAAP-01A-01R	30237	16433	14424	13294	12464	11768
TARGET-50-CAAAAQ-01A-01R	190691102	171231552	52842291	43973195.7	75	wilms tumor	3.52	Yes, age < 30 years	female	NA	NA	Cohort_47	TARGET-50	NA	dbGaP	phs000218	TARGET-50-CAAAAQ-01A-01R	29781	15666	13654	12471	11604	10821
TARGET-50-PAJMKN-01A-01R	138711652	126448852	49348167	39690884.69	75	wilms tumor	1.43	NA	female	White	NA	Cohort_47	TARGET-50	NA	dbGaP	phs000218	TARGET-50-PAJMKN-01A-01R	30833	17402	15184	13953	13035	12218
TARGET-52-PABKLN-01A-01R	273041974	245917660	27194384	23714670.6	75	rhabdoid tumor	1.1	NA	male	White	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PABKLN-01A-01R	26604	13176	10994	9523	8412	7582
TARGET-52-PADWRZ-01A-01R	179968681	161774091	31712875.5	25531965.09	75	rhabdoid tumor	1.05	NA	female	White	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PADWRZ-01A-01R	26199	11610	9421	7969	6876	6029
TARGET-52-PADYCE-01A-01R	175943095	161782760	43847439.5	31284256.945	75	rhabdoid tumor	2.28	NA	male	Black/African American	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PADYCE-01A-01R	26550	11929	9639	8142	7096	6252
TARGET-52-PADYZI-01A-01R	131870255	70890752	17762432	12877379.97	75	rhabdoid tumor	2.97	NA	male	NA	Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PADYZI-01A-01R	23359	12263	9950	8554	7474	6682
TARGET-52-PAEHIP-01A-01R	85782850	82062607	49006226.5	43782283.6	75	rhabdoid tumor	0.48	NA	male	NA	NA	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PAEHIP-01A-01R	27765	13691	11611	10350	9357	8493
TARGET-52-PAJLRA-01A-01R	148971914	143410559	96553443	83245276.8	75	rhabdoid tumor	0.01	NA	female	White	NA	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PAJLRA-01A-01R	28997	13995	12203	11087	10310	9632
TARGET-52-PAJLWM-01A-01R	198877628	178390278	21372792	19296767.11	75	rhabdoid tumor	0.79	NA	male	White	NA	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PAJLWM-01A-01R	22883	12655	10781	9604	8718	7966
TARGET-52-PAJMBW-01A-01R	105610166	90454440	34029802	26604359.32	75	rhabdoid tumor	0.39	NA	male	White	NA	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PAJMBW-01A-01R	26530	13110	10819	9303	8206	7323
TARGET-52-PAJMRB-01A-01R	151587796	91123358	35309887	29897460.39	75	rhabdoid tumor	1.48	NA	female	NA	NA	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PAJMRB-01A-01R	26680	13877	11658	10218	9112	8276
TARGET-52-PAJNER-01A-01R	236838474	202707830	25063016.5	22597325.07	75	rhabdoid tumor	0.17	NA	female	White	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PAJNER-01A-01R	25376	14016	11987	10674	9647	8808
TARGET-52-PAJNFP-01A-01R	246390328	213021192	46333677	42492010.8	75	rhabdoid tumor	0.96	NA	male	White	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PAJNFP-01A-01R	25448	12892	11108	9951	9032	8246
TARGET-52-PAJNFZ-01A-01R	241606432	209295702	27640109.5	25135233.525	75	rhabdoid tumor	1.62	NA	male	Black/African American	NA	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PAJNFZ-01A-01R	24970	13111	10980	9557	8488	7665
TARGET-52-PAJPHJ-01A-01R	81159251	77222219	55898235.5	47847028.8	75	rhabdoid tumor	0.95	NA	female	Black/African American	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PAJPHJ-01A-01R	27515	13778	11901	10724	9889	9172
TARGET-52-PAKHTL-01A-01R	121540993	80604053	37265911	32492882.49	75	rhabdoid tumor	3.12	NA	male	White	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PAKHTL-01A-01R	24580	12726	10844	9626	8728	7970
TARGET-52-PAKLYZ-01A-01R	172290325	166674998	123431251	106706346.8	75	rhabdoid tumor	1.44	NA	male	NA	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PAKLYZ-01A-01R	32007	16223	14267	13107	12241	11503
TARGET-52-PAKPEW-01A-01R	241442771	209685945	57280721.5	31340867.66	75	rhabdoid tumor	2.6	NA	male	White	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PAKPEW-01A-01R	26983	13369	11020	9473	8336	7475
TARGET-52-PAKTCT-01A-01R	109820721	102639664	46718617.5	39902698.14	75	rhabdoid tumor	2.36	NA	male	White	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PAKTCT-01A-01R	26476	12883	10733	9259	8195	7400
TARGET-52-PARECB-01A-01R	264114366	239388664	63805617	59030337.735	75	rhabdoid tumor	0.38	NA	female	NA	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PARECB-01A-01R	26483	13385	11697	10626	9831	9136
TARGET-52-PAREWI-01A-02R	147829203	136743857	59136366.5	49195793.22	75	rhabdoid tumor	0.84	NA	female	White	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PAREWI-01A-02R	25903	12120	10091	8783	7835	7102
TARGET-52-PARGRN-01A-01R	287690386	260961980	43309080	40298242.8	75	rhabdoid tumor	0.4	NA	male	White	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PARGRN-01A-01R	24099	12051	10239	9073	8178	7489
TARGET-52-PARIRN-01A-01R	265995862	233889588	41802231.5	38014267.95	75	rhabdoid tumor	4.01	NA	female	NA	NA	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PARIRN-01A-01R	25612	13359	11477	10306	9357	8556
TARGET-52-PARKKN-01A-01R	107763101	104425535	82023112.5	67020205.14	75	rhabdoid tumor	6.45	NA	female	Black/African American	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PARKKN-01A-01R	32006	16688	14424	13290	12478	11805
TARGET-52-PARPFY-01A-01R	227117716	205391196	42555024.5	38969002.8	75	rhabdoid tumor	0.99	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PARPFY-01A-01R	26106	13783	11860	10615	9666	8862
TARGET-52-PARRCL-01A-01R	193433236	179953388	17639002	15623983.025	75	rhabdoid tumor	0.59	Yes, age < 30 years	female	White	Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PARRCL-01A-01R	23552	13029	10939	9610	8550	7756
TARGET-52-PARTKH-01A-01R	138383855	131161843	82599771	73362955.99	75	rhabdoid tumor	0.73	NA	male	White	Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PARTKH-01A-01R	28586	13977	12034	10833	9874	9103
TARGET-52-PARUGK-01A-01R	227568802	203501028	21339107	18943482.97	75	rhabdoid tumor	0.6	NA	male	White	Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PARUGK-01A-01R	24081	13233	11161	9777	8766	7965
TARGET-52-PARZBI-01A-02R	231487526	215716566	19197989.5	14832223.56	75	rhabdoid tumor	1.44	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PARZBI-01A-02R	27799	15708	13443	12083	10963	10063
TARGET-52-PARZRH-01A-02R	205282236	197300578	125234704.5	102936240.99	75	rhabdoid tumor	1.67	NA	male	White	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PARZRH-01A-02R	30795	14178	12166	11033	10175	9457
TARGET-52-PASABD-01A-01R	193064794	168763576	37051956.5	33349797.9	75	rhabdoid tumor	0.47	NA	female	White	Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PASABD-01A-01R	27128	14467	12422	11093	10077	9212
TARGET-52-PASADZ-01A-01R	231016384	206024522	46600457.5	43054021.2	75	rhabdoid tumor	0.74	NA	female	Black/African American	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PASADZ-01A-01R	24264	12564	10919	9868	9058	8376
TARGET-52-PASAMZ-01A-01R	125404324	121008590	87231826	76672239.325	75	rhabdoid tumor	8.29	NA	female	White	Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PASAMZ-01A-01R	30369	14289	12426	11289	10404	9704
TARGET-52-PASCDH-01A-01R	231851248	202184092	28078408.5	25339415.49	75	rhabdoid tumor	0.97	NA	male	White	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PASCDH-01A-01R	26663	13791	11612	10220	9117	8279
TARGET-52-PASDLA-01A-01R	284016382	257155902	56000418.5	50108311.95	75	rhabdoid tumor	0.91	Yes, age < 30 years	female	White	Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PASDLA-01A-01R	28688	14180	12152	10862	9883	9105
TARGET-52-PASGCL-01A-02R	74304642	70229376	51028273.5	44988828.36	75	rhabdoid tumor	2.27	NA	male	White	Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PASGCL-01A-02R	26934	13985	12244	11240	10487	9848
TARGET-52-PASGGN-01A-01R	129834751	125388705	91786572	81307368.01	75	rhabdoid tumor	0.36	NA	male	White	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PASGGN-01A-01R	29976	14375	12403	11228	10359	9569
TARGET-52-PASILR-01A-01R	78331319	72730866	47847146.5	41541029.805	75	rhabdoid tumor	1.69	NA	female	White	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PASILR-01A-01R	26998	13687	11688	10380	9412	8610
TARGET-52-PASNED-01A-01R	153640627	148900629	102489720	92668974.4	75	rhabdoid tumor	2.83	NA	female	White	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PASNED-01A-01R	29149	14089	12286	11166	10330	9625
TARGET-52-PASRHU-01A-02R	282623666	253843396	48452221	41761782.05	75	rhabdoid tumor	0.84	NA	male	White	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PASRHU-01A-02R	29081	14536	12370	11057	9979	9076
TARGET-52-PASVDP-01A-01R	287153832	254949394	27988883.5	24597913.2	75	rhabdoid tumor	0.39	NA	female	White	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PASVDP-01A-01R	27323	14701	12461	11071	9980	9064
TARGET-52-PASWZZ-01A-01R	306333294	276748126	30777168	28355199.6	75	rhabdoid tumor	0.18	NA	female	Other	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PASWZZ-01A-01R	24757	13440	11574	10360	9359	8532
TARGET-52-PASXGF-01A-01R	133934870	125876456	76858274	67160630	75	rhabdoid tumor	2.21	NA	male	Other	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PASXGF-01A-01R	28756	13693	11769	10539	9538	8705
TARGET-52-PASXNA-01A-01R	249371176	209654084	61542150	55182860.28	75	rhabdoid tumor	0.78	NA	male	White	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PASXNA-01A-01R	27387	14047	12334	11315	10543	9869
TARGET-52-PASYNF-01A-01R	283876710	254632194	42528302.5	38997932	75	rhabdoid tumor	0.56	NA	male	White	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PASYNF-01A-01R	25721	13352	11506	10271	9330	8575
TARGET-52-PASZYE-01A-01R	300181252	262241528	38793176.5	35507157.6	75	rhabdoid tumor	0.85	NA	male	White	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PASZYE-01A-01R	25503	13155	11145	9834	8860	8036
TARGET-52-PATAFT-01A-01R	308278494	271192868	27162085.5	24394111.94	75	rhabdoid tumor	0.94	NA	female	White	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PATAFT-01A-01R	26051	14448	12199	10707	9594	8685
TARGET-52-PATBLF-01A-01R	257224716	232734218	19311602.5	16992562.34	75	rhabdoid tumor	2.08	NA	female	White	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PATBLF-01A-01R	25113	14030	11748	10288	9214	8358
TARGET-52-PATDVL-01A-01R	238095888	218041838	50151643	46104606.4	75	rhabdoid tumor	0.4	NA	male	Black/African American	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PATDVL-01A-01R	27841	14619	12684	11491	10548	9760
TARGET-52-PATENH-01A-01R	254088150	230583214	41637430.5	37779958.4	75	rhabdoid tumor	2.6	NA	female	White	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PATENH-01A-01R	26155	13268	11383	10132	9139	8416
TARGET-52-PATFXW-01A-01R	209303974	187871354	27586281.5	24446115.9	75	rhabdoid tumor	1.56	NA	male	White	NA	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PATFXW-01A-01R	25794	13037	10946	9626	8534	7650
TARGET-52-PATFZZ-01A-01R	262643784	228542684	62849611	57393520.54	75	rhabdoid tumor	1.09	NA	female	Black/African American	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PATFZZ-01A-01R	28040	14610	12796	11677	10805	10080
TARGET-52-PATXEE-01A-01R	253578846	219220312	47634750.5	42031279.15	75	rhabdoid tumor	1.59	NA	female	White	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PATXEE-01A-01R	27952	14113	12127	10927	9958	9162
TARGET-52-PATXKA-01A-01R	188968794	165698338	49066426.5	43986364.4	75	rhabdoid tumor	0.28	NA	female	Black/African American	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PATXKA-01A-01R	28611	15016	12989	11780	10885	10137
TARGET-52-PAUCGJ-01A-01R	317606900	269202660	41876785	37790990	75	rhabdoid tumor	0.77	NA	female	White	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PAUCGJ-01A-01R	25842	13368	11544	10339	9447	8680
TARGET-52-PAUDPV-01A-01R	256581882	225390268	47610186	43338896.8	75	rhabdoid tumor	0.15	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PAUDPV-01A-01R	27182	14008	12108	10969	10063	9326
TARGET-52-PAUEKW-01A-01R	245824318	214268534	50947923.5	44367786.95	75	rhabdoid tumor	14.75	NA	female	Other	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PAUEKW-01A-01R	28316	14372	12438	11270	10371	9574
TARGET-52-PAUFVP-01A-01R	247956536	230041782	73441510	67268260.4	75	rhabdoid tumor	2.03	NA	male	White	Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PAUFVP-01A-01R	28215	14912	13064	11993	11207	10549
TARGET-52-PAUGYZ-01A-01R	272237192	247365424	58085474.5	52023655.2	75	rhabdoid tumor	1.27	NA	female	White	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PAUGYZ-01A-01R	28588	14673	12634	11424	10527	9676
TARGET-52-PAUHAZ-01A-01R	229347200	210824676	47220302.5	42482249.415	75	rhabdoid tumor	0.65	NA	female	White	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PAUHAZ-01A-01R	28088	14316	12259	10955	9993	9144
TARGET-52-PAUNPA-01A-01R	291393130	258673830	59472518	53559270.4	75	rhabdoid tumor	2.84	NA	male	White	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PAUNPA-01A-01R	27493	14399	12614	11483	10548	9786
TARGET-52-PAVCKS-01A-01R	145481620	140843973	103379431	93346856.46	75	rhabdoid tumor	1.78	NA	male	White	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PAVCKS-01A-01R	29365	14428	12671	11646	10823	10083
TARGET-52-PAVDPR-01A-01R	132004589	128364172	98715721	90135348.81	75	rhabdoid tumor	2.05	NA	male	White	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PAVDPR-01A-01R	28363	14266	12582	11556	10827	10191
TARGET-52-PAVITI-01A-01R	142123100	137612807	95508865.5	85513740	75	rhabdoid tumor	2.49	NA	female	White	Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PAVITI-01A-01R	29867	14307	12407	11273	10349	9577
TARGET-52-PAVVIT-01A-01R	127926635	123545601	95936517	86048585.795	75	rhabdoid tumor	4.26	NA	male	White	Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PAVVIT-01A-01R	29086	14411	12733	11660	10901	10229
TARGET-52-PAWFBL-01A-01R	158831197	153316470	107791626.5	96994379.445	75	rhabdoid tumor	1.86	NA	male	White	Not Hispanic or Latino	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PAWFBL-01A-01R	30415	15070	13189	12046	11144	10419
TARGET-52-PAWFWK-01A-01R	168327855	162799380	114710011	101759557.93	75	rhabdoid tumor	0.63	NA	male	White	NA	Cohort_11	TARGET-52	NA	dbGaP	phs000218	TARGET-52-PAWFWK-01A-01R	32189	15065	13094	11925	11017	10316
THR08_0161_S01	44530707	43579002	41015617	31492466.18	101	acute lymphoblastic leukemia	0.2	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF001_E-H8F93ADXX	25712	15731	13673	12601	11869	11293
THR08_0161_S02	45067102	44099241	42079045.5	29656199.47	101	acute lymphoblastic leukemia	0.2	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF001_S-H8F93ADXX	25669	16233	14125	12994	12219	11648
THR08_0162_S01	38165784	37176526	33745071	27194551.125	101	acute lymphoblastic leukemia	0.6	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF002_S-H8RMVADXX	24954	15143	13205	12248	11522	10999
THR08_0162_S02	38727325	37710329	36240748.5	27191561.32	101	acute lymphoblastic leukemia	0.6	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF002_E-HA4VVADXX	26029	16789	14559	13406	12622	12035
THR08_0163_S01	39923027	38943317	37733927	25812824.19	101	acute lymphoblastic leukemia	0.6	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF003_D-HAMJ5ADXX	26352	17487	15150	13940	13119	12468
THR08_0164_S01	40454198	39430004	38128925	21698154.65	101	acute lymphoblastic leukemia	0.6	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF004_D-HAMJ5ADXX	26408	18003	15429	13939	12964	12233
THR08_0165_S01	46145490	45105058	43164431	30059190.32	101	acute lymphoblastic leukemia	1	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF005_D-H8F93ADXX	27288	17315	14944	13653	12829	12177
THR08_0166_S01	48833147	47643796	44888627.5	33039856.465	101	acute lymphoblastic leukemia	0.2	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF006_D-HAMJ5ADXX	26244	16363	14274	13183	12461	11854
THR08_0167_S01	43788254	42788925	41191619	29498955.33	101	acute lymphoblastic leukemia	0.3	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF008_D-H8F93ADXX	26813	17210	14941	13704	12880	12254
THR08_0168_S01	41250851	40349830	38380050.5	28400599.535	101	acute lymphoblastic leukemia	0	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF009_D-H8RMJADXX	26377	16540	14189	13059	12214	11627
THR08_0169_S01	41334530	40406428	38398237	24681487.725	101	acute lymphoblastic leukemia	0	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF010_D-H8RMJADXX	25865	16229	13898	12655	11733	11072
THR08_0170_S01	46634411	45701087	40236981	27868563.6	101	acute lymphoblastic leukemia	0.4	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF011_D-H8RMRADXX	26084	15716	13697	12525	11735	11127
THR08_0171_S01	43501756	42542207	41023191.5	29977419.81	101	acute lymphoblastic leukemia	0.3	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF012_D-H8F5YADXX	26228	16867	14666	13479	12703	12091
THR08_0172_S01	48957788	47745636	45048326	34800974.18	101	acute lymphoblastic leukemia	0.9	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF013_D-HAMJ5ADXX	25460	15774	13857	12783	12078	11540
THR08_0173_S01	41776700	40908975	39370151	27313098.18	101	acute lymphoblastic leukemia	0.3	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF014_D-H8RMRADXX	25343	16339	14109	12893	12126	11533
THR08_0174_S01	45709221	44706522	42137296	31135703.43	101	acute lymphoblastic leukemia	0.6	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF015_D-H8F5YADXX	26858	16470	14276	13056	12282	11688
THR08_0175_S01	54339337	53251567	50386661.5	37118013.66	101	acute lymphoblastic leukemia	0.1	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF016_D-H8RMRADXX	26909	16405	14198	13088	12288	11704
THR08_0176_S01	39707881	38761452	37234085	27243005.01	101	acute lymphoblastic leukemia	0.4	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF017_D-H8RMRADXX	24558	15861	13859	12817	12110	11542
THR08_0177_S01	44283204	43357441	41379317	30987713.295	101	acute lymphoblastic leukemia	0.6	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF018_D-H8RMRADXX	26985	16698	14484	13376	12649	12060
THR08_0178_S01	45166133	44283764	40999169.5	30141233.46	101	acute lymphoblastic leukemia	0.8	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF019_D-H8RMRADXX	27124	16772	14489	13360	12555	12008
THR08_0179_S01	45940746	45002837	41934381.5	28109793.825	101	acute lymphoblastic leukemia	0.2	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF020_D-H8RMRADXX	25922	15964	13701	12548	11753	11137
THR08_0180_S01	39192082	38116056	36400359.5	25407861.105	101	acute lymphoblastic leukemia	0.8	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF021_D-HA4VVADXX	26019	16765	14539	13393	12619	12046
THR08_0181_S01	37627980	36520603	35317701.5	22876014.735	101	acute lymphoblastic leukemia	0.7	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF022_D-HA4VVADXX	26301	17400	14995	13655	12750	12071
THR08_0182_S01	39499906	38445584	36416410	23800162.77	101	acute lymphoblastic leukemia	0.3	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF049_D-HA4VVADXX	26081	17023	14674	13387	12518	11856
THR08_0183_S01	45803978	44793376	43142217	30683202.235	101	acute lymphoblastic leukemia	0.4	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF053_D-H8F5YADXX	26463	17103	14729	13486	12675	12085
THR08_0184_S01	37832860	36925078	35162667.5	26997994.14	101	acute lymphoblastic leukemia	0.3	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF055_D-HAM3AADXX	24925	15642	13618	12609	11923	11341
THR08_0185_S01	45465915	44402240	42802590.5	26920528.605	101	acute lymphoblastic leukemia	0.2	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF059_D-H8F5YADXX	26101	17017	14722	13408	12470	11785
THR08_0186_S01	38528290	37551566	35510449	24941059.19	101	acute lymphoblastic leukemia	0.2	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF060_R-H8RMVADXX	26562	17196	14887	13605	12742	12144
THR08_0186_S02	54501725	53171347	50881286.5	30607503.27	101	acute lymphoblastic leukemia	0.2	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF060_D-HAMJ5ADXX	26643	17084	14776	13417	12497	11754
THR08_0187_S01	37939176	37007130	34417802.5	25065849.51	101	acute lymphoblastic leukemia	0.5	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF061_R-H8RMVADXX	27977	17309	14938	13617	12728	12096
THR08_0187_S02	39310784	38238543	36058176.5	23265569.31	101	acute lymphoblastic leukemia	0.5	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF061_D-HA4VVADXX	27746	17885	15373	14043	13134	12428
THR08_0188_S01	49743945	48641982	45501948.5	33533409.78	101	acute lymphoblastic leukemia	0.2	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF062_D-H8F5YADXX	25517	15435	13394	12301	11567	11020
THR08_0189_S01	44995182	44003670	41725128	32096903.3	101	acute lymphoblastic leukemia	0.4	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF063_D-H8F5YADXX	25193	15750	13788	12706	12047	11524
THR08_0190_S01	46956427	45944817	43415359	30840709.275	101	acute lymphoblastic leukemia	0.6	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF064_D-H8F5YADXX	25979	16474	14410	13243	12469	11841
THR08_0191_S01	48032580	46987071	43990143.5	32038117.41	101	acute lymphoblastic leukemia	0.6	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF065_R-HALUBADXX	26527	16324	14277	13121	12353	11771
THR08_0192_S01	37788541	36768254	34834996.5	23136045.2	101	acute lymphoblastic leukemia	0.9	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF066_D-H8RMVADXX	26191	17150	14752	13520	12693	12037
THR08_0193_S01	36452346	35485762	33845836	23259198	101	acute lymphoblastic leukemia	0.8	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF067_D-H8RMVADXX	25663	16805	14429	13196	12401	11798
THR08_0194_S01	39903391	38848318	36917781.5	26381353.44	101	acute lymphoblastic leukemia	0.3	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF068_D-HA4VVADXX	25885	16500	14250	13080	12303	11692
THR08_0195_S01	36408607	35494775	34056030.5	25746605.5	101	acute lymphoblastic leukemia	0.3	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF069_D-HAM3AADXX	25011	16102	14046	12923	12217	11672
THR08_0196_S01	38213826	37243633	36181041	25274622.865	101	acute lymphoblastic leukemia	0.8	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF070_D-HAM3AADXX	27060	18037	15658	14296	13381	12705
THR08_0197_S01	43219579	42243052	40275974	31773032.25	101	acute lymphoblastic leukemia	0.7	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF071_D-HALUBADXX	25883	16033	14073	12991	12248	11712
THR08_0198_S01	38624947	37680165	35080550	26263524.21	101	acute lymphoblastic leukemia	0.2	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF073_R-H8RMVADXX	26085	16360	14297	13211	12429	11822
THR08_0198_S02	37269873	36340202	35042794.5	24223050.93	101	acute lymphoblastic leukemia	0.2	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF073_D-HAM3AADXX	24865	16295	14054	12892	12145	11565
THR08_0199_S01	49479399	48265056	45640953.5	35164336.64	101	acute lymphoblastic leukemia	0.8	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF074_D-HALUBADXX	27407	16832	14565	13315	12519	11950
THR08_0200_S01	49639343	48472798	45715950	34581357.965	101	acute lymphoblastic leukemia	0.2	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJINF075_D-HAMJ5ADXX	25889	15785	13758	12627	11986	11413
THR08_0201_S01	37936050	37004975	35114708	27550960.26	101	acute undifferentiated leukemia	15.8	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJMLL001_D-HAM3AADXX	26201	16186	14158	13045	12281	11723
THR08_0202_S01	39260444	38157372	36926523.5	24056693.82	101	acute lymphoblastic leukemia	15.4	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJMLL002_D-HA4VVADXX	27374	18351	15813	14512	13655	12951
THR08_0203_S01	45685270	44527732	42870564	27904501.6	101	acute lymphoblastic leukemia	16.8	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJMLL003_D-HAMJ5ADXX	26415	17154	14795	13522	12730	12088
THR08_0204_S01	38643583	37643430	34984583.5	26127737.405	101	acute lymphoblastic leukemia	18.7	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJMLL005_D-H8RMVADXX	25135	15783	13672	12597	11888	11372
THR08_0205_S01	45872903	44837871	42662422.5	33135417	101	acute lymphoblastic leukemia	11.9	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJMLL006_D-H8F93ADXX	24252	15145	13305	12321	11686	11227
THR08_0206_S01	31802078	31036842	29659703.5	24508300.5	101	acute lymphoblastic leukemia	7.7	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJMLL008_D-HALUBADXX	25406	16304	14240	13208	12449	11891
THR08_0207_S01	38169852	37338181	35672662	28241480.3	101	acute lymphoblastic leukemia	18.3	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJMLL009_D-HAM3AADXX	25703	16182	13987	12919	12186	11667
THR08_0208_S01	41030605	40024794	38701635.5	27522398.28	101	acute lymphoblastic leukemia	15.2	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJMLL010_D-HAM3AADXX	25034	16399	14293	13134	12359	11782
THR08_0209_S01	48507941	47422791	44789626.5	31927837.5	101	acute myeloid leukemia	11.8	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJMLL011_D-HALUBADXX	26967	16880	14710	13629	12842	12189
THR08_0210_S01	47431295	46420784	44372226	31659284.67	101	acute myeloid leukemia	11.6	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJMLL012_D-H8F93ADXX	26238	16897	14737	13628	12858	12222
THR08_0211_S01	39816182	38958302	35615995.5	26128502.4	101	acute myeloid leukemia	13.4	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJMLL013_D-H8RMJADXX	26112	15896	13639	12475	11715	11150
THR08_0212_S01	45282862	44337742	40928993	26116379.235	101	acute myeloid leukemia	14.6	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJMLL014_D-HALUBADXX	25792	16381	14224	13044	12273	11648
THR08_0213_S01	46521357	45478241	43365583.5	28526482.395	101	acute lymphoblastic leukemia	17.3	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJMLL016_D-H8F93ADXX	26013	16632	14280	13084	12210	11592
THR08_0214_S01	45850883	44979893	39695979.5	26253723.645	101	acute myeloid leukemia	11.1	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJMLL018_D-H8RMJADXX	26493	16015	13814	12637	11858	11204
THR08_0215_S01	45649021	44640035	40618963	28566159.84	101	acute myeloid leukemia	14.6	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJMLL019_D-HALUBADXX	26490	15948	13706	12542	11714	11108
THR08_0216_S01	41131278	40224801	38275065	26889632.9	101	acute myeloid leukemia	8.8	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJMLL020_D-H8RMJADXX	26799	17125	14810	13587	12729	12089
THR08_0217_S01	41353808	40447387	37721697	28378208.705	101	acute myeloid leukemia	10.9	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJMLL021_D-H8RMJADXX	26921	16661	14370	13172	12403	11832
THR08_0218_S01	42037046	41087555	37585187	25248045.6	101	acute myeloid leukemia	14.3	Yes, age < 30 years	NA	NA	NA	Cohort_12	EGAD00001001098	http://dx.doi.org/10.1038/ng.3230	EGA	EGAD00001001098	SJMLL022_D-H8RMJADXX	28307	17136	14583	13241	12303	11665
THR09_0219_S01	56108529	55306648	35561154	28877451.09	101	lymphoma	15	Yes, age < 30 years	male	NA	NA	Cohort_27	EGAD00001000356	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000356	4116738	28375	15477	13370	12044	11051	10186
THR09_0220_S01	38092834	37546381	25760996	22912135.475	101	lymphoma	8	Yes, age < 30 years	male	NA	NA	Cohort_27	EGAD00001000356	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000356	4135350	24922	14193	12308	11255	10473	9858
THR09_0221_S01	53816486	52644462	35215397.5	27257031.12	101	lymphoma	43	No	male	NA	NA	Cohort_27	EGAD00001000356	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000356	4159170	28648	16324	14122	12906	12025	11229
THR09_0222_S01	49003421	48110256	26613848.5	20502992.46	101	lymphoma	75	No	female	NA	NA	Cohort_27	EGAD00001000356	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000356	4163639	31044	15587	13300	12008	10966	10144
THR09_0223_S01	62495928	61259510	34874003	29760144.12	101	lymphoma	13	Yes, age < 30 years	male	NA	NA	Cohort_27	EGAD00001000356	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000356	4189998	26322	13733	11844	10682	9826	9091
THR09_0224_S01	55888115	54626893	31671109.5	25025580.32	101	lymphoma	4	Yes, age < 30 years	male	NA	NA	Cohort_27	EGAD00001000356	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000356	4194218	28082	14727	12670	11465	10666	9915
THR09_0561_S01	49837250	49164423	34547672	27186120.78	101	lymphoma	12	Yes, age < 30 years	male	NA	NA	Cohort_27	EGAD00001000356	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000356	4119027	33697	14396	12268	11141	10334	9659
THR09_0562_S01	46034841	45550448	30743388	26348383.08	101	lymphoma	4	Yes, age < 30 years	male	NA	NA	Cohort_27	EGAD00001000356	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000356	4125240	26936	13995	12061	10954	10191	9544
THR09_0563_S01	54710110	53991352	35119184.5	29168339.72	101	lymphoma	11	Yes, age < 30 years	male	NA	NA	Cohort_27	EGAD00001000356	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000356	4182393	27858	14541	12447	11179	10270	9586
THR09_0564_S01	48786628	48219783	31459898.5	28527374.4	101	lymphoma	15	Yes, age < 30 years	male	NA	NA	Cohort_27	EGAD00001000356	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000356	4190495	26823	15456	13532	12397	11572	10931
THR09_0565_S01	55574954	54989016	38671608	31188920.375	101	lymphoma	74	No	female	NA	NA	Cohort_27	EGAD00001000356	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000356	4101316	27887	15726	13641	12451	11549	10839
THR09_0566_S01	66720249	66204771	42667260	33671148.9	101	lymphoma	40	No	female	NA	NA	Cohort_27	EGAD00001000356	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000356	4105105	29203	15881	13656	12380	11404	10633
THR09_0567_S01	41449016	41154715	24301925.5	20871169.62	101	lymphoma	66	No	male	NA	NA	Cohort_27	EGAD00001000356	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000356	4108101	26243	15937	13951	12796	11916	11241
THR09_0568_S01	38115785	37841789	22793350.5	18891880.66	101	lymphoma	18	Yes, age < 30 years	female	NA	NA	Cohort_27	EGAD00001000356	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000356	4112512	25980	13977	12015	10910	10072	9429
THR09_0569_S01	53569064	53168093	32779035	26128827.45	101	lymphoma	74	No	male	NA	NA	Cohort_27	EGAD00001000356	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000356	4121361	29556	15988	13846	12558	11626	10868
THR09_0570_S01	65823172	65219684	44974152	36405465.18	101	lymphoma	5	Yes, age < 30 years	male	NA	NA	Cohort_27	EGAD00001000356	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000356	4133511	27971	15223	13164	12027	11178	10492
THR09_0571_S01	54530968	54022517	29091135.5	24618096.31	101	lymphoma	5	Yes, age < 30 years	male	NA	NA	Cohort_27	EGAD00001000356	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000356	4142267	25046	12871	11119	9971	9120	8389
THR09_0572_S01	69392647	68585455	49200595.5	37163590.2	101	lymphoma	48	No	male	NA	NA	Cohort_27	EGAD00001000356	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000356	4158726	31717	17546	15134	13918	12919	12170
THR09_0573_S01	65662069	64843650	42508753.5	35026471.05	101	lymphoma	74	No	female	NA	NA	Cohort_27	EGAD00001000356	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000356	4175837	29361	15743	13631	12344	11405	10669
THR09_0574_S01	55432757	54936648	34021353.5	28511102.75	101	lymphoma	10	Yes, age < 30 years	male	NA	NA	Cohort_27	EGAD00001000356	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000356	4177856	26064	13859	11865	10746	9872	9160
THR09_0575_S01	63595446	62960608	38300723.5	31931866.275	101	lymphoma	51	No	female	NA	NA	Cohort_27	EGAD00001000356	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000356	4189200	28018	15291	13258	11966	11023	10285
THR09_0576_S01	64934389	64289301	35501436	30020081.59	101	lymphoma	17	Yes, age < 30 years	male	NA	NA	Cohort_27	EGAD00001000356	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000356	4193278	26050	13322	11497	10382	9569	8874
THR09_0577_S01	62367917	61788350	36729409	31660368.92	101	lymphoma	4	Yes, age < 30 years	male	NA	NA	Cohort_27	EGAD00001000356	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000356	4194891	26280	13838	11937	10879	10069	9435
THR10_0225_S01	91831540	84336748	69155379.5	55142015.775	101	adrenocortical carcinoma	2.98	Yes, age < 30 years	female	NA	NA	Cohort_32	EGAD00001002680	http://dx.doi.org/10.1038/ncomms7302	EGA	EGAD00001002680	SJACT001_D	31169	16321	14099	12894	12027	11333
THR10_0226_S01	48397954	43651119	32810594.5	29218431.95	101	adrenocortical carcinoma	2.63	Yes, age < 30 years	female	NA	NA	Cohort_32	EGAD00001002680	http://dx.doi.org/10.1038/ncomms7302	EGA	EGAD00001002680	SJACT002_D	25898	15236	13224	12075	11236	10595
THR10_0227_S01	52168711	48599383	35468761.5	31853455.83	101	adrenocortical cancer	1.3	Yes, age < 30 years	female	NA	NA	Cohort_32	EGAD00001002680	http://dx.doi.org/10.1038/ncomms7302	EGA	EGAD00001002680	SJACT003_D	26875	14053	12201	11091	10296	9628
THR10_0228_S01	54709021	51471464	31091527.5	28473724.44	101	adrenocortical adenoma	4.98	Yes, age < 30 years	female	NA	NA	Cohort_32	EGAD00001002680	http://dx.doi.org/10.1038/ncomms7302	EGA	EGAD00001002680	SJACT004_D	24541	13850	11998	10804	9919	9190
THR10_0229_S01	17039051	16093435	14396550	12244007.625	101	adrenocortical carcinoma	15.39	Yes, age < 30 years	female	NA	NA	Cohort_32	EGAD00001002680	http://dx.doi.org/10.1038/ncomms7302	EGA	EGAD00001002680	SJACT005_D	23783	15869	13759	12559	11701	11010
THR10_0230_S01	63584958	61571065	52123552	45772132.05	101	adrenocortical carcinoma	11.72	Yes, age < 30 years	female	NA	NA	Cohort_32	EGAD00001002680	http://dx.doi.org/10.1038/ncomms7302	EGA	EGAD00001002680	SJACT006_D	27634	16232	14236	13281	12491	11920
THR10_0231_S01	67010382	65078853	32636092	26798985.72	101	adrenocortical carcinoma	8.58	Yes, age < 30 years	male	NA	NA	Cohort_32	EGAD00001002680	http://dx.doi.org/10.1038/ncomms7302	EGA	EGAD00001002680	SJACT007_D	26195	13844	11750	10434	9471	8686
THR10_0232_S01	42700749	41717147	32281690	28428467.28	101	adrenocortical carcinoma	3.24	Yes, age < 30 years	female	NA	NA	Cohort_32	EGAD00001002680	http://dx.doi.org/10.1038/ncomms7302	EGA	EGAD00001002680	SJACT060_D	26353	14785	12796	11596	10730	10007
THR10_0233_S01	50204381	48872059	40047683.5	36204929.255	101	adrenocortical carcinoma	3.21	Yes, age < 30 years	female	NA	NA	Cohort_32	EGAD00001002680	http://dx.doi.org/10.1038/ncomms7302	EGA	EGAD00001002680	SJACT061_D	26721	15476	13582	12399	11568	10948
THR10_0234_S01	54490983	53140645	43116933	38859406.86	101	adrenocortical carcinoma	4.72	Yes, age < 30 years	female	NA	NA	Cohort_32	EGAD00001002680	http://dx.doi.org/10.1038/ncomms7302	EGA	EGAD00001002680	SJACT062_D	26284	15282	13360	12267	11451	10810
THR10_0235_S01	43061180	42086054	35164655	31359805.52	101	adrenocortical carcinoma	1.36	Yes, age < 30 years	female	NA	NA	Cohort_32	EGAD00001002680	http://dx.doi.org/10.1038/ncomms7302	EGA	EGAD00001002680	SJACT063_D	25533	15193	13267	12179	11392	10753
THR10_0236_S01	48501383	47331928	40030473	36102003.12	101	adrenocortical carcinoma	2.95	Yes, age < 30 years	female	NA	NA	Cohort_32	EGAD00001002680	http://dx.doi.org/10.1038/ncomms7302	EGA	EGAD00001002680	SJACT064_D	26355	15210	13357	12263	11463	10849
THR10_0237_S01	50273291	49085030	38844889.5	34214116.62	101	adrenocortical carcinoma	1.43	Yes, age < 30 years	female	NA	NA	Cohort_32	EGAD00001002680	http://dx.doi.org/10.1038/ncomms7302	EGA	EGAD00001002680	SJACT065_D	25718	15011	13197	12204	11495	10891
THR10_0238_S01	54162798	52892093	45485720.5	40728816.34	101	adrenocortical carcinoma	1.58	Yes, age < 30 years	female	NA	NA	Cohort_32	EGAD00001002680	http://dx.doi.org/10.1038/ncomms7302	EGA	EGAD00001002680	SJACT066_D	27323	15998	14072	12929	12102	11434
THR10_0239_S01	47417884	45565964	4551309.5	2652200	101	adrenocortical cancer	NA	Yes, age < 30 years	female	NA	NA	Cohort_32	EGAD00001002680	http://dx.doi.org/10.1038/ncomms7302	EGA	EGAD00001002680	SJACT067_D	17531	6541	4148	2990	2337	1928
THR10_0240_S01	51200260	50269707	7521108	5761571.72	101	adrenocortical carcinoma	0.88	Yes, age < 30 years	female	NA	NA	Cohort_32	EGAD00001002680	http://dx.doi.org/10.1038/ncomms7302	EGA	EGAD00001002680	SJACT068_D	18288	5781	3445	2378	1759	1361
THR10_0241_S01	46351794	45255529	7137137	5291318.06	101	adrenocortical carcinoma	4.48	Yes, age < 30 years	male	NA	NA	Cohort_32	EGAD00001002680	http://dx.doi.org/10.1038/ncomms7302	EGA	EGAD00001002680	SJACT069_D	18704	8856	6249	4724	3763	3118
THR10_0242_S01	45528909	44724765	5190639	3482159.475	101	adrenocortical carcinoma	0.81	Yes, age < 30 years	male	NA	NA	Cohort_32	EGAD00001002680	http://dx.doi.org/10.1038/ncomms7302	EGA	EGAD00001002680	SJACT070_D	15323	2523	1136	710	516	405
THR10_0243_S01	55862439	54476958	44267016	38704764.27	101	adrenocortical carcinoma	1.48	Yes, age < 30 years	female	NA	NA	Cohort_32	EGAD00001002680	http://dx.doi.org/10.1038/ncomms7302	EGA	EGAD00001002680	SJACT071_D	27728	15408	13417	12267	11459	10782
THR11_0244_S01	36529563	35594371	32983704	28178062.605	101	glioma	14	Yes, age < 30 years	male	NA	NA	Cohort_23	EGAD00001001666	http://dx.doi.org/10.1007/s00401-016-1539-z	EGA	EGAD00001001666	SJLGG001259_D1-H7FBPADXX	28371	18204	16050	14820	13927	13239
THR11_0245_S01	51988228	50737415	15311392.5	13093151.04	101	glioma	6	Yes, age < 30 years	male	NA	NA	Cohort_23	EGAD00001001666	http://dx.doi.org/10.1007/s00401-016-1539-z	EGA	EGAD00001001666	SJLGG001270_D1-D12NVACXX	25836	13589	10881	9089	7721	6677
THR11_0246_S01	45663752	44508481	35138853.5	28165824.8	101	glioma	15	Yes, age < 30 years	female	NA	NA	Cohort_23	EGAD00001001666	http://dx.doi.org/10.1007/s00401-016-1539-z	EGA	EGAD00001001666	SJLGG001271_D1-C4BCBACXX	29848	17891	15464	14045	12956	12161
THR11_0247_S01	44125749	42829211	36466354.5	28806898.8	101	glioma	13	Yes, age < 30 years	male	NA	NA	Cohort_23	EGAD00001001666	http://dx.doi.org/10.1007/s00401-016-1539-z	EGA	EGAD00001001666	SJLGG001272_D1-C4BCBACXX	29984	18274	15783	14425	13533	12749
THR11_0249_S01	40320990	39207204	33272298.5	27830270.89	101	glioma	3	Yes, age < 30 years	female	NA	NA	Cohort_23	EGAD00001001666	http://dx.doi.org/10.1007/s00401-016-1539-z	EGA	EGAD00001001666	SJLGG010130_D1-C4BCBACXX	28353	17778	15437	14132	13195	12417
THR11_0250_S01	55513814	54084120	47454710.5	38788540.83	101	dysembryoplastic neuroepithelial tumor	9	Yes, age < 30 years	male	NA	NA	Cohort_23	EGAD00001001666	http://dx.doi.org/10.1007/s00401-016-1539-z	EGA	EGAD00001001666	SJLGG010669_D1-C2E05ACXX	30528	18452	16060	14719	13750	12967
THR11_0251_S01	44439673	43259042	40445326.5	33399078.405	101	dysembryoplastic neuroepithelial tumor	5	Yes, age < 30 years	male	NA	NA	Cohort_23	EGAD00001001666	http://dx.doi.org/10.1007/s00401-016-1539-z	EGA	EGAD00001001666	SJLGG010670_D1-C2E05ACXX	29021	18566	16241	15003	14163	13487
THR11_0252_S01	38613257	37663557	33566913.5	27579886.62	101	dysembryoplastic neuroepithelial tumor	15	Yes, age < 30 years	female	NA	NA	Cohort_23	EGAD00001001666	http://dx.doi.org/10.1007/s00401-016-1539-z	EGA	EGAD00001001666	SJLGG010671_D1-C2E05ACXX	28833	18437	16039	14699	13788	13002
THR11_0253_S01	44203862	43051729	38941595	33328078.29	101	dysembryoplastic neuroepithelial tumor	17	Yes, age < 30 years	female	NA	NA	Cohort_23	EGAD00001001666	http://dx.doi.org/10.1007/s00401-016-1539-z	EGA	EGAD00001001666	SJLGG010672_D1-C2E05ACXX	29425	18456	16085	14712	13682	12931
THR11_0254_S01	42840571	41683796	38119743	32235400.12	101	dysembryoplastic neuroepithelial tumor	10	Yes, age < 30 years	female	NA	NA	Cohort_23	EGAD00001001666	http://dx.doi.org/10.1007/s00401-016-1539-z	EGA	EGAD00001001666	SJLGG010673_D1-C2E05ACXX	28715	18321	15930	14672	13705	12947
THR11_0255_S01	47218499	45861704	34115731	29090831	101	dysembryoplastic neuroepithelial tumor	5	Yes, age < 30 years	female	NA	NA	Cohort_23	EGAD00001001666	http://dx.doi.org/10.1007/s00401-016-1539-z	EGA	EGAD00001001666	SJLGG010675_D1-C2E05ACXX	27888	16453	14288	13023	12067	11207
THR11_0256_S01	48135000	47029857	40115756.5	33189801.45	101	dysembryoplastic neuroepithelial tumor	17	Yes, age < 30 years	female	NA	NA	Cohort_23	EGAD00001001666	http://dx.doi.org/10.1007/s00401-016-1539-z	EGA	EGAD00001001666	SJLGG010676_D1-C2E05ACXX	28871	18093	15820	14533	13587	12847
THR11_0257_S01	49504450	48311643	42552154	36217584.39	101	dysembryoplastic neuroepithelial tumor	17	Yes, age < 30 years	male	NA	NA	Cohort_23	EGAD00001001666	http://dx.doi.org/10.1007/s00401-016-1539-z	EGA	EGAD00001001666	SJLGG010677_D1-C2E05ACXX	29320	18303	16038	14771	13890	13152
THR11_0258_S01	51917952	50674846	45382878.5	38303770.44	101	dysembryoplastic neuroepithelial tumor	11	Yes, age < 30 years	female	NA	NA	Cohort_23	EGAD00001001666	http://dx.doi.org/10.1007/s00401-016-1539-z	EGA	EGAD00001001666	SJLGG010678_D1-C2E05ACXX	29468	18263	16014	14703	13730	12991
THR11_0259_S01	49018498	47891142	33401775	30043980.89	101	dysembryoplastic neuroepithelial tumor	15	Yes, age < 30 years	female	NA	NA	Cohort_23	EGAD00001001666	http://dx.doi.org/10.1007/s00401-016-1539-z	EGA	EGAD00001001666	SJLGG010679_D1-C2E05ACXX	26085	15773	13707	12405	11423	10663
THR11_0260_S01	49655012	48510653	34361067	29774554.9	101	dysembryoplastic neuroepithelial tumor	12	Yes, age < 30 years	male	NA	NA	Cohort_23	EGAD00001001666	http://dx.doi.org/10.1007/s00401-016-1539-z	EGA	EGAD00001001666	SJLGG010680_D1-C2E05ACXX	28304	16402	13997	12544	11493	10578
THR11_0261_S01	56132276	54683249	38773082.5	29315724.88	101	glioma	5	Yes, age < 30 years	male	NA	NA	Cohort_23	EGAD00001001666	http://dx.doi.org/10.1007/s00401-016-1539-z	EGA	EGAD00001001666	SJLGG011283_D1-C4GBJACXX	30235	17395	14937	13486	12410	11580
THR11_0262_S01	53405195	51950851	43053503.5	35206024	101	glioma	19	Yes, age < 30 years	female	NA	NA	Cohort_23	EGAD00001001666	http://dx.doi.org/10.1007/s00401-016-1539-z	EGA	EGAD00001001666	SJLGG011284_D1-C4BCBACXX	29753	17620	15293	14015	13075	12280
THR11_0263_S01	40509519	39634708	15132535.5	13143163.2	101	glioma	1	Yes, age < 30 years	female	NA	NA	Cohort_23	EGAD00001001666	http://dx.doi.org/10.1007/s00401-016-1539-z	EGA	EGAD00001001666	SJLGG011285_D1-C4BCBACXX	23970	12025	9226	7473	6217	5274
THR11_0264_S01	48308283	47060143	40034241	33340947.51	101	glioma	18	Yes, age < 30 years	male	NA	NA	Cohort_23	EGAD00001001666	http://dx.doi.org/10.1007/s00401-016-1539-z	EGA	EGAD00001001666	SJLGG011286_D1-C4BCBACXX	29789	18007	15662	14392	13519	12762
THR11_0266_S01	59459026	57999330	25056589	21918171.275	101	glioma	8	Yes, age < 30 years	female	NA	NA	Cohort_23	EGAD00001001666	http://dx.doi.org/10.1007/s00401-016-1539-z	EGA	EGAD00001001666	SJLGG011288_D1-C4BCBACXX	24754	12517	10155	8680	7583	6753
THR11_0267_S01	37748620	36710832	33192611.5	23832280	101	glioma	13	Yes, age < 30 years	male	NA	NA	Cohort_23	EGAD00001001666	http://dx.doi.org/10.1007/s00401-016-1539-z	EGA	EGAD00001001666	SJLGG011289_D1-C4BCBACXX	29064	18812	16139	14754	13805	13073
THR11_0268_S01	68676337	67086244	45036353	32229831.04	101	glioma	16	Yes, age < 30 years	male	NA	NA	Cohort_23	EGAD00001001666	http://dx.doi.org/10.1007/s00401-016-1539-z	EGA	EGAD00001001666	SJLGG011290_D1-C4BCBACXX	31261	17088	14642	13197	12181	11290
THR11_0275_S01	37450372	36408342	34235743	28381685.28	101	dysembryoplastic neuroepithelial tumor	13	Yes, age < 30 years	female	NA	NA	Cohort_23	EGAD00001001666	http://dx.doi.org/10.1007/s00401-016-1539-z	EGA	EGAD00001001666	SJLGG064_D-H7FBPADXX	28525	18769	16462	15240	14326	13637
THR11_0276_S01	36077463	35081873	33098481.5	26431896.66	101	dysembryoplastic neuroepithelial tumor	9	Yes, age < 30 years	female	NA	NA	Cohort_23	EGAD00001001666	http://dx.doi.org/10.1007/s00401-016-1539-z	EGA	EGAD00001001666	SJLGG065_D-H7FBPADXX	28367	18683	16276	14983	14163	13490
THR13_0375_S01	82680673	81178965	63986799	54017004.18	101	glioblastoma multiforme	4	Yes, age < 30 years	female	NA	NA	Cohort_26	phs000900.v1.p1	http://dx.doi.org/10.1038/nm.3855	dbGaP	phs000900	SRR1988328, OHSU-DIPG1-RNA(obsolete)	31782	17139	14792	13557	12663	11905
THR13_0376_S01	28541632	27881486	21550776	17595187.335	101	glioma	5	Yes, age < 30 years	male	NA	NA	Cohort_26	phs000900.v1.p1	http://dx.doi.org/10.1038/nm.3855	dbGaP	phs000900	SRR1988329, SU-DIPG-I-RNA(obsolete)	26882	17348	15011	13687	12711	11885
THR13_0377_S02	44694429	43943826	36716009	31522297.32	100	glioblastoma multiforme	7	Yes, age < 30 years	male	NA	NA	Cohort_26	phs000900.v1.p1	http://dx.doi.org/10.1038/nm.3855	dbGaP	phs000900	SRR1988331, SU-DIPG-II-RNA(obsolete)	28337	16182	14072	12936	12128	11477
THR13_0378_S02	49559177	48771268	42054286	36296037.82	100	glioma	12	Yes, age < 30 years	male	NA	NA	Cohort_26	phs000900.v1.p1	http://dx.doi.org/10.1038/nm.3855	dbGaP	phs000900	SRR1988333, SU-DIPG-III-RNA(obsolete)	27302	15731	13918	12962	12244	11628
THR13_0379_S09	18557279	18298446	15107557.5	14335186.95	101	glioblastoma multiforme	2	Yes, age < 30 years	female	NA	NA	Cohort_26	phs000900.v1.p1	http://dx.doi.org/10.1038/nm.3855	dbGaP	phs000900	SRR1988342, SU-DIPG-IV-RNA(obsolete)	21086	14293	12807	11887	11301	10757
THR13_0380_S02	43120304	42567381	31480342.5	19072757.385	101	glioma	13	Yes, age < 30 years	male	NA	NA	Cohort_26	phs000900.v1.p1	http://dx.doi.org/10.1038/nm.3855	dbGaP	phs000900	SRR1988344, SU-DIPG-IX-RNA(obsolete)	36568	27981	25561	24284	23281	22478
THR13_0381_S10	44222787	41841090	7837861.5	4858480.935	101	glioma	7	Yes, age < 30 years	female	NA	NA	Cohort_26	phs000900.v1.p1	http://dx.doi.org/10.1038/nm.3855	dbGaP	phs000900	SRR1988354, SU-DIPG-VI-RNA(obsolete)	29914	26636	25163	24089	23207	22523
THR13_0382_S02	30792378	30406498	25706210.5	15469674.66	101	glioblastoma multiforme	8	Yes, age < 30 years	male	NA	NA	Cohort_26	phs000900.v1.p1	http://dx.doi.org/10.1038/nm.3855	dbGaP	phs000900	SRR1988356, SU-DIPG-VII-RNA(obsolete)	35665	28126	25683	24350	23341	22506
THR13_0383_S01	33708359	33365831	28399317	17589099.825	101	glioma	9	Yes, age < 30 years	male	NA	NA	Cohort_26	phs000900.v1.p1	http://dx.doi.org/10.1038/nm.3855	dbGaP	phs000900	SRR1988357, SU-DIPG-VIII-RNA(obsolete)	36349	27509	25092	23848	22943	22218
THR13_0384_S02	41317134	40887584	31819861.5	19298118.51	101	glioblastoma multiforme	5	Yes, age < 30 years	male	NA	NA	Cohort_26	phs000900.v1.p1	http://dx.doi.org/10.1038/nm.3855	dbGaP	phs000900	SRR1988359, SU-DIPG-XI-RNA(obsolete)	36975	28282	25892	24538	23508	22703
THR13_0385_S01	77659182	76903597	27478550.5	10040704.74	100	glioma	4	Yes, age < 30 years	female	NA	NA	Cohort_26	phs000900.v1.p1	http://dx.doi.org/10.1038/nm.3855	dbGaP	phs000900	SRR1988360, SU-DIPG-XII-RNA(obsolete)	44489	34852	33244	31999	30890	29970
THR13_0386_S01	60606812	59860648	22158372	8077005.585	101	glioma	3	Yes, age < 30 years	female	NA	NA	Cohort_26	phs000900.v1.p1	http://dx.doi.org/10.1038/nm.3855	dbGaP	phs000900	SRR1988361, VU-DIPG.A-RNA(obsolete)	43250	34295	32599	31387	30378	29465
THR13_0963_S01	18594207	18241360	15107557.5	14335186.95	101	glioma	3	Yes, age < 30 years	female	NA	NA	Cohort_26	phs000900.v1.p1	http://dx.doi.org/10.1038/nm.3855	dbGaP	phs000900	SRR1988361, VU-DIPG.A-RNA	21086	14293	12807	11887	11301	10757
THR13_0964_S01	47432944	38164042	26416270	21474582.53	101	glioma	4	Yes, age < 30 years	female	NA	NA	Cohort_26	phs000900.v1.p1	http://dx.doi.org/10.1038/nm.3855	dbGaP	phs000900	SRR1988360, SU-DIPG-XII-RNA	28710	16728	14262	12805	11693	10774
THR13_0965_S01	51106539	47847173	40171660	30772134.9	101	glioblastoma multiforme	5	Yes, age < 30 years	male	NA	NA	Cohort_26	phs000900.v1.p1	http://dx.doi.org/10.1038/nm.3855	dbGaP	phs000900	SRR1988359, SU-DIPG-XI-RNA	29456	18367	16023	14693	13735	12932
THR13_0966_S01	25886125	25118397	7647114	6234061.74	101	glioma	9	Yes, age < 30 years	male	NA	NA	Cohort_26	phs000900.v1.p1	http://dx.doi.org/10.1038/nm.3855	dbGaP	phs000900	SRR1988357, SU-DIPG-VIII-RNA	22483	11486	8699	7005	5823	4965
THR13_0967_S01	13469580	13132524	11632187.5	9565028.775	101	glioblastoma multiforme	8	Yes, age < 30 years	male	NA	NA	Cohort_26	phs000900.v1.p1	http://dx.doi.org/10.1038/nm.3855	dbGaP	phs000900	SRR1988356, SU-DIPG-VII-RNA	23938	17294	15089	13775	12804	12050
THR13_0968_S01	18273188	17825649	15367893.5	13584017.85	101	glioma	7	Yes, age < 30 years	female	NA	NA	Cohort_26	phs000900.v1.p1	http://dx.doi.org/10.1038/nm.3855	dbGaP	phs000900	SRR1988354, SU-DIPG-VI-RNA	25482	17704	15578	14299	13387	12639
THR13_0969_S01	34737702	33554928	17978090	14789699.525	101	glioma	13	Yes, age < 30 years	male	NA	NA	Cohort_26	phs000900.v1.p1	http://dx.doi.org/10.1038/nm.3855	dbGaP	phs000900	SRR1988344, SU-DIPG-IX-RNA	25963	15377	13200	11863	10849	9973
THR13_0970_S01	21973148	21405339	17331617.5	14978902.835	101	glioblastoma multiforme	2	Yes, age < 30 years	female	NA	NA	Cohort_26	phs000900.v1.p1	http://dx.doi.org/10.1038/nm.3855	dbGaP	phs000900	SRR1988342, SU-DIPG-IV-RNA	26209	17202	14955	13695	12731	11995
THR13_0971_S01	21030524	20459990	16029966	13436680.95	101	glioma	12	Yes, age < 30 years	male	NA	NA	Cohort_26	phs000900.v1.p1	http://dx.doi.org/10.1038/nm.3855	dbGaP	phs000900	SRR1988333, SU-DIPG-III-RNA	26529	17818	15431	14013	12980	12115
THR13_0972_S01	23500069	22794874	16842872	13804374.68	101	glioblastoma multiforme	7	Yes, age < 30 years	male	NA	NA	Cohort_26	phs000900.v1.p1	http://dx.doi.org/10.1038/nm.3855	dbGaP	phs000900	SRR1988331, SU-DIPG-II-RNA	25941	16833	14411	12876	11816	10961
THR13_0973_S01	18328241	17836204	14011480	12131575.065	101	glioma	5	Yes, age < 30 years	male	NA	NA	Cohort_26	phs000900.v1.p1	http://dx.doi.org/10.1038/nm.3855	dbGaP	phs000900	SRR1988329, SU-DIPG-I-RNA	25121	16570	14327	12989	12005	11191
THR13_0974_S01	37261200	33900934	18541196	15753961.91	101	glioblastoma multiforme	4	Yes, age < 30 years	female	NA	NA	Cohort_26	phs000900.v1.p1	http://dx.doi.org/10.1038/nm.3855	dbGaP	phs000900	SRR1988328, OHSU-DIPG1-RNA	26022	15423	12921	11330	10173	9191
THR14_0297_S01	61812945	59750150	47524963	41298677.035	100	glioblastoma multiforme	11.7	Yes, age < 30 years	male	NA	NA	Cohort_20	10.24370/SD_BHJXBDQK	http://dx.doi.org/10.24370/SD_BHJXBDQK	Cavatica	CBTTC	7316-1057-T, aliquot 401550, cohort CPF1505001	29031	16927	14825	13646	12805	12091
THR14_0298_S01	90208409	87055048	58512556	54357040.635	100	glioma	1.7	Yes, age < 30 years	female	NA	NA	Cohort_20	10.24370/SD_BHJXBDQK	http://dx.doi.org/10.24370/SD_BHJXBDQK	Cavatica	CBTTC	7316-1455-T, aliquot 400856, cohort CPF1505001	28854	15560	13714	12617	11790	11086
THR14_0299_S01	93808673	86514227	54970503	47169059.265	100	supratentorial embryonal tumor NOS	2.8	Yes, age < 30 years	female	NA	NA	Cohort_20	10.24370/SD_BHJXBDQK	http://dx.doi.org/10.24370/SD_BHJXBDQK	Cavatica	CBTTC	7316-155-T, aliquot 406957, cohort CPF1505001	30381	17578	15363	13921	12837	11968
THR14_0300_S01	77524444	76194195	61729300.5	54409333.28	100	supratentorial embryonal tumor NOS	17.8	Yes, age < 30 years	male	NA	NA	Cohort_20	10.24370/SD_BHJXBDQK	http://dx.doi.org/10.24370/SD_BHJXBDQK	Cavatica	CBTTC	7316-158-T, aliquot 398452, cohort CPF1505001	28551	16467	14520	13504	12783	12239
THR14_0301_S01	92620802	89999350	67505408.5	58925137.425	100	glioblastoma multiforme	16.2	Yes, age < 30 years	male	NA	NA	Cohort_20	10.24370/SD_BHJXBDQK	http://dx.doi.org/10.24370/SD_BHJXBDQK	Cavatica	CBTTC	7316-161-T, aliquot 406959, cohort CPF1505001	30751	17298	15157	13979	13108	12322
THR14_0302_S01	71965429	46682674	16110999.5	13073461.155	100	glioblastoma multiforme	6.8	Yes, age < 30 years	female	NA	NA	Cohort_20	10.24370/SD_BHJXBDQK	http://dx.doi.org/10.24370/SD_BHJXBDQK	Cavatica	CBTTC	7316-194-RNA_406978 , cohort CPF1505001	26264	15805	13577	12197	11189	10365
THR14_0303_S01	70368710	67566562	45157761	40152347.235	100	glioma	13.5	Yes, age < 30 years	female	NA	NA	Cohort_20	10.24370/SD_BHJXBDQK	http://dx.doi.org/10.24370/SD_BHJXBDQK	Cavatica	CBTTC	7316-204-T, aliquot 398058, cohort CPF1505001	28489	16138	14186	12994	12136	11386
THR14_0304_S01	85666219	84069500	64313045	58063930.5	100	glioblastoma multiforme	16.7	Yes, age < 30 years	female	NA	NA	Cohort_20	10.24370/SD_BHJXBDQK	http://dx.doi.org/10.24370/SD_BHJXBDQK	Cavatica	CBTTC	7316-255-T, aliquot 401560, cohort CPF1505001	29108	16302	14397	13297	12496	11872
THR14_0305_S01	83091171	81460486	64138568.5	57411751.875	100	glioblastoma multiforme	14.4	Yes, age < 30 years	male	NA	NA	Cohort_20	10.24370/SD_BHJXBDQK	http://dx.doi.org/10.24370/SD_BHJXBDQK	Cavatica	CBTTC	7316-287-T, aliquot 398451, cohort CPF1505001	30518	17066	15107	13988	13220	12588
THR14_0306_S01	72728898	71181813	56692921.5	50961667.68	100	glioblastoma multiforme	14.7	Yes, age < 30 years	female	NA	NA	Cohort_20	10.24370/SD_BHJXBDQK	http://dx.doi.org/10.24370/SD_BHJXBDQK	Cavatica	CBTTC	7316-288-T, aliquot 398450, cohort CPF1505001	28302	16086	14322	13277	12482	11847
THR14_0308_S01	84230945	82497973	63205333	56006048.82	100	glioblastoma multiforme	17.7	Yes, age < 30 years	female	NA	NA	Cohort_20	10.24370/SD_BHJXBDQK	http://dx.doi.org/10.24370/SD_BHJXBDQK	Cavatica	CBTTC	7316-343-T, aliquot 401742, cohort CPF1505001	29972	17265	15248	14102	13184	12415
THR14_0309_S01	79034190	77127442	58492406.5	53342336.22	100	glioma	5.2	Yes, age < 30 years	female	NA	NA	Cohort_20	10.24370/SD_BHJXBDQK	http://dx.doi.org/10.24370/SD_BHJXBDQK	Cavatica	CBTTC	7316-388-T, aliquot 398449, cohort CPF1505001	29318	16800	14857	13711	12842	12122
THR14_0310_S01	67624158	65759121	49266243.5	45622908.3	100	glioblastoma multiforme	15.4	Yes, age < 30 years	male	NA	NA	Cohort_20	10.24370/SD_BHJXBDQK	http://dx.doi.org/10.24370/SD_BHJXBDQK	Cavatica	CBTTC	7316-392-T, aliquot 401743, cohort CPF1505001	27175	16076	14218	13084	12239	11494
THR14_0311_S01	90345718	85073457	44989810.5	40267466.07	100	glioblastoma multiforme	11.6	Yes, age < 30 years	female	NA	NA	Cohort_20	10.24370/SD_BHJXBDQK	http://dx.doi.org/10.24370/SD_BHJXBDQK	Cavatica	CBTTC	7316-409-T, aliquot 398448, cohort CPF1505001	29196	15565	13521	12129	11129	10267
THR14_0312_S01	68614327	67078561	51563615.5	47441616.375	100	glioma	18.5	Yes, age < 30 years	male	NA	NA	Cohort_20	10.24370/SD_BHJXBDQK	http://dx.doi.org/10.24370/SD_BHJXBDQK	Cavatica	CBTTC	7316-445-T, aliquot 401741, cohort CPF1505001	28694	16836	14831	13690	12835	12125
THR14_0313_S01	90010854	87827152	65159224.5	59089661.015	100	glioma	7.1	Yes, age < 30 years	male	NA	NA	Cohort_20	10.24370/SD_BHJXBDQK	http://dx.doi.org/10.24370/SD_BHJXBDQK	Cavatica	CBTTC	7316-466-T, aliquot 401561, cohort CPF1505001	28297	16310	14465	13376	12556	11869
THR14_0314_S01	74526792	72733189	52545711	44517190.38	100	supratentorial embryonal tumor NOS	7.6	Yes, age < 30 years	female	NA	NA	Cohort_20	10.24370/SD_BHJXBDQK	http://dx.doi.org/10.24370/SD_BHJXBDQK	Cavatica	CBTTC	7316-512-T, aliquot 401962, cohort CPF1505001	30723	17092	14807	13561	12604	11823
THR14_0315_S01	81047028	78788155	63748908.5	56735943.88	100	supratentorial embryonal tumor NOS	9	Yes, age < 30 years	female	NA	NA	Cohort_20	10.24370/SD_BHJXBDQK	http://dx.doi.org/10.24370/SD_BHJXBDQK	Cavatica	CBTTC	7316-536-T, aliquot 400788, cohort CPF1505001	30038	17616	15560	14331	13474	12827
THR14_0316_S01	65505638	63289361	46658248	42920517.02	100	glioblastoma multiforme	NA	Yes, age < 30 years	female	NA	NA	Cohort_20	10.24370/SD_BHJXBDQK	http://dx.doi.org/10.24370/SD_BHJXBDQK	Cavatica	CBTTC	7316-619-T, aliquot 400121, cohort CPF1505001	26923	15988	14158	13101	12270	11594
THR14_0317_S01	88179706	68101433	23140045	20078833.875	100	glioblastoma multiforme	NA	Yes, age < 30 years	female	NA	NA	Cohort_20	10.24370/SD_BHJXBDQK	http://dx.doi.org/10.24370/SD_BHJXBDQK	Cavatica	CBTTC	7316-620-T, aliquot 400120, cohort CPF1505001	26275	14210	12253	10913	9964	9124
THR14_0318_S01	97672640	93660301	63397167	56934605.04	100	glioblastoma multiforme	NA	Yes, age < 30 years	male	NA	NA	Cohort_20	10.24370/SD_BHJXBDQK	http://dx.doi.org/10.24370/SD_BHJXBDQK	Cavatica	CBTTC	7316-622-T, aliquot 400789, cohort CPF1505001	29745	16363	14362	13100	12166	11367
THR14_0319_S01	79801641	63154540	11568120.5	10069056.54	100	glioblastoma multiforme	NA	Yes, age < 30 years	female	NA	NA	Cohort_20	10.24370/SD_BHJXBDQK	http://dx.doi.org/10.24370/SD_BHJXBDQK	Cavatica	CBTTC	7316-624-T, aliquot 400268, cohort CPF1505001	22072	8711	6049	4625	3747	3143
THR14_0320_S01	74033094	71936773	51465477.5	48298393.5	100	glioblastoma multiforme	1.4	Yes, age < 30 years	male	NA	NA	Cohort_20	10.24370/SD_BHJXBDQK	http://dx.doi.org/10.24370/SD_BHJXBDQK	Cavatica	CBTTC	7316-716-T, aliquot 400787, cohort CPF1505001	26856	15713	13902	12891	12066	11384
THR14_0321_S01	82869060	79619726	54513303.5	49461732	100	supratentorial embryonal tumor NOS	1.8	Yes, age < 30 years	female	NA	NA	Cohort_20	10.24370/SD_BHJXBDQK	http://dx.doi.org/10.24370/SD_BHJXBDQK	Cavatica	CBTTC	7316-784-T, aliquot 401961, cohort CPF1505001	28606	15808	13871	12782	11975	11326
THR14_0322_S01	102631146	57298476	4736750.5	3311814.15	100	glioma	9.8	Yes, age < 30 years	male	NA	NA	Cohort_20	10.24370/SD_BHJXBDQK	http://dx.doi.org/10.24370/SD_BHJXBDQK	Cavatica	CBTTC	7316-804-T, aliquot 400267, cohort CPF1505001	20445	9392	6503	4911	3899	3243
THR14_0323_S01	78952869	46399875	4118672	2955581.78	100	supratentorial embryonal tumor NOS	NA	Yes, age < 30 years	male	NA	NA	Cohort_20	10.24370/SD_BHJXBDQK	http://dx.doi.org/10.24370/SD_BHJXBDQK	Cavatica	CBTTC	7316-840-T, aliquot 400764, cohort CPF1505001	19781	6448	4052	2934	2338	1939
THR14_0324_S01	82199524	80206139	60214284.5	55617595.62	100	glioblastoma multiforme	2.5	Yes, age < 30 years	male	NA	NA	Cohort_20	10.24370/SD_BHJXBDQK	http://dx.doi.org/10.24370/SD_BHJXBDQK	Cavatica	CBTTC	7316-85-T, aliquot 398059, cohort CPF1505001	28216	16298	14477	13386	12567	11908
THR14_0325_S01	77930569	76464335	60626550	51789218.25	100	supratentorial embryonal tumor NOS	1.4	Yes, age < 30 years	male	NA	NA	Cohort_20	10.24370/SD_BHJXBDQK	http://dx.doi.org/10.24370/SD_BHJXBDQK	Cavatica	CBTTC	7316-87-T, aliquot 401963, cohort CPF1505001	30134	16870	14705	13595	12816	12244
THR14_0326_S01	85497014	83411782	61969353.5	55980669.76	100	glioma	10.2	Yes, age < 30 years	female	NA	NA	Cohort_20	10.24370/SD_BHJXBDQK	http://dx.doi.org/10.24370/SD_BHJXBDQK	Cavatica	CBTTC	7316-870-T, aliquot 398453, cohort CPF1505001	28945	16581	14584	13493	12653	11986
THR14_0327_S01	85777427	72111243	31437961	28451064	100	glioblastoma multiforme	11.4	Yes, age < 30 years	female	NA	NA	Cohort_20	10.24370/SD_BHJXBDQK	http://dx.doi.org/10.24370/SD_BHJXBDQK	Cavatica	CBTTC	7316-942-T, aliquot 400855, cohort CPF1505001	27175	14304	12157	10771	9709	8864
THR14_1235_S02	78777318	77053390	57692967.5	50540915.04	100	medulloblastoma	15.2	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_20	10.24370/SD_BHJXBDQK	http://dx.doi.org/10.24370/SD_BHJXBDQK	Cavatica	CBTTC	7316-333-T, aliquot 398057, cohort CPF1505001	28887	16094	14163	13081	12312	11604
THR15_0328_S01	82728616	77800105	35536477	33266162.28	76	osteosarcoma	NA	Yes, age < 30 years	male	NA	NA	Cohort_19	phs000699.v1.p1	http://dx.doi.org/10.1073/pnas.1419260111	dbGaP	phs000699	SRR1701572	25263	14889	13210	12097	11263	10547
THR15_0329_S01	86574921	80427928	32403726	30217609.5	76	osteosarcoma	NA	Yes, age < 30 years	female	NA	NA	Cohort_19	phs000699.v1.p1	http://dx.doi.org/10.1073/pnas.1419260111	dbGaP	phs000699	SRR1701812	23540	13434	11586	10384	9433	8634
THR15_0330_S01	90912978	84446151	24412970	22198149.96	76	osteosarcoma	NA	Yes, age < 30 years	female	NA	NA	Cohort_19	phs000699.v1.p1	http://dx.doi.org/10.1073/pnas.1419260111	dbGaP	phs000699	SRR1701197	23916	13013	10916	9440	8408	7581
THR15_0331_S01	26092969	6085692	3542012.5	3270333.6	76	osteosarcoma	NA	Yes, age < 30 years	female	NA	NA	Cohort_19	phs000699.v1.p1	http://dx.doi.org/10.1073/pnas.1419260111	dbGaP	phs000699	SRR1701090	19749	12774	10360	8740	7539	6607
THR15_0332_S01	68445715	24083628	6592782	5462812.35	76	osteosarcoma	NA	Yes, age < 30 years	male	NA	NA	Cohort_19	phs000699.v1.p1	http://dx.doi.org/10.1073/pnas.1419260111	dbGaP	phs000699	SRR1701102	20803	14130	11996	10585	9542	8711
THR15_0333_S01	117836240	88561184	8149714.5	7261875.69	76	osteosarcoma	NA	Yes, age < 30 years	male	NA	NA	Cohort_19	phs000699.v1.p1	http://dx.doi.org/10.1073/pnas.1419260111	dbGaP	phs000699	SRR1701511	20247	13406	11286	9728	8665	7812
THR15_0334_S01	94511395	88221057	39657284	35762669.64	76	osteosarcoma	NA	Yes, age < 30 years	female	NA	NA	Cohort_19	phs000699.v1.p1	http://dx.doi.org/10.1073/pnas.1419260111	dbGaP	phs000699	SRR1701622	26115	14691	12789	11549	10604	9820
THR15_0335_S01	12628520	9854079	1756475	1610737.975	76	osteosarcoma	NA	Yes, age < 30 years	male	NA	NA	Cohort_19	phs000699.v1.p1	http://dx.doi.org/10.1073/pnas.1419260111	dbGaP	phs000699	SRR1701117	16837	14704	13492	12644	11955	11266
THR15_0336_S01	86603953	80592630	49753843.5	45691218.545	76	osteosarcoma	NA	Yes, age < 30 years	male	NA	NA	Cohort_19	phs000699.v1.p1	http://dx.doi.org/10.1073/pnas.1419260111	dbGaP	phs000699	SRR1701662	27158	15276	13467	12375	11472	10731
THR15_0337_S01	101587548	94775090	52031137.5	47531446.8	76	osteosarcoma	NA	Yes, age < 30 years	male	NA	NA	Cohort_19	phs000699.v1.p1	http://dx.doi.org/10.1073/pnas.1419260111	dbGaP	phs000699	SRR1701796	26510	15042	13213	12115	11299	10643
THR15_0338_S01	81951884	75917293	22487296.5	20902399.07	76	osteosarcoma	NA	Yes, age < 30 years	male	NA	NA	Cohort_19	phs000699.v1.p1	http://dx.doi.org/10.1073/pnas.1419260111	dbGaP	phs000699	SRR1701153	22693	13495	11778	10657	9784	9075
THR15_0339_S01	92189965	86729038	42197962.5	39553119.6	76	osteosarcoma	NA	Yes, age < 30 years	female	NA	NA	Cohort_19	phs000699.v1.p1	http://dx.doi.org/10.1073/pnas.1419260111	dbGaP	phs000699	SRR1701172	24843	14324	12603	11630	10805	10138
THR15_0340_S01	63574179	53480920	8664486.5	7974010.38	76	osteosarcoma	NA	Yes, age < 30 years	female	NA	NA	Cohort_19	phs000699.v1.p1	http://dx.doi.org/10.1073/pnas.1419260111	dbGaP	phs000699	SRR1701307	21103	14879	13076	11906	10945	10217
THR15_0341_S01	84630964	78640426	34758316	32616552.93	76	osteosarcoma	NA	Yes, age < 30 years	female	NA	NA	Cohort_19	phs000699.v1.p1	http://dx.doi.org/10.1073/pnas.1419260111	dbGaP	phs000699	SRR1701742	24268	13924	12285	11170	10281	9540
THR15_0342_S01	91217527	84970799	28664246.5	25985764.085	76	osteosarcoma	NA	Yes, age < 30 years	female	NA	NA	Cohort_19	phs000699.v1.p1	http://dx.doi.org/10.1073/pnas.1419260111	dbGaP	phs000699	SRR1701291	24378	15071	13295	12182	11317	10605
THR15_0343_S01	99948193	90130414	30184976.5	27452101.56	76	osteosarcoma	NA	Yes, age < 30 years	female	NA	NA	Cohort_19	phs000699.v1.p1	http://dx.doi.org/10.1073/pnas.1419260111	dbGaP	phs000699	SRR1701343	25518	14485	12739	11680	10839	10058
THR15_0344_S01	88444194	82298436	40721698	37627929.69	76	osteosarcoma	NA	Yes, age < 30 years	male	NA	NA	Cohort_19	phs000699.v1.p1	http://dx.doi.org/10.1073/pnas.1419260111	dbGaP	phs000699	SRR1701527	25281	15107	13425	12369	11618	10972
THR15_0345_S01	102453106	95774881	58272508.5	53302515.6	76	osteosarcoma	NA	Yes, age < 30 years	female	NA	NA	Cohort_19	phs000699.v1.p1	http://dx.doi.org/10.1073/pnas.1419260111	dbGaP	phs000699	SRR1701405	26644	14674	12857	11698	10835	10116
THR15_0346_S01	93065053	85842910	25339207.5	22843416.285	76	osteosarcoma	NA	Yes, age < 30 years	male	NA	NA	Cohort_19	phs000699.v1.p1	http://dx.doi.org/10.1073/pnas.1419260111	dbGaP	phs000699	SRR1701473	24316	14113	12228	11111	10245	9512
THR15_0347_S01	96713453	89716263	41954426	38165169.735	76	osteosarcoma	NA	Yes, age < 30 years	female	NA	NA	Cohort_19	phs000699.v1.p1	http://dx.doi.org/10.1073/pnas.1419260111	dbGaP	phs000699	SRR1701556	27200	15733	13614	12421	11463	10587
THR15_0348_S01	87894524	62333535	39782011.5	37828803.87	76	osteosarcoma	NA	Yes, age < 30 years	male	NA	NA	Cohort_19	phs000699.v1.p1	http://dx.doi.org/10.1073/pnas.1419260111	dbGaP	phs000699	SRR1701454	25188	15159	13400	12309	11491	10782
THR15_0349_S01	121144205	112848598	62280977	57004608.28	76	osteosarcoma	NA	Yes, age < 30 years	female	NA	NA	Cohort_19	phs000699.v1.p1	http://dx.doi.org/10.1073/pnas.1419260111	dbGaP	phs000699	SRR1701435	27755	15543	13782	12736	11947	11278
THR15_0350_S01	70508908	55231286	30581286.5	28917348.72	76	osteosarcoma	NA	Yes, age < 30 years	female	NA	NA	Cohort_19	phs000699.v1.p1	http://dx.doi.org/10.1073/pnas.1419260111	dbGaP	phs000699	SRR1701327	24251	14880	13172	12070	11295	10652
THR15_0351_S01	92008725	86257426	10206652	9327310.775	76	osteosarcoma	NA	Yes, age < 30 years	male	NA	NA	Cohort_19	phs000699.v1.p1	http://dx.doi.org/10.1073/pnas.1419260111	dbGaP	phs000699	SRR1701598	20286	12098	9800	8352	7215	6352
THR15_0352_S01	85216230	78938652	24916265.5	22692772.89	76	osteosarcoma	NA	Yes, age < 30 years	female	NA	NA	Cohort_19	phs000699.v1.p1	http://dx.doi.org/10.1073/pnas.1419260111	dbGaP	phs000699	SRR1701256	22420	13242	11481	10298	9342	8567
THR15_0353_S01	101733187	93511435	29975545	26843199.32	76	osteosarcoma	NA	Yes, age < 30 years	male	NA	NA	Cohort_19	phs000699.v1.p1	http://dx.doi.org/10.1073/pnas.1419260111	dbGaP	phs000699	SRR1701777	25830	15458	13511	12249	11355	10578
THR15_0354_S01	94132563	87919162	55004589.5	52083741.45	76	osteosarcoma	NA	Yes, age < 30 years	male	NA	NA	Cohort_19	phs000699.v1.p1	http://dx.doi.org/10.1073/pnas.1419260111	dbGaP	phs000699	SRR1701638	25298	14709	13124	12232	11515	10926
THR15_0355_S01	91653360	82521822	30704926.5	27226843	76	osteosarcoma	NA	Yes, age < 30 years	female	NA	NA	Cohort_19	phs000699.v1.p1	http://dx.doi.org/10.1073/pnas.1419260111	dbGaP	phs000699	SRR1701369	25266	14610	12640	11398	10418	9545
THR15_0356_S01	86337401	81104449	53688307	50189000.4	76	osteosarcoma	NA	Yes, age < 30 years	female	NA	NA	Cohort_19	phs000699.v1.p1	http://dx.doi.org/10.1073/pnas.1419260111	dbGaP	phs000699	SRR1701828	26098	14865	13233	12277	11510	10824
THR15_0357_S01	88421021	83428859	57939721.5	54747609.15	76	osteosarcoma	NA	Yes, age < 30 years	male	NA	NA	Cohort_19	phs000699.v1.p1	http://dx.doi.org/10.1073/pnas.1419260111	dbGaP	phs000699	SRR1701489	24827	14662	13088	12138	11455	10837
THR15_0358_S01	112647353	104742270	20869236.5	19466663.2	76	osteosarcoma	NA	Yes, age < 30 years	male	NA	NA	Cohort_19	phs000699.v1.p1	http://dx.doi.org/10.1073/pnas.1419260111	dbGaP	phs000699	SRR1701272	21887	12718	10887	9762	8857	8115
THR15_0359_S01	95910208	89946638	42730012.5	38511744.03	76	osteosarcoma	NA	Yes, age < 30 years	male	NA	NA	Cohort_19	phs000699.v1.p1	http://dx.doi.org/10.1073/pnas.1419260111	dbGaP	phs000699	SRR1701137	26980	14896	12953	11739	10814	10047
THR15_0360_S01	70950119	60706638	29382604.5	27727890.19	76	osteosarcoma	NA	Yes, age < 30 years	male	NA	NA	Cohort_19	phs000699.v1.p1	http://dx.doi.org/10.1073/pnas.1419260111	dbGaP	phs000699	SRR1701687	24486	14432	12535	11318	10389	9584
THR15_0361_S01	61280599	56397419	34519507.5	32502802.255	76	osteosarcoma	NA	Yes, age < 30 years	male	NA	NA	Cohort_19	phs000699.v1.p1	http://dx.doi.org/10.1073/pnas.1419260111	dbGaP	phs000699	SRR1701708	23996	14577	12982	11978	11240	10579
THR15_0362_S01	100063011	94497303	49049774.5	46265300.64	76	osteosarcoma	NA	Yes, age < 30 years	male	NA	NA	Cohort_19	phs000699.v1.p1	http://dx.doi.org/10.1073/pnas.1419260111	dbGaP	phs000699	SRR1701216	25928	15256	13671	12644	11864	11217
THR17_0387_S01	78780009	74623622	61558759.5	41363913.13	100	medulloblastoma	5	Yes, age < 30 years	male	NA	NA	Cohort_34	EGAD00001000158	http://dx.doi.org/10.1038/nature11327	EGA	EGAD00001000158	EGAZ00001000198_81MHLABXX_2_withJunctionsOnGenome_dupsFlagged, MB-0182, MYC-2	32300	18246	15379	13866	12828	12009
THR17_0388_S01	63512958	59236631	43188339.5	32203499.265	100	medulloblastoma	29	Yes, age < 30 years	male	NA	NA	Cohort_34	EGAD00001000158	http://dx.doi.org/10.1038/nature11327	EGA	EGAD00001000158	EGAZ00001000199_81MHLABXX_4_withJunctionsOnGenome_dupsFlagged, MB-412, MYC-4	29478	16633	14176	12804	11791	10983
THR17_0389_S01	73575453	69369578	59163140	42270336	100	medulloblastoma	3	Yes, age < 30 years	male	NA	NA	Cohort_34	EGAD00001000158	http://dx.doi.org/10.1038/nature11327	EGA	EGAD00001000158	EGAZ00001000200_81MHLABXX_5_withJunctionsOnGenome_dupsFlagged, MB-549, MYC-5	31366	18048	15472	14083	13113	12369
THR17_0390_S01	66614029	62850262	56572072.5	41576822.85	100	medulloblastoma	7	Yes, age < 30 years	male	NA	NA	Cohort_34	EGAD00001000158	http://dx.doi.org/10.1038/nature11327	EGA	EGAD00001000158	EGAZ00001000201_81MHLABXX_6_withJunctionsOnGenome_dupsFlagged, MB-591, MYC-6	32024	19807	17034	15510	14447	13638
THR17_0391_S01	72846606	68544794	60123290.5	43158770.54	100	medulloblastoma	4	Yes, age < 30 years	male	NA	NA	Cohort_34	EGAD00001000158	http://dx.doi.org/10.1038/nature11327	EGA	EGAD00001000158	EGAZ00001000202_81MHLABXX_8_withJunctionsOnGenome_dupsFlagged, MB-759, MYC-8	33794	20422	17555	15902	14790	13873
THR17_0392_S01	84452915	78897036	65718603	50208552.4	100	medulloblastoma	4.5	Yes, age < 30 years	male	NA	NA	Cohort_34	EGAD00001000158	http://dx.doi.org/10.1038/nature11327	EGA	EGAD00001000158	EGAZ00001000212_81CMBABXX_3_withJunctionsOnGenome_dupsFlagged, MB-0586, Primary/Met-10	32001	17940	15449	14039	13032	12210
THR17_0393_S01	91303966	85976641	76717387.5	51783308.22	100	medulloblastoma	4	Yes, age < 30 years	female	NA	NA	Cohort_34	EGAD00001000158	http://dx.doi.org/10.1038/nature11327	EGA	EGAD00001000158	EGAZ00001000218_81MAGABXX_3_withJunctionsOnGenome_dupsFlagged, MB-0329, GroupC-1	32763	19522	16808	15272	14202	13425
THR17_0394_S01	72157614	67719549	59466900	43614031.26	100	medulloblastoma	8	Yes, age < 30 years	male	NA	NA	Cohort_34	EGAD00001000158	http://dx.doi.org/10.1038/nature11327	EGA	EGAD00001000158	EGAZ00001000219_81MAGABXX_4_withJunctionsOnGenome_dupsFlagged, MB-0333, GroupC-2	30149	18259	15703	14298	13367	12625
THR17_0395_S01	95319239	89195867	71838056.5	49482605.075	100	medulloblastoma	4.9	Yes, age < 30 years	male	NA	NA	Cohort_34	EGAD00001000158	http://dx.doi.org/10.1038/nature11327	EGA	EGAD00001000158	EGAZ00001000221_81MAGABXX_6_withJunctionsOnGenome_dupsFlagged, MB-0511, GroupC-4	31587	18295	15712	14228	13247	12457
THR17_0396_S01	94575905	87919038	71959600.5	53568765.585	100	medulloblastoma	3.2	Yes, age < 30 years	male	NA	NA	Cohort_34	EGAD00001000158	http://dx.doi.org/10.1038/nature11327	EGA	EGAD00001000158	EGAZ00001000223_81MAGABXX_8_withJunctionsOnGenome_dupsFlagged, MB-0532, GroupC-6	31285	17730	15274	13871	12939	12159
THR17_0397_S01	67622792	63628667	55714713.5	42712013.995	100	medulloblastoma	1	Yes, age < 30 years	male	NA	NA	Cohort_34	EGAD00001000158	http://dx.doi.org/10.1038/nature11327	EGA	EGAD00001000158	EGAZ00001000226_81MAGABXX_1_withJunctionsOnGenome_dupsFlagged, MB-0594, GroupC-9	31166	18044	15555	14247	13273	12506
THR17_0398_S01	85219997	80237140	71338700	50572807.19	100	medulloblastoma	4	Yes, age < 30 years	male	NA	NA	Cohort_34	EGAD00001000158	http://dx.doi.org/10.1038/nature11327	EGA	EGAD00001000158	EGAZ00001000227_81MAGABXX_2_withJunctionsOnGenome_dupsFlagged, MB-0607, GroupC-10	33579	20166	17360	15743	14595	13709
THR17_0399_S01	62423537	59555879	51189940.5	39066942.33	100	medulloblastoma	4	Yes, age < 30 years	male	NA	NA	Cohort_34	EGAD00001000158	http://dx.doi.org/10.1038/nature11327	EGA	EGAD00001000158	EGAZ00001000232_81MK3ABXX_3_withJunctionsOnGenome_dupsFlagged, MB-0439, GroupD-5	30192	18434	15835	14452	13472	12705
THR17_0400_S01	83229145	78828617	66561390.5	47586602.03	100	medulloblastoma	11	Yes, age < 30 years	male	NA	NA	Cohort_34	EGAD00001000158	http://dx.doi.org/10.1038/nature11327	EGA	EGAD00001000158	EGAZ00001000233_81MK3ABXX_4_withJunctionsOnGenome_dupsFlagged, MB-0447, GroupD-6	31471	18315	15655	14191	13208	12464
THR17_0401_S01	78062548	73562295	43738259	31860880.8	100	medulloblastoma	8	Yes, age < 30 years	male	NA	NA	Cohort_34	EGAD00001000158	http://dx.doi.org/10.1038/nature11327	EGA	EGAD00001000158	EGAZ00001000236_81MK3ABXX_7_withJunctionsOnGenome_dupsFlagged, MB-0569, GroupD-9	31588	18276	15649	14149	13000	12154
THR17_0402_S01	54547842	52216083	47853685.5	35397038.07	100	medulloblastoma	9	Yes, age < 30 years	female	NA	NA	Cohort_34	EGAD00001000158	http://dx.doi.org/10.1038/nature11327	EGA	EGAD00001000158	EGAZ00001000237_81MK3ABXX_8_withJunctionsOnGenome_dupsFlagged, MB-0600, GroupD-10	30322	18603	16009	14609	13644	12839
THR17_0403_S01	88540428	82820782	38666856	25389514.5	100	medulloblastoma	10	Yes, age < 30 years	male	NA	NA	Cohort_34	EGAD00001000158	http://dx.doi.org/10.1038/nature11327	EGA	EGAD00001000158	EGAZ00001000235_81MK3ABXX_6_withJunctionsOnGenome_dupsFlagged, MB-0563, GroupD-8	29044	17151	14735	13290	12261	11464
THR18_0404_S01	73232187	69051288	64005156	52515735.16	51	medulloblastoma	8	Yes, age < 30 years	male	NA	NA	Cohort_42	EGAD00001000328	http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001000328	EGAR00001049879_RNA_tumor_ICGC_MB26	32907	16905	14771	13619	12746	12084
THR18_0405_S01	74585083	70310418	50460586	36001748.225	51	medulloblastoma	4	Yes, age < 30 years	female	NA	NA	Cohort_42	EGAD00001000328	http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001000328	EGAR00001049884_RNA_tumor_ICGC_MB35	42783	16437	13789	12227	11144	10330
THR18_0406_S01	99906770	94303211	79362762	68455316.64	51	medulloblastoma	1	Yes, age < 30 years	female	NA	NA	Cohort_42	EGAD00001000328	http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001000328	EGAR00001049886_RNA_tumor_ICGC_MB37	33025	16177	14218	13095	12303	11577
THR18_0407_S01	96492084	93076962	49432268	41424865.77	51	medulloblastoma	6	Yes, age < 30 years	male	NA	NA	Cohort_42	EGAD00001000328	http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001000328	EGAR00001049887_RNA_tumor_ICGC_MB38	37983	15504	12889	11279	10152	9244
THR18_0408_S01	100590047	95369239	65474324	44762800.05	51	medulloblastoma	3	Yes, age < 30 years	male	NA	NA	Cohort_42	EGAD00001000328	http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001000328	EGAR00001049889_RNA_tumor_ICGC_MB45	42390	17060	13707	12062	11007	10209
THR18_0409_S01	95181162	91506740	58012352	51518605.995	51	medulloblastoma	10	Yes, age < 30 years	male	NA	NA	Cohort_42	EGAD00001000328	http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001000328	EGAR00001049891_RNA_tumor_ICGC_MB49	32353	15813	13622	12381	11475	10723
THR19_0440_S01	77322535	74946957	46607328	34059109.95	51	glioma	23	Yes, age < 30 years	female	NA	NA	Cohort_28	EGAD00001000617	http://dx.doi.org/10.1038/ng.2682, http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000617	EGAR00001124529_RNA-seq_PAIRED_ICGC_PA20_s_120110_6	31846	16494	13864	12362	11158	10254
THR19_0441_S01	89685682	87550412	56887043	46382432.8	51	glioma	2	Yes, age < 30 years	male	NA	NA	Cohort_28	EGAD00001000617	http://dx.doi.org/10.1038/ng.2682, http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000617	EGAR00001124530_RNA-seq_PAIRED_ICGC_PA24_s_120110_4	32037	16889	14643	13336	12349	11575
THR19_0442_S01	65260912	60504875	51036861	43586325.51	51	glioma	3	Yes, age < 30 years	male	NA	NA	Cohort_28	EGAD00001000617	http://dx.doi.org/10.1038/ng.2682, http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000617	EGAR00001124531_RNA-seq_PAIRED_ICGC_PA25_s_111201_2b	30176	16284	14150	12914	11920	11153
THR19_0443_S01	48790342	46404467	31922957	28049696.535	51	glioma	2	Yes, age < 30 years	male	NA	NA	Cohort_28	EGAD00001000617	http://dx.doi.org/10.1038/ng.2682, http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000617	EGAR00001124532_RNA-seq_PAIRED_ICGC_PA34_s_110809_4	29063	16440	14415	13176	12267	11531
THR19_0444_S01	69326847	65827412	46165237	40541243.1	51	glioma	9	Yes, age < 30 years	male	NA	NA	Cohort_28	EGAD00001000617	http://dx.doi.org/10.1038/ng.2682, http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000617	EGAR00001124533_RNA-seq_PAIRED_ICGC_PA37_s_110809_2	29959	16711	14724	13441	12500	11699
THR19_0445_S01	155481719	148565814	100899859	77456080.56	51	glioma	15	Yes, age < 30 years	female	NA	NA	Cohort_28	EGAD00001000617	http://dx.doi.org/10.1038/ng.2682, http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000617	EGAR00001124534_RNA-seq_PAIRED_ICGC_PA41_s_110818_1	36053	18537	16004	14610	13655	12832
THR19_0446_S01	126780269	122108708	72304463	63051988.065	51	glioma	3	Yes, age < 30 years	male	NA	NA	Cohort_28	EGAD00001000617	http://dx.doi.org/10.1038/ng.2682, http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000617	EGAR00001124535_RNA-seq_PAIRED_ICGC_PA42_s_110908_3	33362	17764	15548	14228	13214	12406
THR19_0447_S01	144084399	138262980	80465320	73148569.92	51	glioma	9	Yes, age < 30 years	male	NA	NA	Cohort_28	EGAD00001000617	http://dx.doi.org/10.1038/ng.2682, http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000617	EGAR00001124536_RNA-seq_PAIRED_ICGC_PA46_s_110818_2	31129	16006	14193	13039	12107	11321
THR19_0449_S01	82046774	76502519	62587002	56012121.88	51	glioma	10	Yes, age < 30 years	male	NA	NA	Cohort_28	EGAD00001000617	http://dx.doi.org/10.1038/ng.2682, http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000617	EGAR00001124538_RNA-seq_PAIRED_ICGC_PA53_s_111201_1a	29477	15840	13975	12860	11933	11156
THR19_0450_S01	133116899	119941076	102761916	91118159.355	51	glioma	5	Yes, age < 30 years	female	NA	NA	Cohort_28	EGAD00001000617	http://dx.doi.org/10.1038/ng.2682, http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000617	EGAR00001124539_RNA-seq_PAIRED_ICGC_PA55_s_111201_2b	31973	16725	14835	13707	12875	12154
THR19_0451_S01	87969229	82885469	62512777	55355741.865	51	glioma	9	Yes, age < 30 years	male	NA	NA	Cohort_28	EGAD00001000617	http://dx.doi.org/10.1038/ng.2682, http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000617	EGAR00001124540_RNA-seq_PAIRED_ICGC_PA56_s_111201_3b	29296	15097	13173	11871	10849	10048
THR19_0452_S01	112836599	105321406	88573380	79413786.75	51	glioma	13	Yes, age < 30 years	male	NA	NA	Cohort_28	EGAD00001000617	http://dx.doi.org/10.1038/ng.2682, http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000617	EGAR00001124541_RNA-seq_PAIRED_ICGC_PA58_s_111201_4a	31008	16211	14272	13141	12281	11541
THR19_0453_S01	94054565	87994074	75258707	66697691.31	51	glioma	5	Yes, age < 30 years	female	NA	NA	Cohort_28	EGAD00001000617	http://dx.doi.org/10.1038/ng.2682, http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000617	EGAR00001124542_RNA-seq_PAIRED_ICGC_PA59_s_111201_4b	30862	16224	14390	13312	12491	11782
THR19_0454_S01	118793183	109902633	85641561	74997756.24	51	glioma	4	Yes, age < 30 years	female	NA	NA	Cohort_28	EGAD00001000617	http://dx.doi.org/10.1038/ng.2682, http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000617	EGAR00001124543_RNA-seq_PAIRED_ICGC_PA62_s_111201_5b	31215	15819	13848	12544	11549	10736
THR19_0455_S01	106348056	98981437	87499474	74448966.24	51	glioma	17	Yes, age < 30 years	female	NA	NA	Cohort_28	EGAD00001000617	http://dx.doi.org/10.1038/ng.2682, http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000617	EGAR00001124544_RNA-seq_PAIRED_ICGC_PA63_s_111201_5a	31898	16981	14900	13796	12952	12214
THR19_0456_S01	106419155	100139848	73882198	66827795.46	51	glioma	4	Yes, age < 30 years	male	NA	NA	Cohort_28	EGAD00001000617	http://dx.doi.org/10.1038/ng.2682, http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000617	EGAR00001124545_RNA-seq_PAIRED_ICGC_PA64_s_111201_6a	30175	15664	13636	12325	11256	10382
THR19_0457_S01	106644178	99371852	78000810	69533013.48	51	glioma	16	Yes, age < 30 years	male	NA	NA	Cohort_28	EGAD00001000617	http://dx.doi.org/10.1038/ng.2682, http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000617	EGAR00001124546_RNA-seq_PAIRED_ICGC_PA65_s_111201_6b	30310	15780	13970	12778	11869	11150
THR19_0458_S01	113681487	103945027	77096772	61039528	51	glioma	6	Yes, age < 30 years	female	NA	NA	Cohort_28	EGAD00001000617	http://dx.doi.org/10.1038/ng.2682, http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000617	EGAR00001124547_RNA-seq_PAIRED_ICGC_PA69_s_111201_7b	35702	16029	13941	12584	11512	10652
THR19_0459_S01	98595150	92295829	61124456	51589184.195	51	glioma	6	Yes, age < 30 years	male	NA	NA	Cohort_28	EGAD00001000617	http://dx.doi.org/10.1038/ng.2682, http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000617	EGAR00001124548_RNA-seq_PAIRED_ICGC_PA70_s_111201_7a	31972	15960	13872	12637	11626	10783
THR19_0460_S01	91875302	84428425	70128750	64292266.14	51	glioma	2	Yes, age < 30 years	female	NA	NA	Cohort_28	EGAD00001000617	http://dx.doi.org/10.1038/ng.2682, http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000617	EGAR00001124549_RNA-seq_PAIRED_ICGC_PA71_s_111201_8a	29189	16088	14290	13149	12314	11591
THR19_0461_S01	139365657	128040139	103015102	91798584.68	51	glioma	9	Yes, age < 30 years	male	NA	NA	Cohort_28	EGAD00001000617	http://dx.doi.org/10.1038/ng.2682, http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000617	EGAR00001124550_RNA-seq_PAIRED_ICGC_PA73_s_111201_8b	32640	16376	14326	13025	12080	11341
THR19_0462_S01	97768379	92137531	74420937	67271873.04	51	glioma	6	Yes, age < 30 years	male	NA	NA	Cohort_28	EGAD00001000617	http://dx.doi.org/10.1038/ng.2682, http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000617	EGAR00001124551_RNA-seq_PAIRED_ICGC_PA79_s_111201_1a	29406	15715	13956	12845	11975	11221
THR19_0463_S01	126327628	119682190	100875176	82041988.455	51	glioma	14	Yes, age < 30 years	male	NA	NA	Cohort_28	EGAD00001000617	http://dx.doi.org/10.1038/ng.2682, http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000617	EGAR00001124552_RNA-seq_PAIRED_ICGC_PA81_s_111201_2a	33181	17272	15075	13878	12997	12273
THR20_0481_S01	85263077	76340556	66502035	24134136.96	51	medulloblastoma	17	Yes, age < 30 years	male	NA	NA	Cohort_18	EGAD00001001620	http://dx.doi.org/10.1016/j.cell.2013.09.042, http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001001620	EGAR00001049871_RNA_tumor_ICGC_MB15	34916	18196	15201	13462	12182	11124
THR20_0482_S01	91951719	81301385	57407383	26290684.275	51	medulloblastoma	3	Yes, age < 30 years	male	NA	NA	Cohort_18	EGAD00001001620	http://dx.doi.org/10.1016/j.cell.2013.09.042, http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001001620	EGAR00001049872_RNA_tumor_ICGC_MB16	31623	15452	12728	11046	9798	8821
THR20_0483_S01	108252505	101678579	85032699	66865449.465	51	medulloblastoma	6	Yes, age < 30 years	female	NA	NA	Cohort_18	EGAD00001001620	http://dx.doi.org/10.1016/j.cell.2013.09.042, http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001001620	EGAR00001049874_RNA_tumor_ICGC_MB1	34206	17474	15106	13765	12830	12047
THR20_0484_S01	123543698	117271249	103449267	77503842.41	51	medulloblastoma	9	Yes, age < 30 years	female	NA	NA	Cohort_18	EGAD00001001620	http://dx.doi.org/10.1016/j.cell.2013.09.042, http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001001620	EGAR00001049875_RNA_tumor_ICGC_MB20	35951	18890	16235	14817	13842	13098
THR20_0485_S01	89794392	83783277	71631297	62476877.175	51	medulloblastoma	4	Yes, age < 30 years	female	NA	NA	Cohort_18	EGAD00001001620	http://dx.doi.org/10.1016/j.cell.2013.09.042, http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001001620	EGAR00001049876_RNA_tumor_ICGC_MB21	29960	16162	14238	13192	12389	11804
THR20_0486_S01	108296900	102277146	90151024	76144419.12	51	medulloblastoma	10	Yes, age < 30 years	female	NA	NA	Cohort_18	EGAD00001001620	http://dx.doi.org/10.1016/j.cell.2013.09.042, http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001001620	EGAR00001049877_RNA_tumor_ICGC_MB23	33550	17376	15109	13844	12962	12255
THR20_0487_S01	69797885	66136808	63329847	46890707.85	51	medulloblastoma	7	Yes, age < 30 years	male	NA	NA	Cohort_18	EGAD00001001620	http://dx.doi.org/10.1016/j.cell.2013.09.042, http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001001620	EGAR00001049878_RNA_tumor_ICGC_MB24	33887	20108	17326	15788	14727	13914
THR20_0488_S01	99602404	96713579	64392853	56056480.755	51	medulloblastoma	7	Yes, age < 30 years	male	NA	NA	Cohort_18	EGAD00001001620	http://dx.doi.org/10.1016/j.cell.2013.09.042, http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001001620	EGAR00001049880_RNA_tumor_ICGC_MB2	34067	17514	15228	13912	12925	12096
THR20_0489_S01	79515663	74581566	62972396	55538701.1	51	medulloblastoma	14	Yes, age < 30 years	female	NA	NA	Cohort_18	EGAD00001001620	http://dx.doi.org/10.1016/j.cell.2013.09.042, http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001001620	EGAR00001049881_RNA_tumor_ICGC_MB31	30401	15646	13749	12518	11665	10940
THR20_0490_S01	93880344	87456429	74229981	62602754.28	51	medulloblastoma	8	Yes, age < 30 years	female	NA	NA	Cohort_18	EGAD00001001620	http://dx.doi.org/10.1016/j.cell.2013.09.042, http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001001620	EGAR00001049882_RNA_tumor_ICGC_MB32	33325	17624	15347	14041	13111	12313
THR20_0491_S01	83344000	81118869	56147519	45314647.74	51	medulloblastoma	13	Yes, age < 30 years	female	NA	NA	Cohort_18	EGAD00001001620	http://dx.doi.org/10.1016/j.cell.2013.09.042, http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001001620	EGAR00001049883_RNA_tumor_ICGC_MB34	32129	16190	14103	12981	12156	11449
THR20_0492_S01	87524264	86316844	47667534	40911231.045	51	medulloblastoma	4	Yes, age < 30 years	male	NA	NA	Cohort_18	EGAD00001001620	http://dx.doi.org/10.1016/j.cell.2013.09.042, http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001001620	EGAR00001049885_RNA_tumor_ICGC_MB36	30414	15079	13217	12170	11389	10733
THR20_0493_S01	77692068	75590888	53627230	42317113.96	51	medulloblastoma	4	Yes, age < 30 years	male	NA	NA	Cohort_18	EGAD00001001620	http://dx.doi.org/10.1016/j.cell.2013.09.042, http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001001620	EGAR00001049888_RNA_tumor_ICGC_MB39	33499	17611	15212	13824	12806	11988
THR20_0494_S01	74733048	71529425	49132635	41808432.9	51	medulloblastoma	6	Yes, age < 30 years	female	NA	NA	Cohort_18	EGAD00001001620	http://dx.doi.org/10.1016/j.cell.2013.09.042, http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001001620	EGAR00001049890_RNA_tumor_ICGC_MB46	37262	17048	14575	13096	11981	11118
THR20_0495_S01	101966663	96580902	77500697	68631268.86	51	medulloblastoma	10	Yes, age < 30 years	female	NA	NA	Cohort_18	EGAD00001001620	http://dx.doi.org/10.1016/j.cell.2013.09.042, http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001001620	EGAR00001049892_RNA_tumor_ICGC_MB50	30530	15063	13124	12022	11176	10454
THR20_0496_S01	92485505	85494180	75540987	60586609.5	51	medulloblastoma	7	Yes, age < 30 years	male	NA	NA	Cohort_18	EGAD00001001620	http://dx.doi.org/10.1016/j.cell.2013.09.042, http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001001620	EGAR00001049893_RNA_tumor_ICGC_MB51	32490	17579	15165	13821	12902	12137
THR20_0497_S01	72262260	68170957	63659950	50013656.8	51	medulloblastoma	6	Yes, age < 30 years	female	NA	NA	Cohort_18	EGAD00001001620	http://dx.doi.org/10.1016/j.cell.2013.09.042, http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001001620	EGAR00001049894_RNA_tumor_ICGC_MB5	32865	19193	16643	15260	14282	13533
THR20_0498_S01	83333339	81171038	61841976	43783688.395	51	medulloblastoma	14	Yes, age < 30 years	female	NA	NA	Cohort_18	EGAD00001001620	http://dx.doi.org/10.1016/j.cell.2013.09.042, http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001001620	EGAR00001049895_RNA_tumor_ICGC_MB6	34836	19425	16636	15059	13914	13020
THR20_0499_S01	198486001	191092266	73829676	50165414.705	51	medulloblastoma	9	Yes, age < 30 years	female	NA	NA	Cohort_18	EGAD00001001620	http://dx.doi.org/10.1016/j.cell.2013.09.042, http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001001620	EGAR00001352522_RNA-Seq_paired-end_ICGC_MB176_s_130514_2	30149	8175	4697	3044	2185	1689
THR20_0500_S01	204869610	197475309	106801967	61137777.155	51	medulloblastoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_18	EGAD00001001620	http://dx.doi.org/10.1016/j.cell.2013.09.042, http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001001620	EGAR00001352523_RNA-Seq_paired-end_ICGC_MB200_s_130611_7	31042	8566	5147	3419	2479	1882
THR20_0501_S01	199865101	193344635	109296981	50756091.06	51	medulloblastoma	1	Yes, age < 30 years	male	NA	NA	Cohort_18	EGAD00001001620	http://dx.doi.org/10.1016/j.cell.2013.09.042, http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001001620	EGAR00001352526_RNA-Seq_paired-end_ICGC_MB28_s_131010_7	30421	8150	4695	2973	2122	1600
THR20_0502_S01	223942800	211932091	69017099	52390938.6	51	medulloblastoma	5	Yes, age < 30 years	female	NA	NA	Cohort_18	EGAD00001001620	http://dx.doi.org/10.1016/j.cell.2013.09.042, http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001001620	EGAR00001352529_RNA-Seq_paired-end_ICGC_MB206_s_130705_8	26567	6377	3322	2123	1535	1221
THR20_0503_S01	194231002	189307077	139764240	56280510.49	51	medulloblastoma	8	Yes, age < 30 years	male	NA	NA	Cohort_18	EGAD00001001620	http://dx.doi.org/10.1016/j.cell.2013.09.042, http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001001620	EGAR00001352536_RNA-Seq_paired-end_MB-1M21_s_140401_5	35931	11819	8888	7127	5835	4821
THR20_0504_S01	197136454	193991340	152333722	59676652	51	medulloblastoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_18	EGAD00001001620	http://dx.doi.org/10.1016/j.cell.2013.09.042, http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001001620	EGAR00001352537_RNA-Seq_paired-end_MB-4M23_s_140401_3	36018	13696	10894	9161	7897	6877
THR20_0505_S01	198738586	195239669	136593123	61111848.45	51	medulloblastoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_18	EGAD00001001620	http://dx.doi.org/10.1016/j.cell.2013.09.042, http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001001620	EGAR00001352538_RNA-Seq_paired-end_MB-4M26_s_140401_6	35369	12677	9955	8141	6814	5758
THR20_0506_S01	183401531	176643334	129967171	40586649.075	51	medulloblastoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_18	EGAD00001001620	http://dx.doi.org/10.1016/j.cell.2013.09.042, http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001001620	EGAR00001352539_RNA-Seq_paired-end_MB-4M77_s_140401_4	35950	14459	11383	9534	8178	7052
THR20_0507_S01	208054457	204466654	140594911	88319520.835	51	medulloblastoma	13	Yes, age < 30 years	female	NA	NA	Cohort_18	EGAD00001001620	http://dx.doi.org/10.1016/j.cell.2013.09.042, http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001001620	EGAR00001352541_RNA-Seq_paired-end_ICGC_MB19_s_131010_4	35961	16111	13628	12308	11338	10506
THR20_0508_S01	239388465	224994107	65560575	47316329.35	51	medulloblastoma	18	Yes, age < 30 years	male	NA	NA	Cohort_18	EGAD00001001620	http://dx.doi.org/10.1016/j.cell.2013.09.042, http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001001620	EGAR00001352546_RNA-Seq_paired-end_ICGC_MB64_s_130308_8	26851	5680	2893	1882	1332	1050
THR20_0509_S01	204949068	200834655	165444465	61754954.25	51	medulloblastoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_18	EGAD00001001620	http://dx.doi.org/10.1016/j.cell.2013.09.042, http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001001620	EGAR00001352551_RNA-Seq_paired-end_MB-1M1_s_140401_2	36851	14519	11519	9753	8445	7421
THR20_0510_S01	295089486	280637573	106706844	65977591.68	51	medulloblastoma	10	Yes, age < 30 years	female	NA	NA	Cohort_18	EGAD00001001620	http://dx.doi.org/10.1016/j.cell.2013.09.042, http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001001620	EGAD00001001620_ICGC_MB110	30121	7402	4193	2607	1871	1425
THR20_0511_S01	319457636	289197921	97732382	65910624.3	51	medulloblastoma	14	Yes, age < 30 years	female	NA	NA	Cohort_18	EGAD00001001620	http://dx.doi.org/10.1016/j.cell.2013.09.042, http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001001620	EGAD00001001620_ICGC_MB113	27128	5420	2569	1583	1136	881
THR20_0512_S01	285400672	277701658	143419865	55776936.51	51	medulloblastoma	3	Yes, age < 30 years	male	NA	NA	Cohort_18	EGAD00001001620	http://dx.doi.org/10.1016/j.cell.2013.09.042, http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001001620	EGAD00001001620_ICGC_MB12	37227	16532	13312	11419	10060	8922
THR20_0513_S01	234676437	230723025	113551408	81119312.105	51	medulloblastoma	13	Yes, age < 30 years	female	NA	NA	Cohort_18	EGAD00001001620	http://dx.doi.org/10.1016/j.cell.2013.09.042, http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001001620	EGAD00001001620_ICGC_MB18	33763	14030	11947	10713	9730	8831
THR20_0514_S01	290520834	282448136	145917589	67570011.18	51	medulloblastoma	3	Yes, age < 30 years	male	NA	NA	Cohort_18	EGAD00001001620	http://dx.doi.org/10.1016/j.cell.2013.09.042, http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001001620	EGAD00001001620_ICGC_MB40	34185	9827	6479	4433	3180	2417
THR20_0515_S01	197056324	176649182	139839816	82558172.94	51	medulloblastoma	9	Yes, age < 30 years	male	NA	NA	Cohort_18	EGAD00001001620	http://dx.doi.org/10.1016/j.cell.2013.09.042, http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001001620	EGAD00001001620_ICGC_MB7	35819	17527	14672	13216	12200	11459
THR20_0516_S01	211740692	207525223	155394918	85107316.76	51	medulloblastoma	6	Yes, age < 30 years	male	NA	NA	Cohort_18	EGAD00001001620	http://dx.doi.org/10.1016/j.cell.2013.09.042, http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001001620	EGAD00001001620_ICGC_MB9	37514	15650	12991	11490	10386	9395
THR20_0517_S01	299580117	288024230	84790559	67900144.4	51	medulloblastoma	2	Yes, age < 30 years	male	NA	NA	Cohort_18	EGAD00001001620	http://dx.doi.org/10.1016/j.cell.2013.09.042, http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001001620	EGAD00001001620_ICGC_MB90	25810	6735	3763	2419	1755	1363
THR20_0518_S01	279929997	269246932	51335834	24123836.37	51	medulloblastoma	15	Yes, age < 30 years	male	NA	NA	Cohort_18	EGAD00001001620	http://dx.doi.org/10.1016/j.cell.2013.09.042, http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001001620	EGAD00001001620_ICGC_MB91	31773	9176	5767	3851	2775	2095
THR20_0519_S01	280552422	269856611	81423431	29207299.3	51	medulloblastoma	3	Yes, age < 30 years	male	NA	NA	Cohort_18	EGAD00001001620	http://dx.doi.org/10.1016/j.cell.2013.09.042, http://dx.doi.org/10.1038/nature11284	EGA	EGAD00001001620	EGAD00001001620_ICGC_MB95	34794	9060	5319	3409	2344	1751
THR22_0578_S01	61523681	60913485	42899485.5	33500262.9	101	lymphoma	64	No	male	NA	NA	Cohort_25	EGAD00001000648	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000648	4102009	28359	15283	13151	11981	11127	10470
THR22_0579_S01	57417255	56871080	38294795	30483910.4	101	lymphoma	16	Yes, age < 30 years	male	NA	NA	Cohort_25	EGAD00001000648	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000648	4104893	28040	15389	13275	12048	11183	10429
THR22_0580_S01	60445507	59795407	38997978.5	32295614.85	101	lymphoma	59	No	male	NA	NA	Cohort_25	EGAD00001000648	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000648	4107137	28524	15527	13405	12174	11289	10510
THR22_0581_S01	57385822	56774294	39218624.5	31142323.87	101	lymphoma	48	No	female	NA	NA	Cohort_25	EGAD00001000648	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000648	4120193	30159	16180	13894	12675	11761	11028
THR22_0582_S01	62984718	62276375	43395082	32843139.8	101	lymphoma	8	Yes, age < 30 years	male	NA	NA	Cohort_25	EGAD00001000648	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000648	4127766	28338	15462	13195	11970	11138	10390
THR22_0583_S01	38554157	38213754	23284864.5	19759264.05	101	lymphoma	67	No	male	NA	NA	Cohort_25	EGAD00001000648	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000648	4134005	25973	15406	13340	12149	11312	10580
THR22_0584_S01	54611186	54100954	32116217	27428303.28	101	lymphoma	70	No	male	NA	NA	Cohort_25	EGAD00001000648	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000648	4139696	28106	15096	12976	11694	10750	9963
THR22_0585_S01	66734102	65968675	44419171	37163026.375	101	lymphoma	14	Yes, age < 30 years	male	NA	NA	Cohort_25	EGAD00001000648	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000648	4146289	29271	16207	13992	12809	11899	11151
THR22_0586_S01	53339569	52815807	37907278	32804069.55	101	lymphoma	62	No	male	NA	NA	Cohort_25	EGAD00001000648	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000648	4160468	27743	15910	13855	12715	11875	11210
THR22_0587_S01	48299724	47826912	34470859	26902135.775	101	lymphoma	62	No	male	NA	NA	Cohort_25	EGAD00001000648	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000648	4166706	28472	16233	14036	12736	11812	11005
THR22_0588_S01	47679747	47209680	33329352.5	26940025.03	101	lymphoma	56	No	male	NA	NA	Cohort_25	EGAD00001000648	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000648	4170686	28964	16346	14169	12889	11949	11167
THR22_0589_S01	54280022	53733316	36475129.5	30897916.925	101	lymphoma	72	No	male	NA	NA	Cohort_25	EGAD00001000648	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000648	4174905	27845	15784	13722	12495	11584	10853
THR22_0590_S01	55655931	54961143	32943160.5	29014088.39	101	lymphoma	73	No	female	NA	NA	Cohort_25	EGAD00001000648	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000648	4177376	26571	14227	12367	11217	10390	9654
THR22_0591_S01	46108065	45659652	30841848.5	24054119.59	101	lymphoma	52	No	female	NA	NA	Cohort_25	EGAD00001000648	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000648	4177601	31793	16393	14204	12863	11842	11082
THR22_0592_S01	72575872	71743327	47780721.5	40249524.7	101	lymphoma	71	No	male	NA	NA	Cohort_25	EGAD00001000648	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000648	4177987	29881	16012	13953	12735	11799	11048
THR22_0593_S01	46522759	46049352	28385974.5	22408091.425	101	lymphoma	57	No	female	NA	NA	Cohort_25	EGAD00001000648	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000648	4184094	29573	16173	13908	12574	11658	10888
THR22_0594_S01	60498561	59718254	41378007	32187571.31	101	lymphoma	76	No	male	NA	NA	Cohort_25	EGAD00001000648	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000648	4188900	29125	16272	14062	12832	11874	11119
THR22_0595_S01	51848486	51401126	36051414.5	30311231.58	101	lymphoma	16	Yes, age < 30 years	male	NA	NA	Cohort_25	EGAD00001000648	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000648	4191799	28528	15951	13864	12622	11677	10886
THR22_0599_S01	46717877	46225562	32143767	26069745.24	101	lymphoma	6	Yes, age < 30 years	male	NA	NA	Cohort_25	EGAD00001000648	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000648	4130003	27160	14686	12499	11353	10533	9876
THR22_0600_S01	53490493	52838883	37557474	29635693.31	101	lymphoma	72	No	male	NA	NA	Cohort_25	EGAD00001000648	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000648	4131257	29070	16333	14138	12959	12036	11338
THR22_0601_S01	33103212	32747361	22480989	19582785.11	101	lymphoma	68	No	male	NA	NA	Cohort_25	EGAD00001000648	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000648	4131744	25722	14685	12727	11646	10832	10223
THR22_0602_S01	69321421	68625854	46509414.5	38484024.33	101	lymphoma	70	No	female	NA	NA	Cohort_25	EGAD00001000648	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000648	4171706	29876	16101	14055	12819	11920	11195
THR22_0603_S01	54471164	53907087	34559348	28059149.52	101	lymphoma	70	No	male	NA	NA	Cohort_25	EGAD00001000648	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000648	4172511	28750	15297	13212	12009	11083	10347
THR22_0604_S01	54119533	53582451	35067120.5	28610066.275	101	lymphoma	47	No	female	NA	NA	Cohort_25	EGAD00001000648	http://dx.doi.org/10.1016/j.cell.2013.09.042	EGA	EGAD00001000648	4177810	28463	15558	13469	12291	11377	10624
THR23_0606_S01	12601552	7475452	1350468	344526.435	36	Ewing sarcoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_46	SRP006575	No publication	SRA	SRP006575	sra_scrape_09-2016/SRR191682	27142	15439	11526	9439	8156	7276
THR23_0607_S01	15869499	8530063	1452250	354130.425	36	Ewing sarcoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_46	SRP006575	No publication	SRA	SRP006575	sra_scrape_09-2016/SRR191683	27339	14349	10568	8548	7348	6553
THR23_0608_S01	206916	99060	30122	15469.79	36	Ewing sarcoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_46	SRP006575	No publication	SRA	SRP006575	sra_scrape_09-2016/SRR191684	7107	7011	6574	6030	5601	5224
THR23_0609_S01	17310238	11486387	1471246.5	447312.69	36	Ewing sarcoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_46	SRP006575	No publication	SRA	SRP006575	sra_scrape_09-2016/SRR191685	28303	10892	7918	6529	5693	5177
THR24_1458_S01	63584958	61571065	52123552	45772132.05	101	adrenocortical carcinoma	11.719444	Yes, age < 30 years	female	NA	NA	Cohort_44	SJC_Other	https://doi.org/10.1038/ncomms7302	SJC	SJC-DS-1001	SJACT006_D	27634	16232	14236	13281	12491	11920
THR24_1459_S01	65094318	62131915	53912518	36488344.8	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	https://doi.org/10.1016/j.ccr.2012.10.007	SJC	SJC-DS-1001	SJAMLM7001_D	30072	17734	15005	13569	12673	12019
THR24_1460_S01	64561763	62090938	52296606.5	38273967.27	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	https://doi.org/10.1016/j.ccr.2012.10.007	SJC	SJC-DS-1001	SJAMLM7003_D	27557	15410	13121	12001	11238	10668
THR24_1461_S01	130543363	124784154	4214	3485.625	101	acute megakaryoblastic leukemia	2.41	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_5	SJC_AMLM	https://doi.org/10.1016/j.ccr.2012.10.007	SJC	SJC-DS-1001	SJAMLM7004_D	27980	14046	12203	11286	10602	10040
THR24_1462_S01	68769137	66296320	58438378.5	38833946.4	101	acute megakaryoblastic leukemia	2.17	Yes, age < 30 years	female	NA	NA	Cohort_5	SJC_AMLM	https://doi.org/10.1016/j.ccr.2012.10.007	SJC	SJC-DS-1001	SJAMLM7005_D	30605	18287	15503	14013	13001	12295
THR24_1463_S01	66260663	62459346	50921337	40594720.94	101	acute megakaryoblastic leukemia	1	Yes, age < 30 years	male	NA	NA	Cohort_5	SJC_AMLM	https://doi.org/10.1016/j.ccr.2012.10.007	SJC	SJC-DS-1001	SJAMLM7006_D	27911	15503	13385	12286	11595	11055
THR24_1464_S01	66766561	63318775	54758176	35270048.295	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	https://doi.org/10.1016/j.ccr.2012.10.007	SJC	SJC-DS-1001	SJAMLM7007_D	29506	17872	15092	13676	12719	12015
THR24_1465_S01	70854510	68190232	61813348.5	39275789.085	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	https://doi.org/10.1016/j.ccr.2012.10.007	SJC	SJC-DS-1001	SJAMLM7008_D	30445	19082	16266	14677	13631	12851
THR24_1466_S01	102078612	97195529	84071171	56659329.6	101	acute megakaryoblastic leukemia	1.33	Yes, age < 30 years	male	NA	Hispanic or Latino	Cohort_5	SJC_AMLM	https://doi.org/10.1016/j.ccr.2012.10.007	SJC	SJC-DS-1001	SJAMLM7009_D	29216	16602	14127	12797	11997	11345
THR24_1467_S01	53582294	51790223	45864674	38380681.845	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7010472_R1	27735	15819	13836	12753	12003	11472
THR24_1468_S01	52305271	51041647	47059881.5	38228967.04	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	male	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7010475_D1	26228	15293	13406	12413	11749	11229
THR24_1469_S01	51440493	49752609	45906962.5	37243207.875	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7010478_D1	27959	16557	14355	13279	12555	12019
THR24_1470_S01	62647861	61220784	50834114	36189044.045	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7010479_D1	27407	15252	13058	11995	11233	10657
THR24_1471_S01	46012135	44920579	39935829.5	30876391.94	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7010482_D1	26893	15374	13306	12238	11527	10984
THR24_1472_S01	51078628	46258702	28967028.5	9496196.76	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7010483_G2	23419	14972	12276	10625	9437	8510
THR24_1472_S02	43065177	39098977	21429451	12732710.15	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7010483_G3	22005	12818	10737	9425	8498	7770
THR24_1472_S03	45307934	41353586	19251625	10144744.47	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7010483_G4	19693	12301	10003	8491	7382	6530
THR24_1472_S04	47046264	42839118	22464567.5	13559074.62	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7010483_G5	22206	12890	10705	9474	8565	7800
THR24_1472_S05	54422909	53154871	49042175.5	37870489.125	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7010483_R1	25677	15218	13311	12259	11582	11000
THR24_1473_S01	40272238	39388484	35319886	28023387.28	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7010947_D1	24352	14543	12508	11373	10534	9864
THR24_1474_S01	44003411	42976426	38917458	33203746.32	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7010948_R1	24924	14870	13001	12004	11343	10797
THR24_1475_S01	60684321	59080879	54655076.5	38871639.135	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7010949_D1	27338	16471	14319	13156	12286	11685
THR24_1475_S02	63675704	62089145	57228669.5	43799564.27	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7010949_R1	27714	16286	14186	13034	12182	11553
THR24_1475_S03	49077262	47928135	43976275.5	34273342.565	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7010949_R2	25676	15283	13374	12191	11419	10803
THR24_1476_S01	49338305	48252058	43312254	33122300.365	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7010950_D1	24914	14703	12888	11929	11178	10582
THR24_1477_S01	53340035	51945140	47719211	36274199.885	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7010951_D1	26516	15684	13667	12589	11790	11146
THR24_1478_S01	48669894	47549192	43589866	35402245.14	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7010952_D1	25040	15059	13214	12160	11395	10810
THR24_1479_S01	54249255	52992260	47243250	36214026.695	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7010953_D1	27256	16162	14150	12958	12145	11530
THR24_1480_S01	52910556	51552591	46960434	33273516.25	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7010954_D1	26536	15810	13629	12436	11608	10927
THR24_1481_S01	55702245	54375707	47868931	35860703.19	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7010955_D1	27740	16400	14260	12959	12078	11344
THR24_1481_S02	39354322	38423984	34589772.5	26016572.79	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7010955_R1	26744	16427	14254	13014	12073	11391
THR24_1482_S01	55482403	54277747	42093267	33845693.035	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7010956_D1	24874	13985	12019	10877	10008	9386
THR24_1483_S01	46676054	45608362	41295363.5	34519622.25	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7010957_D1	25969	15144	13271	12158	11415	10752
THR24_1484_S01	52214561	51057858	45604840	34756660.4	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7010958_D1	26097	15278	13247	12153	11377	10712
THR24_1485_S01	49702942	48696863	38915185.5	30915091.52	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7010959_D1	25639	14491	12556	11448	10645	9976
THR24_1486_S01	49294054	48186460	42111950	30477048.575	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7010960_D1	25840	15360	13252	12006	11121	10425
THR24_1487_S01	49913566	48735501	38294142	30202559.625	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7010961_D1	24885	14262	12358	11225	10506	9851
THR24_1488_S01	55718366	54274851	51058160.5	33442266.285	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7010962_D1	28149	16993	14621	13298	12328	11539
THR24_1489_S01	58890715	57596984	49954256.5	40337686.125	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7010963_D1	26565	15177	13201	12142	11402	10818
THR24_1490_S01	28969494	28335489	25728944.5	19664679.65	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7010964_D1	25035	16155	13986	12783	12018	11416
THR24_1491_S01	52591576	48208188	43448763.5	30434177.645	101	acute megakaryoblastic leukemia	2.75	Yes, age < 30 years	male	NA	NA	Cohort_5	SJC_AMLM	https://doi.org/10.1016/j.ccr.2012.10.007	SJC	SJC-DS-1001	SJAMLM7010_D	27831	17096	14470	13075	12204	11572
THR24_1492_S01	17180363	16660556	14663474.5	11001747.3	76	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7011108_D1	22566	14450	12546	11426	10620	9937
THR24_1492_S02	40785450	39749807	30846960.5	22735015.29	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7011108_D2	25232	14729	12718	11650	10830	10148
THR24_1493_S01	41920447	40784818	34743959.5	27467236.89	76	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7011109_D1	26500	15085	13113	11932	11138	10472
THR24_1493_S02	47192012	45851907	38572504	30796215.74	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7011109_D2	26541	15356	13316	12207	11439	10827
THR24_1494_S01	53250341	51852228	44946179	34135043.635	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7011233_D1	28052	16300	14021	12827	11973	11312
THR24_1495_S01	46522626	45234276	33395021	27648753.94	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7011234_D1	25588	13602	11485	10247	9381	8697
THR24_1496_S01	40673105	39586024	32786704	24200328.845	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7011235_D1	25874	14842	12773	11695	10878	10264
THR24_1497_S01	48101990	46798313	36046602	23339286.945	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7011236_D1	26874	16424	13968	12595	11740	11059
THR24_1498_S01	40711839	39628465	29578333	22806919.2	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7011237_D1	25272	14364	12325	11176	10366	9708
THR24_1499_S01	60499588	58806790	51886994.5	38043970.77	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7011238_D1	28405	16351	14121	12857	12078	11471
THR24_1500_S01	47649618	43921884	27698433	14576301.9	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7011239_D1	31504	14940	12241	10760	9622	8733
THR24_1501_S01	45190366	41215963	27446155	12206453.685	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7011240_D1	26961	14959	12208	10665	9577	8727
THR24_1502_S01	43349366	42264146	31680443	23461265.555	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7011241_D1	25376	15137	12976	11812	11004	10282
THR24_1503_S01	59453860	57926334	47724839.5	36068780.44	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7011242_D1	26283	15121	13085	11992	11197	10550
THR24_1504_S01	39147823	38224558	34186699	26164933.795	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7011243_D1	26002	16011	13783	12608	11769	11092
THR24_1505_S01	43705938	42653915	36418084	29101490.25	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7011244_D1	24654	14475	12641	11692	10982	10388
THR24_1506_S01	40301092	39414713	23959602.5	15576548.21	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7011245_R1	24228	13954	11681	10408	9494	8810
THR24_1507_S01	40966562	40138001	25573258.5	16970153.67	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7011246_D1	25180	15394	13093	11808	10889	10190
THR24_1508_S01	38804626	38000435	30276376	23606178.74	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7011247_D1	24329	14067	12124	11068	10310	9719
THR24_1509_S01	46667673	45412258	33439902.5	22080570.4	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7011248_D1	25779	14754	12629	11464	10617	9918
THR24_1510_S01	66181697	64406520	47024509	30956161.635	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7011249_D1	27551	16110	13685	12322	11362	10579
THR24_1511_S01	36377408	35203302	31925134.5	24944771.3	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7011321_D1	24562	14799	12858	11761	10949	10327
THR24_1512_S01	81018320	79349517	3517487	2145252.525	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7011322_D1	23957	10477	8253	6888	5910	5153
THR24_1513_S01	32161189	31248022	28091936.5	21912020.515	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7011323_D1	25170	15676	13660	12513	11698	11015
THR24_1514_S01	34698530	33679112	29809853	23723682.72	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7011324_D1	23803	14577	12691	11564	10806	10186
THR24_1515_S01	36184831	35322806	18611272.5	15189052.04	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7011325_D1	22532	13108	11446	10381	9542	8900
THR24_1516_S01	37281009	36365298	14988960	12533863.59	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7011326_D1	21007	11883	10130	8957	8047	7382
THR24_1517_S01	77624143	75567433	10206560.5	7846707.66	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7011327_D1	23994	10651	8775	7594	6711	6033
THR24_1518_S01	43978795	42816154	35722293.5	27828370.57	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7011328_D1	25270	14818	13027	12051	11328	10761
THR24_1519_S01	97035819	91162025	76701735.5	51715516.8	101	acute megakaryoblastic leukemia	1.67	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_5	SJC_AMLM	https://doi.org/10.1016/j.ccr.2012.10.007	SJC	SJC-DS-1001	SJAMLM7011_D	28024	15839	13477	12253	11479	10913
THR24_1520_S01	108354375	102162561	89145370	58841186.805	101	acute megakaryoblastic leukemia	0.63	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_5	SJC_AMLM	https://doi.org/10.1016/j.ccr.2012.10.007	SJC	SJC-DS-1001	SJAMLM7012_D	30391	17747	15015	13555	12638	11989
THR24_1521_S01	86126070	80649130	67215470	50718183.285	101	acute megakaryoblastic leukemia	0.56	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_5	SJC_AMLM	https://doi.org/10.1016/j.ccr.2012.10.007	SJC	SJC-DS-1001	SJAMLM7013_D	27905	15500	13312	12196	11458	10892
THR24_1522_S01	93150054	87628300	73963090	48671743.2	101	acute megakaryoblastic leukemia	0.67	Yes, age < 30 years	female	NA	NA	Cohort_5	SJC_AMLM	https://doi.org/10.1016/j.ccr.2012.10.007	SJC	SJC-DS-1001	SJAMLM7014_D	27252	15040	12875	11714	10918	10288
THR24_1530_S01	53744426	51781647	36975767	24412450.275	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7015541_D1	27947	11645	9428	8071	6953	6155
THR24_1533_S02	25797801	25337682	19965804.5	15375765.79	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7015549_R1	26065	13954	11974	10927	10126	9495
THR24_1535_S01	82603948	78121418	65556713	46078228.09	101	acute megakaryoblastic leukemia	2.17	Yes, age < 30 years	male	NA	NA	Cohort_5	SJC_AMLM	https://doi.org/10.1016/j.ccr.2012.10.007	SJC	SJC-DS-1001	SJAMLM7015_D	27993	15787	13527	12294	11432	10771
THR24_1536_S01	65979048	64606556	51825237.5	41809938.58	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7026_D	27372	15152	13159	12193	11510	10982
THR24_1537_S01	58191932	56641440	49213495	45227243.95	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7027_D	23678	13553	12119	11266	10698	10257
THR24_1538_S01	67590354	66131048	48172898.5	35228218.35	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7028_D	27126	15504	13384	12268	11517	10880
THR24_1539_S01	58225459	57006703	43037782	29288812.34	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7029_D	26008	15473	13274	12085	11184	10529
THR24_1540_S01	39756495	38519421	29573593	20971163.675	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7030_D	38349	14686	12491	11410	10624	10069
THR24_1541_S01	47601407	46435978	42738957.5	31530953.61	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7031_D	27871	16808	14559	13396	12582	11925
THR24_1542_S01	55218012	54035443	35778849.5	27852679.5	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7032_D	26979	15875	13858	12792	12088	11525
THR24_1543_S01	60030557	58854744	47663868	42918399.145	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7033_D	26167	14738	13110	12224	11623	11083
THR24_1544_S01	62776767	61487889	38736343	34852106.895	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7041_D	24095	11848	10145	9012	8194	7439
THR24_1545_S01	75246451	73896861	36649547.5	32468170.58	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7042_D	24276	10637	8611	7348	6396	5612
THR24_1546_S01	69600947	68064002	45647676.5	41036537.2	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7043_D	23617	12172	10471	9446	8633	8017
THR24_1547_S01	50454586	49575985	18618695.5	15329714.57	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7045_D	19942	8433	6490	5304	4480	3848
THR24_1548_S01	57019624	55696298	33789867	28181064.86	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7046_D	26121	13547	11576	10400	9554	8850
THR24_1549_S01	71034608	69459762	6579884	5769316.29	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7047_D	26074	13743	11970	10870	10034	9354
THR24_1550_S01	65303640	63886944	51325120	42725798.84	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7048_D	27608	15089	13149	12094	11301	10621
THR24_1551_S01	61982862	60815306	46246201	42049526.18	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7049_D	23484	12217	10769	9975	9381	8891
THR24_1552_S01	52063315	50790894	37589567	33107400.19	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7050_D	25305	13414	11741	10758	10001	9339
THR24_1553_S01	62932194	61175232	49654129.5	41187402.11	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7051_D	27503	14874	12950	11886	11129	10497
THR24_1554_S01	49436127	47611967	41003363.5	31769667.44	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7052_D	28033	16303	14239	13121	12343	11692
THR24_1555_S01	58847680	56688605	50497678.5	41363723.76	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7053_D	27884	15759	13721	12698	12028	11513
THR24_1556_S01	55665784	53872381	47753589.5	38687650.125	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7054_D	29649	16947	14651	13431	12673	12028
THR24_1557_S01	56588918	55034467	49490571.5	35932545.65	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7055_D	29122	17308	15057	13848	12980	12330
THR24_1558_S01	54171473	52478289	42196030	39699157.4	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7056_D	23205	13207	11783	10885	10212	9655
THR24_1559_S01	136554857	127270195	5654486.5	2919047.19	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7057_D	6098	522	323	252	195	156
THR24_1560_S01	49415339	48202625	37076447.5	30621826.125	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7058_D	26777	14335	12491	11530	10806	10155
THR24_1561_S01	62222598	60700598	41625572	36910590.12	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7059_D	24288	12912	11393	10402	9611	8908
THR24_1562_S01	121656123	113435225	23509448.5	10059196.95	101	acute megakaryoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_5	SJC_AMLM	NA	SJC	SJC-DS-1001	SJAMLM7060_D	21843	10272	7480	5832	4674	3868
THR24_1563_S01	47770811	46559915	44699374.5	33248795.58	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL000013_D1	26271	16795	14665	13545	12761	12183
THR24_1564_S01	35042658	28315004	24228134.5	15577579.08	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL010_D	25493	16759	14524	13251	12320	11611
THR24_1565_S01	51557387	49837221	43033234	34189903.78	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL015_D	32991	15001	13149	12104	11446	10893
THR24_1566_S01	91319617	88908381	81023949.5	51286096.08	101	acute lymphoblastic leukemia	8.17	Yes, age < 30 years	female	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL020013_D1	28823	16845	14473	13209	12344	11656
THR24_1568_S01	47918543	46321591	38431064.5	25469849.79	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL020069_D1	33099	14634	12596	11428	10619	9924
THR24_1569_S01	15919222	15417934	14162769.5	9552093.6	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL020073_D1	27745	15053	12827	11701	10895	10244
THR24_1570_S01	65074584	62628871	56589215	39432769.815	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL020077_D1	31619	15486	13560	12521	11801	11279
THR24_1571_S01	41988646	40558890	35616239.5	22589105.8	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL020081_D1	34762	15002	12850	11705	10845	10156
THR24_1572_S01	38890527	37758990	26788353.5	18830487.6	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL020084_D1	25188	14665	12655	11531	10653	9952
THR24_1573_S01	55997074	53973650	45736190.5	26494626.295	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL020091_D1	38454	15793	13240	11927	11048	10324
THR24_1574_S01	28179195	27436852	25358721	17588116	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL020098_D1	24244	15598	13447	12220	11399	10711
THR24_1575_S01	44675344	42932360	36387366.5	21967998.03	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL020100_D1	35336	15851	13588	12362	11466	10805
THR24_1576_S01	65131542	63280575	56568962	39491680.905	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL020101_D1	25793	15028	12949	11937	11189	10576
THR24_1577_S01	51811264	50282208	45771455	29905915.78	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL020106_D1	25851	15833	13761	12546	11734	11107
THR24_1578_S01	56000689	54422989	49224532.5	35375368.525	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL020111_D1	27048	15835	13555	12363	11554	10901
THR24_1579_S01	63949775	62221786	56946372	35510512.05	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL020113_D1	26420	15830	13596	12362	11505	10848
THR24_1580_S01	58340187	56684776	50243593	37584000.3	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL020122_D1	26611	15105	13089	12010	11353	10752
THR24_1581_S01	52247062	50480583	46339661	31279107.2	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL020138_D1	31954	16614	14344	13058	12227	11579
THR24_1582_S01	45468725	44255686	40554438.5	24782637.17	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL020140_D1	24180	14536	12347	11131	10245	9527
THR24_1583_S01	52475366	51031638	46288493	29735923.365	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL020141_D1	25896	15514	13307	12070	11205	10537
THR24_1584_S01	42631803	41483304	36613006.5	25580031.2	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL020142_D1	24854	15146	13006	11889	11072	10394
THR24_1585_S01	41866008	40330192	37545622.5	24636765.6	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL020145_D1	27739	15051	13024	11917	11164	10561
THR24_1586_S01	58136498	56553928	49183372.5	33437742.435	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL020151_D1	25576	14788	12731	11625	10779	10115
THR24_1587_S01	62872236	61032297	54932894.5	34902470.7	101	acute lymphoblastic leukemia	11.5	Yes, age < 30 years	female	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL020340_D1	27234	15895	13539	12326	11492	10807
THR24_1588_S01	71992026	69934043	53755325.5	35971920.8	101	acute lymphoblastic leukemia	13.5	Yes, age < 30 years	female	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL020374_D1	27783	16421	14184	12968	12146	11477
THR24_1589_S01	43267558	41887915	38971225.5	23537651.28	101	acute lymphoblastic leukemia	11.75	Yes, age < 30 years	female	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL020383_D1	25632	15341	13185	11943	11021	10314
THR24_1590_S01	44950731	43644898	39508559.5	19861134.98	101	acute lymphoblastic leukemia	15.42	Yes, age < 30 years	male	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL020469_D1	27367	16971	14310	12842	11800	10999
THR24_1591_S01	67526702	65275053	58155687.5	28899509.55	101	acute lymphoblastic leukemia	16.25	Yes, age < 30 years	male	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL020570_D1	29930	18461	15493	13867	12748	11902
THR24_1592_S01	54738738	53083968	43417822.5	34491446.7	101	acute lymphoblastic leukemia	13	Yes, age < 30 years	male	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL020579_D1	25092	14351	12523	11456	10691	10083
THR24_1593_S01	63357680	61479505	49867442.5	40522093.82	101	acute lymphoblastic leukemia	14.08	Yes, age < 30 years	male	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL020589_D1	25266	14174	12318	11272	10509	9877
THR24_1594_S01	64695578	62984861	53886471.5	34312215.6	101	acute lymphoblastic leukemia	13.17	Yes, age < 30 years	male	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL020595_D1	26558	14900	12671	11420	10533	9873
THR24_1595_S01	58224943	56603729	48388850	35286366.96	101	acute lymphoblastic leukemia	13.17	Yes, age < 30 years	female	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL020609_D1	26304	14546	12444	11344	10470	9803
THR24_1596_S01	49913217	48655142	41732571.5	33323059.18	101	acute lymphoblastic leukemia	14.58	Yes, age < 30 years	female	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL020625_D1	25018	14264	12411	11314	10506	9894
THR24_1597_S01	55868933	54177578	29417614	22229859.99	101	acute lymphoblastic leukemia	14.42	Yes, age < 30 years	female	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL020649_D1	24160	11999	9961	8637	7664	6873
THR24_1598_S01	55415158	53863741	40764071	32471922.6	101	acute lymphoblastic leukemia	18.08	Yes, age < 30 years	male	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL020704_D1	24277	13212	11282	10138	9286	8601
THR24_1599_S01	84317734	82022310	70117688.5	45022172.98	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL020765_D1	27655	15785	13416	12131	11205	10537
THR24_1600_S01	58059470	56433933	49796011	30275286.42	101	acute lymphoblastic leukemia	10.58	Yes, age < 30 years	female	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL020828_D1	27219	16300	13852	12552	11616	10882
THR24_1601_S01	43270272	42281571	32823682	22230236.8	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL020832_D1	27043	14870	12519	11191	10264	9482
THR24_1602_S01	60682623	59132046	50647307.5	35798875.32	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL020836_D1	25212	14587	12758	11713	10969	10390
THR24_1603_S01	59243552	57618620	46807867	38615346.375	101	acute lymphoblastic leukemia	17.17	Yes, age < 30 years	male	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL020877_D1	23756	12999	11307	10316	9609	8980
THR24_1604_S01	61763892	60250108	39919678.5	33187619.25	101	acute lymphoblastic leukemia	12.42	Yes, age < 30 years	female	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL020882_D1	26368	14473	12531	11538	10689	10015
THR24_1605_S01	63589935	61879685	27524650	17658344.12	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL020941_D1	32280	15179	12668	11372	10423	9645
THR24_1606_S01	54031983	52537846	47191249.5	30501982	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL020953_D1	26058	15476	13187	11956	11096	10400
THR24_1607_S01	54054235	52529848	47719817.5	25793449.08	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL020958_D1	24504	15123	12803	11515	10652	9956
THR24_1608_S01	43282105	42079679	38928871	27403894.855	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL020964_D1	24396	14914	13029	11961	11157	10559
THR24_1609_S01	39800752	38467299	32844117.5	19546448.955	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL020966_D1	34876	15180	12830	11652	10832	10152
THR24_1610_S01	45210449	43906879	40394893	28166360.985	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL020967_D1	24152	14593	12518	11441	10666	10034
THR24_1611_S01	52136180	50688087	46388422.5	31723566.975	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL020977_D1	25885	15443	13029	11723	10781	9997
THR24_1612_S01	72258760	70018229	61761050.5	39530700.54	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL020980_D1	36264	15613	13313	12082	11197	10561
THR24_1613_S01	47080878	45363029	40276764	24693870.73	101	acute lymphoblastic leukemia	16.31	Yes, age < 30 years	male	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL020984_D1	34484	14892	12732	11534	10706	10070
THR24_1614_S01	54545863	52935045	47454028.5	30958173.2	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL020987_D1	25107	14909	12814	11656	10824	10197
THR24_1615_S01	35490260	34520835	31558698	23136355.71	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL020993_D1	24940	15663	13594	12479	11745	11186
THR24_1616_S01	57039868	55363347	47864737	32088229.2	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL020994_D1	33331	15483	13506	12379	11634	11000
THR24_1617_S01	48399976	47025699	43177575	33374498.64	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL020995_D1	26359	16099	14038	12912	12109	11498
THR24_1618_S01	63971310	62054155	56273546.5	37796273.36	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL020998_D1	33065	16107	13894	12700	11900	11243
THR24_1619_S01	67285034	65364533	55462364	38191024.905	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021005_D1	27592	16130	13782	12590	11733	11164
THR24_1620_S01	32451352	31677792	19604830	14692919.01	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021012_D1	23821	11960	10140	8997	7984	7166
THR24_1621_S01	45456204	43981833	35413642.5	25353723.195	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL021018_D1	36704	15173	12977	11768	10919	10237
THR24_1622_S01	51929245	50389430	43457388.5	35187928.16	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021021_D1	24670	13908	11966	10819	10037	9346
THR24_1623_S01	63402287	61558402	54890879	39155431.6	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021023_D1	25874	14784	12588	11399	10497	9792
THR24_1624_S01	45297375	43999601	39672221	26544516.48	101	acute lymphoblastic leukemia	18.31	Yes, age < 30 years	male	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021031_D1	24179	14517	12495	11304	10459	9777
THR24_1625_S01	49418429	48015941	42804157.5	29092473.6	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021043_D1	23909	13930	11895	10793	10045	9405
THR24_1626_S01	29246470	27846497	22265300.5	10968847.64	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL021047_D1	41080	21061	15548	13499	12283	11411
THR24_1627_S01	43708841	42255060	36447204	22793515.425	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL021058_D1	36597	15535	13049	11728	10851	10122
THR24_1628_S01	36355055	35070582	28750317.5	17541776.61	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021059_D1	39064	17806	14579	13199	12203	11511
THR24_1629_S01	54838971	53318318	45333068	33481414.98	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021061_D1	26994	15930	13733	12562	11698	11046
THR24_1630_S01	43904169	42216944	35367797	17459494.68	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL021080_D1	40938	17518	13881	12300	11284	10564
THR24_1631_S01	27738194	26901693	25451507.5	15562040.36	101	acute lymphoblastic leukemia	17	Yes, age < 30 years	female	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL021083_D1	25302	17318	14826	13394	12471	11654
THR24_1632_S01	49608904	48027826	42023903.5	25838685.85	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL021102_D1	35059	16184	13794	12559	11651	10983
THR24_1633_S01	56480372	54709863	47783752.5	32165719.79	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021104_D1	26965	16159	13687	12416	11579	10935
THR24_1634_S01	26904508	26178292	24393007	15094387.47	101	acute lymphoblastic leukemia	19.02	Yes, age < 30 years	female	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021108_D1	24874	17162	14721	13258	12283	11503
THR24_1635_S01	37555399	35938124	30200524.5	16518165.72	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL021109_D1	40895	20315	15509	13659	12557	11776
THR24_1636_S01	52749999	51296528	47716568.5	30462825.465	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021124_D1	26265	16852	14576	13344	12442	11753
THR24_1637_S01	48347612	46987835	42933506	30622471.775	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021128_D1	24921	15007	12929	11781	11025	10366
THR24_1638_S01	54352419	52905658	45139775.5	27243202.76	101	acute lymphoblastic leukemia	16.46	Yes, age < 30 years	female	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021130_D1	26933	15796	13418	12125	11188	10488
THR24_1639_S01	37994107	36830938	32890727.5	20368497.01	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021131_D1	25321	15484	13119	11829	10901	10192
THR24_1640_S01	33010391	31574031	25310237.5	10571505.56	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021145_D1	40340	19248	13479	11323	10162	9350
THR24_1641_S01	34525718	33252510	26302943.5	14637288.96	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021146_D1	38408	16305	12862	11408	10415	9681
THR24_1642_S01	56198099	54640231	47633190.5	32227780.4	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021147_D1	26409	15740	13589	12374	11513	10766
THR24_1643_S01	50543788	49045786	46263769	26178868.38	101	acute lymphoblastic leukemia	18.25	Yes, age < 30 years	male	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021299_D1	26334	15744	13263	11873	10887	10097
THR24_1644_S01	31845697	30924857	29404860.5	18769810.455	101	acute lymphoblastic leukemia	12.75	Yes, age < 30 years	male	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL021305_D1	24078	15499	13339	12103	11201	10532
THR24_1645_S01	66852609	65064197	59175091	38477768.58	101	acute lymphoblastic leukemia	17.08	Yes, age < 30 years	male	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021324_D1	28372	16013	13594	12334	11452	10759
THR24_1646_S01	60116840	58345002	54245612	33863641.68	101	acute lymphoblastic leukemia	15	Yes, age < 30 years	male	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021333_D1	27241	16367	14050	12783	11895	11218
THR24_1647_S01	62950209	61286651	55284865	35638833.03	101	acute lymphoblastic leukemia	14.42	Yes, age < 30 years	male	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021336_D1	26589	14986	12734	11452	10473	9776
THR24_1648_S01	65517606	63696926	38582378	26464041.335	101	acute lymphoblastic leukemia	12.83	Yes, age < 30 years	female	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021358_D1	25165	14859	12675	11499	10581	9912
THR24_1649_S01	48244480	46848618	43442982.5	25578521.265	101	acute lymphoblastic leukemia	6	Yes, age < 30 years	female	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021372_D1	26198	15043	12443	11021	10007	9206
THR24_1650_S01	67965780	65971303	60797900.5	37952518.79	101	acute lymphoblastic leukemia	14.25	Yes, age < 30 years	female	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021405_D1	29372	16868	14283	12880	11880	11131
THR24_1651_S01	58393520	56767058	36938905.5	26831589.2	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021416_D1	25830	13951	11839	10694	9786	9059
THR24_1652_S01	55511959	53968052	50775186.5	28647401.58	101	acute lymphoblastic leukemia	16.67	Yes, age < 30 years	male	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021427_D1	27526	16861	14212	12750	11694	10916
THR24_1653_S01	50661823	49415530	37460060.5	28993694.73	101	acute lymphoblastic leukemia	4	Yes, age < 30 years	male	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021434_D1	26091	14094	12074	10933	10068	9375
THR24_1654_S01	45226636	44068503	39392481.5	26144989.65	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021489_D1	25009	14624	12464	11213	10299	9548
THR24_1655_S01	54471526	52623108	48071028.5	30057374.7	101	acute lymphoblastic leukemia	16.67	Yes, age < 30 years	male	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021491_D1	26179	16974	14593	13325	12445	11787
THR24_1656_S01	66855819	64853282	60474429	36989599.76	101	acute lymphoblastic leukemia	14.75	Yes, age < 30 years	male	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021492_D1	27984	16294	13897	12537	11591	10840
THR24_1657_S01	68606269	66482412	61860459.5	38215088.12	101	acute lymphoblastic leukemia	13.42	Yes, age < 30 years	male	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021511_D1	27311	15956	13599	12182	11240	10489
THR24_1658_S01	49094921	47558558	41284430	23463801.9	101	acute lymphoblastic leukemia	13.17	Yes, age < 30 years	male	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021512_D1	28926	16672	13943	12418	11367	10556
THR24_1659_S01	55286850	53410912	48188331.5	32250906.945	101	acute lymphoblastic leukemia	16.67	Yes, age < 30 years	female	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021514_D1	27046	15188	13002	11748	10814	10119
THR24_1660_S01	57545260	55954441	43946106	26885949.67	101	acute lymphoblastic leukemia	18.42	Yes, age < 30 years	male	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021516_D1	26272	14757	12522	11268	10370	9624
THR24_1661_S01	31439616	30695163	24185243.5	16484111.09	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL021549_D1	24765	14637	12528	11354	10411	9681
THR24_1662_S01	47638897	46258933	17886191.5	13928896.8	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021707_D1	23525	11430	9452	8136	7069	6218
THR24_1663_S01	28573951	28003323	21324059.5	16923076.56	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL021720_D1	24912	15566	13532	12340	11507	10786
THR24_1664_S01	58719897	57395276	48231863.5	34840315.77	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021721_D1	26581	15759	13743	12714	11978	11439
THR24_1665_S01	42624520	39419969	13302437.5	10114442.52	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL021722_D1	22423	14621	12558	11375	10515	9799
THR24_1666_S01	60425480	59161597	42339548	34118978.68	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL021728_D1	25251	15002	13184	12268	11595	11034
THR24_1667_S01	50413095	47698840	41696275.5	31170014.46	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021735_D1	25983	15746	13641	12544	11752	11209
THR24_1668_S01	42050743	37989196	17365357.5	12838767.6	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021737_D1	23147	15311	13209	12095	11297	10641
THR24_1669_S01	46041625	45107451	13814338	10686246.4	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL021738_D1	23204	14094	12155	11005	10127	9344
THR24_1670_S01	89035446	87032199	71321576	55338438.155	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL021748_D1	26625	15033	13272	12298	11561	11038
THR24_1671_S01	48200139	46798746	28952166	21594879.6	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021769_D1	24644	13521	11457	10285	9431	8690
THR24_1672_S01	62898999	61538953	48578969	37663787.02	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL021772_D1	24932	14086	12401	11490	10781	10221
THR24_1673_S01	45720316	44572570	34960038.5	26923897	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021778_D1	23919	13844	11959	10891	10143	9495
THR24_1674_S01	61934938	60387705	43657505	31097641.37	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL021780_D1	27142	15327	13246	12131	11299	10654
THR24_1675_S01	64760028	63243774	48667253.5	34817449.985	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL021784_D1	26928	15217	13074	11860	11048	10383
THR24_1676_S01	40705922	39755876	23284032	17942071.84	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL021786_D1	23443	14654	12730	11739	10957	10324
THR24_1677_S01	45073199	43726371	41048347.5	27925344.54	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021787_D1	25997	16151	13923	12799	11976	11335
THR24_1678_S01	51990261	50641840	44828974.5	32684056.96	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021790_D1	24236	14254	12314	11240	10483	9876
THR24_1679_S01	56285092	55060911	45213234	32915882.22	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL021794_D1	27081	15623	13498	12408	11608	10971
THR24_1680_S01	65139225	63621921	51541526.5	35906637.6	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL021800_D1	25565	14379	12388	11233	10406	9750
THR24_1681_S01	60792893	58887887	52870032.5	38681987.785	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021803_D1	25845	15491	13454	12448	11723	11179
THR24_1682_S01	36898365	36085997	27731736	19631394.14	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL021807_D1	23679	13773	11962	10840	10056	9409
THR24_1683_S01	82691938	80734522	56547133.5	36531088.56	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL021814_D1	25839	15060	13002	11827	10970	10345
THR24_1684_S01	55703600	54094567	43414723.5	31856099.83	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021816_D1	25330	13822	11982	10884	10059	9380
THR24_1685_S01	110517793	107829900	10538484	7469641.2	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021820_D1	26307	13590	11648	10523	9740	9061
THR24_1686_S01	47854271	46773367	40234661	30290968.5	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021832_D1	26064	14619	12555	11318	10483	9821
THR24_1687_S01	48581379	47483594	32425875	21883788.8	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021841_D1	22554	13568	11564	10417	9599	9004
THR24_1688_S01	50431354	48696257	29163656.5	21266318.495	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021849_D1	28514	14852	12523	11321	10477	9748
THR24_1689_S01	23686326	23060669	13409631.5	9680054	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL021856_D1	22057	14286	12185	11000	10110	9424
THR24_1690_S01	37659443	36823598	29661146.5	21464226.03	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL021866_D1	23918	14082	12244	11164	10443	9816
THR24_1691_S01	55693425	54310450	49220863	35871521.84	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL021900_D1	26668	15667	13708	12644	11848	11244
THR24_1692_S01	59267869	57729665	54178220	31188220.685	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL022244_D1	25657	15699	13409	12104	11157	10481
THR24_1693_S01	70051587	68275409	59347292	43085360.37	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL022245_D1	25995	14620	12742	11607	10791	10142
THR24_1694_S01	39338920	38253495	27383046.5	17396281.14	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL022246_D1	24152	14061	11803	10505	9601	8896
THR24_1695_S01	53922729	52446763	45063512.5	32902482.6	101	acute lymphoblastic leukemia	9.17	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL102_D	26276	15717	13614	12531	11833	11216
THR24_1696_S01	47578892	46132359	42528463.5	32180270.815	101	acute lymphoblastic leukemia	5.45	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL215_D	27094	16457	14334	13154	12348	11721
THR24_1697_S01	40992787	39625488	36541616	27082743.09	101	acute lymphoblastic leukemia	7.49	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL218_D	26119	16517	14406	13282	12530	11889
THR24_1698_S01	55690637	54032039	48983993	37063400.22	101	acute lymphoblastic leukemia	14.51	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL227_D	26733	16130	14138	13031	12296	11716
THR24_1699_S01	33935506	32872265	31145865	22799688.6	101	acute lymphoblastic leukemia	8.82	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL230_D	25942	16828	14597	13387	12634	11972
THR24_1700_S01	55982503	54390705	47378136	36611768.655	101	acute lymphoblastic leukemia	11.25	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL231_D	26536	15399	13459	12414	11662	11067
THR24_1701_S01	49402633	48003713	45200908	33621694.645	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_2	SJC_BALL	NA	SJC	SJC-DS-1001	SJBALL237_D	26587	16933	14762	13584	12831	12211
THR24_1702_S01	61499089	59637668	54595646	38727056.495	101	acute lymphoblastic leukemia	13.38	Yes, age < 30 years	male	NA	Hispanic or Latino	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL239_D	27545	17006	14804	13615	12833	12230
THR24_1703_S01	63419581	61571047	54004880	39251827.82	101	acute lymphoblastic leukemia	1.64	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL247_D	28720	17196	14932	13711	12880	12238
THR24_1704_S01	50568122	49213689	42832561.5	30660786.38	101	acute lymphoblastic leukemia	4.64	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_2	SJC_BALL	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJBALL255_D	27953	17073	14677	13411	12588	11938
THR24_1705_S01	45709116	44449363	25063774	19538537.48	101	acute myeloid leukemia	12.19	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF001018_D1	24069	13760	11890	10768	10015	9369
THR24_1705_S02	48989062	47668877	32528784.5	26998355.73	101	acute myeloid leukemia	12.19	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF001018_D2	24486	13329	11630	10624	9948	9406
THR24_1705_S03	43866264	42596552	24974308.5	19371584.54	101	acute myeloid leukemia	12.19	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF001018_D3	24014	13924	12047	10947	10151	9509
THR24_1705_S04	44280654	42996744	18905343.5	14176986.33	101	acute myeloid leukemia	12.19	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF001018_D4	23605	14516	12449	11315	10404	9729
THR24_1705_S05	45110467	43991379	22197071.5	18822390.62	101	acute myeloid leukemia	12.19	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF001018_D5	22690	12923	11239	10257	9550	8946
THR24_1705_S06	42187199	41085021	25535725	21319270.875	101	acute myeloid leukemia	12.19	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF001018_D6	23385	13395	11646	10594	9895	9288
THR24_1705_S07	40171505	39136367	28006265.5	24424913.415	101	acute myeloid leukemia	12.19	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF001018_D7	23202	13042	11446	10530	9855	9291
THR24_1705_S08	21415784	20608979	7395664	5881722	101	acute myeloid leukemia	12.19	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF001018_D8	20440	14238	12222	11109	10256	9577
THR24_1706_S01	45560993	44251414	33868493	27197701.24	101	acute myeloid leukemia	12.2	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF001_D	25085	14386	12564	11554	10787	10172
THR24_1707_S01	90354791	87516187	68335710	54705087.66	101	acute myeloid leukemia	14.05	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF004_D	29273	15003	13114	12083	11305	10738
THR24_1708_S01	88620241	85680237	70612877	54682099.56	101	acute myeloid leukemia	9.06	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF006_D	29494	14760	12940	11915	11193	10627
THR24_1709_S01	52069479	50578020	40269489	32558806.22	101	acute myeloid leukemia	14.8	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF008_D	26811	15034	13093	12011	11277	10636
THR24_1710_S01	44020945	42632965	37901296	30922174.125	101	acute myeloid leukemia	17.32	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF012_D	25268	15196	13376	12395	11732	11203
THR24_1711_S01	85998690	83313301	72098698	55753401.55	101	acute myeloid leukemia	3	Yes, age < 30 years	male	NA	NA	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF020_D	30620	15752	13792	12756	12005	11457
THR24_1712_S01	98518645	95362246	82448839	67093505.625	101	acute myeloid leukemia	11.23	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF022_D	29270	15034	13278	12361	11705	11204
THR24_1713_S01	52317685	50464668	43128611	36078660.375	101	acute myeloid leukemia	16.54	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF023_D	24962	14648	12935	11918	11217	10658
THR24_1714_S01	97662368	94569980	83148114	67349968.04	101	acute myeloid leukemia	18.26	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF025_D	28277	15328	13533	12583	11901	11354
THR24_1715_S01	115102148	111253369	94675157	73374210.26	101	acute myeloid leukemia	6.97	Yes, age < 30 years	female	NA	NA	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF030_D	29966	15231	13413	12405	11722	11183
THR24_1716_S01	61259316	59512586	50061200.5	40705099.5	101	acute myeloid leukemia	6.82	Yes, age < 30 years	male	NA	Hispanic or Latino	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF031_D	27317	15426	13501	12389	11646	11075
THR24_1717_S01	68484892	66449881	53808822.5	40097811.17	101	acute myeloid leukemia	15.98	Yes, age < 30 years	female	NA	NA	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF034_D	25677	14118	12278	11186	10381	9769
THR24_1718_S01	75462699	73062149	64482876	47967982.53	101	acute myeloid leukemia	15.39	Yes, age < 30 years	female	NA	NA	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF041_D	27358	14282	12441	11398	10699	10144
THR24_1719_S01	72338378	70083735	60683940	40380144.3	101	acute myeloid leukemia	10.89	Yes, age < 30 years	male	NA	NA	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF042_D	26710	15294	13162	11952	11147	10530
THR24_1720_S01	51052019	49513212	37313220	28614725.88	101	acute myeloid leukemia	6.57	Yes, age < 30 years	female	NA	NA	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF044_D	27684	15628	13401	12171	11289	10555
THR24_1721_S01	89479437	86385681	42695474.5	34768092	101	acute myeloid leukemia	1.27	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF090_D	28755	15167	13338	12350	11641	11129
THR24_1722_S01	106200597	102598428	88879494	67357773.6	101	acute myeloid leukemia	12.416667	Yes, age < 30 years	female	NA	NA	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF091_D	31365	16324	14122	12978	12160	11536
THR24_1723_S01	48819363	47500082	29160720	20426160.64	101	acute myeloid leukemia	4.96	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF094_D	25817	13748	11709	10418	9415	8525
THR24_1724_S01	46952159	45610836	41198140	30703532.86	101	acute myeloid leukemia	NA	Yes, age < 30 years	male	NA	NA	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF099_D	25199	15131	13199	12134	11391	10773
THR24_1725_S01	67123658	65357752	38206876.5	29014918.155	101	acute myeloid leukemia	16.82	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF100_D	27058	14582	12613	11397	10449	9652
THR24_1726_S01	60845790	58985049	48575254.5	37090878.63	101	acute myeloid leukemia	5.47	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF101_D	27380	15411	13424	12304	11479	10861
THR24_1727_S01	60116147	58485967	40448928.5	30418547.495	101	acute myeloid leukemia	4.33	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF108_D	27909	15378	13187	11992	11066	10300
THR24_1728_S01	95180367	91924469	81116046.5	64597072.875	101	acute myeloid leukemia	7.27	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF110_D	30007	15806	13818	12733	12022	11424
THR24_1729_S01	104726794	101026482	89721689.5	65091796.41	101	acute myeloid leukemia	8.12	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF112_D	30379	16744	14640	13477	12710	12058
THR24_1730_S01	90793438	87742840	76137432	57370041.575	101	acute myeloid leukemia	4.67	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF113_D	29828	15873	13895	12814	12045	11413
THR24_1731_S01	99923207	96826210	83420258.5	61493046.81	101	acute myeloid leukemia	NA	Yes, age < 30 years	female	NA	NA	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF117_D	29445	14472	12493	11382	10613	9958
THR24_1732_S01	92107485	89000657	79073579.5	56711627.31	101	acute myeloid leukemia	NA	Yes, age < 30 years	female	NA	NA	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF123_D	28701	15252	13236	12154	11385	10770
THR24_1733_S01	97924360	94528782	74995357.5	55556882.94	101	acute myeloid leukemia	NA	Yes, age < 30 years	male	NA	NA	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF124_D	30581	14669	12714	11623	10817	10231
THR24_1734_S01	94281814	91056474	78159686.5	54168832.62	101	acute myeloid leukemia	10.51	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF125_D	31520	16507	14250	13028	12196	11509
THR24_1735_S01	54814628	53277832	44195344	35848941.6	101	acute myeloid leukemia	12.916667	Yes, age < 30 years	male	NA	NA	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF138_D	27051	15350	13400	12325	11597	10966
THR24_1736_S01	73358134	70814745	62680644	47349797.88	101	acute myeloid leukemia	5.31	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF139_D	28963	15348	13420	12413	11705	11109
THR24_1737_S01	88061551	85429663	71000582.5	57799722.375	101	acute myeloid leukemia	4.9	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF141_D	30757	15541	13613	12536	11822	11244
THR24_1738_S01	55303743	53593184	10649946.5	8194680.4	101	acute myeloid leukemia	NA	Yes, age < 30 years	female	NA	NA	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF143_D	20487	12292	10277	9072	8146	7407
THR24_1739_S01	44221875	42967557	37728062.5	30083475.96	101	acute myeloid leukemia	14.03	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF145_D	25759	15389	13484	12393	11678	11108
THR24_1740_S01	56304063	54667226	44248515.5	35802991.62	101	acute myeloid leukemia	4.27	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF149_D	26907	15379	13437	12366	11584	11038
THR24_1741_S01	60061856	58517682	36466805	27105972.66	101	acute myeloid leukemia	2.2	Yes, age < 30 years	female	NA	NA	Cohort_16	SJC_CBF	NA	SJC	SJC-DS-1001	SJCBF150_D	25603	13157	11254	10091	9190	8481
THR24_1742_S01	41643940	40676769	37494087.5	26652346.8	101	choroid plexus carcinoma	NA	Yes, age < 30 years	female	NA	NA	Cohort_24	SJC_CPC	NA	SJC	SJC-DS-1001	SJCPC001013_D1	31726	20932	18063	16545	15504	14698
THR24_1742_S02	36145556	35186556	32543457.5	25281978.95	101	choroid plexus carcinoma	NA	Yes, age < 30 years	female	NA	NA	Cohort_24	SJC_CPC	NA	SJC	SJC-DS-1001	SJCPC001013_R1	30074	19391	16737	15314	14383	13653
THR24_1743_S01	37547216	36684106	34830250.5	27690318.8	101	choroid plexus carcinoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_24	SJC_CPC	NA	SJC	SJC-DS-1001	SJCPC001014_D1	29383	18421	16052	14736	13847	13177
THR24_1744_S01	42360661	41228340	37784547.5	31343752.875	101	choroid plexus carcinoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_24	SJC_CPC	NA	SJC	SJC-DS-1001	SJCPC001016_D1	28736	17026	14807	13635	12784	12157
THR24_1745_S01	42234643	41284278	37420307.5	29934218.93	101	choroid plexus carcinoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_24	SJC_CPC	NA	SJC	SJC-DS-1001	SJCPC011756_D1	27830	16800	14748	13591	12771	12083
THR24_1746_S01	46935683	45713734	36959510.5	24849269.75	101	choroid plexus carcinoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_24	SJC_CPC	NA	SJC	SJC-DS-1001	SJCPC011758_D1	30839	19172	16402	14778	13587	12679
THR24_1747_S01	38366762	37339605	33083912	21475255.11	101	choroid plexus carcinoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_24	SJC_CPC	NA	SJC	SJC-DS-1001	SJCPC011759_D1	30564	18815	15891	14358	13317	12511
THR24_1748_S01	41072690	40104541	17774155.5	10916592.96	101	choroid plexus carcinoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_24	SJC_CPC	NA	SJC	SJC-DS-1001	SJCPC011761_D1	28374	13336	10129	8184	6860	5875
THR24_1749_S01	44033179	42809128	39784355.5	27679847.2	101	choroid plexus carcinoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_24	SJC_CPC	NA	SJC	SJC-DS-1001	SJCPC011762_D1	28677	18084	15746	14477	13572	12856
THR24_1750_S01	40180252	39260775	31871636.5	24424655.15	101	choroid plexus carcinoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_24	SJC_CPC	NA	SJC	SJC-DS-1001	SJCPC011764_D1	29055	17131	14812	13399	12430	11703
THR24_1751_S01	40395903	39458991	33331243.5	28103394.76	101	choroid plexus carcinoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_24	SJC_CPC	NA	SJC	SJC-DS-1001	SJCPC011765_D1	26641	15903	14021	12909	12136	11488
THR24_1752_S01	46462591	45149670	40029071	31350257.25	101	choroid plexus carcinoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_24	SJC_CPC	NA	SJC	SJC-DS-1001	SJCPC011766_D1	28440	16935	14727	13544	12708	12043
THR24_1753_S01	39940173	38828207	35456426	25075270.8	101	choroid plexus carcinoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_24	SJC_CPC	NA	SJC	SJC-DS-1001	SJCPC011768_D1	29936	18315	15704	14321	13379	12615
THR24_1753_S02	36915716	35977981	30781839	22726699.065	101	choroid plexus carcinoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_24	SJC_CPC	NA	SJC	SJC-DS-1001	SJCPC011768_R1	29913	17817	15238	13766	12751	11966
THR24_1754_S01	38062333	37186890	32584527.5	24886747.47	101	choroid plexus carcinoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_24	SJC_CPC	NA	SJC	SJC-DS-1001	SJCPC011769_D1	29402	17049	14665	13399	12512	11819
THR24_1755_S01	40119008	39167100	36114006	25921661.7	101	choroid plexus carcinoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_24	SJC_CPC	NA	SJC	SJC-DS-1001	SJCPC011770_D1	29444	18789	16169	14826	13908	13185
THR24_1756_S01	36605080	35682231	28918921.5	21745106.8	101	choroid plexus carcinoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_24	SJC_CPC	NA	SJC	SJC-DS-1001	SJCPC011771_D1	30264	17620	15208	13882	12921	12161
THR24_1757_S01	51553030	50408528	47001696	36564076.78	101	choroid plexus carcinoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_24	SJC_CPC	NA	SJC	SJC-DS-1001	SJCPC011772_D1	29167	17742	15385	14260	13479	12798
THR24_1758_S01	38539994	37848510	30651807	23362549.525	101	choroid plexus carcinoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_24	SJC_CPC	NA	SJC	SJC-DS-1001	SJCPC011773_D1	28908	17974	15545	14218	13322	12644
THR24_1759_S01	38592378	37640541	33913552	26928692.945	101	choroid plexus carcinoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_24	SJC_CPC	NA	SJC	SJC-DS-1001	SJCPC011774_D1	28642	17696	15375	14100	13206	12533
THR24_1760_S01	38806443	37759830	35105508	23930088.29	101	choroid plexus carcinoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_24	SJC_CPC	NA	SJC	SJC-DS-1001	SJCPC011776_D1	31049	19194	16297	14792	13668	12818
THR24_1761_S01	33361825	32535547	29651618.5	23498135.2	101	choroid plexus carcinoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_24	SJC_CPC	NA	SJC	SJC-DS-1001	SJCPC011777_D1	29714	18868	16219	14790	13829	13053
THR24_1761_S02	37359591	36447625	31949219.5	27343258.72	101	choroid plexus carcinoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_24	SJC_CPC	NA	SJC	SJC-DS-1001	SJCPC011777_M1	26546	15749	13833	12831	12132	11551
THR24_1761_S03	37769591	36850408	33294250.5	24423239.47	101	choroid plexus carcinoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_24	SJC_CPC	NA	SJC	SJC-DS-1001	SJCPC011777_R1	30170	18688	16033	14657	13677	12954
THR24_1762_S01	38090985	37175053	32451163	23613015.61	101	choroid plexus carcinoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_24	SJC_CPC	NA	SJC	SJC-DS-1001	SJCPC011778_D1	30620	19012	16342	14942	13918	13085
THR24_1763_S01	34631372	33476976	32034999.5	24618836.56	101	acute lymphoblastic leukemia	12.41	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_37	SJC_E	NA	SJC	SJC-DS-1001	SJE2A018_D	24914	16138	14122	13040	12262	11678
THR24_1764_S01	35968412	34710881	33081860	24699458.245	101	acute lymphoblastic leukemia	8.53	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_37	SJC_E	NA	SJC	SJC-DS-1001	SJE2A037_D	24528	15920	13915	12895	12163	11597
THR24_1765_S01	39485319	38119040	36657840	26504719.41	101	acute lymphoblastic leukemia	3.32	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_37	SJC_E	NA	SJC	SJC-DS-1001	SJE2A038_D	25691	16742	14601	13422	12612	12012
THR24_1766_S01	95189019	92738216	85536396	64754455.15	101	acute lymphoblastic leukemia	7.64	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_37	SJC_E	NA	SJC	SJC-DS-1001	SJE2A040_D	28201	16013	13941	12843	12173	11625
THR24_1767_S01	95715324	93160786	85909607	64162397.145	101	acute lymphoblastic leukemia	3.64	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_37	SJC_E	NA	SJC	SJC-DS-1001	SJE2A043_D	28118	16386	14317	13176	12449	11868
THR24_1768_S01	91698233	89274488	81668129.5	62432002.71	101	acute lymphoblastic leukemia	2.93	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_37	SJC_E	NA	SJC	SJC-DS-1001	SJE2A056_D	27087	15601	13709	12724	11991	11439
THR24_1769_S01	52282670	50951303	48161990	35434178.395	101	acute lymphoblastic leukemia	9.59	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_37	SJC_E	NA	SJC	SJC-DS-1001	SJE2A059_D	25552	15760	13769	12680	11942	11417
THR24_1770_S01	49927260	48769922	45010396	35759948.625	101	acute lymphoblastic leukemia	9.01	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_37	SJC_E	NA	SJC	SJC-DS-1001	SJE2A060_D	26505	16283	14254	13175	12426	11872
THR24_1771_S01	34293324	33196535	30306593	23392641.415	101	ependymoma	3.7	Yes, age < 30 years	female	NA	NA	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD001503_D1	29111	18653	16129	14767	13839	13071
THR24_1772_S01	27305918	26382519	25134095.5	20493083.38	101	ependymoma	2.6	Yes, age < 30 years	female	NA	NA	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD001504_D1	26581	17634	15398	14200	13326	12680
THR24_1773_S01	54673842	53070079	46448592.5	35008080.54	101	ependymoma	1.6	Yes, age < 30 years	male	NA	NA	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD001505_D1	30635	19085	16581	15170	14192	13423
THR24_1774_S01	46391285	45111574	35327700.5	28342442.4	101	ependymoma	2.7	Yes, age < 30 years	female	NA	NA	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD001506_D1	29129	18010	15564	14109	13041	12212
THR24_1775_S01	45253531	43831157	40657430	31399623.215	101	ependymoma	3.6	Yes, age < 30 years	male	NA	NA	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD001507_D1	29206	18637	16347	15026	14069	13337
THR24_1776_S01	54946757	53377916	45122972.5	36172017.955	101	ependymoma	1.1	Yes, age < 30 years	male	NA	NA	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD001508_D1	29962	18258	15968	14610	13619	12844
THR24_1777_S01	44658437	43236879	37420088.5	29984783.4	101	ependymoma	2.4	Yes, age < 30 years	female	NA	NA	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD001509_D1	28335	17322	14939	13662	12704	11933
THR24_1778_S01	45824335	44435158	33537060	25664512.11	101	ependymoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD001511_D1	29399	17861	15420	13920	12856	12006
THR24_1779_S01	48611628	47199737	37859652	30253764.95	101	ependymoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD001512_D1	28488	17719	15385	14091	13165	12430
THR24_1780_S01	49388157	47952298	43472697	35860542.41	101	ependymoma	2	Yes, age < 30 years	male	NA	NA	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD001513_D1	29114	17115	14846	13604	12734	12062
THR24_1781_S01	48927062	47465937	42952533.5	32043801.2	101	ependymoma	4.2	Yes, age < 30 years	male	NA	NA	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD001514_D1	30325	18681	16264	14921	13991	13224
THR24_1782_S01	52771635	51184748	43233611.5	32316246.81	101	ependymoma	1.3	Yes, age < 30 years	male	NA	NA	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD001515_D1	31317	19410	16740	15257	14215	13367
THR24_1783_S01	51314948	49749221	42314936	33546950.4	101	ependymoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD001516_D1	29920	18832	16447	15030	14022	13218
THR24_1784_S01	50647389	49026611	30774606	22753233.3	101	ependymoma	3.3	Yes, age < 30 years	female	NA	NA	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD001517_D1	28513	17715	15227	13703	12545	11634
THR24_1785_S01	53908372	52210391	38681503	29695705	101	ependymoma	2	Yes, age < 30 years	female	NA	NA	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD001518_D1	29683	17702	15297	13844	12839	11999
THR24_1786_S01	43175962	41901326	36850574	26646079.17	101	ependymoma	3.7	Yes, age < 30 years	female	NA	NA	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD001519_D1	30314	19448	16760	15251	14187	13370
THR24_1787_S01	41200313	39951566	36546973.5	26178334.11	101	ependymoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD001520_D1	29856	19488	16828	15305	14257	13392
THR24_1788_S01	55894357	54342138	46252262	36518790.43	101	ependymoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD001521_D1	29288	18098	15715	14377	13352	12629
THR24_1789_S01	19141556	18568281	17881261	11759506.84	101	ependymoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_10	SJC_EPD	NA	SJC	SJC-DS-1001	SJEPD001522_R1	27593	20232	17520	15987	14904	14010
THR24_1790_S01	24192037	23436389	4568158	3866154.72	101	ependymoma	7.1	Yes, age < 30 years	male	NA	NA	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD001523_D1	19626	7857	4957	3532	2749	2213
THR24_1790_S02	22620632	21898101	12089328	9760221.38	101	ependymoma	7.1	Yes, age < 30 years	male	NA	NA	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD001523_R1	25022	17049	14688	13143	11939	10980
THR24_1791_S01	17795002	17242915	14369863	10320510.915	101	ependymoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD001524_R1	26786	18522	15654	13986	12732	11774
THR24_1792_S01	48214928	46929259	33479597	25738142.37	101	ependymoma	0.7	Yes, age < 30 years	female	NA	NA	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD001525_D1	28689	17834	15437	13922	12869	12015
THR24_1793_S01	25317673	24608215	20408105	15093731.355	101	ependymoma	2.3	Yes, age < 30 years	male	NA	NA	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD001526_D1	27616	17963	15384	13866	12751	11823
THR24_1794_S01	36612425	35420484	32733908	25163537.015	101	ependymoma	NA	Yes, age < 30 years	female	NA	NA	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD001527_R1	28600	18908	16405	15047	14055	13317
THR24_1795_S01	57532181	55672543	47723081	35512636.8	101	ependymoma	5.9	Yes, age < 30 years	female	NA	NA	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD001528_D1	30405	18865	16370	14944	13909	13078
THR24_1796_S01	40257826	39133482	34156428.5	25145865.99	101	ependymoma	5	Yes, age < 30 years	female	NA	NA	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD001530_D1	29437	18847	16351	14829	13751	12885
THR24_1797_S01	18893050	18415156	17448620.5	14451536.33	101	ependymoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_10	SJC_EPD	NA	SJC	SJC-DS-1001	SJEPD001531_D1	25006	17759	15512	14311	13451	12787
THR24_1798_S01	30859519	30021776	21597925.5	17738500.8	101	ependymoma	5	Yes, age < 30 years	female	NA	NA	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD001532_R1	26551	17284	15053	13707	12664	11797
THR24_1799_S01	47399762	46081198	18545931	15565614.11	101	ependymoma	1.7	Yes, age < 30 years	female	NA	NA	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD001533_D1	26042	15458	13086	11578	10378	9438
THR24_1800_S01	15060604	14639382	12952186	9771509.5	101	ependymoma	2.2	Yes, age < 30 years	female	NA	NA	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD001534_D1	25654	18287	15699	14240	13136	12220
THR24_1801_S01	26718389	25965915	23105836	17039944	101	ependymoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD001535_R1	28009	19095	16540	15104	14010	13187
THR24_1801_S02	44209111	42774250	27753544.5	21501182.4	101	ependymoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD001535_R2	29554	18146	15611	14122	12939	11993
THR24_1802_S01	39064686	37939981	35290176.5	24979346.595	101	ependymoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD001536_R1	30441	20329	17798	16360	15283	14422
THR24_1803_S01	37866551	36623770	34430240	26520166.095	101	ependymoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD001537_D1	28312	18325	16063	14829	13929	13230
THR24_1804_S01	47991767	46541245	38132868	28421376.795	101	ependymoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD001538_R1	30434	18829	16261	14856	13811	12924
THR24_1805_S01	43810532	42344277	37363011	28456967.6	101	ependymoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD001539_D1	29849	18820	16409	14999	13998	13171
THR24_1806_S01	63585055	61537905	53765588.5	43031207.31	101	ependymoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD001540_D1	29987	17659	15390	14115	13251	12515
THR24_1807_S01	54721584	53029447	41953823	31501530.18	101	ependymoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD001541_D1	30079	18729	16171	14719	13685	12833
THR24_1807_S02	60442182	58613014	49762150	39271205.61	101	ependymoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD001541_R1	29028	17677	15411	14161	13267	12519
THR24_1808_S01	66383079	64510261	53340199.5	44775673.02	101	ependymoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD001542_D1	31381	18497	16141	14771	13744	12998
THR24_1809_S01	55633573	54108228	51049893.5	37745186	101	ependymoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD001543_D1	30334	19318	16792	15390	14416	13688
THR24_1810_S01	57591179	55704022	52497236.5	40713841.35	101	ependymoma	3	Yes, age < 30 years	male	NA	NA	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD001544_D1	28844	18032	15833	14650	13794	13087
THR24_1811_S01	71649679	69426413	57794015.5	39898107.78	101	ependymoma	1.4	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD002_D	32022	19066	16422	14880	13833	13000
THR24_1812_S01	81735206	78992278	65134678.5	47783308.8	101	ependymoma	7.22	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD003_D	32105	18501	15783	14293	13326	12531
THR24_1813_S01	48951201	47383846	42405266.5	29892953.61	101	ependymoma	1.39	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD004_D	30074	18944	16339	14922	13980	13179
THR24_1814_S01	76022345	73549685	6089081.5	4269409.54	101	ependymoma	2.05	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD005_D	33014	19839	17040	15461	14410	13557
THR24_1815_S01	75303593	72536685	55039880	39899806	101	ependymoma	13.13	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD006_D	32585	19505	16804	15259	14208	13344
THR24_1816_S01	73332530	70743591	59804218	38611813.31	101	ependymoma	2.2	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD007_D	32828	20506	17560	15896	14764	13897
THR24_1817_S01	69739324	67314808	58684309	39254358.17	101	ependymoma	10.39	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD008_D	32338	19724	16905	15349	14341	13479
THR24_1818_S01	42137372	40816749	38643293.5	29721987.75	101	ependymoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_10	SJC_EPD	NA	SJC	SJC-DS-1001	SJEPD009108_D1	28676	18339	16064	14791	13905	13213
THR24_1819_S01	65246555	63183860	52635252.5	36887151.735	101	ependymoma	8.1	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD009_D	31741	19351	16535	15077	14038	13262
THR24_1820_S01	52932692	51090504	35033195.5	28187603.295	101	ependymoma	2.5	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD011_D	28633	17509	15113	13873	12986	12213
THR24_1821_S01	85097081	82305339	60101269.5	42599690.24	101	ependymoma	2.06	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD012_D	32996	19601	16862	15325	14250	13415
THR24_1822_S01	52830142	51471236	40250629	31142767.75	101	ependymoma	6.57	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD013_D	30005	17540	15094	13770	12804	12013
THR24_1823_S01	101578064	98525693	42593958	32303760.6	101	ependymoma	5.08	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD014_D	32351	18535	16003	14466	13386	12508
THR24_1824_S01	71541066	69514609	57038104	36267844.34	101	ependymoma	2.72	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD015_D	32388	19613	16592	14992	13896	13037
THR24_1825_S01	63206148	61126935	54235486.5	39883059.2	101	ependymoma	1.35	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD016_D	32013	19770	17042	15640	14608	13849
THR24_1826_S01	91706152	88487635	72267942.5	53881567.2	101	ependymoma	2.89	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD017_D	32776	19500	16882	15502	14498	13722
THR24_1827_S01	100743577	97282118	66305657	48559201.92	101	ependymoma	1.93	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD019_D	32467	19414	16740	15280	14224	13404
THR24_1828_S01	70594383	68269067	43059440	37558142.84	101	ependymoma	2.01	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD021_D	28967	17161	15094	13924	13018	12338
THR24_1829_S01	45392507	44021268	39838085	28935642.15	101	ependymoma	16.29	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_10	SJC_EPD	NA	SJC	SJC-DS-1001	SJEPD023_D	29559	18348	15856	14458	13525	12786
THR24_1830_S01	49828474	48325249	39117220.5	29977275.015	101	ependymoma	2.51	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD025_D	29624	18153	15666	14218	13083	12223
THR24_1831_S01	47446825	45962463	41425365	29249739.09	101	ependymoma	16.81	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD027_D	31029	19540	16936	15459	14348	13546
THR24_1832_S01	50072848	48678343	41241848.5	30058045.38	101	ependymoma	5.88	Yes, age < 30 years	female	NA	NA	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD028_D	31244	19344	16749	15174	14047	13148
THR24_1833_S01	49835431	48451650	42584402	33375638.79	101	ependymoma	2.75	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD029_D	31168	19428	16874	15479	14480	13667
THR24_1834_S01	53422514	51867962	41379710.5	29863242.81	101	ependymoma	5.64	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD030_D	30618	18811	16248	14708	13520	12605
THR24_1835_S01	44886171	43546344	32631183.5	24202119.6	101	ependymoma	2.54	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD031_D	29550	18487	15903	14320	13151	12221
THR24_1835_S02	51836477	50216646	46514193	35839506.165	101	ependymoma	2.54	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD031_R	30548	19541	17095	15685	14713	13931
THR24_1837_S01	46242220	44664298	42071299.5	32984445.39	101	ependymoma	6.55	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD033_D	28709	18237	15944	14689	13854	13188
THR24_1838_S01	55170427	53405729	48750743	36998854.4	101	ependymoma	14.29	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD034_D	31114	18934	16509	15151	14195	13397
THR24_1839_S01	44983854	43739409	32780486.5	25589896.65	101	ependymoma	0.65	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD035_D	28781	18075	15714	14211	13127	12256
THR24_1839_S02	59360151	57550072	42076859.5	33035232.375	101	ependymoma	0.65	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD035_R	29728	17675	15328	13941	12865	12047
THR24_1840_S01	53642085	52008506	46811861.5	37667013.93	101	ependymoma	1.61	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD036_D	28894	17512	15293	14039	13190	12497
THR24_1841_S01	48555645	47138280	42539616.5	32558141.16	101	ependymoma	1.66	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD037_D	29021	18478	16116	14813	13836	13080
THR24_1841_S02	52811321	51451373	40554236	34329310.47	101	ependymoma	1.66	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_10	SJC_EPD	NA	SJC	SJC-DS-1001	SJEPD037_R	29297	17005	14756	13464	12483	11728
THR24_1842_S01	39202000	38190597	28831644	22217796.075	101	ependymoma	0.93	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD038_D	29389	18464	15924	14460	13409	12587
THR24_1843_S01	52791878	51362201	43772038.5	34497528.78	101	ependymoma	5.96	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_10	SJC_EPD	https://doi.org/10.1038/nature13109	SJC	SJC-DS-1001	SJEPD039_D	29517	18357	16040	14618	13667	12881
THR24_1844_S01	68628566	66074981	61076832	45174446.07	101	acute lymphoblastic leukemia	7.81	Yes, age < 30 years	male	NA	NA	Cohort_21	SJC_ERG	NA	SJC	SJC-DS-1001	SJERG002_D	29909	16376	14190	13048	12290	11712
THR24_1845_S01	59433132	57594064	53587546	37622906.675	101	acute lymphoblastic leukemia	6.04	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_21	SJC_ERG	NA	SJC	SJC-DS-1001	SJERG003_D	27975	17101	14844	13621	12862	12207
THR24_1846_S01	69686709	67538767	58760190.5	42350481.95	101	acute lymphoblastic leukemia	15.54	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_21	SJC_ERG	NA	SJC	SJC-DS-1001	SJERG004_D	28060	16400	14333	13122	12317	11633
THR24_1847_S01	91833568	89542079	72105259	48353772.3	101	acute lymphoblastic leukemia	9.36	Yes, age < 30 years	female	NA	NA	Cohort_21	SJC_ERG	NA	SJC	SJC-DS-1001	SJERG005_D	30579	16985	14563	13255	12325	11638
THR24_1848_S01	60719493	58160871	49029119	31978722.46	76	acute lymphoblastic leukemia	13.18	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_21	SJC_ERG	NA	SJC	SJC-DS-1001	SJERG006_D	26802	15288	13002	11842	11080	10497
THR24_1849_S01	46452644	44914977	42212490	30735359.22	101	acute lymphoblastic leukemia	13.8	Yes, age < 30 years	female	NA	Hispanic or Latino	Cohort_21	SJC_ERG	NA	SJC	SJC-DS-1001	SJERG008_D	26815	16779	14634	13475	12668	12065
THR24_1850_S01	97255164	94629821	77361790	51882008.44	101	acute lymphoblastic leukemia	15.63	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_21	SJC_ERG	NA	SJC	SJC-DS-1001	SJERG009_D	29243	16431	14220	13039	12200	11552
THR24_1851_S01	54842591	53214550	48352706.5	34985050.065	101	acute lymphoblastic leukemia	7.98	Yes, age < 30 years	female	NA	NA	Cohort_21	SJC_ERG	NA	SJC	SJC-DS-1001	SJERG010_D	26592	16131	14000	12892	12116	11499
THR24_1852_S01	62203799	59013954	53207962	28716137.47	76	acute lymphoblastic leukemia	4.36	Yes, age < 30 years	female	NA	NA	Cohort_21	SJC_ERG	NA	SJC	SJC-DS-1001	SJERG011_D	26931	16822	14334	12957	12025	11327
THR24_1853_S01	38739435	37566844	34008851.5	26317608.625	101	acute lymphoblastic leukemia	18.71	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_21	SJC_ERG	NA	SJC	SJC-DS-1001	SJERG014_D	25326	15488	13564	12512	11803	11195
THR24_1854_S01	61724029	59265164	52244885.5	27675815.135	76	acute lymphoblastic leukemia	10.79	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_21	SJC_ERG	NA	SJC	SJC-DS-1001	SJERG016_D	27010	16639	14174	12726	11824	11143
THR24_1855_S01	44272373	43108594	39477437.5	23307797.305	101	acute lymphoblastic leukemia	18.65	Yes, age < 30 years	male	NA	NA	Cohort_21	SJC_ERG	NA	SJC	SJC-DS-1001	SJERG020051_D1	26289	16458	14007	12691	11727	10983
THR24_1856_S01	59715710	58146265	49164714.5	31672536.49	101	acute lymphoblastic leukemia	16.85	Yes, age < 30 years	male	NA	NA	Cohort_21	SJC_ERG	NA	SJC	SJC-DS-1001	SJERG020052_D1	26079	14670	12344	10998	10080	9368
THR24_1857_S01	59245744	57291707	52598619	34633951.65	101	acute lymphoblastic leukemia	17.31	Yes, age < 30 years	female	NA	NA	Cohort_21	SJC_ERG	NA	SJC	SJC-DS-1001	SJERG020299_D1	26681	15883	13636	12431	11528	10845
THR24_1858_S01	41343439	40283075	28475665	17121714.54	101	acute lymphoblastic leukemia	16.39	Yes, age < 30 years	male	NA	NA	Cohort_21	SJC_ERG	NA	SJC	SJC-DS-1001	SJERG020300_D1	24311	14746	12324	10915	9902	9117
THR24_1859_S01	38058056	37287257	33109362.5	23862308.34	101	acute lymphoblastic leukemia	17.21	Yes, age < 30 years	male	NA	NA	Cohort_21	SJC_ERG	NA	SJC	SJC-DS-1001	SJERG020302_D1	26796	15992	13642	12475	11578	10860
THR24_1860_S01	77645426	75658565	57885777	41195629.2	101	acute lymphoblastic leukemia	16.14	Yes, age < 30 years	male	NA	NA	Cohort_21	SJC_ERG	NA	SJC	SJC-DS-1001	SJERG020303_D1	27453	14479	12238	10934	10007	9296
THR24_1861_S01	72297460	70412800	61235461.5	41791594.8	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_21	SJC_ERG	NA	SJC	SJC-DS-1001	SJERG020304_D1	27823	14839	12572	11163	10334	9621
THR24_1862_S01	40891877	39623916	37176854.5	21962186.78	101	acute lymphoblastic leukemia	19.68	Yes, age < 30 years	male	NA	NA	Cohort_21	SJC_ERG	NA	SJC	SJC-DS-1001	SJERG020305_D1	25152	15954	13646	12393	11515	10805
THR24_1863_S01	71909650	70132561	55904971	32128601.14	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_21	SJC_ERG	NA	SJC	SJC-DS-1001	SJERG020306_D1	27842	15854	13390	12059	11123	10360
THR24_1864_S01	44875859	43739418	39952443	24694884.25	101	acute lymphoblastic leukemia	16.58	Yes, age < 30 years	male	NA	NA	Cohort_21	SJC_ERG	NA	SJC	SJC-DS-1001	SJERG020307_D1	26395	16189	13705	12459	11529	10829
THR24_1865_S01	52125358	50550077	46151550.5	29465056.53	101	acute lymphoblastic leukemia	18.02	Yes, age < 30 years	male	NA	NA	Cohort_21	SJC_ERG	NA	SJC	SJC-DS-1001	SJERG020308_D1	26942	16480	14178	12961	12097	11439
THR24_1866_S01	51067695	49693750	38776249	25148686.005	101	acute lymphoblastic leukemia	17.5	Yes, age < 30 years	female	NA	NA	Cohort_21	SJC_ERG	NA	SJC	SJC-DS-1001	SJERG020309_D1	25155	14516	12225	10942	9964	9232
THR24_1867_S01	52067646	50519745	39782411.5	28995345.51	101	acute lymphoblastic leukemia	6.98	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_21	SJC_ERG	NA	SJC	SJC-DS-1001	SJERG020_D	26760	14438	12379	11233	10380	9750
THR24_1868_S01	35735622	34487513	27901078.5	18265558.725	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_21	SJC_ERG	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJERG021891_D1	37601	17202	14482	13197	12318	11635
THR24_1869_S01	61435138	59663472	48748029.5	32300338.33	101	acute lymphoblastic leukemia	10	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_21	SJC_ERG	NA	SJC	SJC-DS-1001	SJERG024_D	28283	15998	13733	12488	11604	10865
THR24_1870_S01	52725949	51110220	45014877.5	30317812.785	101	acute lymphoblastic leukemia	4.13	Yes, age < 30 years	female	NA	Hispanic or Latino	Cohort_21	SJC_ERG	NA	SJC	SJC-DS-1001	SJERG026_D	29295	17867	15392	14041	13131	12448
THR24_1871_S01	110576915	107970611	84431815	54019102.065	101	acute lymphoblastic leukemia	10.93	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_21	SJC_ERG	NA	SJC	SJC-DS-1001	SJERG028_D	29654	15936	13774	12586	11748	11126
THR24_1872_S01	40090266	38886961	35734491.5	26843041.61	101	acute lymphoblastic leukemia	3.36	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_21	SJC_ERG	NA	SJC	SJC-DS-1001	SJERG029_D	25965	16360	14242	13131	12363	11779
THR24_1873_S01	39913610	38632309	36386197	26430950.605	101	acute lymphoblastic leukemia	15.74	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_21	SJC_ERG	NA	SJC	SJC-DS-1001	SJERG030_D	26011	16523	14367	13196	12397	11784
THR24_1874_S01	75164863	73328800	60020385	40253311.28	101	acute lymphoblastic leukemia	10.86	Yes, age < 30 years	female	NA	NA	Cohort_21	SJC_ERG	NA	SJC	SJC-DS-1001	SJERG031_D	28210	15973	13793	12634	11761	11121
THR24_1875_S01	63065181	59596218	52758508	34222495.2	101	acute lymphoblastic leukemia	4.08	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJETV001_D	29112	17082	14424	13153	12248	11602
THR24_1876_S01	93334702	89439721	78446029	57546047.52	101	acute lymphoblastic leukemia	8	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV002_D	29556	16701	14410	13234	12416	11815
THR24_1877_S01	55666163	53936350	49244865.5	34363021.6	101	acute lymphoblastic leukemia	3.58	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV003_D	28355	17023	14519	13238	12412	11813
THR24_1878_S01	44263868	42876028	40141078.5	24749334.71	101	acute lymphoblastic leukemia	8.39	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV004_D	27301	18293	15805	14447	13562	12857
THR24_1879_S01	46113081	44760471	42164267.5	29807373.475	101	acute lymphoblastic leukemia	11.45	Yes, age < 30 years	female	NA	NA	Cohort_14	SJC_ETV	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJETV010_D	26488	16650	14412	13255	12479	11918
THR24_1879_S02	42809164	41520878	38613968.5	29794694.16	101	acute lymphoblastic leukemia	11.45	Yes, age < 30 years	female	NA	NA	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV010_R	27276	16523	14395	13230	12464	11894
THR24_1880_S01	61735329	58514572	54192517	37975838.78	101	acute lymphoblastic leukemia	2.67	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJETV022_D	27530	16943	14674	13543	12771	12194
THR24_1881_S01	45748315	44397109	37676067	27532262.745	101	acute lymphoblastic leukemia	4.54	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV024_D	27539	15851	13597	12480	11687	11003
THR24_1882_S01	50441983	48845001	45837069.5	33549746.465	101	acute lymphoblastic leukemia	3.89	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV025_D	27939	17094	14825	13621	12786	12167
THR24_1883_S01	81126199	78605792	67257829	43574456.655	101	acute lymphoblastic leukemia	3.72	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJETV026_D	29944	17263	14666	13360	12465	11774
THR24_1884_S01	46863217	45263366	41266742.5	27214711.695	101	acute lymphoblastic leukemia	7.13	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV027_D	28259	17758	15038	13615	12752	12048
THR24_1885_S01	39653133	38299093	34131904	24043104.11	101	acute lymphoblastic leukemia	1.84	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV028_D	27189	16799	14468	13235	12408	11810
THR24_1886_S01	42473852	41041129	38851537.5	25929345.6	101	acute lymphoblastic leukemia	5.76	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJETV032_D	27429	17776	15190	13776	12927	12240
THR24_1887_S01	43446179	42011737	38836819	23447528.54	101	acute lymphoblastic leukemia	6.72	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV035_D	27544	17661	15004	13585	12642	11936
THR24_1888_S01	51659506	50105914	47195897	33979565.32	101	acute lymphoblastic leukemia	7.41	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJETV036_D	26955	16913	14670	13526	12761	12204
THR24_1889_S01	50271650	48677540	45121941	31981552.98	101	acute lymphoblastic leukemia	5.26	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV039_D	28345	17005	14556	13282	12485	11866
THR24_1890_S01	56151105	54744255	51469110.5	36286373.22	101	acute lymphoblastic leukemia	6.18	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV041_D	27896	17251	14905	13653	12879	12234
THR24_1891_S01	48505357	47043538	44856102.5	30092107.095	101	acute lymphoblastic leukemia	9.74	Yes, age < 30 years	female	NA	NA	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV043_D	27313	17448	15070	13835	12967	12311
THR24_1891_S02	45345606	44007557	39251368.5	26470906.4	101	acute lymphoblastic leukemia	9.74	Yes, age < 30 years	female	NA	NA	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV043_R	27772	17241	14674	13358	12449	11780
THR24_1892_S01	53687568	52025228	46134741	31713872.8	101	acute lymphoblastic leukemia	3.22	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV044_D	28501	17451	14914	13569	12674	12043
THR24_1893_S01	55777122	54176870	51302446	36203155.41	101	acute lymphoblastic leukemia	2.69	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV045_D	28104	17437	15150	13875	13020	12362
THR24_1894_S01	49096871	47650113	45089653.5	32635446.48	101	acute lymphoblastic leukemia	4.7	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV046_D	27007	16940	14693	13496	12681	12095
THR24_1895_S01	49257100	47774192	45435771	32492461.42	101	acute lymphoblastic leukemia	2.06	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV047_D	27025	17082	14943	13788	12972	12384
THR24_1895_S02	47005964	45589306	43750430	32254178.97	101	acute lymphoblastic leukemia	2.06	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV047_R	26500	17049	14898	13747	12960	12377
THR24_1895_S03	50324254	48935295	46457200.5	32602088.14	101	acute lymphoblastic leukemia	2.06	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV047_S	27430	17563	15298	14064	13226	12596
THR24_1896_S01	46780777	45267153	42489279	27079065.045	101	acute lymphoblastic leukemia	10.88	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV048_R	27729	17771	15123	13808	12851	12180
THR24_1897_S01	42275164	41106335	37157458.5	28837033.61	101	acute lymphoblastic leukemia	7.04	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV059_D	26584	16037	14011	12923	12127	11525
THR24_1898_S01	52538608	50678925	39061644.5	28391005.73	101	acute lymphoblastic leukemia	2.75	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV068_D	28628	16632	14259	13007	12183	11507
THR24_1899_S01	36008743	33924746	29328368.5	20978851.6	101	acute lymphoblastic leukemia	2.54	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV069_D	27120	16634	14172	12924	12096	11397
THR24_1900_S01	43017816	41753471	38705480.5	27101327.6	101	acute lymphoblastic leukemia	4.86	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV070_D	27195	17035	14822	13639	12829	12180
THR24_1901_S01	40022758	38279184	22866250.5	16114394	101	acute lymphoblastic leukemia	4.14	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV073_D	25655	16449	14141	12977	12186	11588
THR24_1902_S01	54873660	52511833	31010056	23223009.42	101	acute lymphoblastic leukemia	2.3	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV074_D	27216	15531	13436	12275	11438	10731
THR24_1903_S01	41938029	40126694	23407069	17352537.255	101	acute lymphoblastic leukemia	6.19	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV075_D	25784	15957	13801	12628	11800	11199
THR24_1904_S01	46086017	44812694	42051146	30189763.1	101	acute lymphoblastic leukemia	1.91	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV076_D	27635	17051	14684	13502	12676	12038
THR24_1905_S01	37484920	36275732	32196175	24369917.985	101	acute lymphoblastic leukemia	3.27	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV077_D	27046	16258	14050	12859	12053	11468
THR24_1906_S01	48486266	47012669	43620953	31775173.415	101	acute lymphoblastic leukemia	4.06	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV078_D	27677	16892	14565	13339	12543	11923
THR24_1907_S01	34220353	32792131	30021757.5	18247728.6	101	acute lymphoblastic leukemia	2.09	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV079_D	26830	17546	14870	13402	12418	11682
THR24_1908_S01	47816565	46235352	40142426.5	26895389.22	101	acute lymphoblastic leukemia	5.48	Yes, age < 30 years	male	NA	NA	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV082_D	26973	16334	14003	12808	12012	11363
THR24_1909_S01	47164681	45563652	40743258	27622573.055	101	acute lymphoblastic leukemia	2.68	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV083_D	27008	16442	14210	12961	12182	11572
THR24_1910_S01	57199701	55563182	52018917	32558600.61	101	acute lymphoblastic leukemia	3.47	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV084_D	28354	17864	15169	13701	12803	12129
THR24_1911_S01	51580671	49631692	45692892	28660500.96	101	acute lymphoblastic leukemia	4.1	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV085_D	27666	17280	14796	13495	12604	11949
THR24_1912_S01	67492562	65453198	58889322	31161078.2	101	acute lymphoblastic leukemia	4.52	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJETV086_D	26939	16009	13710	12443	11524	10823
THR24_1913_S01	15068207	13971281	6777957.5	4335817.28	101	acute lymphoblastic leukemia	2.92	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV088_D	21857	14805	12576	11182	10177	9325
THR24_1914_S01	32665331	31393528	24420128	16940718.45	101	acute lymphoblastic leukemia	16.02	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV089_D	26332	15943	13632	12406	11490	10786
THR24_1915_S01	28004953	26880857	24428732.5	17827967.27	101	acute lymphoblastic leukemia	3.69	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV092_D	24795	16200	14006	12869	12110	11520
THR24_1916_S01	38775005	37323510	30723412.5	22133617.055	101	acute lymphoblastic leukemia	6.52	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJETV093_D	27375	16135	13884	12646	11863	11192
THR24_1917_S01	92010499	86226160	80254267.5	48179592.66	101	acute lymphoblastic leukemia	4.35	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV095_D	29613	17980	15325	13926	13021	12298
THR24_1918_S01	39843698	38487868	35115434.5	25803830.52	101	acute lymphoblastic leukemia	8.59	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV096_D	26387	16290	14137	13003	12244	11662
THR24_1919_S01	57704467	55939086	50821490	36423277.06	101	acute lymphoblastic leukemia	3.16	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV098_D	28161	16627	14405	13195	12350	11705
THR24_1920_S01	41338562	39982218	25118240.5	19725386.835	101	acute lymphoblastic leukemia	3.58	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV136_D	26434	14706	12512	11306	10376	9623
THR24_1920_S02	54141389	52577382	48928411	26893573.98	101	acute lymphoblastic leukemia	3.58	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV136_R	28196	17962	15194	13705	12670	11927
THR24_1921_S01	57225932	55606235	51005380.5	36700394.64	101	acute lymphoblastic leukemia	4.22	Yes, age < 30 years	male	NA	Hispanic or Latino	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV190_D	28869	17386	14898	13577	12768	12129
THR24_1921_S02	42753933	41567734	36073826	25502678.09	101	acute lymphoblastic leukemia	4.22	Yes, age < 30 years	male	NA	Hispanic or Latino	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV190_R	27548	16861	14426	13157	12371	11695
THR24_1922_S01	46323810	44897844	35809909	23394048.55	101	acute lymphoblastic leukemia	3.42	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV191_D	27414	15724	13408	12107	11141	10369
THR24_1922_S02	62054691	60124949	54006383.5	39367499.73	101	acute lymphoblastic leukemia	3.42	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV191_R	28967	16908	14570	13404	12575	11987
THR24_1923_S01	68233846	65906527	43436212.5	29190120.4	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	male	NA	NA	Cohort_14	SJC_ETV	NA	SJC	SJC-DS-1001	SJETV195_D	27388	14840	12641	11430	10521	9804
THR24_1924_S01	50265023	48779804	43860187	33687128.8	101	glioma	5.33	Yes, age < 30 years	female	NA	NA	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG001_A	30141	19351	17005	15665	14686	13899
THR24_1925_S01	79021795	76991889	62562531	45134674.11	101	glioma	14.95	Yes, age < 30 years	female	NA	NA	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG002_A	32253	19417	16998	15564	14519	13684
THR24_1925_S02	41527307	40228481	38097739	29475756.96	101	glioma	14.95	Yes, age < 30 years	female	NA	NA	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG002_D	29899	19620	17168	15816	14861	14119
THR24_1926_S01	58826731	57351428	47382758.5	35060044.05	101	glioma	13.09	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG003_A	29896	18431	16008	14724	13806	13052
THR24_1926_S02	77974174	76363688	70059278	58381971.375	101	glioma	13.09	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG003_D	30776	17685	15460	14238	13432	12819
THR24_1927_S01	37524404	36200113	34808336.5	26025627.6	101	glioma	5.47	Yes, age < 30 years	male	NA	NA	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG004_D	28584	19424	17165	15820	14966	14208
THR24_1928_S01	57731175	56220726	40189865	31132506.4	101	glioma	5.35	Yes, age < 30 years	female	NA	NA	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG005_A	30244	17635	15121	13705	12570	11728
THR24_1929_S01	62346754	59962871	53056964	42848477.6	101	glioma	3.66	Yes, age < 30 years	female	NA	NA	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG006_A	31168	18981	16665	15324	14380	13657
THR24_1930_S01	36157875	35214109	26632262.5	20661746.895	101	glioma	10.9	Yes, age < 30 years	male	NA	NA	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG007_A	29865	18927	16417	14914	13839	13011
THR24_1931_S01	18180335	17706332	15862466.5	12557945.6	101	glioma	3.66	Yes, age < 30 years	female	NA	NA	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG008_A	24865	17535	15121	13827	12855	12106
THR24_1932_S01	72545554	70668867	53703436.5	39495318.525	101	glioma	6.01	Yes, age < 30 years	male	NA	NA	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG009_A	30990	18180	15802	14415	13424	12599
THR24_1933_S01	56161492	54282492	49353570	39848135.34	101	glioma	3.46	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG010_D	29832	18183	15892	14620	13699	12939
THR24_1934_S01	38663359	37343053	34861387.5	28759705.65	101	glioma	17.8	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG011_D	27870	18080	15909	14695	13802	13087
THR24_1935_S01	66865091	64912254	59774564	48728480.57	101	glioma	5.96	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG012_D	30317	18639	16325	15113	14211	13504
THR24_1936_S01	61676215	59583856	53084694.5	44053533.755	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_9	SJC_HGG	NA	SJC	SJC-DS-1001	SJHGG013_D	30590	18103	15901	14639	13761	13053
THR24_1937_S01	52775367	51447954	41883994	35886480.26	101	glioma	10.67	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG014_D	27476	15294	13356	12190	11366	10645
THR24_1938_S01	61012771	59239732	53201204	41340153.66	101	glioma	12.87	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG015_D	31393	19086	16628	15296	14355	13629
THR24_1939_S01	41705664	40481049	38140542.5	30583028.63	101	glioma	0.78	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG016_D	27952	18184	15988	14791	13925	13236
THR24_1940_S01	56681432	55012219	49200961.5	38357849.205	101	glioma	9.04	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG017_D	30381	19087	16619	15317	14347	13613
THR24_1941_S01	52626509	51184072	46946301	37251402.65	101	glioma	7.41	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG019_S	29797	17824	15583	14345	13519	12824
THR24_1942_S01	21147263	20596176	19470723	15478170.985	101	glioma	15.4	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG021_D	26668	18529	16146	14787	13878	13145
THR24_1943_S01	49960178	48755840	44902578.5	35951097.875	101	glioma	4.69	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG024_D	30442	18551	16172	14865	13915	13213
THR24_1943_S02	86103775	27991314	25817402	20223786.18	101	glioma	4.69	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG024_R	25932	17318	15229	14058	13243	12620
THR24_1944_S01	42238059	41064137	38380295	31229995.335	101	glioma	7.65	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG026_D	27926	17812	15503	14307	13506	12872
THR24_1945_S01	53900114	52556003	43820940	35112571.47	101	glioma	12.34	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG027_D	29533	17644	15372	14104	13226	12499
THR24_1946_S01	50322087	48871715	32825098	26460393.96	101	glioma	5.86	Yes, age < 30 years	female	NA	NA	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG028_D	28149	15950	13630	12213	11148	10306
THR24_1947_S01	55382520	53827178	50534296.5	40505246.34	101	glioma	14.41	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG031_D	30038	18650	16302	15047	14168	13491
THR24_1948_S01	39244257	38048984	33427043	26790077.89	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG032_D	28385	17649	15291	13958	12940	12167
THR24_1949_S01	52785283	51530396	43764229.5	35272975.815	101	glioma	14.01	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG033_D	30768	18352	15913	14648	13684	12923
THR24_1950_S01	30098975	29146215	27789392.5	22379639.205	101	glioma	9.87	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG034_D	28189	18619	16340	15000	14085	13385
THR24_1951_S01	112166316	108857904	92227128	68002494.165	101	glioma	7.49	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG035_D	34452	19644	17039	15448	14289	13364
THR24_1952_S01	48739001	47730408	29582530	24285279.4	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_9	SJC_HGG	NA	SJC	SJC-DS-1001	SJHGG039_D	28635	15348	13163	11815	10691	9789
THR24_1953_S01	49416636	48060771	45057989	35189949.99	101	glioma	14.78	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG041_D	28758	17646	15390	14224	13412	12804
THR24_1954_S01	60184856	58698859	50045678	40392758.855	101	glioma	5.85	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG042_D	30599	18470	16073	14707	13692	12870
THR24_1955_S01	84646662	82406837	71581031	58455261.54	101	glioma	14.28	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG043_D	31986	18999	16552	15195	14254	13539
THR24_1956_S01	51568926	49716599	45344955	35703198.38	101	glioma	11.78	Yes, age < 30 years	male	NA	NA	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG045_A	30383	19136	16751	15430	14486	13718
THR24_1957_S01	51008720	49728024	44285678	34607087.995	101	glioma	4.27	Yes, age < 30 years	male	NA	NA	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG047_A	29950	18824	16424	15044	14082	13296
THR24_1958_S01	53971469	51993191	47898999	38016894.685	101	glioma	6.12	Yes, age < 30 years	male	NA	NA	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG048_A	30817	19520	17104	15804	14889	14180
THR24_1959_S01	68320570	66680205	57588835	40886814.99	101	glioma	13.77	Yes, age < 30 years	female	NA	NA	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG049_A	31148	19341	16858	15477	14529	13753
THR24_1960_S01	27120252	26371672	22920820	18368833.945	101	glioma	5.7	Yes, age < 30 years	female	NA	NA	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG050_A	27915	18006	15574	14217	13315	12550
THR24_1961_S01	57495063	55150869	49110536	34978110.8	101	glioma	5.94	Yes, age < 30 years	female	NA	NA	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG052_A	29468	18048	15603	14293	13331	12660
THR24_1962_S01	43089877	42013098	34305307	26467191.855	101	glioma	12.3	Yes, age < 30 years	female	NA	NA	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG057_A	28827	18280	15873	14453	13422	12609
THR24_1963_S01	57237091	55775018	47181919	35004450	101	glioma	5.2	Yes, age < 30 years	female	NA	NA	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG058_A	29646	18533	16234	14986	14030	13280
THR24_1964_S01	35410384	34500905	30093348	23297536.87	101	glioma	8.9	Yes, age < 30 years	male	NA	NA	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG059_A	29044	18679	16183	14806	13829	13056
THR24_1965_S01	74186722	72149145	58154482	43310136.21	101	glioma	13.27	Yes, age < 30 years	male	NA	NA	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG060_A	30718	17884	15571	14168	13138	12373
THR24_1966_S01	60397844	58901620	50462946	37374784.1	101	glioma	12.5	Yes, age < 30 years	female	NA	NA	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG062_A	30871	19503	17090	15684	14707	13898
THR24_1967_S01	50427891	49048410	42874954	31629069.135	101	glioma	10.2	Yes, age < 30 years	male	NA	NA	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG064_A	30685	19478	16848	15390	14336	13524
THR24_1968_S01	45547191	44486046	34587632.5	27163777.275	101	glioma	9	Yes, age < 30 years	female	NA	NA	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG066_A	29684	18235	15850	14472	13448	12583
THR24_1969_S01	66250739	64466366	31807019.5	24117165.995	101	glioma	4.42	Yes, age < 30 years	female	NA	NA	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG070_A	29291	17491	14952	13379	12196	11287
THR24_1970_S01	44667528	43549773	36064232.5	28829846.04	101	glioma	11.1	Yes, age < 30 years	male	NA	NA	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG073_A	29141	17690	15270	13848	12853	12101
THR24_1971_S01	96717646	94570524	65438009	52954644.84	101	glioma	1.82	Yes, age < 30 years	male	NA	NA	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG075_A	30811	16992	14846	13472	12429	11564
THR24_1972_S01	53626307	51918350	49383732.5	36256564.94	101	glioma	2.88	Yes, age < 30 years	male	NA	NA	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG081_D	30519	19539	17036	15689	14726	14008
THR24_1973_S01	59928405	58176840	52729640	41882589.595	101	glioma	0.1	Yes, age < 30 years	male	NA	NA	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG082_D	29946	17942	15605	14363	13486	12829
THR24_1974_S01	32296606	31540899	28106361.5	22924812.9	101	glioma	NA	Yes, age < 30 years	female	NA	NA	Cohort_9	SJC_HGG	NA	SJC	SJC-DS-1001	SJHGG083_D	26599	16969	14851	13640	12800	12115
THR24_1975_S01	35792079	34962289	27697787.5	23736193.84	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_9	SJC_HGG	NA	SJC	SJC-DS-1001	SJHGG087_D	27403	17621	15405	14169	13269	12565
THR24_1976_S01	74157869	72063159	59017851	46052659.2	101	glioma	0.16	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG089_A	30357	18097	15737	14407	13414	12611
THR24_1977_S01	40111425	39153743	31549095.5	24272390.34	101	glioma	0.52	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG090_D	28366	17264	14978	13618	12665	11915
THR24_1978_S01	75251885	73063316	67443460.5	53126879.52	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_9	SJC_HGG	NA	SJC	SJC-DS-1001	SJHGG091_D	31096	18786	16473	15182	14299	13600
THR24_1979_S01	33083337	32243441	28727851	24038750.6	101	glioma	17.23	Yes, age < 30 years	male	NA	NA	Cohort_9	SJC_HGG	NA	SJC	SJC-DS-1001	SJHGG094_D	29023	18859	16475	15095	14122	13334
THR24_1980_S01	58265427	55575638	48088216	36909087.2	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_9	SJC_HGG	NA	SJC	SJC-DS-1001	SJHGG096_D	30245	18512	16081	14752	13764	12998
THR24_1981_S01	55991103	54659889	46137780	37875896.18	101	glioma	3.52	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG099_D	28588	16828	14704	13605	12741	12056
THR24_1982_S01	48535216	47360194	43073776	33435039.69	101	glioma	17.24	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG101_A	31077	19764	17125	15759	14834	14086
THR24_1983_S01	34128944	33337804	28643118	22929976.29	101	glioma	4.7	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG102_D	28364	17987	15666	14295	13420	12700
THR24_1984_S01	58658128	57131549	49431604.5	38511951.345	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG103_D	31236	18865	16360	15017	14073	13276
THR24_1985_S01	46712350	45305398	41839370	34503612.4	101	glioma	0.35	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG107_D	29300	18212	15883	14664	13767	13022
THR24_1986_S01	54747015	53403248	44119151.5	36393269.99	101	glioma	3.28	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG112_D	29356	17564	15363	14049	13055	12203
THR24_1986_S02	63881920	62088616	53639424	43789765.25	101	glioma	3.28	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG112_R	30326	18117	15960	14728	13776	13049
THR24_1987_S01	40561904	39595669	26441532	18743503.01	101	glioma	5.28	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG115_D	29924	16188	13528	12004	10856	9950
THR24_1987_S02	42152300	41022254	35631830	27158866.875	101	glioma	5.28	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG115_R	30153	18233	15889	14527	13577	12734
THR24_1988_S01	43996901	43143606	38009469.5	31158309.105	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG127_D	29136	18403	16153	14896	13997	13280
THR24_1989_S01	57664390	56001631	44504170	37537804.98	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG129_D	31224	18291	15948	14522	13456	12611
THR24_1990_S01	62925753	61012604	37267192.5	28844653.02	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG136_D	29197	15740	13306	11794	10634	9717
THR24_1991_S01	44207318	42644494	40027025.5	30968765.49	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG137_D	29537	19101	16701	15432	14557	13853
THR24_1992_S01	43793778	42694280	38723736	30377007.57	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG138_D	29850	18363	16004	14570	13595	12829
THR24_1993_S01	48345443	47261080	37671532	30729822.24	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG139_D	29364	17193	14916	13669	12740	11911
THR24_1994_S01	37677867	36685608	33301918.5	25293216.4	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG140_D	29025	18949	16367	15044	14043	13274
THR24_1995_S01	64461378	63079620	55063980.5	46580696.78	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG141_D	30188	18522	16295	15015	14160	13467
THR24_1996_S01	32803650	31822817	30279989.5	23338712.28	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG142_D	28523	19114	16557	15119	14148	13398
THR24_1997_S01	106703909	104006844	84735424.5	68093232.745	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG143_A	32878	19070	16662	15284	14292	13494
THR24_1998_S01	33246443	32215038	29678233	21979401.2	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG144_A	27969	18596	16205	14913	13968	13175
THR24_1999_S01	78768028	76770329	64090394.5	52330629.39	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG145_D	31682	18615	16337	14996	14106	13364
THR24_2000_S01	41673365	40682054	37911392.5	29972620.08	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_9	SJC_HGG	https://doi.org/10.1038/ng.2938	SJC	SJC-DS-1001	SJHGG146_D	28772	18493	16206	14889	14010	13309
THR24_2001_S01	51122626	49454015	44737892.5	29952468	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_44	SJC_Other	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJHYPER025_D	35075	16803	14415	13226	12374	11722
THR24_2003_S01	63186836	61427438	54046758.5	37182340.265	101	acute lymphoblastic leukemia	5.2	Yes, age < 30 years	male	NA	NA	Cohort_39	SJC_HYPO	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJHYPO020_D	26570	15210	13126	12057	11310	10722
THR24_2004_S01	37537690	36391146	32781599.5	23845671.26	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_39	SJC_HYPO	NA	SJC	SJC-DS-1001	SJHYPO107_D	30055	16260	14151	13018	12249	11638
THR24_2005_S01	48704968	47071240	44816041	31582410.255	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_39	SJC_HYPO	NA	SJC	SJC-DS-1001	SJHYPO108_D	27712	16641	14588	13419	12680	12055
THR24_2006_S01	53697133	51855883	48541272.5	35191832.13	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_39	SJC_HYPO	NA	SJC	SJC-DS-1001	SJHYPO112_D	28075	16122	14050	12947	12181	11626
THR24_2007_S01	60171745	58402896	53418756.5	39696775.58	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_39	SJC_HYPO	NA	SJC	SJC-DS-1001	SJHYPO121_D	26287	15693	13730	12686	11976	11437
THR24_2008_S01	49979103	48522084	45636914	31297702.8	101	acute lymphoblastic leukemia	3.72	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_39	SJC_HYPO	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJHYPO147_D	27455	17298	14773	13509	12673	12048
THR24_2009_S01	38044925	36697437	29101653	20177246.8	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_39	SJC_HYPO	https://doi.org/10.1056/NEJMoa1403088	SJC	SJC-DS-1001	SJHYPO151_D	35680	15476	13250	12132	11354	10741
THR24_2010_S01	103243610	96474314	77224361.5	50965086.4	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_43	SJC_INF	NA	SJC	SJC-DS-1001	SJINF001102_D1	28161	15765	13483	12352	11576	11053
THR24_2011_S01	44530707	43579002	41015617	31492466.18	101	acute lymphoblastic leukemia	0.19	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_43	SJC_INF	https://doi.org/10.1038/ng.3230	SJC	SJC-DS-1001	SJINF001_E	25712	15731	13673	12601	11869	11293
THR24_2012_S01	54339337	53251567	50386661.5	37118013.66	101	acute lymphoblastic leukemia	0.11	Yes, age < 30 years	female	NA	Hispanic or Latino	Cohort_43	SJC_INF	https://doi.org/10.1038/ng.3230	SJC	SJC-DS-1001	SJINF016_D	26909	16405	14198	13088	12288	11704
THR24_2013_S01	39499906	38445584	36416410	23800162.77	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_43	SJC_INF	https://doi.org/10.1038/ng.3230	SJC	SJC-DS-1001	SJINF049_D	26081	17023	14674	13387	12518	11856
THR24_2014_S01	38365163	37449952	35893857	27675189.86	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_43	SJC_INF	https://doi.org/10.1038/ng.3230	SJC	SJC-DS-1001	SJINF068_F	24797	15746	13679	12697	12003	11456
THR24_2015_S01	49479399	48265056	45640953.5	35164336.64	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	NA	NA	NA	Cohort_43	SJC_INF	https://doi.org/10.1038/ng.3230	SJC	SJC-DS-1001	SJINF074_D	27407	16832	14565	13315	12519	11950
THR24_2016_S01	84833786	82507443	55858550	47634358.31	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG001206_D1	29827	16447	14370	13135	12151	11328
THR24_2017_S01	59079513	57308185	51835643.5	43557554.34	101	glioma	2.82	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG001211_D1	28762	17331	15253	14138	13361	12762
THR24_2018_S01	34981244	33901194	31158293.5	26544351.295	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG001212_D1	26441	17626	15519	14335	13596	12952
THR24_2019_S01	55155302	53305535	46093833	38836752.63	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_15	SJC_LGG	NA	SJC	SJC-DS-1001	SJLGG001220_D1	30251	18581	16124	14776	13812	13078
THR24_2020_S01	48807705	47347882	38662816	30255788.25	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG001262_D1	28917	18500	16196	14816	13888	13110
THR24_2021_S01	46228484	44312146	41234920	33065352.45	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG001264_D1	28226	18566	16296	15086	14256	13573
THR24_2022_S01	108965750	105664419	89705062	74502587.005	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_15	SJC_LGG	NA	SJC	SJC-DS-1001	SJLGG001268_D1	31315	17649	15360	14162	13300	12608
THR24_2023_S01	46547811	45361114	12460117.5	11005740.4	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_15	SJC_LGG	NA	SJC	SJC-DS-1001	SJLGG001278_D1	21969	10433	7701	5979	4950	4198
THR24_2024_S01	47548287	45957155	37745574	24178399.6	101	glioma	5.36	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG001_D	30550	18953	16051	14489	13379	12546
THR24_2025_S01	66254424	63897210	53655258	40190479.56	101	glioma	6.86	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG002_D	31057	18217	15668	14401	13457	12719
THR24_2026_S01	68870105	66894882	53538374.5	38358876.78	101	glioma	1.04	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG003_D	31640	18231	15596	14200	13202	12423
THR24_2027_S01	50245897	48800831	37921737.5	31640720.28	101	glioma	0.42	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG004_D	28766	17514	15341	14115	13251	12539
THR24_2028_S01	85015288	82773878	35763136	28065817.33	101	glioma	5.46	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG005_D	29955	15816	13357	11769	10643	9689
THR24_2029_S01	91172064	88231759	73637352	59521095.6	101	glioma	1.24	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG006_D	33132	18687	16208	14899	13984	13328
THR24_2029_S02	76464181	74225814	45713734.5	29784955.87	101	glioma	1.24	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG006_R	31519	16906	14021	12492	11377	10476
THR24_2030_S01	53126896	51560262	31230056.5	22997190.735	101	glioma	0.89	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG007_D	29672	16394	13825	12357	11266	10331
THR24_2031_S01	50249892	48267800	35914244.5	30778636.98	101	glioma	17.99	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG008_D	29001	17205	14912	13581	12624	11835
THR24_2032_S01	55336623	53924127	48080161.5	38822272.035	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_15	SJC_LGG	NA	SJC	SJC-DS-1001	SJLGG010129_D1	30689	18649	16287	14941	14041	13336
THR24_2033_S01	50378448	49125330	41551033.5	34162272.965	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_15	SJC_LGG	NA	SJC	SJC-DS-1001	SJLGG010674_D1	29039	18089	15785	14495	13513	12737
THR24_2034_S01	47276220	45868710	34122178	29094758	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_15	SJC_LGG	NA	SJC	SJC-DS-1001	SJLGG010675_D1	27888	16453	14288	13022	12067	11207
THR24_2035_S01	45421626	43785572	39784501	31737604.47	101	glioma	4.16	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG010_D	28795	17889	15585	14407	13582	12943
THR24_2036_S01	56224601	55112700	9986186.5	8173333.7	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_15	SJC_LGG	NA	SJC	SJC-DS-1001	SJLGG011287_D1	23057	8608	5490	3906	2955	2345
THR24_2037_S01	68676337	67086244	45036353	32229831.04	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_15	SJC_LGG	NA	SJC	SJC-DS-1001	SJLGG011290_D1	31261	17088	14642	13197	12181	11290
THR24_2038_S01	55207940	53529141	38149374.5	28171876.8	101	glioma	12.28	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG011_D	30230	17081	14635	13272	12294	11485
THR24_2039_S01	48759578	47280415	41081247.5	31791394.88	101	glioma	12.91	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG012_D	29193	17678	15254	14019	13167	12520
THR24_2040_S01	40215375	38715608	33498409	20699885.22	101	glioma	9.75	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG015_D	30673	19354	16234	14540	13473	12554
THR24_2041_S01	53351024	51022049	34514103.5	25311367.63	101	glioma	13.95	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_15	SJC_LGG	NA	SJC	SJC-DS-1001	SJLGG016_D	30594	17885	15307	13847	12770	11897
THR24_2042_S01	88253614	85048411	59748303.5	48988347.615	101	glioma	5.65	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG018_D	29642	18090	15968	14722	13821	13093
THR24_2043_S01	75071256	72407640	55643389	46201748.54	101	glioma	5.33	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG025_D	29798	17557	15296	14077	13171	12455
THR24_2044_S01	70344037	67685627	55128736.5	45181258.14	101	glioma	2.81	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG030_D	31615	18782	16342	15009	14028	13271
THR24_2045_S01	57808895	55590570	43553596.5	35066527.9	101	glioma	11.37	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG031_D	31050	18851	16391	15003	14041	13284
THR24_2046_S01	52309979	50524000	35587667	29504064.72	101	glioma	8.62	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG033_D	29397	17097	14824	13433	12416	11551
THR24_2047_S01	51127190	49145883	43096429	34897338.8	101	glioma	15.24	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG034_D	30011	18414	15963	14644	13734	12999
THR24_2048_S01	51999171	50491260	35944788.5	29297934.075	101	glioma	5.45	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG035_D	29366	17418	15049	13711	12674	11895
THR24_2049_S01	50504755	49043118	26145618	21263917.905	101	glioma	2.84	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG036_D	28638	16121	13740	12168	11049	10032
THR24_2050_S01	5305044	4925670	3609190	2851765.045	101	glioma	2.9	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG037_D	20120	15399	12946	11390	10205	9255
THR24_2051_S01	69809332	67476891	42110854	32987051.145	101	glioma	12.61	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG038_D	29396	16101	13824	12453	11407	10516
THR24_2052_S01	82570533	77167170	63153149.5	51413549.18	101	glioma	10.05	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG039_D	30187	17624	15330	14057	13188	12400
THR24_2053_S01	59006619	57013367	43068435.5	37348938.51	101	glioma	7.62	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG040_D	29006	17215	14996	13693	12729	11915
THR24_2054_S01	49998771	48068698	31026669.5	27390600.51	101	glioma	8.9	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG042_D	26399	16098	14145	12944	12020	11282
THR24_2055_S01	45712038	43971571	38951991.5	31666531.035	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG044_D	28947	18211	15924	14620	13759	13028
THR24_2056_S01	108604303	104877344	73225101	54602736.87	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG045_D	33975	17660	15096	13694	12629	11828
THR24_2057_S01	46072544	44646817	35086077	26782570.4	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG046_D	30481	18285	15623	14257	13246	12401
THR24_2058_S01	42906322	41511939	35218725	26211428.685	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG047_D	30391	18785	16125	14658	13658	12837
THR24_2059_S01	71125004	68834096	41510189.5	32455489.86	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG048_D	30157	17997	15461	14010	12941	12062
THR24_2060_S01	53177034	51386856	44460997	35731737.13	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG049_D	29678	18057	15770	14549	13615	12942
THR24_2061_S01	59279407	57151209	43151675	35207493.13	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG050_D	30478	18119	15776	14432	13442	12712
THR24_2062_S01	64069638	61931638	56525752	46190413.23	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG051_D	30294	19029	16601	15337	14484	13831
THR24_2063_S01	59560956	57647986	49701455	40927405.35	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG052_D	29863	18398	16083	14806	13965	13285
THR24_2064_S01	59355788	57278629	50844770.5	41153358.215	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG053_D	29882	18893	16586	15283	14358	13715
THR24_2065_S01	59579729	57437775	48086681.5	38674361.2	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG054_D	29154	18518	16185	14913	14023	13330
THR24_2066_S01	67897277	65601521	37011428	32994518.48	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG055_D	27034	15531	13413	12064	10985	10080
THR24_2067_S01	53321620	51700973	47842038.5	38499561.75	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_15	SJC_LGG	https://doi.org/10.1038/ng.2611	SJC	SJC-DS-1001	SJLGG061_D	29401	18695	16354	15054	14194	13469
THR24_2068_S01	35428825	34470349	31735169.5	26044132.635	101	glioma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_15	SJC_LGG	NA	SJC	SJC-DS-1001	SJLGG065_R	28123	18589	16185	14876	14006	13299
THR24_2069_S01	92578748	85855906	73276927	45622042.28	101	medulloblastoma	13.57	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_38	SJC_MB	NA	SJC	SJC-DS-1001	SJMB008_D	32822	19116	16056	14339	13112	12263
THR24_2070_S01	54225413	52587143	48913935.5	39268035.065	101	medulloblastoma	4.35	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_38	SJC_MB	NA	SJC	SJC-DS-1001	SJMB026_D	29751	18536	16183	14913	13961	13258
THR24_2071_S01	18372243	17015760	15408941.5	10503375.27	101	medulloblastoma	8.55	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_38	SJC_MB	NA	SJC	SJC-DS-1001	SJMB030_D	27781	19785	16902	15227	14098	13255
THR24_2072_S01	33102147	31455364	25521988.5	20841642.745	101	medulloblastoma	6.93	Yes, age < 30 years	male	NA	Hispanic or Latino	Cohort_38	SJC_MB	NA	SJC	SJC-DS-1001	SJMB031_D	27401	16061	13823	12569	11655	10934
THR24_2073_S01	41665720	40395094	38074374	28616755.785	101	medulloblastoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_38	SJC_MB	NA	SJC	SJC-DS-1001	SJMB052_D	28635	18011	15671	14319	13456	12774
THR24_2074_S01	44324238	42873848	37243994.5	27842696.01	101	medulloblastoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_38	SJC_MB	NA	SJC	SJC-DS-1001	SJMB087_D	28328	16507	14236	12990	12098	11348
THR24_2075_S01	93611255	86709678	78921361	46157943.3	101	medulloblastoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_38	SJC_MB	NA	SJC	SJC-DS-1001	SJMB122_D	33490	20687	17424	15639	14373	13463
THR24_2076_S01	61669781	57985223	41399839	22500517.12	101	medulloblastoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_38	SJC_MB	NA	SJC	SJC-DS-1001	SJMB139_D	27363	16578	14212	12636	11514	10565
THR24_2077_S01	40321122	39046010	25161691.5	21297567.33	101	melanoma	11.416667	Yes, age < 30 years	female	NA	NA	Cohort_40	SJC_MEL	NA	SJC	SJC-DS-1001	SJMEL001002_D1	27111	15367	13253	11985	11052	10208
THR24_2078_S01	43120640	41906886	31372057.5	26235740.7	101	melanoma	14.25	Yes, age < 30 years	female	NA	NA	Cohort_40	SJC_MEL	NA	SJC	SJC-DS-1001	SJMEL001003_D1	25042	14571	12724	11681	10940	10297
THR24_2078_S02	41636344	40085087	17999938.5	13523258.61	101	melanoma	14.25	Yes, age < 30 years	female	NA	NA	Cohort_40	SJC_MEL	NA	SJC	SJC-DS-1001	SJMEL001003_D2	26727	15312	13025	11613	10543	9697
THR24_2079_S01	42231628	41002828	23851179	19707925.785	101	melanoma	16.75	Yes, age < 30 years	male	NA	NA	Cohort_40	SJC_MEL	NA	SJC	SJC-DS-1001	SJMEL001004_D1	25980	15356	13373	12201	11307	10607
THR24_2079_S02	38091309	36949494	31073975.5	23973509.06	101	melanoma	16.75	Yes, age < 30 years	male	NA	NA	Cohort_40	SJC_MEL	NA	SJC	SJC-DS-1001	SJMEL001004_D2	27872	16987	14757	13460	12557	11908
THR24_2080_S01	35146563	34245390	27192881	23356449.43	101	melanoma	3.75	Yes, age < 30 years	male	NA	NA	Cohort_40	SJC_MEL	NA	SJC	SJC-DS-1001	SJMEL001005_D1	25197	14227	12377	11379	10518	9815
THR24_2084_S01	50715045	49267176	42642169.5	35834798	101	melanoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_40	SJC_MEL	NA	SJC	SJC-DS-1001	SJMEL011755_M1	28131	16366	14246	13106	12289	11637
THR24_2085_S01	48507941	47422791	44789626.5	31927837.5	101	leukemia	11.83	Yes, age < 30 years	female	NA	NA	Cohort_44	SJC_Other	https://doi.org/10.1038/ng.3230	SJC	SJC-DS-1001	SJMLL011_D	26967	16880	14710	13629	12842	12189
THR24_2086_S01	49490646	48257833	31934145.5	28063170.27	101	osteosarcoma	19	Yes, age < 30 years	male	Black/African American	NA	Cohort_29	SJC_OS	https://doi.org/10.1016/j.celrep.2014.03.003	SJC	SJC-DS-1001	SJOS001103_D1	27198	16109	14087	12925	12078	11411
THR24_2087_S01	33498274	32509081	29192926.5	26384859	101	osteosarcoma	NA	Yes, age < 30 years	male	NA	NA	Cohort_29	SJC_OS	https://doi.org/10.1016/j.celrep.2014.03.003	SJC	SJC-DS-1001	SJOS001104_M1	26621	16358	14367	13302	12544	11926
THR24_2088_S01	49848595	48260387	42425405.5	36292244.92	101	osteosarcoma	6	Yes, age < 30 years	female	Black/African American	NA	Cohort_29	SJC_OS	https://doi.org/10.1016/j.celrep.2014.03.003, https://doi.org/10.1158/1541-7786.mcr-18-0620	SJC	SJC-DS-1001	SJOS001105_D1	27843	17324	15199	13971	13166	12491
THR24_2089_S01	48599220	47067555	39965287.5	35599533.84	101	osteosarcoma	13	Yes, age < 30 years	male	Black/African American	NA	Cohort_29	SJC_OS	https://doi.org/10.1016/j.celrep.2014.03.003	SJC	SJC-DS-1001	SJOS001107_M1	27805	16517	14467	13356	12528	11926
THR24_2090_S01	33314257	32446697	26240738	23972475.5	101	osteosarcoma	NA	Yes, age < 30 years	female	NA	NA	Cohort_29	SJC_OS	https://doi.org/10.1016/j.celrep.2014.03.003	SJC	SJC-DS-1001	SJOS001108_M1	24658	14782	12806	11561	10601	9876
THR24_2091_S01	67058633	65173104	57553296	49020970.875	101	osteosarcoma	NA	Yes, age < 30 years	female	NA	NA	Cohort_29	SJC_OS	https://doi.org/10.1016/j.celrep.2014.03.003	SJC	SJC-DS-1001	SJOS001109_D1	29651	17369	15112	13907	13054	12436
THR24_2092_S01	79735107	76456837	48711414	45058837.565	101	osteosarcoma	NA	Yes, age < 30 years	female	NA	NA	Cohort_29	SJC_OS	https://doi.org/10.1016/j.celrep.2014.03.003	SJC	SJC-DS-1001	SJOS001111_M1	26696	14204	12155	10814	9877	9094
THR24_2093_S01	47907482	46457415	39096105.5	33536436.155	101	osteosarcoma	16	Yes, age < 30 years	male	White	NA	Cohort_29	SJC_OS	https://doi.org/10.1016/j.celrep.2014.03.003	SJC	SJC-DS-1001	SJOS001112_D1	27640	16198	14262	13128	12323	11621
THR24_2094_S01	91713850	88930606	70712804	63810341.345	101	osteosarcoma	NA	Yes, age < 30 years	male	NA	NA	Cohort_29	SJC_OS	https://doi.org/10.1016/j.celrep.2014.03.003	SJC	SJC-DS-1001	SJOS001113_M1	29613	16471	14494	13453	12716	12121
THR24_2095_S01	22681226	22007532	18164111	16003471.99	101	osteosarcoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_29	SJC_OS	https://doi.org/10.1016/j.celrep.2014.03.003	SJC	SJC-DS-1001	SJOS001116_M1	25554	16785	14651	13475	12587	11894
THR24_2096_S01	50494674	48789489	44114441.5	35963266.875	101	osteosarcoma	16	Yes, age < 30 years	female	White	NA	Cohort_29	SJC_OS	https://doi.org/10.1016/j.celrep.2014.03.003	SJC	SJC-DS-1001	SJOS001120_D1	28630	17360	15148	13971	13149	12490
THR24_2097_S01	69612003	67455896	55568588	49816551.595	101	osteosarcoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_29	SJC_OS	https://doi.org/10.1016/j.celrep.2014.03.003	SJC	SJC-DS-1001	SJOS001129_M2	29324	16979	15026	13916	13148	12477
THR24_2098_S01	63598616	61473894	18022354.5	16095325.6	101	osteosarcoma	10	Yes, age < 30 years	male	White	NA	Cohort_29	SJC_OS	https://doi.org/10.1016/j.celrep.2014.03.003	SJC	SJC-DS-1001	SJOS006_D	23159	12774	10511	9095	8120	7369
THR24_2099_S01	46007180	44384971	14594087	11781598.92	101	osteosarcoma	15	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_29	SJC_OS	https://doi.org/10.1016/j.celrep.2014.03.003	SJC	SJC-DS-1001	SJOS007_D	24443	14249	11868	10399	9363	8577
THR24_2100_S01	28971444	28002277	12088448.5	9924764.25	101	osteosarcoma	21	Yes, age < 30 years	female	White	NA	Cohort_29	SJC_OS	https://doi.org/10.1016/j.celrep.2014.03.003	SJC	SJC-DS-1001	SJOS008_D	24256	13033	10405	8894	7874	7079
THR24_2101_S01	31908231	30947970	25692442.5	18768065.6	101	osteosarcoma	9	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_29	SJC_OS	https://doi.org/10.1016/j.celrep.2014.03.003, https://doi.org/10.1158/1541-7786.mcr-18-0620	SJC	SJC-DS-1001	SJOS010_D	28252	17326	14729	13391	12421	11634
THR24_2102_S01	44410849	43248479	28281463.5	24432511.92	101	osteosarcoma	13	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_29	SJC_OS	https://doi.org/10.1016/j.celrep.2014.03.003	SJC	SJC-DS-1001	SJOS011_D	27349	15507	13350	12096	11213	10384
THR24_2103_S01	31708774	30572134	27371317.5	24575113.99	101	osteosarcoma	16	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_29	SJC_OS	https://doi.org/10.1016/j.celrep.2014.03.003	SJC	SJC-DS-1001	SJOS012_M	26773	16641	14650	13494	12705	12061
THR24_2104_S01	45068278	43382108	37970559.5	33848712.175	101	osteosarcoma	14	Yes, age < 30 years	female	White	Not Hispanic or Latino	Cohort_29	SJC_OS	https://doi.org/10.1016/j.celrep.2014.03.003	SJC	SJC-DS-1001	SJOS013_D	27647	16733	14762	13603	12779	12144
THR24_2105_S01	39096507	38095878	25599755.5	21903463.5	101	osteosarcoma	10	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_29	SJC_OS	https://doi.org/10.1016/j.celrep.2014.03.003	SJC	SJC-DS-1001	SJOS014_D	26571	15152	13218	12061	11162	10427
THR24_2106_S01	49939555	48154522	40643704	35664244.5	101	osteosarcoma	8	Yes, age < 30 years	male	White	Not Hispanic or Latino	Cohort_29	SJC_OS	https://doi.org/10.1016/j.celrep.2014.03.003	SJC	SJC-DS-1001	SJOS017_D	26972	16332	14386	13320	12600	11975
THR24_2107_S01	52937108	51200503	34538825	30856532	101	osteosarcoma	9	Yes, age < 30 years	male	Black/African American	Not Hispanic or Latino	Cohort_29	SJC_OS	https://doi.org/10.1016/j.celrep.2014.03.003	SJC	SJC-DS-1001	SJOS018_D	26189	15155	13294	12193	11329	10608
THR24_2108_S01	52834281	51147674	38966923.5	32944473.16	101	osteosarcoma	11	Yes, age < 30 years	female	White	NA	Cohort_29	SJC_OS	https://doi.org/10.1016/j.celrep.2014.03.003	SJC	SJC-DS-1001	SJOS019_D	28325	16047	13989	12785	11943	11208
THR24_2109_S01	57380516	55779429	50908345	35888461.675	101	acute lymphoblastic leukemia	12.49	Yes, age < 30 years	female	NA	NA	Cohort_22	SJC_PHALL	NA	SJC	SJC-DS-1001	SJPHALL003_D	26536	15858	13898	12844	12144	11597
THR24_2110_S01	67171881	65312798	57238165.5	42404994.84	101	acute lymphoblastic leukemia	14.99	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_22	SJC_PHALL	NA	SJC	SJC-DS-1001	SJPHALL004_D	27265	15572	13572	12482	11783	11222
THR24_2111_S01	69368463	67546424	58499483.5	43661918.3	101	acute lymphoblastic leukemia	8.82	Yes, age < 30 years	female	NA	Hispanic or Latino	Cohort_22	SJC_PHALL	NA	SJC	SJC-DS-1001	SJPHALL005_D	27434	15597	13657	12629	11877	11276
THR24_2112_S01	64512755	62689408	58084888	40650265.6	101	acute lymphoblastic leukemia	6.38	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_22	SJC_PHALL	NA	SJC	SJC-DS-1001	SJPHALL006_D	27694	16686	14566	13426	12634	11995
THR24_2113_S01	57224373	55827804	51942328.5	39256422.27	101	acute lymphoblastic leukemia	5.86	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_22	SJC_PHALL	NA	SJC	SJC-DS-1001	SJPHALL007_D	27003	16521	14467	13358	12598	12037
THR24_2114_S01	61730718	59995335	53375778.5	37904539.14	101	acute lymphoblastic leukemia	12.7	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_22	SJC_PHALL	NA	SJC	SJC-DS-1001	SJPHALL008_D	27632	16399	14335	13190	12440	11831
THR24_2115_S01	62352380	60496084	56082072.5	40998110.18	101	acute lymphoblastic leukemia	14.73	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_22	SJC_PHALL	NA	SJC	SJC-DS-1001	SJPHALL009_D	28135	16602	14497	13334	12532	11969
THR24_2116_S01	63792274	62121944	56710902.5	39294241.6	101	acute lymphoblastic leukemia	11.88	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_22	SJC_PHALL	NA	SJC	SJC-DS-1001	SJPHALL010_D	27821	16880	14672	13501	12666	12048
THR24_2117_S01	65328982	63712626	57270140	38600594.145	101	acute lymphoblastic leukemia	2	Yes, age < 30 years	female	NA	NA	Cohort_22	SJC_PHALL	NA	SJC	SJC-DS-1001	SJPHALL012_D	27446	16477	14367	13190	12381	11736
THR24_2118_S01	68298982	66675665	60785307.5	44966695.41	101	acute lymphoblastic leukemia	5.66	Yes, age < 30 years	male	NA	NA	Cohort_22	SJC_PHALL	NA	SJC	SJC-DS-1001	SJPHALL013_D	27399	16212	14272	13161	12438	11827
THR24_2119_S01	61793380	60063943	54765022	40707687.93	101	acute lymphoblastic leukemia	3.94	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_22	SJC_PHALL	NA	SJC	SJC-DS-1001	SJPHALL015_D	27477	16444	14404	13314	12506	11888
THR24_2120_S01	45532120	43990781	41242547	26795763.495	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	male	NA	NA	Cohort_22	SJC_PHALL	NA	SJC	SJC-DS-1001	SJPHALL020033_D1	25945	16280	14054	12825	12019	11392
THR24_2121_S01	55074550	53112538	48434855	33291890	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	female	NA	NA	Cohort_22	SJC_PHALL	NA	SJC	SJC-DS-1001	SJPHALL020034_D1	25684	15194	13038	11790	10910	10318
THR24_2122_S01	48526109	46882049	42785203.5	29408764	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	male	NA	NA	Cohort_22	SJC_PHALL	NA	SJC	SJC-DS-1001	SJPHALL020035_D1	27098	15862	13489	12189	11233	10508
THR24_2123_S01	61754139	59555985	54556253	35987213.6	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	male	NA	NA	Cohort_22	SJC_PHALL	NA	SJC	SJC-DS-1001	SJPHALL020036_D1	26773	15952	13715	12521	11689	10969
THR24_2124_S01	52216192	50389076	46214763	29237879	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	female	NA	NA	Cohort_22	SJC_PHALL	NA	SJC	SJC-DS-1001	SJPHALL020037_D1	26031	15318	13038	11810	10874	10140
THR24_2125_S01	50358119	48604069	42386592	26617413.2	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	female	NA	NA	Cohort_22	SJC_PHALL	NA	SJC	SJC-DS-1001	SJPHALL020038_D1	25032	14433	12080	10728	9748	9055
THR24_2126_S01	54169812	52258903	46945788	31522183.815	101	acute lymphoblastic leukemia	2.92	Yes, age < 30 years	male	NA	NA	Cohort_22	SJC_PHALL	NA	SJC	SJC-DS-1001	SJPHALL020040_D1	25352	14495	12541	11438	10656	10095
THR24_2127_S01	53972082	52054536	49253981.5	30408099.77	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	male	NA	NA	Cohort_22	SJC_PHALL	NA	SJC	SJC-DS-1001	SJPHALL020043_D1	27177	16711	14344	13069	12133	11392
THR24_2128_S01	46456509	44767238	42220284	28346890.8	101	acute lymphoblastic leukemia	NA	Yes, age < 30 years	male	NA	NA	Cohort_22	SJC_PHALL	NA	SJC	SJC-DS-1001	SJPHALL020044_D1	26543	16772	14576	13372	12575	11974
THR24_2129_S01	50664890	48898996	45860663.5	30617265.6	101	acute lymphoblastic leukemia	14.33	Yes, age < 30 years	male	NA	NA	Cohort_22	SJC_PHALL	NA	SJC	SJC-DS-1001	SJPHALL020046_D1	27440	17085	14699	13462	12610	11979
THR24_2130_S01	46502545	44851599	41874285.5	26195454.32	101	acute lymphoblastic leukemia	16.5	Yes, age < 30 years	male	NA	NA	Cohort_22	SJC_PHALL	NA	SJC	SJC-DS-1001	SJPHALL020047_D1	26350	16747	14412	13208	12271	11578
THR24_2131_S01	64354280	62903359	52848186.5	39153421.71	101	acute lymphoblastic leukemia	17.92	Yes, age < 30 years	male	NA	NA	Cohort_22	SJC_PHALL	NA	SJC	SJC-DS-1001	SJPHALL020_D	28092	16082	14087	12878	12044	11450
THR24_2132_S01	57671748	56296689	45142069	33614805.84	101	acute lymphoblastic leukemia	11.58	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_22	SJC_PHALL	NA	SJC	SJC-DS-1001	SJPHALL021_D	28351	16011	13978	12881	12099	11516
THR24_2133_S01	62100516	60317675	54155244	41515407.395	101	acute lymphoblastic leukemia	15.9	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_22	SJC_PHALL	NA	SJC	SJC-DS-1001	SJPHALL026_D	26604	15939	14006	12939	12249	11697
THR24_2134_S01	68721229	66746837	60144255.5	43496511.25	101	acute lymphoblastic leukemia	4.91	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_22	SJC_PHALL	NA	SJC	SJC-DS-1001	SJPHALL029_D	27088	15922	14021	12976	12287	11713
THR24_2135_S01	79745285	77047894	72542585	57539589.74	101	retinoblastoma	NA	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_44	SJC_Other	NA	SJC	SJC-DS-1001	SJRB001130_M1	31166	19110	16789	15496	14649	13944
THR24_2136_S01	41686722	39839663	33030130.5	23089704.4	101	retinoblastoma	1.1	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_44	SJC_Other	NA	SJC	SJC-DS-1001	SJRB003_D	29915	19030	16093	14521	13528	12726
THR24_2137_S01	45401887	42767350	29012355.5	24262111.125	101	rhabdomyosarcoma	4.41	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_17	SJC_RHB	https://doi.org/10.1016/j.ccr.2013.11.002	SJC	SJC-DS-1001	SJRHB001_D	27094	14501	12461	11213	10232	9495
THR24_2138_S01	112431020	98684733	43478662.5	38534563.86	101	rhabdomyosarcoma	2.53	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_17	SJC_RHB	https://doi.org/10.1016/j.ccr.2013.11.002	SJC	SJC-DS-1001	SJRHB002_D	28381	14424	12376	10971	9857	8921
THR24_2139_S01	61643628	60058686	30830357	25055781.08	101	rhabdomyosarcoma	3.47	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_17	SJC_RHB	https://doi.org/10.1016/j.ccr.2013.11.002	SJC	SJC-DS-1001	SJRHB003_D	27287	15161	13017	11744	10817	10102
THR24_2140_S01	57176589	51588806	30440330.5	24457898.625	101	rhabdomyosarcoma	9.24	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_17	SJC_RHB	https://doi.org/10.1016/j.ccr.2013.11.002	SJC	SJC-DS-1001	SJRHB005_D	28382	15135	13022	11756	10813	10003
THR24_2141_S01	74587435	69709883	42044275	35736403.38	101	rhabdomyosarcoma	7.84	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_17	SJC_RHB	https://doi.org/10.1016/j.ccr.2013.11.002	SJC	SJC-DS-1001	SJRHB006_D	29469	15381	13320	12265	11488	10822
THR24_2142_S01	53201562	49311757	28200016	21318607.805	101	rhabdomyosarcoma	16.916667	Yes, age < 30 years	male	NA	NA	Cohort_17	SJC_RHB	https://doi.org/10.1016/j.ccr.2013.11.002	SJC	SJC-DS-1001	SJRHB007_D	28353	14843	12531	11032	9874	8940
THR24_2143_S01	28707788	27423859	20456002	17394055.94	101	rhabdomyosarcoma	16.7	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_17	SJC_RHB	https://doi.org/10.1016/j.ccr.2013.11.002	SJC	SJC-DS-1001	SJRHB008_D	26371	14688	12590	11223	10209	9407
THR24_2144_S01	44162025	42980604	34012900.5	22597361.15	101	rhabdomyosarcoma	7.9	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_17	SJC_RHB	https://doi.org/10.1016/j.ccr.2013.11.002	SJC	SJC-DS-1001	SJRHB009_D	30450	17524	14690	12987	11806	10899
THR24_2145_S01	46163961	41815802	31293327.5	23058219.6	101	rhabdomyosarcoma	6.18	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_17	SJC_RHB	https://doi.org/10.1016/j.ccr.2013.11.002	SJC	SJC-DS-1001	SJRHB010_D	29379	15991	13561	12286	11345	10564
THR24_2146_S01	53926707	47886968	32487263	25893077.92	101	rhabdomyosarcoma	4.59	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_17	SJC_RHB	https://doi.org/10.1016/j.ccr.2013.11.002	SJC	SJC-DS-1001	SJRHB011_D	30914	16697	14310	13016	11934	11057
THR24_2147_S01	63960194	51723134	19045603	16602861.6	101	rhabdomyosarcoma	17.31	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_17	SJC_RHB	https://doi.org/10.1016/j.ccr.2013.11.002	SJC	SJC-DS-1001	SJRHB012_D	25976	14756	12733	11456	10456	9604
THR24_2147_S02	53799065	52417767	47547976.5	36056344.94	101	rhabdomyosarcoma	17.31	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_17	SJC_RHB	https://doi.org/10.1016/j.ccr.2013.11.002	SJC	SJC-DS-1001	SJRHB012_R	29543	17173	14903	13623	12742	12112
THR24_2147_S03	54654095	53403624	38706190	29144611.08	101	rhabdomyosarcoma	17.31	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_17	SJC_RHB	https://doi.org/10.1016/j.ccr.2013.11.002	SJC	SJC-DS-1001	SJRHB012_S	29909	15701	13368	12006	10943	10124
THR24_2148_S01	80920459	67659681	44671803.5	26420967.3	101	rhabdomyosarcoma	1.37	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_17	SJC_RHB	https://doi.org/10.1016/j.ccr.2013.11.002	SJC	SJC-DS-1001	SJRHB013_D	44599	16130	13483	11927	10898	9990
THR24_2149_S01	52758534	51453313	33888890.5	26059349.55	101	rhabdomyosarcoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_17	SJC_RHB	https://doi.org/10.1016/j.ccr.2013.11.002	SJC	SJC-DS-1001	SJRHB015_D	28151	16280	14072	12796	11885	11143
THR24_2150_S01	56313541	55014723	47824378	37461121.24	101	rhabdomyosarcoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_17	SJC_RHB	https://doi.org/10.1016/j.ccr.2013.11.002	SJC	SJC-DS-1001	SJRHB016_D	29158	16531	14306	13054	12226	11544
THR24_2151_S01	55490767	54291954	32918208.5	27146139.75	101	rhabdomyosarcoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_17	SJC_RHB	https://doi.org/10.1016/j.ccr.2013.11.002	SJC	SJC-DS-1001	SJRHB017_D	26418	15264	13263	12085	11137	10455
THR24_2152_S01	44009323	42892907	33171126	28457887.875	101	rhabdomyosarcoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_17	SJC_RHB	https://doi.org/10.1016/j.ccr.2013.11.002	SJC	SJC-DS-1001	SJRHB018_D	28608	15567	13342	12073	11122	10268
THR24_2153_S01	56121247	54511386	27429549	19244556.63	101	rhabdomyosarcoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_17	SJC_RHB	https://doi.org/10.1016/j.ccr.2013.11.002	SJC	SJC-DS-1001	SJRHB019_D	27065	15354	13044	11623	10570	9735
THR24_2154_S01	50228198	48851944	42324644.5	29635557.945	101	rhabdomyosarcoma	1.166667	Yes, age < 30 years	female	NA	NA	Cohort_17	SJC_RHB	https://doi.org/10.1016/j.ccr.2013.11.002	SJC	SJC-DS-1001	SJRHB020_A	29981	18209	15671	14293	13367	12590
THR24_2155_S01	59143912	57776178	47153126.5	38324307.75	101	rhabdomyosarcoma	14.416667	Yes, age < 30 years	male	NA	NA	Cohort_17	SJC_RHB	https://doi.org/10.1016/j.ccr.2013.11.002	SJC	SJC-DS-1001	SJRHB022_D	30107	16891	14658	13449	12547	11839
THR24_2156_S01	58732749	57251339	49618853.5	42723723.04	101	rhabdomyosarcoma	2.583333	Yes, age < 30 years	male	NA	NA	Cohort_17	SJC_RHB	https://doi.org/10.1016/j.ccr.2013.11.002	SJC	SJC-DS-1001	SJRHB023_D	28628	16005	14125	13017	12287	11665
THR24_2157_S01	49747002	48129545	39625199.5	35416145.88	101	rhabdomyosarcoma	0.71	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_17	SJC_RHB	https://doi.org/10.1016/j.ccr.2013.11.002	SJC	SJC-DS-1001	SJRHB026_D	27565	16391	14377	13352	12650	12043
THR24_2157_S02	70371349	67894409	55941943.5	46862252.25	101	rhabdomyosarcoma	0.71	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_17	SJC_RHB	NA	SJC	SJC-DS-1001	SJRHB026_R	30230	17368	15118	13943	13093	12381
THR24_2157_S03	66286852	64294191	54056349.5	43780575.2	101	rhabdomyosarcoma	0.71	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_17	SJC_RHB	NA	SJC	SJC-DS-1001	SJRHB026_S	29959	16986	14809	13601	12732	12061
THR24_2158_S01	37346316	36384583	31246280.5	25638328.5	101	rhabdomyosarcoma	1.89	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_17	SJC_RHB	https://doi.org/10.1016/j.ccr.2013.11.002	SJC	SJC-DS-1001	SJRHB027_D	26689	15066	13037	11908	11045	10378
THR24_2159_S01	57638785	56200553	36060928.5	30152416.7	101	rhabdomyosarcoma	15.26	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_17	SJC_RHB	https://doi.org/10.1016/j.ccr.2013.11.002	SJC	SJC-DS-1001	SJRHB028_D	28275	16208	14124	12950	12093	11385
THR24_2160_S01	56338416	54949832	46819995	38791357.875	101	rhabdomyosarcoma	0.37	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_17	SJC_RHB	https://doi.org/10.1016/j.ccr.2013.11.002	SJC	SJC-DS-1001	SJRHB031_D	30731	17555	15368	14186	13363	12691
THR24_2161_S01	66669152	64850472	56317318.5	44274469.085	101	rhabdomyosarcoma	13.85	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_17	SJC_RHB	https://doi.org/10.1016/j.ccr.2013.11.002	SJC	SJC-DS-1001	SJRHB033_D	32024	19049	16551	15228	14259	13499
THR24_2162_S01	58550272	57136016	43945662.5	39291100.68	101	rhabdomyosarcoma	0.12	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_17	SJC_RHB	https://doi.org/10.1016/j.ccr.2013.11.002	SJC	SJC-DS-1001	SJRHB034_D	28723	16179	14214	13047	12218	11488
THR24_2163_S01	49972508	48617816	43748206.5	36429206.54	101	rhabdomyosarcoma	7.25	Yes, age < 30 years	female	NA	NA	Cohort_17	SJC_RHB	https://doi.org/10.1016/j.ccr.2013.11.002	SJC	SJC-DS-1001	SJRHB035_R	30197	18078	15809	14473	13573	12825
THR24_2164_S01	49239768	47965910	19222381	13847175.52	101	rhabdomyosarcoma	14.23	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_17	SJC_RHB	https://doi.org/10.1016/j.ccr.2013.11.002	SJC	SJC-DS-1001	SJRHB036_A	26773	14688	12226	10627	9454	8506
THR24_2165_S01	41573667	40418083	36211012.5	28912620.275	101	rhabdomyosarcoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_17	SJC_RHB	https://doi.org/10.1016/j.ccr.2013.11.002	SJC	SJC-DS-1001	SJRHB038_R	29250	17926	15573	14216	13324	12622
THR24_2166_S01	69482556	67596474	58395906	52296753.6	101	rhabdomyosarcoma	3.25	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_17	SJC_RHB	https://doi.org/10.1016/j.ccr.2013.11.002	SJC	SJC-DS-1001	SJRHB039_D	31269	17482	15168	13863	12920	12193
THR24_2167_S01	67701381	66147432	37360279	30850066.555	101	rhabdomyosarcoma	1.92	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_17	SJC_RHB	https://doi.org/10.1016/j.ccr.2013.11.002	SJC	SJC-DS-1001	SJRHB043_R	28351	13873	11692	10276	9161	8246
THR24_2168_S01	54983992	53499201	48290238	39831434.7	101	rhabdomyosarcoma	6.15	Yes, age < 30 years	female	NA	NA	Cohort_17	SJC_RHB	https://doi.org/10.1016/j.ccr.2013.11.002	SJC	SJC-DS-1001	SJRHB044_M	30882	18385	16038	14801	13898	13149
THR24_2169_S01	49816276	48541973	40176114.5	31900397.49	101	rhabdomyosarcoma	2.84	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_17	SJC_RHB	https://doi.org/10.1016/j.ccr.2013.11.002	SJC	SJC-DS-1001	SJRHB045_D	30512	18005	15623	14357	13464	12741
THR24_2170_S01	55865105	54649828	43894453	33924780.44	101	rhabdomyosarcoma	5.26	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_17	SJC_RHB	https://doi.org/10.1016/j.ccr.2013.11.002	SJC	SJC-DS-1001	SJRHB047_D	28969	15660	13525	12361	11473	10748
THR24_2171_S01	35476651	34652926	31128134	26527502.12	101	rhabdomyosarcoma	2.41	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_17	SJC_RHB	https://doi.org/10.1016/j.ccr.2013.11.002	SJC	SJC-DS-1001	SJRHB048_D	27800	16564	14475	13360	12586	11961
THR24_2172_S01	45083851	44178924	34918156.5	30705787.79	101	rhabdomyosarcoma	7.76	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_17	SJC_RHB	https://doi.org/10.1016/j.ccr.2013.11.002	SJC	SJC-DS-1001	SJRHB050_D	26511	14387	12682	11700	10935	10292
THR24_2173_S01	49231973	48078841	42118671	34257967.5	101	rhabdomyosarcoma	16.666667	Yes, age < 30 years	female	NA	NA	Cohort_17	SJC_RHB	https://doi.org/10.1016/j.ccr.2013.11.002	SJC	SJC-DS-1001	SJRHB054_R	29568	16930	14736	13490	12604	11883
THR24_2174_S01	68191131	66625627	57864803.5	50200160.33	101	rhabdomyosarcoma	12.92	Yes, age < 30 years	male	NA	Not Hispanic or Latino	Cohort_17	SJC_RHB	https://doi.org/10.1016/j.ccr.2013.11.002	SJC	SJC-DS-1001	SJRHB056_D	30618	17070	14898	13730	12926	12282
THR24_2175_S01	48590315	47482556	41726556.5	35726139.95	101	rhabdomyosarcoma	4.25	Yes, age < 30 years	male	NA	NA	Cohort_17	SJC_RHB	https://doi.org/10.1016/j.ccr.2013.11.002	SJC	SJC-DS-1001	SJRHB057_R	27649	15856	13920	12906	12112	11504
THR24_2176_S01	47648297	45305295	40667793.5	28173502.585	101	acute lymphoblastic leukemia	6.14	Yes, age < 30 years	female	NA	Not Hispanic or Latino	Cohort_44	SJC_Other	NA	SJC	SJC-DS-1001	SJTALL002_D	27130	16744	14168	12856	11948	11266
THR24_2177_S01	38938984	38019435	31334912.5	26299771.96	101	wilms tumor	NA	Yes, age < 30 years	NA	NA	NA	Cohort_45	SJC_WLM	NA	SJC	SJC-DS-1001	SJWLM010703_G1	25924	15634	13647	12503	11693	11012
THR24_2178_S01	44103597	42949594	31568186	26243762.475	101	wilms tumor	NA	Yes, age < 30 years	NA	NA	NA	Cohort_45	SJC_WLM	NA	SJC	SJC-DS-1001	SJWLM010704_G1	26200	15668	13540	12353	11459	10691
THR24_2179_S01	39224487	38279492	33427003	28801045.88	101	wilms tumor	NA	Yes, age < 30 years	NA	NA	NA	Cohort_45	SJC_WLM	NA	SJC	SJC-DS-1001	SJWLM010705_G1	26704	16586	14427	13248	12486	11822
THR24_2180_S01	56933679	55570159	36665600.5	28085649.21	101	wilms tumor	NA	Yes, age < 30 years	NA	NA	NA	Cohort_45	SJC_WLM	NA	SJC	SJC-DS-1001	SJWLM010706_G1	27430	15054	12848	11544	10526	9690
THR24_2181_S01	46008459	44873634	34313323.5	27417240.325	101	wilms tumor	NA	Yes, age < 30 years	NA	NA	NA	Cohort_45	SJC_WLM	NA	SJC	SJC-DS-1001	SJWLM010707_G1	27415	16249	13956	12613	11669	10908
THR24_2182_S01	55255600	53867367	39222643.5	31264269.6	101	wilms tumor	NA	Yes, age < 30 years	NA	NA	NA	Cohort_45	SJC_WLM	NA	SJC	SJC-DS-1001	SJWLM010708_G1	26912	15078	13047	11895	10987	10259
THR25_0635_S01	173830891	170624420	82793534	73284601.2	75	osteosarcoma	17	Yes, age < 30 years	female	NA	NA	Cohort_36	EGAD00001000826	http://dx.doi.org/10.1038/ncomms15936	EGA	EGAD00001000826	EGAN00001179688	30696	14986	13024	11827	10959	10225
THR25_0636_S01	157576199	145669275	44311574	1927453.77	75	not reported - QC fail by PI	13	Yes, age < 30 years	male	NA	NA	Cohort_36	EGAD00001000826	http://dx.doi.org/10.1038/ncomms15936	EGA	EGAD00001000826	EGAN00001179689	39488	38163	36088	33941	31674	29402
THR25_0637_S01	167967015	151126636	65441255	38980771.28	75	osteosarcoma	15	Yes, age < 30 years	male	NA	NA	Cohort_36	EGAD00001000826	http://dx.doi.org/10.1038/ncomms15936	EGA	EGAD00001000826	EGAN00001179690	38835	15491	13103	11779	10805	10043
THR25_0638_S01	159169417	151947662	47130349	41071775.61	75	osteosarcoma	26	Yes, age < 30 years	female	NA	NA	Cohort_36	EGAD00001000826	http://dx.doi.org/10.1038/ncomms15936	EGA	EGAD00001000826	EGAN00001179691	26646	14203	12274	10912	9922	9130
THR25_0639_S01	205063391	201486798	115643593.5	98103626.685	75	osteosarcoma	19	Yes, age < 30 years	male	NA	NA	Cohort_36	EGAD00001000826	http://dx.doi.org/10.1038/ncomms15936	EGA	EGAD00001000826	EGAN00001179692	30482	15452	13684	12703	11923	11308
THR25_0640_S01	189796257	186148390	83953920	73003200.67	75	osteosarcoma	11	Yes, age < 30 years	female	NA	NA	Cohort_36	EGAD00001000826	http://dx.doi.org/10.1038/ncomms15936	EGA	EGAD00001000826	EGAN00001179693	29892	16093	14149	12950	12095	11403
THR25_0641_S01	167016158	163704029	83036270.5	68608876.095	75	not reported	NA	NA	NA	NA	NA	Cohort_36	EGAD00001000826	http://dx.doi.org/10.1038/ncomms15936	EGA	EGAD00001000826	EGAN00001179694	30469	15539	13662	12504	11650	10899
THR25_0642_S01	166970701	157665741	11198258.5	5324468.72	75	not reported	17	Yes, age < 30 years	female	NA	NA	Cohort_36	EGAD00001000826	http://dx.doi.org/10.1038/ncomms15936	EGA	EGAD00001000826	EGAN00001179695	26398	12337	9573	8067	7163	6434
THR25_0643_S01	171696613	168451413	93404488.5	79542073.6	75	osteosarcoma	11	Yes, age < 30 years	female	NA	NA	Cohort_36	EGAD00001000826	http://dx.doi.org/10.1038/ncomms15936	EGA	EGAD00001000826	EGAN00001179696	29453	15626	13814	12791	12016	11355
THR25_0644_S01	166830607	157745234	34501445.5	26081481.01	75	osteosarcoma	16	Yes, age < 30 years	male	NA	NA	Cohort_36	EGAD00001000826	http://dx.doi.org/10.1038/ncomms15936	EGA	EGAD00001000826	EGAN00001179697	31833	14176	12117	10772	9767	8974
THR28_0686_S01	85140068	81911611	53094016	46382672.79	75	embryonal rhabdomyosarcoma	2	Yes, age < 30 years	NA	NA	NA	Cohort_48	SRP040454	No publication	SRA	SRP040454	SRS579793, SRR1201251	28769	14751	12659	11358	10379	9551
THR28_0687_S01	76209310	72942604	51276283	42749722.68	75	embryonal rhabdomyosarcoma	21	Yes, age < 30 years	NA	NA	NA	Cohort_48	SRP040454	No publication	SRA	SRP040454	SRS579795, SRR1201252	28261	15675	13633	12418	11471	10720
THR28_0688_S01	128627690	123863360	81656830	68564572.24	75	embryonal rhabdomyosarcoma	15	Yes, age < 30 years	NA	NA	NA	Cohort_48	SRP040454	No publication	SRA	SRP040454	SRS579794, SRR1201253	31122	15918	13683	12376	11367	10587
THR29_0720_S01	168567420	162965161	97388979	80253973.32	100	alveolar rhabdomyosarcoma	14	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	NCI_0040_tumor, SRR5144178	32371	17222	14962	13693	12753	12008
THR29_0721_S01	86278355	83764523	51226830.5	44560842.5	101	alveolar rhabdomyosarcoma	NA	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_007_tumor, SRR5144179	29714	15487	13350	12017	10928	10038
THR29_0722_S01	76000000	73702935	49038513	41992208.335	101	embryonal rhabdomyosarcoma	NA	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_008_tumor, SRR5144180	30173	16167	13860	12407	11300	10371
THR29_0723_S01	66672882	63791790	50649420	37092948.46	101	alveolar rhabdomyosarcoma	NA	Yes, age < 30 years	female	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_049_tumor, SRR5144181	30669	17805	15289	13899	12904	12094
THR29_0724_S01	76184165	74172901	54759427.5	44831718.75	101	alveolar rhabdomyosarcoma	NA	Yes, age < 30 years	female	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_051_tumor, SRR5144182	30051	16302	14074	12795	11809	11006
THR29_0725_S01	78233060	75788657	57168118	45673145.6	101	embryonal rhabdomyosarcoma	NA	Yes, age < 30 years	female	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_055_tumor, SRR5144183	31103	17360	15033	13709	12713	11953
THR29_0726_S01	72000000	69915196	42765693.5	34568584.65	101	alveolar rhabdomyosarcoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_057_tumor, SRR5144184	27992	14514	12425	11122	10121	9305
THR29_0727_S01	66671059	64445077	47185621	37180454.8	101	alveolar rhabdomyosarcoma	NA	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_061_tumor, SRR5144185	30211	16957	14733	13311	12287	11492
THR29_0728_S01	145032713	139468542	80013741	72558696.44	101	embryonal rhabdomyosarcoma	NA	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2015_tumor, SRR5144186	29486	15473	13502	12284	11362	10547
THR29_0729_S01	171344813	167234700	114145540	91096301.065	101	alveolar rhabdomyosarcoma	5	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_202_tumor, SRR5144190	35129	17604	14999	13523	12449	11590
THR29_0730_S01	198893471	188438774	104346805	91553735.16	101	embryonal rhabdomyosarcoma	13	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2024_tumor, SRR5144187	31281	14883	12787	11472	10468	9656
THR29_0731_S01	94190831	91627001	64240305.5	53855655.75	101	spindle cell/sclerosing rhabdomyosarcoma	1	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2028_tumor, SRR5144188	29411	15797	13887	12654	11744	11030
THR29_0732_S01	74479651	72278816	59108209	45256927.105	101	embryonal rhabdomyosarcoma	1	Yes, age < 30 years	female	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2029_tumor, SRR5144189	32218	18403	15970	14531	13534	12733
THR29_0733_S01	76147816	73846354	56613574.5	46446202.495	101	embryonal rhabdomyosarcoma	6	Yes, age < 30 years	female	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2030_tumor, SRR5144191	30933	16965	14759	13483	12523	11796
THR29_0734_S01	103200976	100314833	71498089	55521968.67	101	alveolar rhabdomyosarcoma	1	Yes, age < 30 years	female	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2031_tumor, SRR5144192	30330	15891	13772	12559	11624	10922
THR29_0735_S01	200669734	195623010	111355702	87636921.3	101	embryonal rhabdomyosarcoma	5	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2032_tumor, SRR5144193	33630	16422	14164	12790	11746	10842
THR29_0736_S01	186835113	181857856	132247738.5	98813403.2	101	embryonal rhabdomyosarcoma	5	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2034_tumor, SRR5144194	33077	17473	15222	13845	12897	12132
THR29_0737_S01	76101431	73742730	55848397	43634018.65	101	alveolar rhabdomyosarcoma	3	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2037_tumor, SRR5144195	31907	17536	15146	13664	12664	11859
THR29_0738_S01	210029048	201581218	122100114.5	93722078.295	101	alveolar rhabdomyosarcoma	13	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2038_tumor, SRR5144196	32357	15786	13582	12305	11296	10493
THR29_0739_S01	197651552	190392721	136563300	102908767.6	101	alveolar rhabdomyosarcoma	15	Yes, age < 30 years	female	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2039_tumor, SRR5144197	32659	17066	14824	13583	12655	11964
THR29_0740_S01	178637186	171699579	103042893	91004400.7	101	embryonal rhabdomyosarcoma	6	Yes, age < 30 years	female	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2040_tumor, SRR5144198	32280	15470	13245	11837	10822	9958
THR29_0741_S01	70403351	68231255	49737513	42571505.26	101	embryonal rhabdomyosarcoma	2	Yes, age < 30 years	female	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2041_tumor, SRR5144199	30133	16751	14645	13414	12506	11727
THR29_0742_S01	157474977	152839271	96742473	74760415.29	101	alveolar rhabdomyosarcoma	8	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2046_tumor, SRR5144200	32036	16922	14649	13356	12357	11528
THR29_0743_S01	171395421	167242643	113151990	87847212.96	101	alveolar rhabdomyosarcoma	9	Yes, age < 30 years	female	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2047_tumor, SRR5144201	32789	16982	14643	13399	12455	11712
THR29_0744_S01	150051307	146455595	102529769	79820283.07	101	rhabdomyosarcoma	0	Yes, age < 30 years	female	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2049_tumor, SRR5144202	31723	16934	14721	13449	12535	11827
THR29_0745_S01	147713577	142927870	94986262.5	79401576.87	101	embryonal rhabdomyosarcoma	12	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_205_tumor, SRR5144209	32509	16798	14465	13118	12098	11282
THR29_0746_S01	146920292	143009421	94206252.5	79783470	101	alveolar rhabdomyosarcoma	2	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2051_tumor, SRR5144203	30877	16039	13888	12718	11830	11130
THR29_0747_S01	139040200	135239041	92212880	73275367.23	101	embryonal rhabdomyosarcoma	5	Yes, age < 30 years	female	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2052_tumor, SRR5144204	30805	15763	13628	12455	11559	10806
THR29_0748_S01	76626829	74482688	55211339.5	47504395.015	101	embryonal rhabdomyosarcoma	0	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2053_tumor, SRR5144205	30058	16807	14720	13506	12699	12004
THR29_0749_S01	112968836	110376215	71633048.5	60501028.99	100	embryonal rhabdomyosarcoma	6	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2054_tumor, SRR5144206	29084	14396	12454	11285	10332	9580
THR29_0750_S01	82000673	80058853	49444338	42323399.46	101	embryonal rhabdomyosarcoma	3	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2056_tumor, SRR5144207	30052	15201	13009	11549	10456	9508
THR29_0751_S01	196657073	187378145	143887750.5	103669637.34	101	alveolar rhabdomyosarcoma	1	Yes, age < 30 years	female	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2058_tumor, SRR5144208	32317	17226	14888	13546	12661	11973
THR29_0752_S01	153217896	148823510	106765673.5	89840389.485	101	embryonal rhabdomyosarcoma	8	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_206_tumor, SRR5144213	33426	17578	15219	13998	12988	12225
THR29_0753_S01	78026998	76059905	54192742	45682188.475	101	alveolar rhabdomyosarcoma	0	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2061_tumor, SRR5144210	28932	15667	13667	12554	11653	10947
THR29_0754_S01	183877537	176327294	122542744	97871322.12	101	alveolar rhabdomyosarcoma	0	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2063_tumor, SRR5144211	31449	16210	14039	12792	11901	11161
THR29_0755_S01	94292086	91778756	70989275.5	58700247.3	101	alveolar rhabdomyosarcoma	4	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2065_tumor, SRR5144212	32189	17617	15290	13957	12964	12247
THR29_0756_S01	80268650	77905983	61553367.5	42020898.77	101	alveolar rhabdomyosarcoma	7	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2071_tumor, SRR5144214	30486	16973	14720	13403	12387	11567
THR29_0757_S01	190461384	184283240	122597459.5	93858950	101	alveolar rhabdomyosarcoma	9	Yes, age < 30 years	female	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2072_tumor, SRR5144215	33491	17236	14975	13674	12690	11900
THR29_0758_S01	151011723	146969969	99444178.5	79731960.39	100	rhabdomyosarcoma	5	Yes, age < 30 years	female	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2074_tumor, SRR5144216	31316	15959	13883	12625	11783	11046
THR29_0759_S01	137311519	133041863	93946364	79165027.48	101	embryonal rhabdomyosarcoma	4	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2075_tumor, SRR5144217	30406	15076	13037	11848	10977	10261
THR29_0760_S01	200854931	193565226	130040029.5	96959965.005	101	alveolar rhabdomyosarcoma	12	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2076_tumor, SRR5144218	33598	17661	15314	14001	12959	12152
THR29_0761_S01	170161523	164238671	113125546	89117286.68	101	embryonal rhabdomyosarcoma	3	Yes, age < 30 years	female	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2078_tumor, SRR5144219	33345	17371	14979	13651	12696	11970
THR29_0762_S01	82699669	80369306	59200047	47753027.4	101	alveolar rhabdomyosarcoma	17	Yes, age < 30 years	female	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2079_tumor, SRR5144220	30338	16176	14003	12642	11703	10980
THR29_0763_S01	185333312	181188725	107036612.5	87560348.85	101	embryonal rhabdomyosarcoma	6	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_208_tumor, SRR5144226	31597	15536	13342	12052	11064	10201
THR29_0764_S01	169687731	164747005	104853976	80742724.4	101	spindle cell/sclerosing rhabdomyosarcoma	12	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2080_tumor, SRR5144221	32076	16065	13947	12712	11802	11045
THR29_0765_S01	157165513	151825142	113207648	95248710.865	101	embryonal rhabdomyosarcoma	5	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2081_tumor, SRR5144222	31960	16386	14279	13074	12205	11502
THR29_0766_S01	88002039	85411750	65446371	52009344.66	101	spindle cell/sclerosing rhabdomyosarcoma	15	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2083_tumor, SRR5144223	31781	17261	14983	13688	12733	11978
THR29_0767_S01	163023154	153832583	113801143	89730693.635	101	embryonal rhabdomyosarcoma	11	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2084_tumor, SRR5144224	35026	18542	15989	14529	13439	12575
THR29_0768_S01	146925402	142615996	100803890	82759473.33	100	embryonal rhabdomyosarcoma	2	Yes, age < 30 years	female	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2085_tumor, SRR5144225	33863	17739	15401	13940	12912	12069
THR29_0769_S01	136413765	131877700	43359335.5	39518457.12	101	alveolar rhabdomyosarcoma	13	Yes, age < 30 years	female	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_209_tumor, SRR5144230	25622	11386	9103	7699	6591	5840
THR29_0770_S01	176861784	171725918	120130626.5	94842872.8	100	embryonal rhabdomyosarcoma	4	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2090_tumor, SRR5144227	33592	16493	14193	12869	11913	11107
THR29_0771_S01	197748439	191195352	120956723.5	87349549.905	101	alveolar rhabdomyosarcoma	6	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2093_tumor, SRR5144228	32532	16632	14407	13103	12185	11373
THR29_0772_S01	189751087	183023925	99870020.5	80066600.8	101	alveolar rhabdomyosarcoma	14	Yes, age < 30 years	female	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2094_tumor, SRR5144229	30855	15767	13680	12458	11520	10751
THR29_0773_S01	151790220	146649137	85668513	73339307.965	101	alveolar rhabdomyosarcoma	1	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_210_tumor, SRR5144234	30508	14890	12770	11423	10413	9611
THR29_0774_S01	169244538	153451622	80863398	67503641.4	101	alveolar rhabdomyosarcoma	17	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2104_tumor, SRR5144231	31028	16033	13895	12553	11631	10818
THR29_0775_S01	122749075	115730801	72737000.5	56457532.885	101	alveolar rhabdomyosarcoma	14	Yes, age < 30 years	female	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2105_tumor, SRR5144232	31183	16368	14117	12802	11704	10821
THR29_0776_S01	179603416	172912330	91784357	76593140.52	101	rhabdomyosarcoma	20	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2107_tumor, SRR5144233	32705	15942	13611	12185	11071	10171
THR29_0777_S01	138523795	134283889	74034247.5	60686906.115	101	embryonal rhabdomyosarcoma	5	Yes, age < 30 years	female	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_211_tumor, SRR5144239	31433	16846	14674	13374	12345	11505
THR29_0778_S01	132831053	127311466	84180893.5	75115181.25	101	embryonal rhabdomyosarcoma	1	Yes, age < 30 years	female	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2110_tumor, SRR5144235	29713	15818	13941	12851	12013	11298
THR29_0779_S01	151284944	144975212	87525723	79701006	101	rhabdomyosarcoma	7	Yes, age < 30 years	female	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2111_tumor, SRR5144236	29702	15096	13316	12184	11342	10565
THR29_0780_S01	111787108	108337225	75880214	63934208.08	101	alveolar rhabdomyosarcoma	17	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2114_tumor, SRR5144237	30034	16229	14252	13018	12175	11430
THR29_0781_S01	151661333	147255442	96485069.5	85047819.01	100	rhabdomyosarcoma	1	Yes, age < 30 years	female	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_2117_tumor, SRR5144238	31680	16347	14221	12971	12040	11288
THR29_0782_S01	79908368	77801154	53647033	49071397.16	101	embryonal rhabdomyosarcoma	0	Yes, age < 30 years	female	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_212_tumor, SRR5144240	29042	15190	13303	12211	11356	10620
THR29_0783_S01	184793892	178489556	121500351	100625563.5	101	embryonal rhabdomyosarcoma	17	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_214_tumor, SRR5144241	33158	16799	14626	13357	12488	11693
THR29_0784_S01	176984524	172441267	101937319.5	82430651.235	101	embryonal rhabdomyosarcoma	3	Yes, age < 30 years	female	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_216_tumor, SRR5144242	31123	16075	14005	12735	11768	10991
THR29_0785_S01	137958849	134060058	86257251	71568855.05	101	embryonal rhabdomyosarcoma	3	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_217_tumor, SRR5144243	30700	15954	13876	12618	11695	10937
THR29_0786_S01	165190777	161641778	105193514	86492077.21	101	embryonal rhabdomyosarcoma	1	Yes, age < 30 years	female	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_223_tumor, SRR5144245	33380	17350	15117	13800	12896	12211
THR29_0787_S01	179755462	175198760	115372557	89122261.31	101	alveolar rhabdomyosarcoma	0	Yes, age < 30 years	female	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_224_tumor, SRR5144246	32976	17483	15187	13893	12958	12186
THR29_0788_S01	105942780	103047993	73526795.5	58639516.65	101	alveolar rhabdomyosarcoma	12	Yes, age < 30 years	female	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_225_tumor, SRR5144247	30549	16550	14399	13211	12303	11595
THR29_0789_S01	79700662	76213359	50029328	40935902.4	101	embryonal rhabdomyosarcoma	4	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_226_tumor, SRR5144248	28330	15601	13553	12371	11445	10705
THR29_0790_S01	73892137	71316077	48953582	39414949.785	101	alveolar rhabdomyosarcoma	14	Yes, age < 30 years	female	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_227_tumor, SRR5144249	28964	16221	14077	12724	11739	10931
THR29_0791_S01	95801994	93242146	56432750	49019711.51	101	embryonal rhabdomyosarcoma	8	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_228_tumor, SRR5144250	30006	15242	12879	11408	10318	9444
THR29_0792_S01	138486814	134661247	63052094.5	53983454.335	101	embryonal rhabdomyosarcoma	4	Yes, age < 30 years	female	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_230_tumor, SRR5144251	29656	15346	13163	11767	10710	9815
THR29_0793_S01	136142133	132216557	87614228	70320050.955	101	embryonal rhabdomyosarcoma	8	Yes, age < 30 years	female	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_231_tumor, SRR5144252	33373	17061	14527	13174	12133	11315
THR29_0794_S01	144649257	140140055	72553954	60639039.2	101	alveolar rhabdomyosarcoma	16	Yes, age < 30 years	female	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_232_tumor, SRR5144253	30258	15765	13598	12231	11212	10355
THR29_0795_S01	143241174	138862030	90531288.5	73221457.705	101	alveolar rhabdomyosarcoma	1	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_235_tumor, SRR5144254	31684	17273	15104	13734	12734	11914
THR29_0796_S01	118024215	113513969	76163339	61029262.49	101	alveolar rhabdomyosarcoma	3	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_238_tumor, SRR5144255	30136	16263	14087	12772	11778	10979
THR29_0797_S01	112809026	108536807	76677021.5	61082416.98	101	embryonal rhabdomyosarcoma	2	Yes, age < 30 years	female	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_239_tumor, SRR5144256	30553	16119	13936	12784	11921	11165
THR29_0798_S01	109614841	105527528	56148842.5	48120091.11	101	embryonal rhabdomyosarcoma	7	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_240_tumor, SRR5144257	30548	16123	13692	12214	11084	10202
THR29_0799_S01	95306655	91362698	56384978	48241990.66	101	embryonal rhabdomyosarcoma	9	Yes, age < 30 years	female	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_242_tumor, SRR5144258	28391	14232	12250	11071	10189	9451
THR29_0800_S01	73791542	69925997	41456063.5	36275382.22	101	alveolar rhabdomyosarcoma	1	Yes, age < 30 years	female	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_244_tumor, SRR5144259	28571	15097	12939	11481	10473	9677
THR29_0801_S01	99828031	95584167	57094791	49162168.77	101	alveolar rhabdomyosarcoma	15	Yes, age < 30 years	female	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_246_tumor, SRR5144260	28899	15275	13226	11864	10853	10021
THR29_0802_S01	182322089	177571297	68617433.5	58149350.61	101	alveolar rhabdomyosarcoma	15	Yes, age < 30 years	male	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_247_tumor, SRR5144261	29632	15075	12872	11459	10351	9496
THR29_0803_S01	169920032	161657229	75634681.5	66859154.34	101	alveolar rhabdomyosarcoma	4	Yes, age < 30 years	female	NA	NA	Cohort_8	phs000720.v2.p1	http://dx.doi.org/10.1158/2159-8290.CD-13-0639	dbGaP	phs000720	RMS_248_tumor, SRR5144262	30295	15713	13629	12293	11323	10466
THR30_0804_S01	86699361	84050120	65607515	55956812.6	101	Ewing sarcoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163668, S4_tumor	29316	16742	14647	13545	12731	12091
THR30_0805_S01	96226698	93432904	58557013	51662915.2	101	Ewing sarcoma	10	Yes, age < 30 years	male	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163670, S6_tumor	27976	14788	13021	11876	11091	10407
THR30_0806_S01	99582207	96681460	72810631.5	62082393.375	101	Ewing sarcoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163667, S3_tumor	30577	17063	14908	13781	12903	12222
THR30_0807_S01	101692191	98585576	71719186.5	62378309.625	101	Ewing sarcoma	11	Yes, age < 30 years	female	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163666, S2_tumor	29619	16486	14462	13244	12399	11712
THR30_0808_S01	93486214	90677692	55939466.5	48028821.61	101	Ewing sarcoma	14	Yes, age < 30 years	male	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163669, S5_tumor	29281	15693	13684	12460	11545	10753
THR30_0809_S01	95820934	92931186	67163531.5	60179059.875	101	Ewing sarcoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163665, S1_tumor	28618	15593	13730	12661	11892	11286
THR30_0810_S01	110270766	106593445	80346947.5	70614247.5	101	Ewing sarcoma	15	Yes, age < 30 years	male	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163671, EWS101_tumor	29733	16135	14172	13029	12281	11630
THR30_0811_S01	103035101	99618329	66439895.5	58530876.74	101	Ewing sarcoma	15	Yes, age < 30 years	male	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163672, EWS102_tumor	30536	16359	14327	13109	12253	11479
THR30_0812_S01	110753120	107442427	72849406	66271541.25	101	Ewing sarcoma	12	Yes, age < 30 years	female	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163673, EWS103_tumor	27984	14949	13141	11994	11163	10531
THR30_0813_S01	100516310	97527196	73050587	63717224.55	101	Ewing sarcoma	15	Yes, age < 30 years	female	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163674, EWS104_tumor	29697	15926	13884	12765	11956	11338
THR30_0814_S01	107392722	103780404	76124245	60948138.81	101	Ewing sarcoma	4	Yes, age < 30 years	male	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163675, EWS105_tumor	30361	16631	14525	13302	12388	11612
THR30_0815_S01	97154075	94084833	70246062	61918453.27	101	Ewing sarcoma	11	Yes, age < 30 years	female	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163676, EWS106_tumor	29040	16092	14202	13101	12326	11677
THR30_0816_S01	117853135	114949243	79095039	67996197.375	101	Ewing sarcoma	12	Yes, age < 30 years	female	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163677, EWS107_tumor	29766	14968	13067	11950	11131	10524
THR30_0817_S01	97474820	94782347	67169705	53915872.205	101	Ewing sarcoma	4	Yes, age < 30 years	male	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163678, EWS108_tumor	30772	16526	14211	12841	11805	11000
THR30_0818_S01	109953283	106902419	66040485.5	55997223.75	101	Ewing sarcoma	4	Yes, age < 30 years	male	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163679, EWS109_tumor	29266	15512	13419	12113	11070	10203
THR30_0819_S01	93155383	90475255	67130222	55545204.33	101	Ewing sarcoma	14	Yes, age < 30 years	male	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163680, EWS110_tumor	30461	16615	14470	13163	12228	11466
THR30_0820_S01	123634471	120202520	89665113.5	73640356.405	101	Ewing sarcoma	12	Yes, age < 30 years	male	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163681, EWS111_tumor	31412	17128	14876	13637	12748	12044
THR30_0821_S01	96515004	93933379	50886462.5	45743599.055	101	Ewing sarcoma	4	Yes, age < 30 years	female	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163682, EWS112_tumor	28468	14743	12827	11557	10582	9773
THR30_0822_S01	91473607	88726889	68028839	57025795.75	101	Ewing sarcoma	3	Yes, age < 30 years	female	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163683, EWS113_tumor	29737	16446	14381	13255	12422	11736
THR30_0823_S01	64132572	62270445	49467196.5	40525684.43	101	Ewing sarcoma	18	Yes, age < 30 years	female	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163684, EWS115_tumor	28927	16456	14383	13220	12386	11758
THR30_0824_S01	46053364	44654765	36261557.5	30147139.64	101	Ewing sarcoma	8	Yes, age < 30 years	female	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163685, EWS116_tumor	28044	16460	14291	13034	12186	11442
THR30_0825_S01	46704643	45306342	36259360.5	31641976.875	101	Ewing sarcoma	11	Yes, age < 30 years	female	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163686, EWS118_tumor	27902	16479	14379	13218	12409	11726
THR30_0826_S01	41094138	39892102	33066980	28356177.98	101	Ewing sarcoma	16	Yes, age < 30 years	female	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163687, EWS119_tumor	26715	16318	14339	13202	12347	11720
THR30_0827_S01	55154151	53692184	42425383.5	37207755.375	101	Ewing sarcoma	7	Yes, age < 30 years	female	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163688, EWS120_tumor	26896	15164	13244	12213	11482	10916
THR30_0828_S01	62081153	60372411	48015795	42093444.05	101	Ewing sarcoma	13	Yes, age < 30 years	female	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163689, EWS121_tumor	29436	17256	15137	13976	13118	12397
THR30_0829_S01	62723877	60949858	47915438.5	41625115.64	101	Ewing sarcoma	10	Yes, age < 30 years	female	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163690, EWS122_tumor	28633	16620	14479	13346	12533	11861
THR30_0830_S01	41677217	40502989	33266627.5	29416321.64	101	Ewing sarcoma	13	Yes, age < 30 years	female	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163691, EWS123_tumor	26343	15952	13964	12886	12148	11547
THR30_0831_S01	86979560	83178932	61301131	54143930.76	101	Ewing sarcoma	11	Yes, age < 30 years	female	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163692, EWS125_tumor	29168	15883	13806	12646	11828	11138
THR30_0832_S01	129538825	123166349	89822166	74108698.895	101	Ewing sarcoma	6	Yes, age < 30 years	female	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163693, EWS126_tumor	31385	16614	14420	13196	12310	11605
THR30_0833_S01	83327063	79679209	53878852.5	45461414.845	101	Ewing sarcoma	14	Yes, age < 30 years	female	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163694, EWS127_tumor	30127	16873	14640	13369	12414	11643
THR30_0834_S01	127765526	122634995	89162796.5	74116622.195	101	Ewing sarcoma	24	Yes, age < 30 years	female	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163695, EWS129_tumor	31287	17420	15220	13910	13024	12264
THR30_0835_S01	102043255	98651365	62836032.5	55832087.1	101	Ewing sarcoma	15	Yes, age < 30 years	female	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163696, EWS130_tumor	27852	15115	13287	12182	11330	10649
THR30_0836_S01	110946195	107436758	69728403.5	62883596.25	101	Ewing sarcoma	14	Yes, age < 30 years	female	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163697, EWS132_tumor	29681	16269	14322	13159	12271	11503
THR30_0837_S01	109741036	105771715	72097047.5	59766580.335	101	Ewing sarcoma	16	Yes, age < 30 years	female	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163698, EWS133_tumor	30041	15957	13811	12644	11768	11067
THR30_0838_S01	100848434	97323252	66842198.5	52842822.71	101	Ewing sarcoma	10	Yes, age < 30 years	male	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163699, EWS135_tumor	29443	16059	14027	12782	11853	11151
THR30_0839_S01	98699955	95478736	71537417.5	59381380.135	101	Ewing sarcoma	2	Yes, age < 30 years	male	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163701, EWS137_tumor	29879	16924	14843	13603	12711	12038
THR30_0840_S01	108283443	104642991	78902695.5	67491401.38	101	Ewing sarcoma	1	Yes, age < 30 years	male	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163700, EWS136_tumor	30614	16886	14764	13627	12779	12108
THR30_0841_S01	111734585	107661054	77301959	61270489.78	101	Ewing sarcoma	7	Yes, age < 30 years	male	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163702, EWS138_tumor	29789	16764	14679	13482	12621	11904
THR30_0842_S01	90903592	88274007	56741514.5	50480809.875	101	Ewing sarcoma	13	Yes, age < 30 years	male	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163703, EWS139_tumor	29727	16444	14405	13185	12256	11481
THR30_0843_S01	97412977	94627843	63444039	55304338.82	101	Ewing sarcoma	11	Yes, age < 30 years	female	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163704, EWS140_tumor	27013	14034	12345	11377	10624	10019
THR30_0844_S01	114931598	111892476	74381155	67032843.39	101	Ewing sarcoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163705, EWS2001_tumor	28524	15047	13269	12256	11481	10849
THR30_0845_S01	127717556	123840782	91021346.5	74734209.55	101	Ewing sarcoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163706, EWS2004_tumor	30140	17115	14976	13812	13007	12351
THR30_0846_S01	74264968	72105803	51645151	46170431.25	101	Ewing sarcoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163707, EWS2005_tumor	28652	15889	13901	12763	11931	11248
THR30_0847_S01	93745091	90791645	57361009	53678121.48	101	Ewing sarcoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163708, EWS2007_tumor	27311	14601	12792	11689	10858	10121
THR30_0848_S01	113660286	110359187	76269418	67046480.48	101	Ewing sarcoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163709, EWS2013_tumor	29837	15822	13799	12656	11798	11107
THR30_0849_S01	98546676	95513595	60941467.5	54706136.25	101	Ewing sarcoma	11	Yes, age < 30 years	male	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163710, EWS2016_tumor	27210	14324	12580	11612	10887	10299
THR30_0850_S01	117721106	113968518	68499944.5	60494819.77	101	Ewing sarcoma	16	Yes, age < 30 years	male	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163711, EWS2019_tumor	30062	15861	13849	12588	11671	10974
THR30_0851_S01	164508975	160581950	102563307.5	87425163.6	101	Ewing sarcoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163712, EWS2023_tumor	31981	15721	13664	12475	11637	10903
THR30_0852_S01	116000000	112558660	76807292	68639612.05	101	Ewing sarcoma	0.58	Yes, age < 30 years	male	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163713, NCI0021_tumor	29743	15843	13852	12768	11941	11229
THR30_0853_S01	82800723	79810698	57009882.5	46420275.6	101	Ewing sarcoma	14	Yes, age < 30 years	male	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163714, NCI0039_tumor	29181	16382	14231	12996	12153	11429
THR30_0854_S01	87922701	85810380	62522814.5	53299177.875	101	Ewing sarcoma	24	Yes, age < 30 years	female	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163715, NCI0041_tumor	29337	16006	13933	12681	11888	11200
THR30_0855_S01	101721674	99258233	69459040.5	60424523.625	101	Ewing sarcoma	12	Yes, age < 30 years	male	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163716, NCI0047_tumor	30485	16445	14403	13306	12392	11639
THR30_0856_S01	109806988	107571120	68604850	60813493.125	101	Ewing sarcoma	17	Yes, age < 30 years	male	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163718, NCI0071_tumor	29199	14992	13148	12032	11149	10438
THR30_0857_S01	81435456	77786467	54948961.5	46076266.125	101	Ewing sarcoma	18	Yes, age < 30 years	female	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163717, NCI0050_tumor	29754	15946	13803	12606	11735	11014
THR30_0858_S01	105007126	102842668	59962724	52500125.12	101	Ewing sarcoma	15	Yes, age < 30 years	female	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163719, NCI0074_tumor	28965	15191	13268	12138	11287	10551
THR30_0859_S01	81214443	78062433	38613274.5	34065958.09	101	Ewing sarcoma	21	Yes, age < 30 years	male	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163720, NCI0097_tumor	28792	16165	13963	12615	11697	10858
THR30_0860_S01	99672099	97320319	68984582.5	60057741	101	Ewing sarcoma	8	Yes, age < 30 years	female	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163721, NCI0115_tumor	29173	15757	13784	12657	11841	11155
THR30_0861_S01	73897690	70207124	40776674.5	32599148.89	101	Ewing sarcoma	16	Yes, age < 30 years	male	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163722, NCI0135_tumor	29638	17548	15338	14022	12983	12130
THR30_0862_S01	106047587	100939387	48735595	40717534.8	101	Ewing sarcoma	28	Yes, age < 30 years	female	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163723, NCI0150_tumor	30792	17223	14975	13537	12487	11582
THR30_0863_S01	87722582	85426719	58209316.5	51198932.52	101	Ewing sarcoma	13	Yes, age < 30 years	male	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163724, NCI0165_tumor	27362	14518	12732	11671	10883	10224
THR30_0864_S01	101243579	98482824	71360423	61161918.75	101	Ewing sarcoma	16	Yes, age < 30 years	female	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163725, NCI0167_tumor	29542	15800	13775	12642	11857	11180
THR30_0865_S01	99529578	96308451	66756399.5	40864500.33	101	Ewing sarcoma	18	Yes, age < 30 years	female	NA	NA	Cohort_13	phs000768.v2.p1	http://dx.doi.org/10.1371/journal.pgen.1004475	dbGaP	phs000768	SRR5163726, NCI0198_tumor	32892	13560	11274	9793	8610	7616
THR31_0866_S01	100716562	96236771	40958277.5	29707593.04	101	neuroblastoma	15	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080	dbGaP	phs000673	SRR4305696	29893	16362	14032	12539	11422	10509
THR31_0867_S01	95073665	88851828	20609362	16405186.4	101	meningioma	11	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080	dbGaP	phs000673	SRR4305699	25382	15614	13358	12059	11042	10186
THR31_0868_S01	88788612	85710258	51188262	41556309.04	101	acute lymphoblastic leukemia	9	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080	dbGaP	phs000673	SRR4305703	24992	13939	12360	11432	10758	10191
THR31_0868_S02	85305157	82908696	44507946	36701149.15	110	acute lymphoblastic leukemia	9	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080	dbGaP	phs000673	SRR4305707	25566	13305	11695	10763	10031	9372
THR31_0869_S01	99926949	92738742	33188625	24416707.23	101	rhabdomyosarcoma	14	Yes, age < 30 years	male	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080	dbGaP	phs000673	SRR4305715	26916	15300	13163	11748	10686	9823
THR31_0870_S01	99621309	93837707	47856009.5	35835872	101	acute lymphoblastic leukemia	1	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080	dbGaP	phs000673	SRR4305719	25454	13472	11700	10566	9705	8969
THR31_0871_S01	70027282	65510874	27310374.5	24747662.52	101	acute myeloid leukemia	4	Yes, age < 30 years	male	NA	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080	dbGaP	phs000673	SRR4305723	24594	13219	11595	10531	9668	8958
THR31_0872_S01	48141926	45156347	16127985.5	14466224.085	110	rhabdomyosarcoma	16	Yes, age < 30 years	male	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080	dbGaP	phs000673	SRR4305729	24667	14812	12804	11601	10657	9918
THR31_0873_S01	62561749	58663578	33835193.5	26046700.135	101	germ cell tumor	17	Yes, age < 30 years	male	NA	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080	dbGaP	phs000673	SRR4305731	27528	15872	13688	12346	11372	10587
THR31_0874_S01	64661078	58871341	30954521.5	22739586.87	101	PEComa	15	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080	dbGaP	phs000673	SRR4305737	27948	15216	12892	11520	10498	9665
THR31_0875_S01	64345244	62010081	39498377.5	34912839.84	100	acute lymphoblastic leukemia	14	Yes, age < 30 years	male	NA	Hispanic or Latino	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080	dbGaP	phs000673	SRR4305742	24825	14201	12645	11745	11098	10554
THR31_0876_S01	76143351	68887535	38163835	29668961.07	101	wilms tumor	18	Yes, age < 30 years	male	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080	dbGaP	phs000673	SRR4305747	28535	16405	14095	12565	11494	10612
THR31_0877_S01	75064845	71463861	41586963.5	33349423.415	101	acute lymphoblastic leukemia	5	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080	dbGaP	phs000673	SRR4305754	26204	13720	11901	10777	9892	9113
THR31_0878_S01	60332645	54369865	15132651	13894233.43	101	hepatocellular carcinoma	5	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080	dbGaP	phs000673	SRR4305761	22269	13196	11324	10085	9057	8298
THR31_0879_S01	63732212	60653906	33990856	27070193.67	101	acute myeloid leukemia	19	Yes, age < 30 years	male	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080	dbGaP	phs000673	SRR4305767	24690	14500	12657	11556	10811	10132
THR31_0880_S01	60580897	58891054	19663306	18655503.12	101	fibrolamellar hepatocellular carcinoma	16	Yes, age < 30 years	male	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080	dbGaP	phs000673	SRR4305778	22254	11791	9724	8403	7445	6680
THR31_0881_S01	87923023	83158783	30380186	27874197.12	100	neuroblastoma	15	Yes, age < 30 years	male	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080	dbGaP	phs000673	SRR4305780	24578	12687	10604	9260	8142	7218
THR31_0882_S01	84188994	70174474	12728977	10753177.38	100	neuroblastoma	6	Yes, age < 30 years	male	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080	dbGaP	phs000673	SRR4305784	23455	11014	8424	6828	5801	5011
THR31_0883_S01	45600123	42291502	23058603	20197753.83	101	neuroblastoma	6	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080	dbGaP	phs000673	SRR4305790	26797	15497	13329	11964	10878	9945
THR31_0884_S01	72539634	70462176	37529253.5	35362115.42	100	hepatoblastoma	1	Yes, age < 30 years	male	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080	dbGaP	phs000673	SRR4305794	25861	14856	12912	11763	10812	9997
THR31_0885_S01	47608723	45682451	27510120.5	24134893.54	101	acute myeloid leukemia	14	Yes, age < 30 years	male	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080	dbGaP	phs000673	SRR4305799	24532	13262	11748	10677	9894	9205
THR31_0886_S01	67684111	62343675	25883663	23922081.86	100	alveolar rhabdomyosarcoma	18	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080	dbGaP	phs000673	SRR4305806	25101	14475	12480	11136	10061	9168
THR31_0887_S01	66624778	64597900	38634437.5	36081416.905	100	osteosarcoma	16	Yes, age < 30 years	male	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080	dbGaP	phs000673	SRR4305812	25491	14576	12961	11899	11099	10428
THR31_0888_S01	48575662	46997710	29010719.5	26691000.48	110	rhabdomyosarcoma	6	Yes, age < 30 years	female	NA	Hispanic or Latino	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080	dbGaP	phs000673	SRR4305819	24288	13846	12136	11035	10223	9580
THR31_0889_S01	51741296	48679187	26626468	24354081.515	110	acute lymphoblastic leukemia	13	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080	dbGaP	phs000673	SRR4305823	22633	12083	10530	9488	8675	8047
THR31_0890_S01	74978271	71501385	40204678.5	35139364.875	100	acute lymphoblastic leukemia	23	Yes, age < 30 years	male	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080	dbGaP	phs000673	SRR4305828	26204	14008	12262	11129	10264	9533
THR31_0891_S01	74377495	71536706	46779253.5	40934291.4	100	acute lymphoblastic leukemia	12	Yes, age < 30 years	male	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080	dbGaP	phs000673	SRR4305832	24443	13956	12384	11434	10716	10136
THR31_0892_S01	109592048	104967239	62285081.5	57875033.7	100	undifferentiated spindle cell sarcoma	3	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080	dbGaP	phs000673	SRR4305839	26245	14993	13439	12486	11807	11247
THR31_0893_S01	46804048	44566784	24206075.5	22322579.115	110	osteosarcoma	18	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080	dbGaP	phs000673	SRR4305843	26106	14619	12921	11847	11012	10284
THR31_0894_S01	64540316	61863897	37325959	32961450.925	110	epithelioid sarcoma	11	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080	dbGaP	phs000673	SRR4305847	28853	15402	13449	12257	11304	10584
THR31_0895_S01	64193763	61838081	30019599	26082079.1	100	osteosarcoma	12	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080	dbGaP	phs000673	SRR4305851	27111	15174	13073	11776	10785	9977
THR31_0896_S01	71257627	68542242	34606530.5	32397709.12	100	myofibromatosis	1	Yes, age < 30 years	male	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080	dbGaP	phs000673	SRR4305855	24475	14648	13003	11967	11160	10480
THR31_0897_S01	70949863	67892445	35223002.5	28865921.7	100	acute lymphoblastic leukemia	9	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080	dbGaP	phs000673	SRR4305859	24585	13462	11829	10851	10084	9463
THR31_0898_S01	65642214	64500795	44808792	37510848	100	acute lymphoblastic leukemia	5	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080	dbGaP	phs000673	SRR4305863	25827	14899	13123	12179	11452	10856
THR31_0899_S01	49210661	48067325	33360358.5	29705107.075	100	acute myeloid leukemia	1	Yes, age < 30 years	male	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080	dbGaP	phs000673	SRR4305869	23903	13751	12234	11429	10826	10359
THR31_0900_S01	74527477	70837143	34547278.5	30900410.25	100	cholangiocarcinoma	17	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080	dbGaP	phs000673	SRR4305871	25916	14429	12669	11536	10592	9818
THR31_0901_S01	69028415	66948286	39497376	34498789.875	100	lymphoma	2	Yes, age < 30 years	male	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080	dbGaP	phs000673	SRR4305875	26509	14325	12469	11297	10397	9646
THR31_0902_S01	65830683	63010966	29357067.5	27561410.64	100	acute myeloid leukemia	18	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080	dbGaP	phs000673	SRR4305882	23045	12012	10464	9417	8464	7681
THR31_0903_S01	77728236	75219383	40792636	35303974.76	100	acute myeloid leukemia	18	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080	dbGaP	phs000673	SRR4305886	24938	12825	11284	10281	9501	8819
THR31_0904_S01	73515037	66256515	26111820	22344863.31	100	medulloblastoma	3	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080,  http://dx.doi.org/10.1038/nature23306	dbGaP	phs000673	SRR4305891	25334	14160	12445	11411	10584	9913
THR31_0905_S01	105658127	100703542	44228336	37658876.25	110	pleuropulmonary blastoma	4	Yes, age < 30 years	male	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080,  http://dx.doi.org/10.1038/nature23306	dbGaP	phs000673	SRR4305894	28338	16525	14474	13332	12438	11740
THR31_0906_S01	68364789	66112562	38907673	34591467.75	100	Ewing sarcoma	17	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080,  http://dx.doi.org/10.1038/nature23306	dbGaP	phs000673	SRR4305898	26407	15305	13462	12217	11340	10602
THR31_0907_S01	119873131	118900986	83013582	76104835.68	125	nasopharyngeal carcinoma	14	Yes, age < 30 years	male	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080,  http://dx.doi.org/10.1038/nature23306	dbGaP	phs000673	SRR4305903	28848	15295	13549	12598	11876	11271
THR31_0908_S01	98380162	91516706	2143447.5	1899506.51	110	hypereosinophillic syndrome	4	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080,  http://dx.doi.org/10.1038/nature23306	dbGaP	phs000673	SRR4305916	17233	1745	848	556	431	359
THR31_0909_S01	46766306	44062817	17455748.5	13602047.56	110	acute myeloid leukemia	17	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080,  http://dx.doi.org/10.1038/nature23306	dbGaP	phs000673	SRR4305919	20654	8949	7275	6192	5500	4969
THR31_0910_S01	77761322	72866914	41243457.5	34569637.875	100	juvenile myelomonocytic leukemia	3	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080,  http://dx.doi.org/10.1038/nature23306	dbGaP	phs000673	SRR4305922	24414	12901	11197	10168	9413	8758
THR31_0911_S01	57379663	55655188	37832950.5	34235846.6	100	undifferentiated sarcoma NOS	9	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080,  http://dx.doi.org/10.1038/nature23306	dbGaP	phs000673	SRR4305935	25663	15608	13808	12783	12118	11577
THR31_0912_S01	64550027	62200325	40811839.5	35042212.34	100	acute myeloid leukemia	22	Yes, age < 30 years	male	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080,  http://dx.doi.org/10.1038/nature23306	dbGaP	phs000673	SRR4305950	24288	13849	12301	11385	10695	10109
THR31_0913_S01	60961633	58426379	33490900.5	30860602.95	100	melanotic neuroectodermal tumor	0	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080,  http://dx.doi.org/10.1038/nature23306	dbGaP	phs000673	SRR4305966	26099	16131	14334	13237	12378	11638
THR31_0914_S01	50442664	49346399	34814091.5	29868953.08	125	neuroblastoma	6	Yes, age < 30 years	male	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080,  http://dx.doi.org/10.1038/nature23306	dbGaP	phs000673	SRR4305968	27582	16233	14221	13029	12090	11305
THR31_0915_S01	65100742	61322822	23766762.5	21730319.41	100	fibromatosis	7	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080,  http://dx.doi.org/10.1038/nature23306	dbGaP	phs000673	SRR4305980	23387	14372	12688	11602	10747	10069
THR31_0916_S01	67059227	64796082	22986458.5	21537273.585	100	myofibromatosis	12	Yes, age < 30 years	male	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080,  http://dx.doi.org/10.1038/nature23306	dbGaP	phs000673	SRR4305984	23526	14151	12383	11256	10372	9608
THR31_0917_S01	81619029	79132986	42338236.5	38884266.4	125	adrenocortical carcinoma	14	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080,  http://dx.doi.org/10.1038/nature23306	dbGaP	phs000673	SRR4305988	25121	14029	12288	11186	10395	9709
THR31_0918_S01	72421646	67575663	35405208	30816041.1	100	glioma	1	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080,  http://dx.doi.org/10.1038/nature23306	dbGaP	phs000673	SRR4305992	25942	14783	13012	11929	11067	10295
THR31_0919_S01	61169449	57597257	29148083	26182053.72	125	embryonal rhabdomyosarcoma	1	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080,  http://dx.doi.org/10.1038/nature23306	dbGaP	phs000673	SRR4306008	26833	14976	13001	11796	10904	10095
THR31_0920_S01	73691184	70507635	43497445	39603401.96	125	acute lymphoblastic leukemia	9	Yes, age < 30 years	male	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080,  http://dx.doi.org/10.1038/nature23306	dbGaP	phs000673	SRR4306015	22948	12741	11442	10689	10131	9662
THR31_0921_S01	79153964	75080931	45836727.5	40844238.03	125	undifferentiated sarcoma NOS	13	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080,  http://dx.doi.org/10.1038/nature23306	dbGaP	phs000673	SRR4306019	28584	15853	13868	12733	11786	11041
THR31_0922_S01	53762007	51740414	35864306.5	30728859.44	110	acute lymphoblastic leukemia	12	Yes, age < 30 years	male	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080,  http://dx.doi.org/10.1038/nature23306	dbGaP	phs000673	SRR4306023	24943	14223	12562	11623	10895	10327
THR31_0923_S01	57727298	53900635	37452605	29496454.62	110	acute lymphoblastic leukemia	2	Yes, age < 30 years	male	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080,  http://dx.doi.org/10.1038/nature23306	dbGaP	phs000673	SRR4306027	23992	14152	12444	11460	10740	10150
THR31_0924_S01	72698033	69836451	44025736.5	36179561.63	125	lymphoma	20	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080,  http://dx.doi.org/10.1038/nature23306	dbGaP	phs000673	SRR4306033	29302	15503	13426	12206	11266	10504
THR31_0925_S01	65690921	62154992	31863295.5	26023450.32	101	neuroendocrine carcinoma	27	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080,  http://dx.doi.org/10.1038/nature23306	dbGaP	phs000673	SRR4306092	27416	14027	11449	9912	8735	7891
THR31_0926_S01	173897565	156545217	85765297	66304031.43	101	adrenocortical carcinoma	18	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080,  http://dx.doi.org/10.1038/nature23306	dbGaP	phs000673	SRR4306162	27752	14866	13104	12045	11221	10548
THR31_0927_S01	83597019	76549960	47015378.5	36232080	101	desmoplastic small round cell tumor	28	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080,  http://dx.doi.org/10.1038/nature23306	dbGaP	phs000673	SRR4306186	27778	16747	14649	13366	12467	11711
THR31_0928_S01	99221690	94404615	51797261	41502189.3	101	adrenocortical carcinoma	26	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080,  http://dx.doi.org/10.1038/nature23306	dbGaP	phs000673	SRR4306201	28032	15914	13839	12619	11687	10930
THR31_0929_S01	47707175	45773129	28079695	24590217.375	110	ovarian serous cystadenocarcinoma	26	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080,  http://dx.doi.org/10.1038/nature23306	dbGaP	phs000673	SRR4306587	27034	15150	13109	11913	11019	10250
THR31_0930_S01	72989040	70558694	31950864	30025626.715	100	hepatocellular carcinoma	19	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080,  http://dx.doi.org/10.1038/nature23306	dbGaP	phs000673	SRR4306641	23152	12440	10739	9534	8688	7920
THR31_0931_S01	75615930	73333674	48630962	43811236.875	100	desmoplastic small round cell tumor	22	Yes, age < 30 years	male	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080,  http://dx.doi.org/10.1038/nature23306	dbGaP	phs000673	SRR4306645	26770	15995	14174	13144	12374	11694
THR31_0932_S01	65926660	62778385	35642135.5	31033451.28	100	desmoplastic small round cell tumor	26	Yes, age < 30 years	male	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080,  http://dx.doi.org/10.1038/nature23306	dbGaP	phs000673	SRR4306669	28784	16517	14385	13053	12068	11260
THR31_0933_S01	69523673	67297782	35363259	32614560.765	100	fibrolamellar hepatocellular carcinoma	22	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080,  http://dx.doi.org/10.1038/nature23306	dbGaP	phs000673	SRR4306790	25580	14028	12215	11017	10061	9232
THR31_0934_S01	57424903	55056744	15031470	12892311.51	100	nasopharyngeal carcinoma	29	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080,  http://dx.doi.org/10.1038/nature23306	dbGaP	phs000673	SRR4306848	25211	14744	12296	10631	9429	8388
THR31_0935_S01	67951186	65545591	39037517.5	33172806.42	100	desmoplastic small round cell tumor	23	Yes, age < 30 years	male	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080,  http://dx.doi.org/10.1038/nature23306	dbGaP	phs000673	SRR4306880	27764	16812	14805	13636	12765	12011
THR31_0936_S01	60152651	58242556	35789094	33027174.725	110	undifferentiated spindle cell sarcoma	24	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080,  http://dx.doi.org/10.1038/nature23306	dbGaP	phs000673	SRR4307087	25868	14913	13328	12284	11479	10741
THR31_0937_S01	75560198	74731737	54626108	48610574.225	125	Ewing sarcoma	22	Yes, age < 30 years	male	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080,  http://dx.doi.org/10.1038/nature23306	dbGaP	phs000673	SRR4307317	27585	15647	13857	12824	12072	11466
THR31_0938_S01	62628024	61629437	38604982.5	36072065.985	125	hepatocellular carcinoma	20	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080,  http://dx.doi.org/10.1038/nature23306	dbGaP	phs000673	SRR4307349	26646	14623	12828	11575	10601	9744
THR31_0939_S01	60917691	58189471	30806121.5	24993550.53	101	undifferentiated sarcoma NOS	23	Yes, age < 30 years	female	White	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080,  http://dx.doi.org/10.1038/nature23306	dbGaP	phs000673	SRR4307665	25172	14400	12524	11376	10456	9667
THR31_0940_S01	70406473	69413678	50480966	44905210.2	125	ependymoma	25	Yes, age < 30 years	male	NA	NA	Cohort_6	phs000673.v2.p1	http://dx.doi.org/10.1001/jama.2015.10080,  http://dx.doi.org/10.1038/nature23306	dbGaP	phs000673	SRR4307868	27847	16474	14535	13462	12638	11990
THR31_1382_S01	100165782	90643331	13276797.5	9016494.425	101	osteosarcoma	57	No	male	White	NA	Cohort_6	phs000673.v2.p1	NA	dbGaP	phs000673	SRR4306146	23978	14155	11809	10251	9170	8311
THR31_1383_S01	87137727	82827693	47800618	35682212	101	rhabdomyosarcoma	31	No	female	Black/African American	NA	Cohort_6	phs000673.v2.p1	NA	dbGaP	phs000673	SRR4306150	28957	16665	14481	13134	12127	11275
THR31_1384_S01	95426872	87702916	22766395.5	18051611.785	101	Ewing sarcoma	40	No	male	White	NA	Cohort_6	phs000673.v2.p1	NA	dbGaP	phs000673	SRR4306220	26733	16576	14295	12893	11853	11035
THR31_1385_S01	68401437	63289143	32837484.5	22510856.205	101	gastrointestinal stromal tumor	49	No	male	White	NA	Cohort_6	phs000673.v2.p1	NA	dbGaP	phs000673	SRR4306304	37386	15990	13546	12181	11207	10449
THR31_1386_S01	65553287	62026324	41626184	37608475.125	101	synovial sarcoma	49	No	female	White	NA	Cohort_6	phs000673.v2.p1	NA	dbGaP	phs000673	SRR4306417	25787	15665	13956	12968	12178	11527
THR31_1387_S01	74280439	71901665	26535769	24735796.325	101	fibrolamellar hepatocellular carcinoma	35	No	female	White	NA	Cohort_6	phs000673.v2.p1	NA	dbGaP	phs000673	SRR4306425	24116	12986	10905	9569	8497	7650
THR31_1388_S01	62097443	57966422	38428146.5	35716506.26	101	gastrointestinal stromal tumor	72	No	female	Black/African American	NA	Cohort_6	phs000673.v2.p1	NA	dbGaP	phs000673	SRR4306438	23625	13674	12195	11308	10658	10092
THR31_1389_S01	43734516	42036645	23735851.5	21403867.125	110	gastrointestinal stromal tumor	34	No	male	White	NA	Cohort_6	phs000673.v2.p1	NA	dbGaP	phs000673	SRR4306599	25409	14531	12740	11595	10723	9982
THR31_1390_S01	63936675	60432781	18949563	15668592.19	100	embryonal rhabdomyosarcoma	35	No	female	White	NA	Cohort_6	phs000673.v2.p1	NA	dbGaP	phs000673	SRR4306840	25792	16449	14387	13084	12126	11273
THR31_1391_S01	74305996	71889459	40108113	36882579.39	100	gastrointestinal stromal tumor	61	No	female	White	NA	Cohort_6	phs000673.v2.p1	NA	dbGaP	phs000673	SRR4306953	26858	14972	13310	12277	11501	10857
THR31_1392_S01	46926335	45036758	29351935.5	27157486.3	125	synovial sarcoma	57	No	male	White	NA	Cohort_6	phs000673.v2.p1	NA	dbGaP	phs000673	SRR4307029	25143	15311	13637	12644	11890	11270
THR31_1393_S01	76302529	70930067	37464845	32751387.36	125	synovial sarcoma	57	No	female	White	NA	Cohort_6	phs000673.v2.p1	NA	dbGaP	phs000673	SRR4307134	26469	14984	13194	12138	11264	10571
THR31_1394_S01	67170078	65769133	44974955.5	38185459.65	125	rhabdomyosarcoma	55	No	male	White	NA	Cohort_6	phs000673.v2.p1	NA	dbGaP	phs000673	SRR4307392	28094	15684	13700	12502	11609	10908
THR32_0941_S01	109267570	107487509	72959504	67902686.305	101	supratentorial embryonal tumor NOS	3	Yes, age < 30 years	female	NA	NA	Cohort_31	EGAD00001001927	http://dx.doi.org/10.1016/j.cell.2016.01.015	EGA	EGAD00001001927	dkfz_CNS-PNET_15-0069, EGAN00001367410, GSM1881279	29750	15596	13662	12567	11745	11108
THR32_0942_S01	173143280	168221803	92086974	79268644.035	101	supratentorial embryonal tumor NOS	10	Yes, age < 30 years	male	NA	NA	Cohort_31	EGAD00001001927	http://dx.doi.org/10.1016/j.cell.2016.01.015	EGA	EGAD00001001927	dkfz_CNS-PNET_15-0095, EGAN00001367411, GSM1881248	30932	17148	15021	13691	12751	11949
THR32_0943_S01	173125237	168985028	117834081.5	101968004.6	101	supratentorial embryonal tumor NOS	2	Yes, age < 30 years	female	NA	NA	Cohort_31	EGAD00001001927	http://dx.doi.org/10.1016/j.cell.2016.01.015	EGA	EGAD00001001927	dkfz_CNS-PNET_15-0147, EGAN00001367412, GSM1881214	30812	16536	14575	13453	12700	12048
THR32_0944_S01	180146361	174736945	74733649.5	66831788.4	101	supratentorial embryonal tumor NOS	16	Yes, age < 30 years	male	NA	NA	Cohort_31	EGAD00001001927	http://dx.doi.org/10.1016/j.cell.2016.01.015	EGA	EGAD00001001927	dkfz_CNS-PNET_15-0184, EGAN00001367415, GSM1881234	29544	15645	13425	12079	11108	10304
THR32_0945_S01	185101902	180057170	126857775	108933425.25	101	supratentorial embryonal tumor NOS	2	Yes, age < 30 years	female	NA	NA	Cohort_31	EGAD00001001927	http://dx.doi.org/10.1016/j.cell.2016.01.015	EGA	EGAD00001001927	dkfz_CNS-PNET_15-0223, EGAN00001367416, GSM1881215	31677	16800	14803	13679	12913	12280
THR32_0946_S01	191249492	186083666	89180776	81467107.5	101	supratentorial embryonal tumor NOS	11	Yes, age < 30 years	male	NA	NA	Cohort_31	EGAD00001001927	http://dx.doi.org/10.1016/j.cell.2016.01.015	EGA	EGAD00001001927	dkfz_CNS-PNET_15-0224, EGAN00001367417, GSM1881235	28057	14162	12319	11244	10378	9625
THR32_0947_S01	183044969	178582913	103614822	89675824.875	101	Ewing sarcoma	16	Yes, age < 30 years	male	NA	NA	Cohort_31	EGAD00001001927	http://dx.doi.org/10.1016/j.cell.2016.01.015	EGA	EGAD00001001927	dkfz_CNS-PNET_15-0256, EGAN00001367419, GSM1881212	29045	15004	13196	12079	11294	10684
THR32_0948_S01	103772102	102138057	60329033.5	55603774.125	101	supratentorial embryonal tumor NOS	8	Yes, age < 30 years	female	NA	NA	Cohort_31	EGAD00001001927	http://dx.doi.org/10.1016/j.cell.2016.01.015	EGA	EGAD00001001927	dkfz_CNS-PNET_15-0280, EGAN00001367421, GSM1881227	27721	14461	12638	11469	10595	9844
THR32_0949_S01	181056479	176473321	106684412	97181620.475	101	supratentorial embryonal tumor NOS	2	Yes, age < 30 years	female	NA	NA	Cohort_31	EGAD00001001927	http://dx.doi.org/10.1016/j.cell.2016.01.015	EGA	EGAD00001001927	dkfz_CNS-PNET_15-0285, EGAN00001367422, GSM1881210	28983	14592	12755	11734	10937	10272
THR32_0950_S01	102153712	100477239	68984768	61940149.125	101	supratentorial embryonal tumor NOS	2	Yes, age < 30 years	male	NA	NA	Cohort_31	EGAD00001001927	http://dx.doi.org/10.1016/j.cell.2016.01.015	EGA	EGAD00001001927	dkfz_CNS-PNET_15-0289, EGAN00001367423, GSM1881273	29569	16157	14184	13100	12252	11575
THR32_0951_S01	167953669	162186400	104278426	94657972.64	101	supratentorial embryonal tumor NOS	3	Yes, age < 30 years	female	NA	NA	Cohort_31	EGAD00001001927	http://dx.doi.org/10.1016/j.cell.2016.01.015	EGA	EGAD00001001927	dkfz_CNS-PNET_15-0302, EGAN00001367424, GSM1881231	29323	15559	13859	12861	12157	11530
THR32_0952_S01	169670027	164845054	111163104.5	95009901.91	101	supratentorial embryonal tumor NOS	4	Yes, age < 30 years	female	NA	NA	Cohort_31	EGAD00001001927	http://dx.doi.org/10.1016/j.cell.2016.01.015	EGA	EGAD00001001927	dkfz_CNS-PNET_15-0319, EGAN00001367425, GSM1881225	30979	16502	14513	13368	12549	11839
THR32_0953_S01	202006465	196020867	135386134	125303606.15	101	ependymoma	5	Yes, age < 30 years	male	NA	NA	Cohort_31	EGAD00001001927	http://dx.doi.org/10.1016/j.cell.2016.01.015	EGA	EGAD00001001927	dkfz_EPN_15-0019, EGAN00001367426, GSM1881244	29158	15661	14079	13201	12507	11978
THR32_0954_S01	171109484	164604525	117451427	93109401.58	101	ependymoma	4	Yes, age < 30 years	female	NA	NA	Cohort_31	EGAD00001001927	http://dx.doi.org/10.1016/j.cell.2016.01.015	EGA	EGAD00001001927	dkfz_EPN_15-0027, EGAN00001367427, GSM1881111	32560	17768	15556	14325	13420	12727
THR32_0955_S01	104990662	103094241	69176601	63723171.19	101	ependymoma	15	Yes, age < 30 years	female	NA	NA	Cohort_31	EGAD00001001927	http://dx.doi.org/10.1016/j.cell.2016.01.015	EGA	EGAD00001001927	dkfz_EPN_15-0032, EGAN00001367428, GSM1881264	27971	15226	13360	12246	11457	10795
THR32_0956_S01	130829981	128622630	95167669.5	81539059.74	101	ependymoma	12	Yes, age < 30 years	male	NA	NA	Cohort_31	EGAD00001001927	http://dx.doi.org/10.1016/j.cell.2016.01.015	EGA	EGAD00001001927	dkfz_EPN_15-0034, EGAN00001367429, GSM1881275	29592	15563	13833	12878	12199	11614
THR32_0957_S01	192195061	186068337	137336627.5	120104210.94	101	embryonal tumor with multilayered rosettes	NA	Yes, age < 30 years	male	NA	NA	Cohort_31	EGAD00001001927	http://dx.doi.org/10.1016/j.cell.2016.01.015	EGA	EGAD00001001927	dkfz_ETMR_15-0011, EGAN00001367430, GSM1881271	29966	15861	14072	13103	12394	11815
THR32_0958_S01	200418754	193836980	82112306	59147336.535	51	glioblastoma multiforme	16	Yes, age < 30 years	female	NA	NA	Cohort_31	EGAD00001001927	http://dx.doi.org/10.1016/j.cell.2016.01.015	EGA	EGAD00001001927	dkfz_HGG_15-0001, EGAN00001367431, GSM1881134	30934	12016	9812	8208	6885	5861
THR32_0959_S01	215966812	173865854	115045547	81264271.05	51	glioblastoma multiforme	9	Yes, age < 30 years	male	NA	NA	Cohort_31	EGAD00001001927	http://dx.doi.org/10.1016/j.cell.2016.01.015	EGA	EGAD00001001927	dkfz_HGG_15-0008, EGAN00001367432, GSM1881133	32375	10860	7881	5915	4536	3602
THR32_0960_S01	138014837	135591358	102827322	89613340.78	101	glioblastoma multiforme	19	Yes, age < 30 years	female	NA	NA	Cohort_31	EGAD00001001927	http://dx.doi.org/10.1016/j.cell.2016.01.015	EGA	EGAD00001001927	dkfz_HGG_15-0010, EGAN00001367433, GSM1903584	31655	16526	14656	13633	12864	12219
THR32_0961_S01	186693666	180787834	120898281	66185805.56	51	medulloblastoma	2	Yes, age < 30 years	female	NA	NA	Cohort_31	EGAD00001001927	http://dx.doi.org/10.1016/j.cell.2016.01.015	EGA	EGAD00001001927	dkfz_MB_15-0047, EGAN00001367434, GSM1881255	31862	9993	6764	4816	3594	2780
THR32_0962_S01	186665169	173125926	61855790	47908065.04	51	medulloblastoma	2	Yes, age < 30 years	female	NA	NA	Cohort_31	EGAD00001001927	http://dx.doi.org/10.1016/j.cell.2016.01.015	EGA	EGAD00001001927	dkfz_MB_15-0048, EGAN00001367435, GSM1903770	27708	7841	4765	3225	2399	1875
THR33_0979_S01	293658372	228957583	60550045	45856167.72	51	medulloblastoma	39	No	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB101, EGAR00001544535,EGAR00001544538, SP107403	25981	4832	2315	1463	1058	849
THR33_0980_S01	302973846	247209229	91042046	66260627.27	51	medulloblastoma	23	Yes, age < 30 years	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB102, EGAR00001544539,EGAR00001544540, SP107404	27145	6244	3318	2108	1514	1178
THR33_0981_S01	279646750	186078001	59617073	43206276.96	51	medulloblastoma	35	No	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB104, EGAR00001544541,EGAR00001544542, SP107405	24238	3820	1807	1197	898	746
THR33_0982_S01	274263030	196177226	83231628	56038606.585	51	medulloblastoma	3	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB106, EGAR00001544543,EGAR00001544544, SP78931	27210	6154	3269	2080	1518	1183
THR33_0983_S01	293994449	203434205	100694336	55536743.535	51	medulloblastoma	15	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB107, EGAR00001544545,EGAR00001544546, SP78933	29903	6533	3382	2090	1501	1158
THR33_0984_S01	313751634	280045124	170278195	85112831.355	51	medulloblastoma	10	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB108, EGAR00001545124,EGAR00001545125, SP78935	31857	9084	5794	3912	2741	2070
THR33_0986_S01	293089764	243979582	35246045	24410836.34	51	medulloblastoma	4	Yes, age < 30 years	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB111, EGAR00001544549,EGAR00001544550, SP78939	29339	6663	3653	2372	1732	1353
THR33_0987_S01	323627009	273256085	138522675	85031625.15	51	medulloblastoma	7	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB112, EGAR00001544551,EGAR00001544552, SP78941	30588	8312	4891	3147	2237	1704
THR33_0989_S01	294738861	239224116	81435724	54218686.05	51	medulloblastoma	8	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB114, EGAR00001544555,EGAR00001544556, SP78945	28291	6640	3554	2194	1581	1209
THR33_0990_S01	549163266	512966855	302276225	169904107.3	51	medulloblastoma	16	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB115, EGAR00001544557,EGAR00001544558,EGAR00001544559, SP78947	34484	12247	9695	7957	6696	5689
THR33_0991_S01	328340436	267185856	138111248	84612187.205	51	medulloblastoma	13	Yes, age < 30 years	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB117, EGAR00001544560,EGAR00001544561, SP78949	30021	7817	4394	2717	1932	1485
THR33_0992_S01	300223006	244265999	110844522	71773332.75	51	medulloblastoma	11	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB118, EGAR00001544562,EGAR00001544563, SP78951	29127	6713	3508	2168	1511	1156
THR33_0993_S01	290523287	263200708	151869448	85769522.18	51	medulloblastoma	5	Yes, age < 30 years	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB119, EGAR00001544564,EGAR00001544565, SP78953	32341	9027	5645	3771	2637	1978
THR33_0994_S01	294352744	235501511	123617180	76718019.15	51	medulloblastoma	8	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB121, EGAR00001544569,EGAR00001544570, SP78955	28504	6609	3559	2235	1575	1204
THR33_0995_S01	268197401	231226903	149937329	84566424.215	51	medulloblastoma	11	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB122, EGAR00001544571,EGAR00001544572, SP78957	32268	10245	6983	4918	3668	2772
THR33_0996_S01	308476383	271908012	182606762	91141421.5	51	medulloblastoma	17	Yes, age < 30 years	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB124, EGAR00001544573,EGAR00001544574, SP78959	33406	10185	6754	4728	3422	2612
THR33_0997_S01	294471271	259391072	122979392	59608511.66	51	medulloblastoma	46	No	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB128, EGAR00001544575,EGAR00001544576, SP191886	30047	6607	3313	2040	1438	1113
THR33_0998_S01	314806313	256006699	94903981	65111027.62	51	medulloblastoma	16	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB129, EGAR00001544577,EGAR00001544578, SP79144	28229	5422	2603	1619	1173	930
THR33_1000_S01	316871227	270994009	116843875	81666547.295	51	medulloblastoma	7	Yes, age < 30 years	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB130, EGAR00001544579,EGAR00001544580, SP79146	28607	7255	3998	2576	1874	1476
THR33_1001_S01	282371311	206608116	80240143	57429885.04	51	medulloblastoma	5	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB131, EGAR00001544581,EGAR00001544582, SP79148	25598	5471	2924	1962	1492	1208
THR33_1002_S01	284971555	215570321	58340182	43802592.68	51	medulloblastoma	5	Yes, age < 30 years	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB132, EGAR00001544583,EGAR00001544584, SP79150	24670	4572	2191	1397	1039	840
THR33_1003_S01	301963647	238899971	39828706	31713218.68	51	medulloblastoma	3	Yes, age < 30 years	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB134, EGAR00001544585,EGAR00001544586, SP79066	24261	4955	2454	1571	1134	907
THR33_1004_S01	317715146	248212461	55424992	42335852.68	51	medulloblastoma	26	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB136, EGAR00001544587,EGAR00001544588, SP191894	25550	6124	3195	2011	1414	1119
THR33_1005_S01	294183937	210800976	53513906	36003159.765	51	medulloblastoma	10	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB137, EGAR00001544589,EGAR00001544590, SP79154	28945	4337	2013	1281	959	773
THR33_1006_S01	299111589	254242965	110522859	57283369.9	51	medulloblastoma	3	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB139, EGAR00001544591,EGAR00001544592, SP79160	29694	7307	4077	2588	1832	1406
THR33_1007_S01	343342059	304731330	169841278	96571501.845	51	medulloblastoma	27	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB140, EGAR00001544593,EGAR00001544594, SP191904	33811	9742	5948	3893	2742	2062
THR33_1008_S01	334061590	275263597	123588806	87618612.31	51	medulloblastoma	4	Yes, age < 30 years	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB141, EGAR00001544595,EGAR00001544596, SP79163	27446	6464	3448	2171	1544	1183
THR33_1009_S01	246010593	221586425	1751282	151040.54	51	medulloblastoma	7	Yes, age < 30 years	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB146, EGAR00001544597, SP107438	20	20	20	20	20	20
THR33_1010_S01	225639626	189298716	1050349	90194.79	51	medulloblastoma	NA	NA	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB148, EGAR00001544598, SP191923	14	14	14	14	14	14
THR33_1012_S01	196706838	151354117	638615	71831.895	51	medulloblastoma	4	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB164, EGAR00001544605, SP107453	13	13	13	13	13	13
THR33_1013_S01	208678073	188218719	2304382	156647.12	51	medulloblastoma	5	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB165, EGAR00001544606, SP107454	23	23	23	23	23	23
THR33_1014_S01	185839266	154363546	823519	87403.26	51	medulloblastoma	7	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB166, EGAR00001544607, SP107455	12	12	12	12	12	12
THR33_1015_S01	200677287	194383622	2612219	149497.53	51	medulloblastoma	9	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB168, EGAR00001544608, SP107457	29	29	29	29	29	29
THR33_1017_S01	203721674	184199899	2076219	136605.63	51	medulloblastoma	21	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB170, EGAR00001544609, SP107458	21	21	21	21	21	21
THR33_1018_S01	192826788	165752869	2967783	138563.18	51	medulloblastoma	16	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB174, EGAR00001544610, SP107460	28	28	28	28	28	28
THR33_1019_S01	194835254	166832164	2371377	139661.27	51	medulloblastoma	11	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB175, EGAR00001544611, SP107461	18	18	18	18	18	18
THR33_1021_S01	239397164	176573925	2177388	117071.29	51	medulloblastoma	6	Yes, age < 30 years	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB177, EGAR00001544613, SP107462	24	24	24	24	24	24
THR33_1022_S01	185644462	135966988	780139	79448.11	51	medulloblastoma	27	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB178, EGAR00001544614, SP107463	15	15	15	15	15	15
THR33_1023_S01	202683546	175848711	1175953	129813.74	51	medulloblastoma	24	Yes, age < 30 years	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB179, EGAR00001544615, SP191992	16	16	16	16	16	16
THR33_1024_S01	204245321	177755839	2548235	150164.42	51	medulloblastoma	26	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB180, EGAR00001544620, SP107464	26	26	26	26	26	26
THR33_1025_S01	196561419	172862613	2083674	138914.02	51	medulloblastoma	22	Yes, age < 30 years	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB181, EGAR00001544621, SP107466	23	23	23	23	23	23
THR33_1026_S01	240741640	197120276	4179040	156991.1	51	medulloblastoma	3	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB183, EGAR00001544622, SP107467	29	29	29	29	29	29
THR33_1027_S01	239576538	210961191	3516535	171549.49	51	medulloblastoma	12	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB184, EGAR00001544623, SP107468	24	24	24	24	24	24
THR33_1028_S01	217879312	177881016	1719244	137606.7	51	medulloblastoma	3	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB185, EGAR00001544624, SP107469	20	20	20	20	20	20
THR33_1029_S01	233029501	197577938	1618831	132877.71	51	medulloblastoma	3	Yes, age < 30 years	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB188, EGAR00001544625, SP107472	22	22	22	22	22	22
THR33_1031_S01	205536091	164096382	811654	77430.735	51	medulloblastoma	70	No	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB193, EGAR00001544628, SP192021	9	9	9	9	9	9
THR33_1032_S01	205290179	178356019	988779	108160.15	51	medulloblastoma	31	No	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB194, EGAR00001544629, SP192033	14	14	14	14	14	14
THR33_1033_S01	210511968	188057683	2315758	152908.42	51	medulloblastoma	8	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB198, EGAR00001544630, SP107477	22	22	22	22	22	22
THR33_1034_S01	208657479	181572758	1701838	148189.72	51	medulloblastoma	9	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB199, EGAR00001544631, SP107478	18	18	18	18	18	18
THR33_1037_S01	223804961	151129306	708050	56705.715	51	medulloblastoma	20	Yes, age < 30 years	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB204, EGAR00001544641, SP192039	9	9	9	9	9	9
THR33_1038_S01	231618169	203370973	2707590	169415.54	51	medulloblastoma	5	Yes, age < 30 years	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB205, EGAR00001544642, SP107479	26	26	26	26	26	26
THR33_1041_S01	223038978	207815224	3481055	174972.6	51	medulloblastoma	NA	NA	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB213, EGAR00001544645, SP192060	27	27	27	27	27	27
THR33_1043_S01	226835900	213913820	3033881	171616.005	51	medulloblastoma	9	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB224, EGAR00001544646, SP107545	27	27	27	27	27	27
THR33_1044_S01	225656739	200438233	2540309	138324.06	51	medulloblastoma	5	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB226, EGAR00001544647, SP107546	22	22	22	22	22	22
THR33_1045_S01	225751006	207123224	2309713	173302.22	51	medulloblastoma	4	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB227, EGAR00001544648, SP107547	26	26	26	26	26	26
THR33_1046_S01	220055249	205088345	3287241	176045.73	51	medulloblastoma	8	Yes, age < 30 years	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB228, EGAR00001544649, SP107548	29	29	29	29	29	29
THR33_1047_S01	212561134	200031508	2799817	163622.27	51	medulloblastoma	4	Yes, age < 30 years	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB230, EGAR00001544651, SP107549	31	31	31	31	31	31
THR33_1048_S01	178294341	158908488	2249371	144720.03	51	medulloblastoma	3	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB232, EGAR00001544652, SP107550	24	24	24	24	24	24
THR33_1049_S01	186230930	183583625	2029326	148249.5	51	medulloblastoma	9	Yes, age < 30 years	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB233, EGAR00001544653, SP107552	21	21	21	21	21	21
THR33_1050_S01	205194413	185402725	1718950	160700.89	51	medulloblastoma	27	Yes, age < 30 years	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB234, EGAR00001544654, SP192086	19	19	19	19	19	19
THR33_1051_S01	199304200	175456585	1249143	139022.31	51	medulloblastoma	2	Yes, age < 30 years	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB235, EGAR00001544655, SP107553	19	19	19	19	19	19
THR33_1052_S01	219060476	203244847	2725021	164197.04	51	medulloblastoma	18	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB236, EGAR00001544656, SP107554	21	21	21	21	21	21
THR33_1053_S01	210750134	185186378	2083841	169745.31	51	medulloblastoma	11	Yes, age < 30 years	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB237, EGAR00001544657, SP107555	21	21	21	21	21	21
THR33_1054_S01	190965321	188557704	1218893	110045.18	51	medulloblastoma	28	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB239, EGAR00001544658, SP192089	18	18	18	18	18	18
THR33_1056_S01	215331412	196814219	2412861	175689.99	51	medulloblastoma	4	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB241, EGAR00001544661, SP192097	24	24	24	24	24	24
THR33_1057_S01	214174905	196209322	2892838	179242.965	51	medulloblastoma	10	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB243, EGAR00001544662, SP192105	30	30	30	30	30	30
THR33_1058_S01	198712214	196002041	1354314	127579.34	51	medulloblastoma	3	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB244, EGAR00001544663, SP192108	16	16	16	16	16	16
THR33_1059_S01	193464245	189980479	1501648	105145.67	51	medulloblastoma	25	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB246, EGAR00001544664, SP192111	18	18	18	18	18	18
THR33_1060_S01	214669941	196340018	3748998	157545.78	51	medulloblastoma	10	Yes, age < 30 years	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB247, EGAR00001544665, SP107556	33	33	33	33	33	33
THR33_1061_S01	211235231	171590897	1175129	121891.91	51	medulloblastoma	4	Yes, age < 30 years	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB248, EGAR00001544666, SP192114	20	20	20	20	20	20
THR33_1063_S01	194363274	190324528	2071175	135732.45	51	medulloblastoma	7	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB250, EGAR00001544667, SP192121	20	20	20	20	20	20
THR33_1064_S01	226470259	219910044	2720743	136557.61	51	medulloblastoma	5	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB260, EGAR00001544670, SP192129	20	20	20	20	20	20
THR33_1065_S01	200347012	185412744	4504062	135842.355	51	medulloblastoma	45	No	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB262, EGAR00001544671, SP192136	30	30	30	30	30	30
THR33_1066_S01	208744153	204081750	3460141	162877.275	51	medulloblastoma	5	Yes, age < 30 years	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB264, EGAR00001544672, SP192141	40	40	40	40	40	40
THR33_1067_S01	204265261	192119138	3904841	149875.11	51	medulloblastoma	9	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB265, EGAR00001544673, SP192144	35	35	35	35	35	35
THR33_1068_S01	225202008	220258253	3260471	138057.975	51	medulloblastoma	1	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB266, EGAR00001544674, SP192148	26	26	26	26	26	26
THR33_1069_S01	203987641	192569669	3446034	142432.785	51	medulloblastoma	3	Yes, age < 30 years	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB268, EGAR00001544675, SP192156	28	28	28	28	28	28
THR33_1070_S01	201765642	193898734	1856866	154980.14	51	medulloblastoma	9	Yes, age < 30 years	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB269, EGAR00001544676, SP192163	18	18	18	18	18	18
THR33_1072_S01	201393642	183782426	4506573	135197.37	51	medulloblastoma	5	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB270, EGAR00001544677, SP192167	32	32	32	32	32	32
THR33_1073_S01	201885608	195384574	2711334	145681.9	51	medulloblastoma	3	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB271, EGAR00001544678, SP192171	27	27	27	27	27	27
THR33_1074_S01	219875629	214715304	3690073	159666.705	51	medulloblastoma	2	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB274, EGAR00001544679, SP192182	19	19	19	19	19	19
THR33_1075_S01	207067031	201759480	1040675	127050.63	51	medulloblastoma	3	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB275, EGAR00001544680, SP192190	12	12	12	12	12	12
THR33_1076_S01	209051983	204002623	1393668	131991.79	51	medulloblastoma	11	Yes, age < 30 years	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB276, EGAR00001544681, SP192193	21	21	21	21	21	21
THR33_1077_S01	218512376	209656061	4310917	152510.985	51	medulloblastoma	4	Yes, age < 30 years	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB277, EGAR00001544682, SP192198	36	36	36	36	36	36
THR33_1078_S01	201882188	188104785	4781281	155049.84	51	medulloblastoma	8	Yes, age < 30 years	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB278, EGAR00001544683, SP192205	37	37	37	37	37	37
THR33_1079_S01	212394825	207712176	2455932	160317.63	51	medulloblastoma	14	Yes, age < 30 years	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB280, EGAR00001544686, SP192221	20	20	20	20	20	20
THR33_1080_S01	206991219	203311129	2668267	154061.82	51	medulloblastoma	12	Yes, age < 30 years	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB281, EGAR00001544687, SP192226	28	28	28	28	28	28
THR33_1081_S01	202419825	198437306	3044528	145492.875	51	medulloblastoma	29	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB284, EGAR00001544688, SP192235	24	24	24	24	24	24
THR33_1082_S01	215371346	210158196	3305661	164282.58	51	medulloblastoma	7	Yes, age < 30 years	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB286, EGAR00001544689, SP192241	28	28	28	28	28	28
THR33_1083_S01	223841268	219375318	1888000	144020.8	51	medulloblastoma	2	Yes, age < 30 years	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB287, EGAR00001544690, SP192244	21	21	21	21	21	21
THR33_1084_S01	205344053	200250414	1961734	154119.21	51	medulloblastoma	6	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB288, EGAR00001544691, SP192247	19	19	19	19	19	19
THR33_1085_S01	199773215	191326924	2895431	140440.41	51	medulloblastoma	8	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB289, EGAR00001544692, SP192251	23	23	23	23	23	23
THR33_1087_S01	235468068	230340130	2122588	134013.53	51	medulloblastoma	29	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB290, EGAR00001544693, SP192253	17	17	17	17	17	17
THR33_1088_S01	240529003	214564315	2872442	138424.275	51	medulloblastoma	7	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB291, EGAR00001544694, SP192255	23	23	23	23	23	23
THR33_1089_S01	236340476	228303407	2363618	151632.855	51	medulloblastoma	4	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB292, EGAR00001544695, SP192258	18	18	18	18	18	18
THR33_1090_S01	242436944	234894133	2839894	165156.75	51	medulloblastoma	28	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB293, EGAR00001544696, SP192270	24	24	24	24	24	24
THR33_1091_S01	247618832	241300496	4214694	186506.1	51	medulloblastoma	4	Yes, age < 30 years	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB294, EGAR00001544697, SP192275	29	29	29	29	29	29
THR33_1092_S01	226789677	219962931	3823319	153560.12	51	medulloblastoma	2	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB295, EGAR00001544698, SP192279	29	29	29	29	29	29
THR33_1093_S01	241287664	232207125	3865253	160049.835	51	medulloblastoma	5	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB296, EGAR00001544699, SP192282	31	31	31	31	31	31
THR33_1094_S01	194868291	186453496	3348461	145919.565	51	medulloblastoma	10	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB297, EGAR00001544700, SP192284	23	23	23	23	23	23
THR33_1095_S01	193249368	187634486	2993553	148627.71	51	medulloblastoma	8	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB299, EGAR00001544701, SP192287	25	25	25	25	25	25
THR33_1097_S01	198984009	194851976	2947235	150649.29	51	medulloblastoma	7	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB302, EGAR00001544703, SP192291	25	25	25	25	25	25
THR33_1098_S01	198601055	193938970	2325200	140049.36	51	medulloblastoma	9	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB303, EGAR00001544704, SP192295	27	27	27	27	27	27
THR33_1099_S01	193565330	189398096	2474749	135356.265	51	medulloblastoma	8	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB304, EGAR00001544705, SP192298	24	24	24	24	24	24
THR33_1108_S01	193249368	187634486	2993553	148627.71	51	medulloblastoma	16	Yes, age < 30 years	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB3, EGAR00001544702, SP78661	25	25	25	25	25	25
THR33_1115_S01	252995049	212500538	87392686	66204014.595	51	medulloblastoma	20	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB53, EGAR00001544764,EGAR00001544765, SP107356	27074	5950	3145	2097	1565	1248
THR33_1116_S01	364591970	332170015	189483897	122317962.75	51	medulloblastoma	31	No	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB54, EGAR00001544766,EGAR00001544767, SP192314	37370	11334	8521	6634	5240	4294
THR33_1117_S01	316036057	282783426	143085491	101823734.1	51	medulloblastoma	42	No	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB56, EGAR00001544768,EGAR00001544769, SP107357	40068	9689	6691	4869	3753	3005
THR33_1119_S01	300833079	271492236	117578096	87517529.67	51	medulloblastoma	19	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB58, EGAR00001544772,EGAR00001544773, SP78804	33260	10655	7918	6037	4729	3790
THR33_1120_S01	342693128	318252832	170536793	111525110.515	51	medulloblastoma	32	No	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB59, EGAR00001544774,EGAR00001544775, SP107359	31171	9924	6656	4716	3521	2746
THR33_1122_S01	305418153	251777818	105592963	88613359.755	51	medulloblastoma	23	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB60, EGAR00001544779,EGAR00001544780, SP107360	25668	6743	3902	2605	1943	1555
THR33_1123_S01	347268906	310645673	165873514	122478078.465	51	medulloblastoma	28	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB61, EGAR00001544781,EGAR00001544782, SP107361	32084	10660	7793	5923	4686	3847
THR33_1124_S01	323471035	307109951	113577847	83273778.28	51	medulloblastoma	50	No	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB62, EGAR00001544783,EGAR00001544784, SP192318	27475	5697	3125	2088	1528	1243
THR33_1125_S01	445154764	309051950	68999046	37025472.68	51	medulloblastoma	27	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB63, EGAR00001544785,EGAR00001544786,EGAR00001544787, SP107362	33727	12400	9279	7121	5574	4547
THR33_1127_S01	306507082	270300450	148001232	112550840.91	51	medulloblastoma	18	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB65, EGAR00001544790,EGAR00001544791, SP78807	30087	8421	5207	3550	2610	2033
THR33_1128_S01	308960824	272565080	151163131	118979322.88	51	medulloblastoma	22	Yes, age < 30 years	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB68, EGAR00001544792,EGAR00001544793, SP107367	28808	7685	4509	3033	2215	1750
THR33_1130_S01	296940096	264743617	167280036	123394080.705	51	medulloblastoma	28	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB70, EGAR00001544796,EGAR00001544797, SP78809	29931	8784	5812	4161	3073	2408
THR33_1131_S01	311343874	280357463	186385416	137430231.99	51	medulloblastoma	20	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB71, EGAR00001544798,EGAR00001544799, SP78811	31635	10374	7465	5584	4278	3410
THR33_1134_S01	272119493	233782813	107921058	58394694.02	51	medulloblastoma	12	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB84, EGAR00001544804,EGAR00001544805, SP78814	32682	8041	4543	2850	1997	1519
THR33_1135_S01	282325047	256974539	105323124	60484126.26	51	medulloblastoma	5	Yes, age < 30 years	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB85, EGAR00001544806,EGAR00001544807, SP78815	31525	9359	6184	4259	3051	2323
THR33_1136_S01	274125795	154016897	51441876	37038742.65	51	medulloblastoma	4	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB86, EGAR00001544808,EGAR00001544809, SP78816	28997	7374	4236	2715	1955	1495
THR33_1137_S01	277711658	186883978	41227817	29732097.835	51	medulloblastoma	2	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB88, EGAR00001544810,EGAR00001544811, SP78817	25348	4274	2094	1374	1047	862
THR33_1139_S01	311343874	280357463	186385416	137430231.99	51	medulloblastoma	11	Yes, age < 30 years	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB8, EGAR00001544800,EGAR00001544801, SP78665	31635	10374	7465	5584	4278	3410
THR33_1142_S01	272507271	235925294	93892422	56765261.735	51	medulloblastoma	10	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB92, EGAR00001544820,EGAR00001544821, SP78821	31355	8372	5013	3243	2246	1709
THR33_1143_S01	273356739	254107893	156269825	71831637.6	51	medulloblastoma	15	Yes, age < 30 years	female	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB94, EGAR00001544822,EGAR00001544823, SP78822	32865	9680	6441	4454	3235	2501
THR33_1145_S01	272354052	186066865	74324365	47846792.25	51	medulloblastoma	3	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB96, EGAR00001544826,EGAR00001544827, SP78824	27137	6174	3233	2033	1463	1132
THR33_1146_S01	315529816	281376415	92471154	66529821.12	51	medulloblastoma	8	Yes, age < 30 years	male	NA	NA	Cohort_4	EGAD00001003279	http://dx.doi.org/10.1038/nature22973	EGA	EGAD00001003279	ICGC_MB98, EGAR00001544828,EGAR00001544829, SP78825	27864	7575	4519	2960	2136	1673
THR37_1294_S01	58628548	56875477	34021740	29326820.7	125	ependymoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_35	SRP092501	http://dx.doi.org/10.1126/scitranslmed.aah6904	SRA	SRP092501	SRS1778820, GSM2372319	34730	19098	15189	12995	11798	10869
THR37_1295_S01	99409780	96852978	49687994.5	47454430.905	125	ependymoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_35	SRP092501	http://dx.doi.org/10.1126/scitranslmed.aah6904	SRA	SRP092501	SRS1778818, GSM2372320	26348	14842	13352	12327	11557	10923
THR37_1296_S01	27380161	26827406	20129958.5	18942390.4	125	ependymoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_35	SRP092501	http://dx.doi.org/10.1126/scitranslmed.aah6904	SRA	SRP092501	SRS1778819, GSM2372321	23065	15710	14212	13343	12704	12157
THR37_1297_S01	26726954	25980782	18131582.5	17028382.15	125	ependymoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_35	SRP092501	http://dx.doi.org/10.1126/scitranslmed.aah6904	SRA	SRP092501	SRS1778821, GSM2372322	23449	14905	13435	12514	11766	11139
THR37_1298_S01	11943959	11519275	8043838	6595569.36	125	ependymoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_35	SRP092501	http://dx.doi.org/10.1126/scitranslmed.aah6904	SRA	SRP092501	SRS1778823, GSM2372323	30986	21391	17593	15116	13307	11894
THR37_1299_S01	25335863	24670030	18479362	17370789.975	125	ependymoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_35	SRP092501	http://dx.doi.org/10.1126/scitranslmed.aah6904	SRA	SRP092501	SRS1778822, GSM2372324	22470	14235	12689	11703	10935	10285
THR37_1300_S01	12932094	12473856	8195036.5	7693933.12	125	ependymoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_35	SRP092501	http://dx.doi.org/10.1126/scitranslmed.aah6904	SRA	SRP092501	SRS1778824, GSM2372325	20307	12977	11133	9869	8913	8106
THR37_1301_S01	26261569	25352543	18364645	17445422.61	125	ependymoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_35	SRP092501	http://dx.doi.org/10.1126/scitranslmed.aah6904	SRA	SRP092501	SRS1778826, GSM2372326	22503	14375	12941	11942	11145	10503
THR37_1302_S01	27073007	26589068	21283757.5	19924824.64	125	ependymoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_35	SRP092501	http://dx.doi.org/10.1126/scitranslmed.aah6904	SRA	SRP092501	SRS1778825, GSM2372327	23328	15788	14329	13456	12791	12265
THR37_1303_S01	24301896	23270037	16642095	15585874.29	125	ependymoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_35	SRP092501	http://dx.doi.org/10.1126/scitranslmed.aah6904	SRA	SRP092501	SRS1778827, GSM2372328	22071	13876	12312	11305	10422	9734
THR37_1304_S01	25715320	25278295	20226287	19166213.12	125	ependymoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_35	SRP092501	http://dx.doi.org/10.1126/scitranslmed.aah6904	SRA	SRP092501	SRS1778828, GSM2372329	23166	15961	14515	13635	12927	12383
THR37_1305_S01	21493375	19626307	12922079.5	11802781.62	125	ependymoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_35	SRP092501	http://dx.doi.org/10.1126/scitranslmed.aah6904	SRA	SRP092501	SRS1778829, GSM2372330	21660	11166	9100	7743	6775	5982
THR37_1306_S01	25205117	22793003	14720768.5	13832680.05	125	ependymoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_35	SRP092501	http://dx.doi.org/10.1126/scitranslmed.aah6904	SRA	SRP092501	SRS1778830, GSM2372331	21521	10903	8799	7452	6502	5730
THR37_1307_S01	26174137	25718874	20689133.5	19617452.8	125	ependymoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_35	SRP092501	http://dx.doi.org/10.1126/scitranslmed.aah6904	SRA	SRP092501	SRS1778831, GSM2372332	22075	15305	14010	13228	12655	12149
THR37_1308_S01	61776510	52226590	15513806.5	13977050.01	110	ependymoma	NA	Yes, age < 30 years	NA	NA	NA	Cohort_35	SRP092501	http://dx.doi.org/10.1126/scitranslmed.aah6904	SRA	SRP092501	SRS1778832, GSM2372333	24287	6481	4147	3027	2386	1987
THR39_1360_S01	88067091	84675966	44291008	39191080.125	101	synovial sarcoma	NA	NA	NA	NA	NA	Cohort_33	SRP126664	http://dx.doi.org/10.1016/j.ccell.2018.05.002	SRA	SRP126664	SRS2755847,GSM2887701	27273	16041	14186	13138	12330	11728
THR39_1361_S01	91209969	87182978	45613759	40029004.3	101	synovial sarcoma	NA	NA	NA	NA	NA	Cohort_33	SRP126664	http://dx.doi.org/10.1016/j.ccell.2018.05.002	SRA	SRP126664	SRS2755849,GSM2887703	29046	17129	15065	13862	13057	12352
THR39_1362_S01	89971134	87276998	65224932.5	56370166.34	101	synovial sarcoma	NA	NA	NA	NA	NA	Cohort_33	SRP126664	http://dx.doi.org/10.1016/j.ccell.2018.05.002	SRA	SRP126664	SRS2755850,GSM2887705	31042	18275	16073	14838	13937	13220
THR39_1363_S01	92232640	88508407	41230491.5	36129284.625	101	synovial sarcoma	NA	NA	NA	NA	NA	Cohort_33	SRP126664	http://dx.doi.org/10.1016/j.ccell.2018.05.002	SRA	SRP126664	SRS2755852,GSM2887702	26466	15199	13376	12370	11670	11081
THR39_1364_S01	79936177	76510281	17766441	15337854.5	101	synovial sarcoma	NA	NA	NA	NA	NA	Cohort_33	SRP126664	http://dx.doi.org/10.1016/j.ccell.2018.05.002	SRA	SRP126664	SRS2755853,GSM2887707	24865	16431	14433	13298	12569	11897
THR39_1365_S01	66158817	63003535	43073047	37853740.28	101	synovial sarcoma	NA	NA	NA	NA	NA	Cohort_33	SRP126664	http://dx.doi.org/10.1016/j.ccell.2018.05.002	SRA	SRP126664	SRS2755854,GSM2887704	28883	17657	15488	14265	13433	12778
THR39_1366_S01	84264294	81280134	21370599.5	18725179.875	101	synovial sarcoma	NA	NA	NA	NA	NA	Cohort_33	SRP126664	http://dx.doi.org/10.1016/j.ccell.2018.05.002	SRA	SRP126664	SRS2755855,GSM2887710	25315	16775	14842	13734	12986	12370
THR39_1367_S01	79545682	76847770	42273291.5	38452998	101	synovial sarcoma	NA	NA	NA	NA	NA	Cohort_33	SRP126664	http://dx.doi.org/10.1016/j.ccell.2018.05.002	SRA	SRP126664	SRS2755856,GSM2887713	26737	15923	14143	13104	12377	11773
THR39_1368_S01	84894398	80328013	35470789	30058924.54	101	synovial sarcoma	NA	NA	NA	NA	NA	Cohort_33	SRP126664	http://dx.doi.org/10.1016/j.ccell.2018.05.002	SRA	SRP126664	SRS2755858,GSM2887712	26788	16619	14637	13501	12721	12126
THR39_1369_S01	82883280	78623893	35469790.5	30587526.96	101	synovial sarcoma	NA	NA	NA	NA	NA	Cohort_33	SRP126664	http://dx.doi.org/10.1016/j.ccell.2018.05.002	SRA	SRP126664	SRS2755860,GSM2887715	27402	16496	14471	13309	12505	11881
THR39_1370_S01	82940537	78675842	38001119	32804722.46	101	synovial sarcoma	NA	NA	NA	NA	NA	Cohort_33	SRP126664	http://dx.doi.org/10.1016/j.ccell.2018.05.002	SRA	SRP126664	SRS2755861,GSM2887716	26780	16204	14271	13218	12467	11829
THR39_1371_S01	79793673	76354490	35412758	30512631.765	101	synovial sarcoma	NA	NA	NA	NA	NA	Cohort_33	SRP126664	http://dx.doi.org/10.1016/j.ccell.2018.05.002	SRA	SRP126664	SRS2755862,GSM2887718	27554	16968	14908	13753	12934	12293
THR39_1372_S01	73935276	70701435	35960105.5	30647644.72	101	synovial sarcoma	NA	NA	NA	NA	NA	Cohort_33	SRP126664	http://dx.doi.org/10.1016/j.ccell.2018.05.002	SRA	SRP126664	SRS2755863,GSM2887717	27926	17624	15496	14269	13353	12692
THR39_1373_S01	76330024	72767978	41481298	35556236.1	101	synovial sarcoma	NA	NA	NA	NA	NA	Cohort_33	SRP126664	http://dx.doi.org/10.1016/j.ccell.2018.05.002	SRA	SRP126664	SRS2755865,GSM2887709	28680	17270	15075	13873	13032	12353
THR39_1374_S01	90843749	87823034	54812930	47608302.75	101	synovial sarcoma	NA	NA	NA	NA	NA	Cohort_33	SRP126664	http://dx.doi.org/10.1016/j.ccell.2018.05.002	SRA	SRP126664	SRS2755873,GSM2887714	27145	15424	13560	12582	11830	11275
THR39_1375_S01	81256432	78636367	55471593	48238347.22	101	synovial sarcoma	NA	NA	NA	NA	NA	Cohort_33	SRP126664	http://dx.doi.org/10.1016/j.ccell.2018.05.002	SRA	SRP126664	SRS2755874,GSM2887706	29712	18071	15856	14641	13777	13087
THR39_1376_S01	72148516	69228728	44306141	37157001.54	101	synovial sarcoma	NA	NA	NA	NA	NA	Cohort_33	SRP126664	http://dx.doi.org/10.1016/j.ccell.2018.05.002	SRA	SRP126664	SRS2755875,GSM2887719	27548	16228	14234	13080	12280	11680
THR39_1377_S01	85388119	82318830	29986032	25909554.06	101	synovial sarcoma	NA	NA	NA	NA	NA	Cohort_33	SRP126664	http://dx.doi.org/10.1016/j.ccell.2018.05.002	SRA	SRP126664	SRS2755877,GSM2887711	27603	17528	15438	14235	13421	12749
THR39_1378_S01	77982628	71020423	12978045.5	10226627.95	101	synovial sarcoma	NA	NA	NA	NA	NA	Cohort_33	SRP126664	http://dx.doi.org/10.1016/j.ccell.2018.05.002	SRA	SRP126664	SRS2755879,GSM2887708	24709	13847	11395	9781	8559	7634
